{
  "document_name": "E3_Guideline.pdf",
  "model": "prebuilt-layout",
  "pages": [
    {
      "page_number": 1,
      "width": 8.2639,
      "height": 11.6944,
      "unit": "inch",
      "blocks": [
        {
          "block_id": "p1_line_0",
          "block_type": "paragraph",
          "text": "INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL",
          "bbox": [
            1.1629,
            1.0127,
            7.2865,
            1.1792
          ]
        },
        {
          "block_id": "p1_line_1",
          "block_type": "paragraph",
          "text": "REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN",
          "bbox": [
            1.1633,
            1.1959,
            7.2888,
            1.3657
          ]
        },
        {
          "block_id": "p1_line_2",
          "block_type": "paragraph",
          "text": "USE",
          "bbox": [
            1.1717,
            1.387,
            1.5183,
            1.5394
          ]
        },
        {
          "block_id": "p1_line_3",
          "block_type": "paragraph",
          "text": "ICH HARMONISED TRIPARTITE GUIDELINE",
          "bbox": [
            2.5419,
            2.3114,
            5.9087,
            2.4853
          ]
        },
        {
          "block_id": "p1_line_4",
          "block_type": "paragraph",
          "text": "STRUCTURE AND CONTENT OF CLINICAL STUDY REPORTS",
          "bbox": [
            1.6445,
            3.1792,
            6.8063,
            3.3789
          ]
        },
        {
          "block_id": "p1_line_5",
          "block_type": "paragraph",
          "text": "E3",
          "bbox": [
            4.0899,
            3.4564,
            4.3584,
            3.64
          ]
        },
        {
          "block_id": "p1_line_6",
          "block_type": "paragraph",
          "text": "Current Step 4 version",
          "bbox": [
            3.4211,
            4.3352,
            5.0388,
            4.5124
          ]
        },
        {
          "block_id": "p1_line_7",
          "block_type": "paragraph",
          "text": "dated 30 November 1995",
          "bbox": [
            3.3449,
            4.5976,
            5.1131,
            4.7661
          ]
        },
        {
          "block_id": "p1_line_8",
          "block_type": "paragraph",
          "text": "This Guideline has been developed by the appropriate ICH Expert Working Group and",
          "bbox": [
            1.1752,
            5.7828,
            7.296,
            5.9786
          ]
        },
        {
          "block_id": "p1_line_9",
          "block_type": "paragraph",
          "text": "has been subject to consultation by the regulatory parties, in accordance with the ICH",
          "bbox": [
            1.1688,
            5.9696,
            7.2982,
            6.1608
          ]
        },
        {
          "block_id": "p1_line_10",
          "block_type": "paragraph",
          "text": "Process. At Step 4 of the Process the final draft is recommended for adoption to the",
          "bbox": [
            1.1714,
            6.1532,
            7.2917,
            6.3402
          ]
        },
        {
          "block_id": "p1_line_11",
          "block_type": "paragraph",
          "text": "regulatory bodies of the European Union, Japan and USA.",
          "bbox": [
            1.1639,
            6.344,
            5.2882,
            6.5306
          ]
        }
      ]
    },
    {
      "page_number": 2,
      "width": 8.2639,
      "height": 11.6944,
      "unit": "inch",
      "blocks": [
        {
          "block_id": "p2_line_0",
          "block_type": "paragraph",
          "text": "E3",
          "bbox": [
            3.5772,
            1.0056,
            3.7884,
            1.1531
          ]
        },
        {
          "block_id": "p2_line_1",
          "block_type": "paragraph",
          "text": "Document History",
          "bbox": [
            2.9459,
            1.182,
            4.4181,
            1.3618
          ]
        },
        {
          "block_id": "p2_line_2",
          "block_type": "paragraph",
          "text": "First",
          "bbox": [
            1.1394,
            1.9816,
            1.471,
            2.1193
          ]
        },
        {
          "block_id": "p2_line_3",
          "block_type": "paragraph",
          "text": "Codification",
          "bbox": [
            0.9182,
            2.1426,
            1.7006,
            2.2936
          ]
        },
        {
          "block_id": "p2_line_4",
          "block_type": "paragraph",
          "text": "History",
          "bbox": [
            3.3636,
            2.0589,
            3.8657,
            2.2166
          ]
        },
        {
          "block_id": "p2_line_5",
          "block_type": "paragraph",
          "text": "Date",
          "bbox": [
            5.7015,
            2.0625,
            6.0308,
            2.201
          ]
        },
        {
          "block_id": "p2_line_6",
          "block_type": "paragraph",
          "text": "New",
          "bbox": [
            6.631,
            1.8339,
            6.9369,
            1.97
          ]
        },
        {
          "block_id": "p2_line_7",
          "block_type": "paragraph",
          "text": "Codification",
          "bbox": [
            6.3986,
            1.9952,
            7.1808,
            2.145
          ]
        },
        {
          "block_id": "p2_line_8",
          "block_type": "paragraph",
          "text": "November",
          "bbox": [
            6.404,
            2.2458,
            7.164,
            2.3968
          ]
        },
        {
          "block_id": "p2_line_9",
          "block_type": "paragraph",
          "text": "2005",
          "bbox": [
            6.6232,
            2.4258,
            6.9446,
            2.5592
          ]
        },
        {
          "block_id": "p2_line_10",
          "block_type": "paragraph",
          "text": "E3",
          "bbox": [
            1.2165,
            2.7009,
            1.3991,
            2.8372
          ]
        },
        {
          "block_id": "p2_line_11",
          "block_type": "paragraph",
          "text": "Approval by the Steering Committee under Step 2",
          "bbox": [
            1.8732,
            2.6967,
            5.362,
            2.8714
          ]
        },
        {
          "block_id": "p2_line_12",
          "block_type": "paragraph",
          "text": "and release for public consultation.",
          "bbox": [
            1.8711,
            2.8695,
            4.1413,
            3.0313
          ]
        },
        {
          "block_id": "p2_line_13",
          "block_type": "paragraph",
          "text": "29",
          "bbox": [
            5.7846,
            2.7049,
            5.9476,
            2.836
          ]
        },
        {
          "block_id": "p2_line_14",
          "block_type": "paragraph",
          "text": "March",
          "bbox": [
            5.6473,
            2.8648,
            6.0804,
            3.0076
          ]
        },
        {
          "block_id": "p2_line_15",
          "block_type": "paragraph",
          "text": "1995",
          "bbox": [
            5.7166,
            3.0421,
            6.0255,
            3.1757
          ]
        },
        {
          "block_id": "p2_line_16",
          "block_type": "paragraph",
          "text": "E3",
          "bbox": [
            6.6947,
            2.7009,
            6.878,
            2.8353
          ]
        },
        {
          "block_id": "p2_line_17",
          "block_type": "paragraph",
          "text": "Current Step 4 version",
          "bbox": [
            2.8308,
            3.4152,
            4.6308,
            3.5951
          ]
        },
        {
          "block_id": "p2_line_18",
          "block_type": "paragraph",
          "text": "E3",
          "bbox": [
            1.1718,
            3.746,
            1.3586,
            3.884
          ]
        },
        {
          "block_id": "p2_line_19",
          "block_type": "paragraph",
          "text": "Approval by the Steering Committee under Step 4 and",
          "bbox": [
            1.7902,
            3.7345,
            5.4005,
            3.913
          ]
        },
        {
          "block_id": "p2_line_20",
          "block_type": "paragraph",
          "text": "recommendation for adoption to the three ICH",
          "bbox": [
            1.7861,
            3.9076,
            5.3997,
            4.0771
          ]
        },
        {
          "block_id": "p2_line_21",
          "block_type": "paragraph",
          "text": "regulatory bodies.",
          "bbox": [
            1.7866,
            4.0829,
            2.9583,
            4.245
          ]
        },
        {
          "block_id": "p2_line_22",
          "block_type": "paragraph",
          "text": "30",
          "bbox": [
            5.8052,
            3.7482,
            5.9667,
            3.8823
          ]
        },
        {
          "block_id": "p2_line_23",
          "block_type": "paragraph",
          "text": "November",
          "bbox": [
            5.5441,
            3.9087,
            6.2241,
            4.0572
          ]
        },
        {
          "block_id": "p2_line_24",
          "block_type": "paragraph",
          "text": "1995",
          "bbox": [
            5.7334,
            4.0857,
            6.0443,
            4.2206
          ]
        },
        {
          "block_id": "p2_line_25",
          "block_type": "paragraph",
          "text": "E3",
          "bbox": [
            6.6881,
            3.7455,
            6.8751,
            3.8812
          ]
        },
        {
          "block_id": "table_0",
          "block_type": "table",
          "page_number": 2,
          "bbox": [
            0.7968,
            1.752,
            7.2751,
            4.3245
          ],
          "headers": [
            "First Codification",
            "History",
            "Date",
            "New Codification November 2005"
          ],
          "rows": [
            [
              "E3",
              "Approval by the Steering Committee under Step 2 and release for public consultation.",
              "29 March 1995",
              "E3"
            ],
            [
              "Current Step 4 version",
              "",
              "",
              ""
            ],
            [
              "E3",
              "Approval by the Steering Committee under Step 4 and recommendation for adoption to the three ICH regulatory bodies.",
              "30 November 1995",
              "E3"
            ]
          ]
        }
      ]
    },
    {
      "page_number": 3,
      "width": 8.2639,
      "height": 11.6944,
      "unit": "inch",
      "blocks": [
        {
          "block_id": "p3_line_0",
          "block_type": "paragraph",
          "text": "STRUCTURE AND CONTENT OF CLINICAL STUDY REPORTS",
          "bbox": [
            1.6414,
            1.0236,
            6.8072,
            1.2232
          ]
        },
        {
          "block_id": "p3_line_1",
          "block_type": "paragraph",
          "text": "ICH Harmonised Tripartite Guideline",
          "bbox": [
            2.7131,
            1.4097,
            5.7367,
            1.5931
          ]
        },
        {
          "block_id": "p3_line_2",
          "block_type": "paragraph",
          "text": "Having reached Step 4 of the ICH Process at the ICH Steering Committee meeting",
          "bbox": [
            1.3013,
            1.7158,
            7.1567,
            1.9085
          ]
        },
        {
          "block_id": "p3_line_3",
          "block_type": "paragraph",
          "text": "on 30 November 1995, this guideline is recommended for adoption",
          "bbox": [
            1.8843,
            1.9055,
            6.5727,
            2.0873
          ]
        },
        {
          "block_id": "p3_line_4",
          "block_type": "paragraph",
          "text": "to the three regulatory parties to ICH",
          "bbox": [
            2.8842,
            2.0876,
            5.5721,
            2.2727
          ]
        },
        {
          "block_id": "p3_line_5",
          "block_type": "paragraph",
          "text": "TABLE OF CONTENTS",
          "bbox": [
            3.225,
            2.636,
            5.2256,
            2.8208
          ]
        },
        {
          "block_id": "p3_line_6",
          "block_type": "paragraph",
          "text": "INTRODUCTION TO THE GUIDELINE.",
          "bbox": [
            1.1579,
            3.0007,
            4.2616,
            3.1726
          ]
        },
        {
          "block_id": "p3_line_7",
          "block_type": "paragraph",
          "text": "1",
          "bbox": [
            7.1852,
            3.0225,
            7.2679,
            3.1566
          ]
        },
        {
          "block_id": "p3_line_8",
          "block_type": "paragraph",
          "text": "1.",
          "bbox": [
            1.1784,
            3.3337,
            1.3077,
            3.4713
          ]
        },
        {
          "block_id": "p3_line_9",
          "block_type": "paragraph",
          "text": "TITLE PAGE",
          "bbox": [
            1.5815,
            3.3157,
            2.6343,
            3.4771
          ]
        },
        {
          "block_id": "p3_line_10",
          "block_type": "paragraph",
          "text": "3",
          "bbox": [
            7.1826,
            3.3301,
            7.2709,
            3.4678
          ]
        },
        {
          "block_id": "p3_line_11",
          "block_type": "paragraph",
          "text": "2.",
          "bbox": [
            1.1747,
            3.6374,
            1.3108,
            3.7785
          ]
        },
        {
          "block_id": "p3_line_12",
          "block_type": "paragraph",
          "text": "SYNOPSIS",
          "bbox": [
            1.5795,
            3.6237,
            2.4527,
            3.7858
          ]
        },
        {
          "block_id": "p3_line_13",
          "block_type": "paragraph",
          "text": "3",
          "bbox": [
            7.1864,
            3.6382,
            7.2699,
            3.7732
          ]
        },
        {
          "block_id": "p3_line_14",
          "block_type": "paragraph",
          "text": "3.",
          "bbox": [
            1.1736,
            3.947,
            1.3102,
            4.09
          ]
        },
        {
          "block_id": "p3_line_15",
          "block_type": "paragraph",
          "text": "TABLE OF CONTENTS FOR THE INDIVIDUAL CLINICAL STUDY",
          "bbox": [
            1.5813,
            3.9234,
            6.8358,
            4.1009
          ]
        },
        {
          "block_id": "p3_line_16",
          "block_type": "paragraph",
          "text": "REPORT",
          "bbox": [
            1.5841,
            4.1179,
            2.3205,
            4.2756
          ]
        },
        {
          "block_id": "p3_line_17",
          "block_type": "paragraph",
          "text": "4",
          "bbox": [
            7.1919,
            4.1353,
            7.2768,
            4.267
          ]
        },
        {
          "block_id": "p3_line_18",
          "block_type": "paragraph",
          "text": "4.",
          "bbox": [
            1.1761,
            4.4421,
            1.311,
            4.5824
          ]
        },
        {
          "block_id": "p3_line_19",
          "block_type": "paragraph",
          "text": "LIST OF ABBREVIATIONS AND DEFINITION OF TERMS",
          "bbox": [
            1.5784,
            4.4141,
            6.1789,
            4.591
          ]
        },
        {
          "block_id": "p3_line_20",
          "block_type": "paragraph",
          "text": "4",
          "bbox": [
            7.1888,
            4.442,
            7.2701,
            4.5746
          ]
        },
        {
          "block_id": "p3_line_21",
          "block_type": "paragraph",
          "text": "5.",
          "bbox": [
            1.1743,
            4.7433,
            1.3106,
            4.8913
          ]
        },
        {
          "block_id": "p3_line_22",
          "block_type": "paragraph",
          "text": "ETHICS",
          "bbox": [
            1.5782,
            4.7334,
            2.2478,
            4.8931
          ]
        },
        {
          "block_id": "p3_line_23",
          "block_type": "paragraph",
          "text": "4",
          "bbox": [
            7.191,
            4.7527,
            7.2759,
            4.886
          ]
        },
        {
          "block_id": "p3_line_24",
          "block_type": "paragraph",
          "text": "5.1",
          "bbox": [
            1.1727,
            5.0516,
            1.3865,
            5.2004
          ]
        },
        {
          "block_id": "p3_line_25",
          "block_type": "paragraph",
          "text": "INDEPENDENT ETHICS COMMITTEE (IEC) OR INSTITUTIONAL REVIEW",
          "bbox": [
            1.5785,
            5.0293,
            7.2261,
            5.2134
          ]
        },
        {
          "block_id": "p3_line_26",
          "block_type": "paragraph",
          "text": "BOARD (IRB)",
          "bbox": [
            1.5795,
            5.2191,
            2.5956,
            5.4023
          ]
        },
        {
          "block_id": "p3_line_27",
          "block_type": "paragraph",
          "text": "4",
          "bbox": [
            7.1921,
            5.2421,
            7.2785,
            5.3765
          ]
        },
        {
          "block_id": "p3_line_28",
          "block_type": "paragraph",
          "text": "5.2",
          "bbox": [
            1.1744,
            5.539,
            1.3987,
            5.693
          ]
        },
        {
          "block_id": "p3_line_29",
          "block_type": "paragraph",
          "text": "ETHICAL CONDUCT OF THE STUDY",
          "bbox": [
            1.5794,
            5.5224,
            4.4122,
            5.6994
          ]
        },
        {
          "block_id": "p3_line_30",
          "block_type": "paragraph",
          "text": "4",
          "bbox": [
            7.1912,
            5.5498,
            7.2769,
            5.6869
          ]
        },
        {
          "block_id": "p3_line_31",
          "block_type": "paragraph",
          "text": "5.3",
          "bbox": [
            1.1728,
            5.8477,
            1.3956,
            6.0027
          ]
        },
        {
          "block_id": "p3_line_32",
          "block_type": "paragraph",
          "text": "PATIENT INFORMATION AND CONSENT",
          "bbox": [
            1.5748,
            5.8326,
            4.7575,
            6.0068
          ]
        },
        {
          "block_id": "p3_line_33",
          "block_type": "paragraph",
          "text": "4",
          "bbox": [
            7.1918,
            5.8567,
            7.275,
            5.9924
          ]
        },
        {
          "block_id": "p3_line_34",
          "block_type": "paragraph",
          "text": "6.",
          "bbox": [
            1.1773,
            6.1624,
            1.3079,
            6.3061
          ]
        },
        {
          "block_id": "p3_line_35",
          "block_type": "paragraph",
          "text": "INVESTIGATORS AND STUDY ADMINISTRATIVE STRUCTURE",
          "bbox": [
            1.5773,
            6.1373,
            6.7037,
            6.3193
          ]
        },
        {
          "block_id": "p3_line_36",
          "block_type": "paragraph",
          "text": "4",
          "bbox": [
            7.1894,
            6.167,
            7.2726,
            6.3024
          ]
        },
        {
          "block_id": "p3_line_37",
          "block_type": "paragraph",
          "text": "7.",
          "bbox": [
            1.1765,
            6.4644,
            1.3115,
            6.6142
          ]
        },
        {
          "block_id": "p3_line_38",
          "block_type": "paragraph",
          "text": "INTRODUCTION",
          "bbox": [
            1.578,
            6.4526,
            2.9636,
            6.6218
          ]
        },
        {
          "block_id": "p3_line_39",
          "block_type": "paragraph",
          "text": "5",
          "bbox": [
            7.1819,
            6.4702,
            7.27,
            6.6083
          ]
        },
        {
          "block_id": "p3_line_40",
          "block_type": "paragraph",
          "text": "8.",
          "bbox": [
            1.1731,
            6.7776,
            1.3108,
            6.9236
          ]
        },
        {
          "block_id": "p3_line_41",
          "block_type": "paragraph",
          "text": "STUDY OBJECTIVES",
          "bbox": [
            1.5751,
            6.7593,
            3.316,
            6.9314
          ]
        },
        {
          "block_id": "p3_line_42",
          "block_type": "paragraph",
          "text": "5",
          "bbox": [
            7.1842,
            6.779,
            7.2699,
            6.9177
          ]
        },
        {
          "block_id": "p3_line_43",
          "block_type": "paragraph",
          "text": "9.",
          "bbox": [
            1.1724,
            7.0838,
            1.3088,
            7.2333
          ]
        },
        {
          "block_id": "p3_line_44",
          "block_type": "paragraph",
          "text": "INVESTIGATIONAL PLAN",
          "bbox": [
            1.5718,
            7.0661,
            3.7233,
            7.2409
          ]
        },
        {
          "block_id": "p3_line_45",
          "block_type": "paragraph",
          "text": "5",
          "bbox": [
            7.1827,
            7.0865,
            7.27,
            7.2271
          ]
        },
        {
          "block_id": "p3_line_46",
          "block_type": "paragraph",
          "text": "9.1",
          "bbox": [
            1.1708,
            7.3908,
            1.3889,
            7.5431
          ]
        },
        {
          "block_id": "p3_line_47",
          "block_type": "paragraph",
          "text": "OVERALL STUDY DESIGN AND PLAN - DESCRIPTION",
          "bbox": [
            1.5809,
            7.3718,
            5.7572,
            7.5511
          ]
        },
        {
          "block_id": "p3_line_48",
          "block_type": "paragraph",
          "text": "5",
          "bbox": [
            7.1842,
            7.3957,
            7.2708,
            7.5352
          ]
        },
        {
          "block_id": "p3_line_49",
          "block_type": "paragraph",
          "text": "9.2",
          "bbox": [
            1.1715,
            7.7,
            1.3971,
            7.8505
          ]
        },
        {
          "block_id": "p3_line_50",
          "block_type": "paragraph",
          "text": "DISCUSSION OF STUDY DESIGN, INCLUDING THE CHOICE OF",
          "bbox": [
            1.5761,
            7.6791,
            6.4919,
            7.8626
          ]
        },
        {
          "block_id": "p3_line_51",
          "block_type": "paragraph",
          "text": "CONTROL GROUPS",
          "bbox": [
            1.5876,
            7.8695,
            3.1007,
            8.0373
          ]
        },
        {
          "block_id": "p3_line_52",
          "block_type": "paragraph",
          "text": "6",
          "bbox": [
            7.1849,
            7.8888,
            7.2761,
            8.0259
          ]
        },
        {
          "block_id": "p3_line_53",
          "block_type": "paragraph",
          "text": "9.3",
          "bbox": [
            1.1727,
            8.1895,
            1.3955,
            8.3416
          ]
        },
        {
          "block_id": "p3_line_54",
          "block_type": "paragraph",
          "text": "SELECTION OF STUDY POPULATION",
          "bbox": [
            1.5763,
            8.1734,
            4.4997,
            8.3478
          ]
        },
        {
          "block_id": "p3_line_55",
          "block_type": "paragraph",
          "text": "7",
          "bbox": [
            7.1887,
            8.1942,
            7.2724,
            8.3341
          ]
        },
        {
          "block_id": "p3_line_56",
          "block_type": "paragraph",
          "text": "9.3.1",
          "bbox": [
            1.5877,
            8.4973,
            1.9343,
            8.6509
          ]
        },
        {
          "block_id": "p3_line_57",
          "block_type": "paragraph",
          "text": "Inclusion Criteria",
          "bbox": [
            2.1558,
            8.4919,
            3.4366,
            8.6542
          ]
        },
        {
          "block_id": "p3_line_58",
          "block_type": "paragraph",
          "text": "7",
          "bbox": [
            7.1874,
            8.5,
            7.2726,
            8.6382
          ]
        },
        {
          "block_id": "p3_line_59",
          "block_type": "paragraph",
          "text": "9.3.2",
          "bbox": [
            1.5877,
            8.8056,
            1.9422,
            8.959
          ]
        },
        {
          "block_id": "p3_line_60",
          "block_type": "paragraph",
          "text": "Exclusion Criteria",
          "bbox": [
            2.1597,
            8.7996,
            3.4787,
            8.9647
          ]
        },
        {
          "block_id": "p3_line_61",
          "block_type": "paragraph",
          "text": "7",
          "bbox": [
            7.1879,
            8.8093,
            7.2738,
            8.9489
          ]
        },
        {
          "block_id": "p3_line_62",
          "block_type": "paragraph",
          "text": "9.3.3",
          "bbox": [
            1.5881,
            9.1153,
            1.9414,
            9.2652
          ]
        },
        {
          "block_id": "p3_line_63",
          "block_type": "paragraph",
          "text": "Removal of Patients from Therapy or Assessment",
          "bbox": [
            2.1556,
            9.1077,
            5.6886,
            9.2821
          ]
        },
        {
          "block_id": "p3_line_64",
          "block_type": "paragraph",
          "text": "7",
          "bbox": [
            7.1841,
            9.1158,
            7.271,
            9.2545
          ]
        },
        {
          "block_id": "p3_line_65",
          "block_type": "paragraph",
          "text": "9.4",
          "bbox": [
            1.1726,
            9.4276,
            1.3991,
            9.5712
          ]
        },
        {
          "block_id": "p3_line_66",
          "block_type": "paragraph",
          "text": "TREATMENTS",
          "bbox": [
            1.5789,
            9.41,
            2.7141,
            9.5771
          ]
        },
        {
          "block_id": "p3_line_67",
          "block_type": "paragraph",
          "text": "7",
          "bbox": [
            7.1931,
            9.4278,
            7.2727,
            9.5661
          ]
        },
        {
          "block_id": "p3_line_68",
          "block_type": "paragraph",
          "text": "9.4.1",
          "bbox": [
            1.5881,
            9.7335,
            1.9355,
            9.8805
          ]
        },
        {
          "block_id": "p3_line_69",
          "block_type": "paragraph",
          "text": "Treatments Administered",
          "bbox": [
            2.1607,
            9.7242,
            4.0167,
            9.89
          ]
        },
        {
          "block_id": "p3_line_70",
          "block_type": "paragraph",
          "text": "7",
          "bbox": [
            7.1887,
            9.7354,
            7.2719,
            9.8715
          ]
        },
        {
          "block_id": "p3_line_71",
          "block_type": "paragraph",
          "text": "9.4.2",
          "bbox": [
            1.5879,
            10.042,
            1.9436,
            10.1885
          ]
        },
        {
          "block_id": "p3_line_72",
          "block_type": "paragraph",
          "text": "Identity of Investigational Product(s)",
          "bbox": [
            2.1542,
            10.0325,
            4.8004,
            10.2108
          ]
        },
        {
          "block_id": "p3_line_73",
          "block_type": "paragraph",
          "text": "7",
          "bbox": [
            7.1872,
            10.0444,
            7.2725,
            10.1798
          ]
        },
        {
          "block_id": "p3_line_74",
          "block_type": "paragraph",
          "text": "9.4.3",
          "bbox": [
            1.5877,
            10.3506,
            1.942,
            10.4971
          ]
        },
        {
          "block_id": "p3_line_75",
          "block_type": "paragraph",
          "text": "Method of Assigning Patients to Treatment Groups",
          "bbox": [
            2.1508,
            10.3373,
            5.8091,
            10.5225
          ]
        },
        {
          "block_id": "p3_line_76",
          "block_type": "paragraph",
          "text": "8",
          "bbox": [
            7.1834,
            10.358,
            7.2755,
            10.4876
          ]
        },
        {
          "block_id": "p3_line_77",
          "block_type": "paragraph",
          "text": "i",
          "bbox": [
            4.1889,
            10.9513,
            4.2567,
            11.0824
          ]
        },
        {
          "block_id": "table_1",
          "block_type": "table",
          "page_number": 3,
          "bbox": [
            1.1193,
            2.9777,
            7.3325,
            10.5532
          ],
          "headers": [
            "First Codification",
            "History",
            "Date",
            "New Codification November 2005"
          ],
          "rows": [
            [
              "INTRODUCTION TO THE GUIDELINE. 1",
              ""
            ],
            [
              "1.",
              "TITLE PAGE 3"
            ],
            [
              "2.",
              "SYNOPSIS 3"
            ],
            [
              "3.",
              "TABLE OF CONTENTS FOR THE INDIVIDUAL CLINICAL STUDY REPORT 4"
            ],
            [
              "4.",
              "LIST OF ABBREVIATIONS AND DEFINITION OF TERMS 4"
            ],
            [
              "5.",
              "ETHICS 4"
            ],
            [
              "5.1",
              "INDEPENDENT ETHICS COMMITTEE (IEC) OR INSTITUTIONAL REVIEW BOARD (IRB) 4"
            ],
            [
              "5.2",
              "ETHICAL CONDUCT OF THE STUDY 4"
            ],
            [
              "5.3",
              "PATIENT INFORMATION AND CONSENT 4"
            ],
            [
              "6.",
              "INVESTIGATORS AND STUDY ADMINISTRATIVE STRUCTURE 4"
            ],
            [
              "7.",
              "INTRODUCTION 5"
            ],
            [
              "8.",
              "STUDY OBJECTIVES 5"
            ],
            [
              "9.",
              "INVESTIGATIONAL PLAN 5"
            ],
            [
              "9.1",
              "OVERALL STUDY DESIGN AND PLAN - DESCRIPTION 5"
            ],
            [
              "9.2",
              "DISCUSSION OF STUDY DESIGN, INCLUDING THE CHOICE OF CONTROL GROUPS 6"
            ],
            [
              "9.3",
              "SELECTION OF STUDY POPULATION 7"
            ],
            [
              "",
              "9.3.1 Inclusion Criteria 7"
            ],
            [
              "",
              "9.3.2 Exclusion Criteria 7"
            ],
            [
              "",
              "9.3.3 Removal of Patients from Therapy or Assessment 7"
            ],
            [
              "9.4",
              "TREATMENTS 7"
            ],
            [
              "",
              "9.4.1 Treatments Administered 7"
            ],
            [
              "",
              "9.4.2 Identity of Investigational Product(s) 7"
            ],
            [
              "",
              "9.4.3 Method of Assigning Patients to Treatment Groups 8"
            ]
          ]
        }
      ]
    },
    {
      "page_number": 4,
      "width": 8.2639,
      "height": 11.6944,
      "unit": "inch",
      "blocks": [
        {
          "block_id": "p4_line_0",
          "block_type": "paragraph",
          "text": "Structure and Content of Clinical Study Reports",
          "bbox": [
            0.9729,
            0.7138,
            4.079,
            0.8872
          ]
        },
        {
          "block_id": "p4_line_1",
          "block_type": "paragraph",
          "text": "9.4.4",
          "bbox": [
            1.3931,
            1.0611,
            1.7463,
            1.2053
          ]
        },
        {
          "block_id": "p4_line_2",
          "block_type": "paragraph",
          "text": "Selection of Doses in the Study",
          "bbox": [
            1.966,
            1.0463,
            4.1764,
            1.2267
          ]
        },
        {
          "block_id": "p4_line_3",
          "block_type": "paragraph",
          "text": "8",
          "bbox": [
            6.9869,
            1.0634,
            7.0817,
            1.202
          ]
        },
        {
          "block_id": "p4_line_4",
          "block_type": "paragraph",
          "text": "9.4.5",
          "bbox": [
            1.3914,
            1.3685,
            1.7423,
            1.517
          ]
        },
        {
          "block_id": "p4_line_5",
          "block_type": "paragraph",
          "text": "Selection and Timing of Dose for each Patient",
          "bbox": [
            1.9669,
            1.3539,
            5.2191,
            1.5341
          ]
        },
        {
          "block_id": "p4_line_6",
          "block_type": "paragraph",
          "text": "8",
          "bbox": [
            6.9824,
            1.3729,
            7.0791,
            1.5075
          ]
        },
        {
          "block_id": "p4_line_7",
          "block_type": "paragraph",
          "text": "9.4.6",
          "bbox": [
            1.3926,
            1.6753,
            1.7447,
            1.8252
          ]
        },
        {
          "block_id": "p4_line_8",
          "block_type": "paragraph",
          "text": "Blinding",
          "bbox": [
            1.9671,
            1.6689,
            2.6068,
            1.8364
          ]
        },
        {
          "block_id": "p4_line_9",
          "block_type": "paragraph",
          "text": "8",
          "bbox": [
            6.9861,
            1.683,
            7.0803,
            1.8182
          ]
        },
        {
          "block_id": "p4_line_10",
          "block_type": "paragraph",
          "text": "9.4.7",
          "bbox": [
            1.3922,
            1.9834,
            1.7452,
            2.1339
          ]
        },
        {
          "block_id": "p4_line_11",
          "block_type": "paragraph",
          "text": "Prior and Concomitant Therapy",
          "bbox": [
            1.9639,
            1.97,
            4.249,
            2.1561
          ]
        },
        {
          "block_id": "p4_line_12",
          "block_type": "paragraph",
          "text": "9",
          "bbox": [
            6.9838,
            1.99,
            7.0784,
            2.1271
          ]
        },
        {
          "block_id": "p4_line_13",
          "block_type": "paragraph",
          "text": "9.4.8",
          "bbox": [
            1.3924,
            2.2899,
            1.7456,
            2.4433
          ]
        },
        {
          "block_id": "p4_line_14",
          "block_type": "paragraph",
          "text": "Treatment Compliance.",
          "bbox": [
            1.9636,
            2.2827,
            3.623,
            2.4625
          ]
        },
        {
          "block_id": "p4_line_15",
          "block_type": "paragraph",
          "text": "9",
          "bbox": [
            6.9825,
            2.2961,
            7.0763,
            2.4331
          ]
        },
        {
          "block_id": "p4_line_16",
          "block_type": "paragraph",
          "text": "9.5",
          "bbox": [
            0.9758,
            2.6021,
            1.1992,
            2.7517
          ]
        },
        {
          "block_id": "p4_line_17",
          "block_type": "paragraph",
          "text": "EFFICACY AND SAFETY VARIABLES",
          "bbox": [
            1.3872,
            2.5837,
            4.2475,
            2.7553
          ]
        },
        {
          "block_id": "p4_line_18",
          "block_type": "paragraph",
          "text": "9",
          "bbox": [
            6.9822,
            2.6058,
            7.0775,
            2.7441
          ]
        },
        {
          "block_id": "p4_line_19",
          "block_type": "paragraph",
          "text": "9.5.1",
          "bbox": [
            1.3928,
            2.9052,
            1.7351,
            3.0612
          ]
        },
        {
          "block_id": "p4_line_20",
          "block_type": "paragraph",
          "text": "Efficacy and Safety Measurements Assessed and Flow Chart",
          "bbox": [
            1.9676,
            2.8924,
            6.284,
            3.079
          ]
        },
        {
          "block_id": "p4_line_21",
          "block_type": "paragraph",
          "text": "9",
          "bbox": [
            6.9783,
            2.9131,
            7.0762,
            3.0523
          ]
        },
        {
          "block_id": "p4_line_22",
          "block_type": "paragraph",
          "text": "9.5.2",
          "bbox": [
            1.3916,
            3.2126,
            1.7441,
            3.3694
          ]
        },
        {
          "block_id": "p4_line_23",
          "block_type": "paragraph",
          "text": "Appropriateness of Measurements",
          "bbox": [
            1.9574,
            3.2098,
            4.419,
            3.3891
          ]
        },
        {
          "block_id": "p4_line_24",
          "block_type": "paragraph",
          "text": "10",
          "bbox": [
            6.9093,
            3.2201,
            7.0795,
            3.3633
          ]
        },
        {
          "block_id": "p4_line_25",
          "block_type": "paragraph",
          "text": "9.5.3",
          "bbox": [
            1.3933,
            3.5215,
            1.7416,
            3.6772
          ]
        },
        {
          "block_id": "p4_line_26",
          "block_type": "paragraph",
          "text": "Primary Efficacy Variable(s)",
          "bbox": [
            1.961,
            3.5124,
            3.9968,
            3.698
          ]
        },
        {
          "block_id": "p4_line_27",
          "block_type": "paragraph",
          "text": "10",
          "bbox": [
            6.9054,
            3.5282,
            7.0778,
            3.6726
          ]
        },
        {
          "block_id": "p4_line_28",
          "block_type": "paragraph",
          "text": "9.5.4",
          "bbox": [
            1.3898,
            3.8302,
            1.7453,
            3.9876
          ]
        },
        {
          "block_id": "p4_line_29",
          "block_type": "paragraph",
          "text": "Drug Concentration Measurements",
          "bbox": [
            1.9601,
            3.8201,
            4.4934,
            4.0045
          ]
        },
        {
          "block_id": "p4_line_30",
          "block_type": "paragraph",
          "text": "10",
          "bbox": [
            6.9051,
            3.8369,
            7.0777,
            3.9794
          ]
        },
        {
          "block_id": "p4_line_31",
          "block_type": "paragraph",
          "text": "9.6",
          "bbox": [
            0.9754,
            4.1425,
            1.1991,
            4.2928
          ]
        },
        {
          "block_id": "p4_line_32",
          "block_type": "paragraph",
          "text": "DATA QUALITY ASSURANCE",
          "bbox": [
            1.3782,
            4.1227,
            3.6452,
            4.3039
          ]
        },
        {
          "block_id": "p4_line_33",
          "block_type": "paragraph",
          "text": "11",
          "bbox": [
            6.9065,
            4.1465,
            7.0703,
            4.2834
          ]
        },
        {
          "block_id": "p4_line_34",
          "block_type": "paragraph",
          "text": "9.7",
          "bbox": [
            0.9756,
            4.4493,
            1.2012,
            4.5994
          ]
        },
        {
          "block_id": "p4_line_35",
          "block_type": "paragraph",
          "text": "STATISTICAL METHODS PLANNED IN THE PROTOCOL AND",
          "bbox": [
            1.3849,
            4.4315,
            6.0713,
            4.6089
          ]
        },
        {
          "block_id": "p4_line_36",
          "block_type": "paragraph",
          "text": "DETERMINATION OF SAMPLE SIZE",
          "bbox": [
            1.3822,
            4.6174,
            4.178,
            4.7883
          ]
        },
        {
          "block_id": "p4_line_37",
          "block_type": "paragraph",
          "text": "11",
          "bbox": [
            6.9078,
            4.6353,
            7.071,
            4.7777
          ]
        },
        {
          "block_id": "p4_line_38",
          "block_type": "paragraph",
          "text": "9.7.1",
          "bbox": [
            1.3922,
            4.9385,
            1.7354,
            5.0906
          ]
        },
        {
          "block_id": "p4_line_39",
          "block_type": "paragraph",
          "text": "Statistical and Analytical Plans",
          "bbox": [
            1.9641,
            4.9323,
            4.2386,
            5.1052
          ]
        },
        {
          "block_id": "p4_line_40",
          "block_type": "paragraph",
          "text": "11",
          "bbox": [
            6.9056,
            4.9442,
            7.0708,
            5.0856
          ]
        },
        {
          "block_id": "p4_line_41",
          "block_type": "paragraph",
          "text": "9.7.2",
          "bbox": [
            1.3898,
            5.2453,
            1.7416,
            5.4006
          ]
        },
        {
          "block_id": "p4_line_42",
          "block_type": "paragraph",
          "text": "Determination of Sample Size",
          "bbox": [
            1.9614,
            5.2407,
            4.1113,
            5.4189
          ]
        },
        {
          "block_id": "p4_line_43",
          "block_type": "paragraph",
          "text": "12",
          "bbox": [
            6.9059,
            5.2512,
            7.08,
            5.3925
          ]
        },
        {
          "block_id": "p4_line_44",
          "block_type": "paragraph",
          "text": "9.8",
          "bbox": [
            0.9752,
            5.5566,
            1.2023,
            5.7109
          ]
        },
        {
          "block_id": "p4_line_45",
          "block_type": "paragraph",
          "text": "CHANGES IN THE CONDUCT OF THE STUDY OR",
          "bbox": [
            1.3898,
            5.5406,
            5.1681,
            5.7183
          ]
        },
        {
          "block_id": "p4_line_46",
          "block_type": "paragraph",
          "text": "PLANNED ANALYSES",
          "bbox": [
            1.3793,
            5.7331,
            3.0976,
            5.9002
          ]
        },
        {
          "block_id": "p4_line_47",
          "block_type": "paragraph",
          "text": "12",
          "bbox": [
            6.9052,
            5.7473,
            7.0796,
            5.8929
          ]
        },
        {
          "block_id": "p4_line_48",
          "block_type": "paragraph",
          "text": "10.",
          "bbox": [
            0.9805,
            6.056,
            1.2027,
            6.2039
          ]
        },
        {
          "block_id": "p4_line_49",
          "block_type": "paragraph",
          "text": "STUDY PATIENTS",
          "bbox": [
            1.3764,
            6.0439,
            2.892,
            6.2084
          ]
        },
        {
          "block_id": "p4_line_50",
          "block_type": "paragraph",
          "text": "12",
          "bbox": [
            6.8998,
            6.057,
            7.0796,
            6.1987
          ]
        },
        {
          "block_id": "p4_line_51",
          "block_type": "paragraph",
          "text": "10.1",
          "bbox": [
            0.982,
            6.3635,
            1.2799,
            6.5112
          ]
        },
        {
          "block_id": "p4_line_52",
          "block_type": "paragraph",
          "text": "DISPOSITION OF PATIENTS",
          "bbox": [
            1.3735,
            6.3503,
            3.5814,
            6.52
          ]
        },
        {
          "block_id": "p4_line_53",
          "block_type": "paragraph",
          "text": "12",
          "bbox": [
            6.9049,
            6.3625,
            7.0784,
            6.5084
          ]
        },
        {
          "block_id": "p4_line_54",
          "block_type": "paragraph",
          "text": "10.2",
          "bbox": [
            0.9829,
            6.6729,
            1.2849,
            6.8183
          ]
        },
        {
          "block_id": "p4_line_55",
          "block_type": "paragraph",
          "text": "PROTOCOL DEVIATIONS",
          "bbox": [
            1.3666,
            6.6561,
            3.3435,
            6.8281
          ]
        },
        {
          "block_id": "p4_line_56",
          "block_type": "paragraph",
          "text": "13",
          "bbox": [
            6.9052,
            6.6724,
            7.0786,
            6.8163
          ]
        },
        {
          "block_id": "p4_line_57",
          "block_type": "paragraph",
          "text": "11.",
          "bbox": [
            0.9799,
            6.9826,
            1.2009,
            7.1266
          ]
        },
        {
          "block_id": "p4_line_58",
          "block_type": "paragraph",
          "text": "EFFICACY EVALUATION",
          "bbox": [
            1.3752,
            6.9652,
            3.4491,
            7.1343
          ]
        },
        {
          "block_id": "p4_line_59",
          "block_type": "paragraph",
          "text": "13",
          "bbox": [
            6.8984,
            6.9826,
            7.0782,
            7.1246
          ]
        },
        {
          "block_id": "p4_line_60",
          "block_type": "paragraph",
          "text": "11.1",
          "bbox": [
            0.9825,
            7.291,
            1.2771,
            7.4333
          ]
        },
        {
          "block_id": "p4_line_61",
          "block_type": "paragraph",
          "text": "DATA SETS ANALYSED",
          "bbox": [
            1.3431,
            7.277,
            3.2017,
            7.4463
          ]
        },
        {
          "block_id": "p4_line_62",
          "block_type": "paragraph",
          "text": "13",
          "bbox": [
            6.9071,
            7.2899,
            7.0796,
            7.4329
          ]
        },
        {
          "block_id": "p4_line_63",
          "block_type": "paragraph",
          "text": "11.2",
          "bbox": [
            0.9827,
            7.5976,
            1.2832,
            7.743
          ]
        },
        {
          "block_id": "p4_line_64",
          "block_type": "paragraph",
          "text": "DEMOGRAPHIC AND OTHER BASELINE CHARACTERISTICS",
          "bbox": [
            1.3461,
            7.5768,
            6.0764,
            7.7542
          ]
        },
        {
          "block_id": "p4_line_65",
          "block_type": "paragraph",
          "text": "13",
          "bbox": [
            6.9041,
            7.597,
            7.0776,
            7.7424
          ]
        },
        {
          "block_id": "p4_line_66",
          "block_type": "paragraph",
          "text": "11.3",
          "bbox": [
            0.9832,
            7.9066,
            1.284,
            8.0518
          ]
        },
        {
          "block_id": "p4_line_67",
          "block_type": "paragraph",
          "text": "MEASUREMENTS OF TREATMENT COMPLIANCE",
          "bbox": [
            1.3686,
            7.8858,
            5.2435,
            8.0668
          ]
        },
        {
          "block_id": "p4_line_68",
          "block_type": "paragraph",
          "text": "15",
          "bbox": [
            6.906,
            7.9077,
            7.0764,
            8.0514
          ]
        },
        {
          "block_id": "p4_line_69",
          "block_type": "paragraph",
          "text": "11.4",
          "bbox": [
            0.9833,
            8.2152,
            1.2842,
            8.3614
          ]
        },
        {
          "block_id": "p4_line_70",
          "block_type": "paragraph",
          "text": "EFFICACY RESULTS AND TABULATIONS OF INDIVIDUAL PATIENT",
          "bbox": [
            1.3781,
            8.1898,
            6.6488,
            8.3768
          ]
        },
        {
          "block_id": "p4_line_71",
          "block_type": "paragraph",
          "text": "DATA",
          "bbox": [
            1.3844,
            8.3899,
            1.8426,
            8.5427
          ]
        },
        {
          "block_id": "p4_line_72",
          "block_type": "paragraph",
          "text": "15",
          "bbox": [
            6.9068,
            8.4002,
            7.0807,
            8.5414
          ]
        },
        {
          "block_id": "p4_line_73",
          "block_type": "paragraph",
          "text": "11.4.1",
          "bbox": [
            1.4005,
            8.706,
            1.8232,
            8.8508
          ]
        },
        {
          "block_id": "p4_line_74",
          "block_type": "paragraph",
          "text": "Analysis of Efficacy",
          "bbox": [
            1.9619,
            8.6995,
            3.3746,
            8.8722
          ]
        },
        {
          "block_id": "p4_line_75",
          "block_type": "paragraph",
          "text": "15",
          "bbox": [
            6.9078,
            8.7081,
            7.0791,
            8.8483
          ]
        },
        {
          "block_id": "p4_line_76",
          "block_type": "paragraph",
          "text": "11.4.2",
          "bbox": [
            1.4,
            9.0124,
            1.8285,
            9.1608
          ]
        },
        {
          "block_id": "p4_line_77",
          "block_type": "paragraph",
          "text": "Statistical/Analytical Issues",
          "bbox": [
            1.96,
            9.005,
            3.9727,
            9.1773
          ]
        },
        {
          "block_id": "p4_line_78",
          "block_type": "paragraph",
          "text": "15",
          "bbox": [
            6.9049,
            9.0146,
            7.079,
            9.1571
          ]
        },
        {
          "block_id": "p4_line_79",
          "block_type": "paragraph",
          "text": "11.4.2.1",
          "bbox": [
            1.9829,
            9.3206,
            2.5319,
            9.4701
          ]
        },
        {
          "block_id": "p4_line_80",
          "block_type": "paragraph",
          "text": "Adjustments for Covariates",
          "bbox": [
            2.7127,
            9.3133,
            4.6878,
            9.487
          ]
        },
        {
          "block_id": "p4_line_81",
          "block_type": "paragraph",
          "text": "16",
          "bbox": [
            6.9041,
            9.3248,
            7.0787,
            9.4642
          ]
        },
        {
          "block_id": "p4_line_82",
          "block_type": "paragraph",
          "text": "11.4.2.2",
          "bbox": [
            1.9823,
            9.6266,
            2.5414,
            9.7776
          ]
        },
        {
          "block_id": "p4_line_83",
          "block_type": "paragraph",
          "text": "Handling of Dropouts or Missing Data",
          "bbox": [
            2.7068,
            9.6206,
            5.4342,
            9.8017
          ]
        },
        {
          "block_id": "p4_line_84",
          "block_type": "paragraph",
          "text": "16",
          "bbox": [
            6.9054,
            9.6338,
            7.0785,
            9.7711
          ]
        },
        {
          "block_id": "p4_line_85",
          "block_type": "paragraph",
          "text": "11.4.2.3",
          "bbox": [
            1.9834,
            9.9364,
            2.5401,
            10.088
          ]
        },
        {
          "block_id": "p4_line_86",
          "block_type": "paragraph",
          "text": "Interim Analyses and Data Monitoring",
          "bbox": [
            2.7044,
            9.9285,
            5.5,
            10.1096
          ]
        },
        {
          "block_id": "p4_line_87",
          "block_type": "paragraph",
          "text": "16",
          "bbox": [
            6.9068,
            9.9414,
            7.0793,
            10.0812
          ]
        },
        {
          "block_id": "p4_line_88",
          "block_type": "paragraph",
          "text": "11.4.2.4",
          "bbox": [
            1.9832,
            10.2453,
            2.5429,
            10.3948
          ]
        },
        {
          "block_id": "p4_line_89",
          "block_type": "paragraph",
          "text": "Multicentre Studies",
          "bbox": [
            2.7055,
            10.2402,
            4.1491,
            10.404
          ]
        },
        {
          "block_id": "p4_line_90",
          "block_type": "paragraph",
          "text": "17",
          "bbox": [
            6.9044,
            10.2487,
            7.0778,
            10.3888
          ]
        },
        {
          "block_id": "p4_line_91",
          "block_type": "paragraph",
          "text": "ii",
          "bbox": [
            3.9714,
            10.947,
            4.0867,
            11.082
          ]
        },
        {
          "block_id": "table_2",
          "block_type": "table",
          "page_number": 4,
          "bbox": [
            0.9287,
            0.7247,
            7.1487,
            10.4396
          ],
          "headers": [
            "First Codification",
            "History",
            "Date",
            "New Codification November 2005"
          ],
          "rows": [
            [
              "Structure and Content of Clinical Study Reports",
              "",
              ""
            ],
            [
              "",
              "9.4.4 Selection of Doses in the Study",
              "8"
            ],
            [
              "",
              "9.4.5 Selection and Timing of Dose for each Patient",
              "8"
            ],
            [
              "",
              "9.4.6 Blinding",
              "8"
            ],
            [
              "",
              "9.4.7 Prior and Concomitant Therapy",
              "9"
            ],
            [
              "",
              "9.4.8 Treatment Compliance.",
              "9"
            ],
            [
              "9.5",
              "EFFICACY AND SAFETY VARIABLES",
              "9"
            ],
            [
              "",
              "9.5.1 Efficacy and Safety Measurements Assessed and Flow Chart",
              "9"
            ],
            [
              "",
              "9.5.2 Appropriateness of Measurements",
              "10"
            ],
            [
              "",
              "9.5.3 Primary Efficacy Variable(s)",
              "10"
            ],
            [
              "",
              "9.5.4 Drug Concentration Measurements",
              "10"
            ],
            [
              "9.6",
              "DATA QUALITY ASSURANCE",
              "11"
            ],
            [
              "9.7",
              "STATISTICAL METHODS PLANNED IN THE PROTOCOL AND DETERMINATION OF SAMPLE SIZE",
              "11"
            ],
            [
              "",
              "9.7.1 Statistical and Analytical Plans",
              "11"
            ],
            [
              "",
              "9.7.2 Determination of Sample Size",
              "12"
            ],
            [
              "9.8",
              "CHANGES IN THE CONDUCT OF THE STUDY OR PLANNED ANALYSES",
              "12"
            ],
            [
              "10.",
              "STUDY PATIENTS",
              "12"
            ],
            [
              "10.1",
              "DISPOSITION OF PATIENTS",
              "12"
            ],
            [
              "10.2",
              "PROTOCOL DEVIATIONS",
              "13"
            ],
            [
              "11.",
              "EFFICACY EVALUATION",
              "13"
            ],
            [
              "11.1",
              "DATA SETS ANALYSED",
              "13"
            ],
            [
              "11.2",
              "DEMOGRAPHIC AND OTHER BASELINE CHARACTERISTICS",
              "13"
            ],
            [
              "11.3",
              "MEASUREMENTS OF TREATMENT COMPLIANCE",
              "15"
            ],
            [
              "11.4",
              "EFFICACY RESULTS AND TABULATIONS OF INDIVIDUAL PATIENT DATA",
              "15"
            ],
            [
              "",
              "11.4.1 Analysis of Efficacy",
              "15"
            ],
            [
              "",
              "11.4.2 Statistical/Analytical Issues",
              "15"
            ],
            [
              "",
              "11.4.2.1 Adjustments for Covariates",
              "16"
            ],
            [
              "",
              "11.4.2.2 Handling of Dropouts or Missing Data",
              "16"
            ],
            [
              "",
              "11.4.2.3 Interim Analyses and Data Monitoring",
              "16"
            ],
            [
              "",
              "11.4.2.4 Multicentre Studies",
              "17"
            ]
          ]
        }
      ]
    },
    {
      "page_number": 5,
      "width": 8.2639,
      "height": 11.6944,
      "unit": "inch",
      "blocks": [
        {
          "block_id": "p5_line_0",
          "block_type": "paragraph",
          "text": "Structure and Content of Clinical Study Reports",
          "bbox": [
            4.1868,
            0.7138,
            7.2879,
            0.8837
          ]
        },
        {
          "block_id": "p5_line_1",
          "block_type": "paragraph",
          "text": "11.4.2.5",
          "bbox": [
            2.1779,
            1.0597,
            2.7378,
            1.2077
          ]
        },
        {
          "block_id": "p5_line_2",
          "block_type": "paragraph",
          "text": "Multiple Comparison/Multiplicity",
          "bbox": [
            2.905,
            1.0457,
            5.3135,
            1.2334
          ]
        },
        {
          "block_id": "p5_line_3",
          "block_type": "paragraph",
          "text": "17",
          "bbox": [
            7.1018,
            1.0584,
            7.2734,
            1.2031
          ]
        },
        {
          "block_id": "p5_line_4",
          "block_type": "paragraph",
          "text": "11.4.2.6",
          "bbox": [
            2.1765,
            1.3659,
            2.738,
            1.5153
          ]
        },
        {
          "block_id": "p5_line_5",
          "block_type": "paragraph",
          "text": "Use of an \"Efficacy Subset\" of Patients.",
          "bbox": [
            2.9111,
            1.3571,
            5.6571,
            1.5315
          ]
        },
        {
          "block_id": "p5_line_6",
          "block_type": "paragraph",
          "text": "17",
          "bbox": [
            7.1021,
            1.3668,
            7.2721,
            1.5114
          ]
        },
        {
          "block_id": "p5_line_7",
          "block_type": "paragraph",
          "text": "11.4.2.7",
          "bbox": [
            2.178,
            1.6736,
            2.7388,
            1.824
          ]
        },
        {
          "block_id": "p5_line_8",
          "block_type": "paragraph",
          "text": "Active-Control Studies Intended to Show Equivalence",
          "bbox": [
            2.9024,
            1.6617,
            6.7311,
            1.8438
          ]
        },
        {
          "block_id": "p5_line_9",
          "block_type": "paragraph",
          "text": "17",
          "bbox": [
            7.1003,
            1.6743,
            7.2734,
            1.8201
          ]
        },
        {
          "block_id": "p5_line_10",
          "block_type": "paragraph",
          "text": "11.4.2.8",
          "bbox": [
            2.1787,
            1.9827,
            2.7406,
            2.1342
          ]
        },
        {
          "block_id": "p5_line_11",
          "block_type": "paragraph",
          "text": "Examination of Subgroups",
          "bbox": [
            2.9133,
            1.9741,
            4.8203,
            2.1584
          ]
        },
        {
          "block_id": "p5_line_12",
          "block_type": "paragraph",
          "text": "18",
          "bbox": [
            7.1016,
            1.9846,
            7.2784,
            2.1297
          ]
        },
        {
          "block_id": "p5_line_13",
          "block_type": "paragraph",
          "text": "11.4.3",
          "bbox": [
            1.597,
            2.2929,
            2.0206,
            2.4421
          ]
        },
        {
          "block_id": "p5_line_14",
          "block_type": "paragraph",
          "text": "Tabulation of Individual Response Data",
          "bbox": [
            2.1584,
            2.2813,
            4.9989,
            2.4604
          ]
        },
        {
          "block_id": "p5_line_15",
          "block_type": "paragraph",
          "text": "18",
          "bbox": [
            7.0992,
            2.2923,
            7.2772,
            2.4372
          ]
        },
        {
          "block_id": "p5_line_16",
          "block_type": "paragraph",
          "text": "11.4.4",
          "bbox": [
            1.5945,
            2.6024,
            2.0206,
            2.7487
          ]
        },
        {
          "block_id": "p5_line_17",
          "block_type": "paragraph",
          "text": "Drug Dose, Drug Concentration, and Relationships to Response.",
          "bbox": [
            2.1547,
            2.5875,
            6.6793,
            2.7774
          ]
        },
        {
          "block_id": "p5_line_18",
          "block_type": "paragraph",
          "text": "19",
          "bbox": [
            7.1001,
            2.6017,
            7.272,
            2.7458
          ]
        },
        {
          "block_id": "p5_line_19",
          "block_type": "paragraph",
          "text": "11.4.5",
          "bbox": [
            1.5959,
            2.908,
            2.0209,
            3.0594
          ]
        },
        {
          "block_id": "p5_line_20",
          "block_type": "paragraph",
          "text": "Drug-Drug and Drug-Disease Interactions",
          "bbox": [
            2.1515,
            2.8953,
            5.1745,
            3.0815
          ]
        },
        {
          "block_id": "p5_line_21",
          "block_type": "paragraph",
          "text": "19",
          "bbox": [
            7.1006,
            2.9102,
            7.2766,
            3.0543
          ]
        },
        {
          "block_id": "p5_line_22",
          "block_type": "paragraph",
          "text": "11.4.6",
          "bbox": [
            1.595,
            3.2184,
            2.0217,
            3.3684
          ]
        },
        {
          "block_id": "p5_line_23",
          "block_type": "paragraph",
          "text": "By-Patient Displays",
          "bbox": [
            2.1609,
            3.2098,
            3.6079,
            3.3875
          ]
        },
        {
          "block_id": "p5_line_24",
          "block_type": "paragraph",
          "text": "19",
          "bbox": [
            7.1059,
            3.2217,
            7.2742,
            3.3633
          ]
        },
        {
          "block_id": "p5_line_25",
          "block_type": "paragraph",
          "text": "11.4.7 Efficacy Conclusions",
          "bbox": [
            1.5959,
            3.5118,
            3.64,
            3.6944
          ]
        },
        {
          "block_id": "p5_line_26",
          "block_type": "paragraph",
          "text": "19",
          "bbox": [
            7.102,
            3.5279,
            7.2745,
            3.6716
          ]
        },
        {
          "block_id": "p5_line_27",
          "block_type": "paragraph",
          "text": "12.",
          "bbox": [
            1.1771,
            3.8394,
            1.3984,
            3.985
          ]
        },
        {
          "block_id": "p5_line_28",
          "block_type": "paragraph",
          "text": "SAFETY EVALUATION",
          "bbox": [
            1.5769,
            3.8246,
            3.4449,
            3.9927
          ]
        },
        {
          "block_id": "p5_line_29",
          "block_type": "paragraph",
          "text": "19",
          "bbox": [
            7.0934,
            3.8402,
            7.2726,
            3.9849
          ]
        },
        {
          "block_id": "p5_line_30",
          "block_type": "paragraph",
          "text": "12.1",
          "bbox": [
            1.1789,
            4.1445,
            1.4726,
            4.2876
          ]
        },
        {
          "block_id": "p5_line_31",
          "block_type": "paragraph",
          "text": "EXTENT OF EXPOSURE",
          "bbox": [
            1.5811,
            4.1307,
            3.4415,
            4.2955
          ]
        },
        {
          "block_id": "p5_line_32",
          "block_type": "paragraph",
          "text": "20",
          "bbox": [
            7.0982,
            4.1444,
            7.275,
            4.2886
          ]
        },
        {
          "block_id": "p5_line_33",
          "block_type": "paragraph",
          "text": "12.2",
          "bbox": [
            1.1803,
            4.4491,
            1.4823,
            4.5989
          ]
        },
        {
          "block_id": "p5_line_34",
          "block_type": "paragraph",
          "text": "ADVERSE EVENTS (AES)",
          "bbox": [
            1.5756,
            4.4318,
            3.5099,
            4.6175
          ]
        },
        {
          "block_id": "p5_line_35",
          "block_type": "paragraph",
          "text": "21",
          "bbox": [
            7.0972,
            4.4489,
            7.2678,
            4.5959
          ]
        },
        {
          "block_id": "p5_line_36",
          "block_type": "paragraph",
          "text": "12.2.1",
          "bbox": [
            1.5956,
            4.7558,
            2.0156,
            4.9089
          ]
        },
        {
          "block_id": "p5_line_37",
          "block_type": "paragraph",
          "text": "Brief Summary of Adverse Events",
          "bbox": [
            2.1563,
            4.7482,
            4.5941,
            4.9256
          ]
        },
        {
          "block_id": "p5_line_38",
          "block_type": "paragraph",
          "text": "21",
          "bbox": [
            7.0958,
            4.7582,
            7.2652,
            4.9033
          ]
        },
        {
          "block_id": "p5_line_39",
          "block_type": "paragraph",
          "text": "12.2.2 Display of Adverse Events",
          "bbox": [
            1.6217,
            5.0604,
            4.0431,
            5.234
          ]
        },
        {
          "block_id": "p5_line_40",
          "block_type": "paragraph",
          "text": "21",
          "bbox": [
            7.0944,
            5.0658,
            7.2673,
            5.214
          ]
        },
        {
          "block_id": "p5_line_41",
          "block_type": "paragraph",
          "text": "12.2.3",
          "bbox": [
            1.5952,
            5.3743,
            2.0214,
            5.5269
          ]
        },
        {
          "block_id": "p5_line_42",
          "block_type": "paragraph",
          "text": "Analysis of Adverse Events",
          "bbox": [
            2.146,
            5.3676,
            4.112,
            5.546
          ]
        },
        {
          "block_id": "p5_line_43",
          "block_type": "paragraph",
          "text": "22",
          "bbox": [
            7.0958,
            5.375,
            7.2755,
            5.5228
          ]
        },
        {
          "block_id": "p5_line_44",
          "block_type": "paragraph",
          "text": "12.2.4",
          "bbox": [
            1.5963,
            5.6822,
            2.0265,
            5.8332
          ]
        },
        {
          "block_id": "p5_line_45",
          "block_type": "paragraph",
          "text": "Listing of Adverse Events by Patient",
          "bbox": [
            2.1559,
            5.6722,
            4.7874,
            5.8543
          ]
        },
        {
          "block_id": "p5_line_46",
          "block_type": "paragraph",
          "text": "23",
          "bbox": [
            7.0956,
            5.6826,
            7.2751,
            5.8286
          ]
        },
        {
          "block_id": "p5_line_47",
          "block_type": "paragraph",
          "text": "12.3",
          "bbox": [
            1.1796,
            5.9919,
            1.4792,
            6.1412
          ]
        },
        {
          "block_id": "p5_line_48",
          "block_type": "paragraph",
          "text": "DEATHS, OTHER SERIOUS ADVERSE EVENTS, AND OTHER",
          "bbox": [
            1.5774,
            5.9728,
            6.2234,
            6.1564
          ]
        },
        {
          "block_id": "p5_line_49",
          "block_type": "paragraph",
          "text": "SIGNIFICANT ADVERSE EVENTS",
          "bbox": [
            1.5839,
            6.1613,
            4.1792,
            6.3314
          ]
        },
        {
          "block_id": "p5_line_50",
          "block_type": "paragraph",
          "text": "23",
          "bbox": [
            7.0978,
            6.175,
            7.2746,
            6.3212
          ]
        },
        {
          "block_id": "p5_line_51",
          "block_type": "paragraph",
          "text": "12.3.1",
          "bbox": [
            1.5954,
            6.4831,
            2.0136,
            6.6333
          ]
        },
        {
          "block_id": "p5_line_52",
          "block_type": "paragraph",
          "text": "Listing of Deaths, other Serious Adverse Events and Other Significant",
          "bbox": [
            2.1494,
            6.4671,
            7.1586,
            6.6583
          ]
        },
        {
          "block_id": "p5_line_53",
          "block_type": "paragraph",
          "text": "Adverse Events",
          "bbox": [
            2.1664,
            6.668,
            3.296,
            6.8284
          ]
        },
        {
          "block_id": "p5_line_54",
          "block_type": "paragraph",
          "text": "23",
          "bbox": [
            7.098,
            6.6717,
            7.2737,
            6.8177
          ]
        },
        {
          "block_id": "p5_line_55",
          "block_type": "paragraph",
          "text": "12.3.1.1",
          "bbox": [
            2.1799,
            6.9773,
            2.7299,
            7.1295
          ]
        },
        {
          "block_id": "p5_line_56",
          "block_type": "paragraph",
          "text": "Deaths",
          "bbox": [
            2.909,
            6.9757,
            3.4376,
            7.1286
          ]
        },
        {
          "block_id": "p5_line_57",
          "block_type": "paragraph",
          "text": "23",
          "bbox": [
            7.0989,
            6.9791,
            7.275,
            7.1256
          ]
        },
        {
          "block_id": "p5_line_58",
          "block_type": "paragraph",
          "text": "12.3.1.2 Other Serious Adverse Events",
          "bbox": [
            2.1757,
            7.2767,
            5.0758,
            7.4491
          ]
        },
        {
          "block_id": "p5_line_59",
          "block_type": "paragraph",
          "text": "24",
          "bbox": [
            7.0972,
            7.2892,
            7.2785,
            7.4343
          ]
        },
        {
          "block_id": "p5_line_60",
          "block_type": "paragraph",
          "text": "12.3.1.3",
          "bbox": [
            2.1788,
            7.5939,
            2.7352,
            7.7476
          ]
        },
        {
          "block_id": "p5_line_61",
          "block_type": "paragraph",
          "text": "Other Significant Adverse Events.",
          "bbox": [
            2.9124,
            7.5855,
            5.3186,
            7.7648
          ]
        },
        {
          "block_id": "p5_line_62",
          "block_type": "paragraph",
          "text": "24",
          "bbox": [
            7.0936,
            7.596,
            7.2793,
            7.7425
          ]
        },
        {
          "block_id": "p5_line_63",
          "block_type": "paragraph",
          "text": "12.3.2",
          "bbox": [
            1.5966,
            7.9018,
            2.0227,
            8.0543
          ]
        },
        {
          "block_id": "p5_line_64",
          "block_type": "paragraph",
          "text": "Narratives of Deaths, Other Serious Adverse Events and",
          "bbox": [
            2.1611,
            7.892,
            6.2029,
            8.0719
          ]
        },
        {
          "block_id": "p5_line_65",
          "block_type": "paragraph",
          "text": "Certain Other Significant Adverse Events.",
          "bbox": [
            2.1724,
            8.076,
            5.1526,
            8.2566
          ]
        },
        {
          "block_id": "p5_line_66",
          "block_type": "paragraph",
          "text": "24",
          "bbox": [
            7.097,
            8.0876,
            7.2773,
            8.2329
          ]
        },
        {
          "block_id": "p5_line_67",
          "block_type": "paragraph",
          "text": "12.3.3",
          "bbox": [
            1.5959,
            8.3933,
            2.0231,
            8.5478
          ]
        },
        {
          "block_id": "p5_line_68",
          "block_type": "paragraph",
          "text": "Analysis and Discussion of Deaths, Other Serious Adverse Events",
          "bbox": [
            2.1588,
            8.3823,
            6.8413,
            8.5645
          ]
        },
        {
          "block_id": "p5_line_69",
          "block_type": "paragraph",
          "text": "and Other Significant Adverse Events",
          "bbox": [
            2.1626,
            8.571,
            4.8794,
            8.744
          ]
        },
        {
          "block_id": "p5_line_70",
          "block_type": "paragraph",
          "text": "24",
          "bbox": [
            7.0958,
            8.5792,
            7.2784,
            8.7243
          ]
        },
        {
          "block_id": "p5_line_71",
          "block_type": "paragraph",
          "text": "12.4",
          "bbox": [
            1.1792,
            8.8918,
            1.4787,
            9.0329
          ]
        },
        {
          "block_id": "p5_line_72",
          "block_type": "paragraph",
          "text": "CLINICAL LABORATORY EVALUATION",
          "bbox": [
            1.5864,
            8.8739,
            4.651,
            9.0413
          ]
        },
        {
          "block_id": "p5_line_73",
          "block_type": "paragraph",
          "text": "25",
          "bbox": [
            7.0967,
            8.8867,
            7.2749,
            9.0304
          ]
        },
        {
          "block_id": "p5_line_74",
          "block_type": "paragraph",
          "text": "12.4.1",
          "bbox": [
            1.5969,
            9.1957,
            2.0154,
            9.3415
          ]
        },
        {
          "block_id": "p5_line_75",
          "block_type": "paragraph",
          "text": "Listing of Individual Laboratory Measurements by Patient (16.2.8)",
          "bbox": [
            2.158,
            9.1814,
            6.8935,
            9.3704
          ]
        },
        {
          "block_id": "p5_line_76",
          "block_type": "paragraph",
          "text": "and Each Abnormal Laboratory Value (14.3.4)",
          "bbox": [
            2.1641,
            9.3704,
            5.4483,
            9.5446
          ]
        },
        {
          "block_id": "p5_line_77",
          "block_type": "paragraph",
          "text": "25",
          "bbox": [
            7.0949,
            9.3746,
            7.2736,
            9.5226
          ]
        },
        {
          "block_id": "p5_line_78",
          "block_type": "paragraph",
          "text": "12.4.2",
          "bbox": [
            1.5945,
            9.6874,
            2.0192,
            9.8332
          ]
        },
        {
          "block_id": "p5_line_79",
          "block_type": "paragraph",
          "text": "Evaluation of Each Laboratory Parameter",
          "bbox": [
            2.1614,
            9.6796,
            5.1687,
            9.8494
          ]
        },
        {
          "block_id": "p5_line_80",
          "block_type": "paragraph",
          "text": "25",
          "bbox": [
            7.0977,
            9.6838,
            7.2747,
            9.8303
          ]
        },
        {
          "block_id": "p5_line_81",
          "block_type": "paragraph",
          "text": "12.4.2.1",
          "bbox": [
            2.1747,
            9.9952,
            2.7278,
            10.1412
          ]
        },
        {
          "block_id": "p5_line_82",
          "block_type": "paragraph",
          "text": "Laboratory Values Over Time",
          "bbox": [
            2.9032,
            9.9895,
            5.0441,
            10.1584
          ]
        },
        {
          "block_id": "p5_line_83",
          "block_type": "paragraph",
          "text": "26",
          "bbox": [
            7.0968,
            9.9965,
            7.277,
            10.1391
          ]
        },
        {
          "block_id": "p5_line_84",
          "block_type": "paragraph",
          "text": "12.4.2.2",
          "bbox": [
            2.1751,
            10.3017,
            2.7356,
            10.4518
          ]
        },
        {
          "block_id": "p5_line_85",
          "block_type": "paragraph",
          "text": "Individual Patient Changes.",
          "bbox": [
            2.9053,
            10.2955,
            4.8935,
            10.4717
          ]
        },
        {
          "block_id": "p5_line_86",
          "block_type": "paragraph",
          "text": "26",
          "bbox": [
            7.0974,
            10.3061,
            7.2791,
            10.4459
          ]
        },
        {
          "block_id": "p5_line_87",
          "block_type": "paragraph",
          "text": "iii",
          "bbox": [
            4.1433,
            10.9474,
            4.3089,
            11.0842
          ]
        }
      ]
    },
    {
      "page_number": 6,
      "width": 8.2639,
      "height": 11.6944,
      "unit": "inch",
      "blocks": [
        {
          "block_id": "p6_line_0",
          "block_type": "paragraph",
          "text": "Structure and Content of Clinical Study Reports",
          "bbox": [
            0.9736,
            0.7138,
            4.0784,
            0.8847
          ]
        },
        {
          "block_id": "p6_line_1",
          "block_type": "paragraph",
          "text": "12.4.2.3 Individual Clinically Significant Abnormalities",
          "bbox": [
            1.9814,
            1.045,
            6.0615,
            1.2257
          ]
        },
        {
          "block_id": "p6_line_2",
          "block_type": "paragraph",
          "text": "26",
          "bbox": [
            6.8995,
            1.0616,
            7.0788,
            1.2018
          ]
        },
        {
          "block_id": "p6_line_3",
          "block_type": "paragraph",
          "text": "12.5 VITAL SIGNS, PHYSICAL FINDINGS AND OTHER OBSERVATIONS",
          "bbox": [
            0.9839,
            1.3476,
            6.4962,
            1.5241
          ]
        },
        {
          "block_id": "p6_line_4",
          "block_type": "paragraph",
          "text": "RELATED TO SAFETY",
          "bbox": [
            1.3806,
            1.5369,
            3.1044,
            1.7013
          ]
        },
        {
          "block_id": "p6_line_5",
          "block_type": "paragraph",
          "text": "27",
          "bbox": [
            6.8979,
            1.5485,
            7.0789,
            1.6944
          ]
        },
        {
          "block_id": "p6_line_6",
          "block_type": "paragraph",
          "text": "12.6 SAFETY CONCLUSIONS",
          "bbox": [
            0.9917,
            1.8458,
            3.2574,
            2.0134
          ]
        },
        {
          "block_id": "p6_line_7",
          "block_type": "paragraph",
          "text": "27",
          "bbox": [
            6.8992,
            1.8587,
            7.0772,
            2.0041
          ]
        },
        {
          "block_id": "p6_line_8",
          "block_type": "paragraph",
          "text": "13.",
          "bbox": [
            0.9808,
            2.1757,
            1.2024,
            2.3195
          ]
        },
        {
          "block_id": "p6_line_9",
          "block_type": "paragraph",
          "text": "DISCUSSION AND OVERALL CONCLUSIONS",
          "bbox": [
            1.3719,
            2.1527,
            5.0428,
            2.3316
          ]
        },
        {
          "block_id": "p6_line_10",
          "block_type": "paragraph",
          "text": "27",
          "bbox": [
            6.8961,
            2.1722,
            7.0761,
            2.3175
          ]
        },
        {
          "block_id": "p6_line_11",
          "block_type": "paragraph",
          "text": "14.",
          "bbox": [
            0.9799,
            2.4836,
            1.2034,
            2.6276
          ]
        },
        {
          "block_id": "p6_line_12",
          "block_type": "paragraph",
          "text": "TABLES, FIGURES AND GRAPHS REFERRED TO BUT NOT",
          "bbox": [
            1.2035,
            2.4668,
            6.197,
            2.6372
          ]
        },
        {
          "block_id": "p6_line_13",
          "block_type": "paragraph",
          "text": "INCLUDED IN THE TEXT",
          "bbox": [
            1.3803,
            2.6517,
            3.4617,
            2.8147
          ]
        },
        {
          "block_id": "p6_line_14",
          "block_type": "paragraph",
          "text": "27",
          "bbox": [
            6.8964,
            2.6621,
            7.0782,
            2.8082
          ]
        },
        {
          "block_id": "p6_line_15",
          "block_type": "paragraph",
          "text": "14.1 DEMOGRAPHIC DATA",
          "bbox": [
            0.9894,
            2.9626,
            3.1125,
            3.1226
          ]
        },
        {
          "block_id": "p6_line_16",
          "block_type": "paragraph",
          "text": "27",
          "bbox": [
            6.9,
            2.9707,
            7.0772,
            3.1163
          ]
        },
        {
          "block_id": "p6_line_17",
          "block_type": "paragraph",
          "text": "14.2",
          "bbox": [
            0.9841,
            3.2792,
            1.2835,
            3.4269
          ]
        },
        {
          "block_id": "p6_line_18",
          "block_type": "paragraph",
          "text": "EFFICACY DATA",
          "bbox": [
            1.3821,
            3.2696,
            2.6915,
            3.4334
          ]
        },
        {
          "block_id": "p6_line_19",
          "block_type": "paragraph",
          "text": "28",
          "bbox": [
            6.8999,
            3.2809,
            7.0809,
            3.4246
          ]
        },
        {
          "block_id": "p6_line_20",
          "block_type": "paragraph",
          "text": "14.3",
          "bbox": [
            0.9831,
            3.588,
            1.2822,
            3.7371
          ]
        },
        {
          "block_id": "p6_line_21",
          "block_type": "paragraph",
          "text": "SAFETY DATA",
          "bbox": [
            1.256,
            3.582,
            2.5078,
            3.7412
          ]
        },
        {
          "block_id": "p6_line_22",
          "block_type": "paragraph",
          "text": "28",
          "bbox": [
            6.9021,
            3.5906,
            7.0801,
            3.7318
          ]
        },
        {
          "block_id": "p6_line_23",
          "block_type": "paragraph",
          "text": "14.3.1 Displays of Adverse Events",
          "bbox": [
            1.3973,
            3.8829,
            3.9188,
            4.0646
          ]
        },
        {
          "block_id": "p6_line_24",
          "block_type": "paragraph",
          "text": "28",
          "bbox": [
            6.9,
            3.8962,
            7.0825,
            4.0408
          ]
        },
        {
          "block_id": "p6_line_25",
          "block_type": "paragraph",
          "text": "14.3.2",
          "bbox": [
            1.4013,
            4.2021,
            1.8275,
            4.3579
          ]
        },
        {
          "block_id": "p6_line_26",
          "block_type": "paragraph",
          "text": "Listings of Deaths, Other Serious and Significant Adverse Events",
          "bbox": [
            1.9585,
            4.1919,
            6.6243,
            4.3768
          ]
        },
        {
          "block_id": "p6_line_27",
          "block_type": "paragraph",
          "text": "28",
          "bbox": [
            6.8958,
            4.2023,
            7.0769,
            4.3483
          ]
        },
        {
          "block_id": "p6_line_28",
          "block_type": "paragraph",
          "text": "14.3.3 Narratives of Deaths, Other Serious and Certain Other Significant",
          "bbox": [
            1.4023,
            4.4996,
            6.7065,
            4.6881
          ]
        },
        {
          "block_id": "p6_line_29",
          "block_type": "paragraph",
          "text": "Adverse Events",
          "bbox": [
            1.9657,
            4.6891,
            3.0963,
            4.8528
          ]
        },
        {
          "block_id": "p6_line_30",
          "block_type": "paragraph",
          "text": "28",
          "bbox": [
            6.9004,
            4.6973,
            7.0814,
            4.8411
          ]
        },
        {
          "block_id": "p6_line_31",
          "block_type": "paragraph",
          "text": "14.3.4 Abnormal Laboratory Value Listing (Each Patient)",
          "bbox": [
            1.402,
            4.9909,
            5.591,
            5.174
          ]
        },
        {
          "block_id": "p6_line_32",
          "block_type": "paragraph",
          "text": "28",
          "bbox": [
            6.8986,
            5.0057,
            7.079,
            5.1495
          ]
        },
        {
          "block_id": "p6_line_33",
          "block_type": "paragraph",
          "text": "15.",
          "bbox": [
            0.9808,
            5.3115,
            1.2017,
            5.462
          ]
        },
        {
          "block_id": "p6_line_34",
          "block_type": "paragraph",
          "text": "REFERENCE LIST",
          "bbox": [
            1.3822,
            5.2993,
            2.9081,
            5.4677
          ]
        },
        {
          "block_id": "p6_line_35",
          "block_type": "paragraph",
          "text": "28",
          "bbox": [
            6.898,
            5.3127,
            7.0802,
            5.4573
          ]
        },
        {
          "block_id": "p6_line_36",
          "block_type": "paragraph",
          "text": "16.",
          "bbox": [
            0.9809,
            5.6228,
            1.2032,
            5.7715
          ]
        },
        {
          "block_id": "p6_line_37",
          "block_type": "paragraph",
          "text": "APPENDICES",
          "bbox": [
            1.3709,
            5.6131,
            2.5228,
            5.7745
          ]
        },
        {
          "block_id": "p6_line_38",
          "block_type": "paragraph",
          "text": "28",
          "bbox": [
            6.8957,
            5.6206,
            7.0785,
            5.7638
          ]
        },
        {
          "block_id": "p6_line_39",
          "block_type": "paragraph",
          "text": "16.1",
          "bbox": [
            0.9826,
            5.9288,
            1.2756,
            6.0817
          ]
        },
        {
          "block_id": "p6_line_40",
          "block_type": "paragraph",
          "text": "STUDY INFORMATION",
          "bbox": [
            1.3817,
            5.9157,
            3.1759,
            6.087
          ]
        },
        {
          "block_id": "p6_line_41",
          "block_type": "paragraph",
          "text": "28",
          "bbox": [
            6.8997,
            5.93,
            7.0809,
            6.0755
          ]
        },
        {
          "block_id": "p6_line_42",
          "block_type": "paragraph",
          "text": "16.1.1",
          "bbox": [
            1.402,
            6.2369,
            1.8236,
            6.3886
          ]
        },
        {
          "block_id": "p6_line_43",
          "block_type": "paragraph",
          "text": "Protocol and protocol amendments",
          "bbox": [
            1.9634,
            6.2298,
            4.4299,
            6.4055
          ]
        },
        {
          "block_id": "p6_line_44",
          "block_type": "paragraph",
          "text": "28",
          "bbox": [
            6.9018,
            6.2402,
            7.0801,
            6.3826
          ]
        },
        {
          "block_id": "p6_line_45",
          "block_type": "paragraph",
          "text": "16.1.2",
          "bbox": [
            1.4015,
            6.5436,
            1.8289,
            6.6975
          ]
        },
        {
          "block_id": "p6_line_46",
          "block_type": "paragraph",
          "text": "Sample case report form (unique pages only)",
          "bbox": [
            1.9632,
            6.536,
            5.1257,
            6.7265
          ]
        },
        {
          "block_id": "p6_line_47",
          "block_type": "paragraph",
          "text": "28",
          "bbox": [
            6.9032,
            6.547,
            7.0804,
            6.6907
          ]
        },
        {
          "block_id": "p6_line_48",
          "block_type": "paragraph",
          "text": "16.1.3",
          "bbox": [
            1.4024,
            6.8519,
            1.8273,
            7.0061
          ]
        },
        {
          "block_id": "p6_line_49",
          "block_type": "paragraph",
          "text": "List of IECs or IRBs (plus the name of the committee Chair if required",
          "bbox": [
            1.9593,
            6.8392,
            6.9712,
            7.0275
          ]
        },
        {
          "block_id": "p6_line_50",
          "block_type": "paragraph",
          "text": "by the regulatory authority) - Representative written information for",
          "bbox": [
            1.9658,
            7.0273,
            6.8486,
            7.2134
          ]
        },
        {
          "block_id": "p6_line_51",
          "block_type": "paragraph",
          "text": "patient and sample consent forms",
          "bbox": [
            1.965,
            7.212,
            4.3782,
            7.396
          ]
        },
        {
          "block_id": "p6_line_52",
          "block_type": "paragraph",
          "text": "28",
          "bbox": [
            6.8994,
            7.2193,
            7.0801,
            7.362
          ]
        },
        {
          "block_id": "p6_line_53",
          "block_type": "paragraph",
          "text": "16.1.4",
          "bbox": [
            1.4004,
            7.5262,
            1.8295,
            7.6802
          ]
        },
        {
          "block_id": "p6_line_54",
          "block_type": "paragraph",
          "text": "List and description of investigators and other important participants",
          "bbox": [
            1.9621,
            7.5172,
            6.9133,
            7.7042
          ]
        },
        {
          "block_id": "p6_line_55",
          "block_type": "paragraph",
          "text": "in the study, including brief (1 page) CVs or equivalent summaries of",
          "bbox": [
            1.9672,
            7.6993,
            6.8785,
            7.8858
          ]
        },
        {
          "block_id": "p6_line_56",
          "block_type": "paragraph",
          "text": "training and experience relevant to the performance of the clinical",
          "bbox": [
            1.971,
            7.8823,
            6.6701,
            8.0685
          ]
        },
        {
          "block_id": "p6_line_57",
          "block_type": "paragraph",
          "text": "study",
          "bbox": [
            1.9735,
            8.0799,
            2.3814,
            8.2415
          ]
        },
        {
          "block_id": "p6_line_58",
          "block_type": "paragraph",
          "text": "28",
          "bbox": [
            6.9018,
            8.0788,
            7.082,
            8.2194
          ]
        },
        {
          "block_id": "p6_line_59",
          "block_type": "paragraph",
          "text": "16.1.5",
          "bbox": [
            1.4033,
            8.3825,
            1.8286,
            8.5371
          ]
        },
        {
          "block_id": "p6_line_60",
          "block_type": "paragraph",
          "text": "Signatures of principal or coordinating investigator(s) or sponsor's",
          "bbox": [
            1.97,
            8.3749,
            6.6612,
            8.5625
          ]
        },
        {
          "block_id": "p6_line_61",
          "block_type": "paragraph",
          "text": "responsible medical officer, depending on the regulatory authority's",
          "bbox": [
            1.9674,
            8.5622,
            6.7538,
            8.7398
          ]
        },
        {
          "block_id": "p6_line_62",
          "block_type": "paragraph",
          "text": "requirement",
          "bbox": [
            1.9653,
            8.7556,
            2.8747,
            8.9173
          ]
        },
        {
          "block_id": "p6_line_63",
          "block_type": "paragraph",
          "text": "28",
          "bbox": [
            6.9021,
            8.7529,
            7.0816,
            8.8937
          ]
        },
        {
          "block_id": "p6_line_64",
          "block_type": "paragraph",
          "text": "16.1.6",
          "bbox": [
            1.4016,
            9.0578,
            1.8294,
            9.2093
          ]
        },
        {
          "block_id": "p6_line_65",
          "block_type": "paragraph",
          "text": "Listing of patients receiving test drug(s)/investigational product(s) from",
          "bbox": [
            1.9651,
            9.0497,
            7.0446,
            9.2332
          ]
        },
        {
          "block_id": "p6_line_66",
          "block_type": "paragraph",
          "text": "specific batches, where more than one batch was used",
          "bbox": [
            1.9695,
            9.2342,
            5.7947,
            9.4194
          ]
        },
        {
          "block_id": "p6_line_67",
          "block_type": "paragraph",
          "text": "28",
          "bbox": [
            6.9005,
            9.2506,
            7.08,
            9.3902
          ]
        },
        {
          "block_id": "p6_line_68",
          "block_type": "paragraph",
          "text": "16.1.7",
          "bbox": [
            1.4011,
            9.555,
            1.8261,
            9.7021
          ]
        },
        {
          "block_id": "p6_line_69",
          "block_type": "paragraph",
          "text": "Randomisation scheme and codes (patient identification and treatment",
          "bbox": [
            1.9664,
            9.5463,
            7.002,
            9.7211
          ]
        },
        {
          "block_id": "p6_line_70",
          "block_type": "paragraph",
          "text": "assigned)",
          "bbox": [
            1.9692,
            9.7416,
            2.654,
            9.9072
          ]
        },
        {
          "block_id": "p6_line_71",
          "block_type": "paragraph",
          "text": "29",
          "bbox": [
            6.9037,
            9.7426,
            7.0774,
            9.877
          ]
        },
        {
          "block_id": "p6_line_72",
          "block_type": "paragraph",
          "text": "16.1.8",
          "bbox": [
            1.4029,
            10.0483,
            1.829,
            10.1944
          ]
        },
        {
          "block_id": "p6_line_73",
          "block_type": "paragraph",
          "text": "Audit certificates (if available)",
          "bbox": [
            1.9605,
            10.04,
            4.1259,
            10.2094
          ]
        },
        {
          "block_id": "p6_line_74",
          "block_type": "paragraph",
          "text": "(see Annex IVa and IVb of the guideline)",
          "bbox": [
            1.9741,
            10.2229,
            4.8536,
            10.3936
          ]
        },
        {
          "block_id": "p6_line_75",
          "block_type": "paragraph",
          "text": "29",
          "bbox": [
            6.8983,
            10.2323,
            7.0768,
            10.3697
          ]
        },
        {
          "block_id": "p6_line_76",
          "block_type": "paragraph",
          "text": "16.1.9",
          "bbox": [
            1.4011,
            10.5425,
            1.8275,
            10.6841
          ]
        },
        {
          "block_id": "p6_line_77",
          "block_type": "paragraph",
          "text": "Documentation of statistical methods",
          "bbox": [
            1.9595,
            10.5358,
            4.6286,
            10.6982
          ]
        },
        {
          "block_id": "p6_line_78",
          "block_type": "paragraph",
          "text": "29",
          "bbox": [
            6.9003,
            10.5445,
            7.0759,
            10.6776
          ]
        },
        {
          "block_id": "p6_line_79",
          "block_type": "paragraph",
          "text": "iv",
          "bbox": [
            3.9535,
            10.9552,
            4.1003,
            11.0877
          ]
        }
      ]
    },
    {
      "page_number": 7,
      "width": 8.2639,
      "height": 11.6944,
      "unit": "inch",
      "blocks": [
        {
          "block_id": "p7_line_0",
          "block_type": "paragraph",
          "text": "Structure and Content of Clinical Study Reports",
          "bbox": [
            4.1849,
            0.7138,
            7.2886,
            0.8857
          ]
        },
        {
          "block_id": "p7_line_1",
          "block_type": "paragraph",
          "text": "16.1.10 Documentation of inter-laboratory standardisation methods and quality",
          "bbox": [
            1.5949,
            1.0507,
            7.2362,
            1.2321
          ]
        },
        {
          "block_id": "p7_line_2",
          "block_type": "paragraph",
          "text": "assurance procedures if used",
          "bbox": [
            2.167,
            1.2453,
            4.2319,
            1.4161
          ]
        },
        {
          "block_id": "p7_line_3",
          "block_type": "paragraph",
          "text": "29",
          "bbox": [
            7.0958,
            1.247,
            7.2771,
            1.3924
          ]
        },
        {
          "block_id": "p7_line_4",
          "block_type": "paragraph",
          "text": "16.1.11 Publications based on the study",
          "bbox": [
            1.5927,
            1.5475,
            4.4044,
            1.7187
          ]
        },
        {
          "block_id": "p7_line_5",
          "block_type": "paragraph",
          "text": "29",
          "bbox": [
            7.0958,
            1.5536,
            7.2765,
            1.7008
          ]
        },
        {
          "block_id": "p7_line_6",
          "block_type": "paragraph",
          "text": "16.1.12 Important publications referenced in the report",
          "bbox": [
            1.5941,
            1.8516,
            5.5132,
            2.0251
          ]
        },
        {
          "block_id": "p7_line_7",
          "block_type": "paragraph",
          "text": "29",
          "bbox": [
            7.0957,
            1.8609,
            7.2758,
            2.0023
          ]
        },
        {
          "block_id": "p7_line_8",
          "block_type": "paragraph",
          "text": "16.2. PATIENT DATA LISTINGS",
          "bbox": [
            1.1816,
            2.1527,
            3.603,
            2.3221
          ]
        },
        {
          "block_id": "p7_line_9",
          "block_type": "paragraph",
          "text": "29",
          "bbox": [
            7.0968,
            2.1663,
            7.2755,
            2.3106
          ]
        },
        {
          "block_id": "p7_line_10",
          "block_type": "paragraph",
          "text": "16.2.1",
          "bbox": [
            1.5968,
            2.4762,
            2.0157,
            2.6219
          ]
        },
        {
          "block_id": "p7_line_11",
          "block_type": "paragraph",
          "text": "Discontinued patients",
          "bbox": [
            2.0895,
            2.4711,
            3.736,
            2.6381
          ]
        },
        {
          "block_id": "p7_line_12",
          "block_type": "paragraph",
          "text": "29",
          "bbox": [
            7.0962,
            2.4738,
            7.2754,
            2.6201
          ]
        },
        {
          "block_id": "p7_line_13",
          "block_type": "paragraph",
          "text": "16.2.2 Protocol deviations",
          "bbox": [
            1.5939,
            2.7764,
            3.5317,
            2.9395
          ]
        },
        {
          "block_id": "p7_line_14",
          "block_type": "paragraph",
          "text": "29",
          "bbox": [
            7.0963,
            2.7835,
            7.274,
            2.9286
          ]
        },
        {
          "block_id": "p7_line_15",
          "block_type": "paragraph",
          "text": "16.2.3",
          "bbox": [
            1.5961,
            3.0922,
            2.0235,
            3.2414
          ]
        },
        {
          "block_id": "p7_line_16",
          "block_type": "paragraph",
          "text": "Patients excluded from the efficacy analysis",
          "bbox": [
            2.1531,
            3.0858,
            5.2856,
            3.2624
          ]
        },
        {
          "block_id": "p7_line_17",
          "block_type": "paragraph",
          "text": "29",
          "bbox": [
            7.0948,
            3.0931,
            7.2761,
            3.2372
          ]
        },
        {
          "block_id": "p7_line_18",
          "block_type": "paragraph",
          "text": "16.2.4",
          "bbox": [
            1.5962,
            3.3999,
            2.0255,
            3.5485
          ]
        },
        {
          "block_id": "p7_line_19",
          "block_type": "paragraph",
          "text": "Demographic data",
          "bbox": [
            2.153,
            3.3918,
            3.4798,
            3.5687
          ]
        },
        {
          "block_id": "p7_line_20",
          "block_type": "paragraph",
          "text": "29",
          "bbox": [
            7.0969,
            3.4003,
            7.275,
            3.5446
          ]
        },
        {
          "block_id": "p7_line_21",
          "block_type": "paragraph",
          "text": "16.2.5",
          "bbox": [
            1.5982,
            3.7048,
            2.0255,
            3.8592
          ]
        },
        {
          "block_id": "p7_line_22",
          "block_type": "paragraph",
          "text": "Compliance and/or drug concentration data (if available)",
          "bbox": [
            2.162,
            3.693,
            6.1748,
            3.8847
          ]
        },
        {
          "block_id": "p7_line_23",
          "block_type": "paragraph",
          "text": "29",
          "bbox": [
            7.0965,
            3.7074,
            7.2739,
            3.8544
          ]
        },
        {
          "block_id": "p7_line_24",
          "block_type": "paragraph",
          "text": "16.2.6",
          "bbox": [
            1.5946,
            4.0163,
            2.0262,
            4.1666
          ]
        },
        {
          "block_id": "p7_line_25",
          "block_type": "paragraph",
          "text": "Individual efficacy response data",
          "bbox": [
            2.1554,
            4.0073,
            4.5111,
            4.1856
          ]
        },
        {
          "block_id": "p7_line_26",
          "block_type": "paragraph",
          "text": "29",
          "bbox": [
            7.0935,
            4.0153,
            7.2746,
            4.1622
          ]
        },
        {
          "block_id": "p7_line_27",
          "block_type": "paragraph",
          "text": "16.2.7",
          "bbox": [
            1.597,
            4.323,
            2.0268,
            4.4758
          ]
        },
        {
          "block_id": "p7_line_28",
          "block_type": "paragraph",
          "text": "Adverse event listings (each patient)",
          "bbox": [
            2.0269,
            4.3169,
            4.7604,
            4.499
          ]
        },
        {
          "block_id": "p7_line_29",
          "block_type": "paragraph",
          "text": "29",
          "bbox": [
            7.0963,
            4.3276,
            7.2764,
            4.4698
          ]
        },
        {
          "block_id": "p7_line_30",
          "block_type": "paragraph",
          "text": "16.2.8.",
          "bbox": [
            1.596,
            4.6337,
            2.052,
            4.7838
          ]
        },
        {
          "block_id": "p7_line_31",
          "block_type": "paragraph",
          "text": "Listing of individual laboratory measurements by patient, when",
          "bbox": [
            2.1568,
            4.6238,
            6.6989,
            4.8097
          ]
        },
        {
          "block_id": "p7_line_32",
          "block_type": "paragraph",
          "text": "required by regulatory authorities",
          "bbox": [
            2.1587,
            4.8137,
            4.6059,
            4.999
          ]
        },
        {
          "block_id": "p7_line_33",
          "block_type": "paragraph",
          "text": "29",
          "bbox": [
            7.0966,
            4.8201,
            7.2769,
            4.9674
          ]
        },
        {
          "block_id": "p7_line_34",
          "block_type": "paragraph",
          "text": "16.3 CASE REPORT FORMS",
          "bbox": [
            1.1825,
            5.1127,
            3.3381,
            5.2855
          ]
        },
        {
          "block_id": "p7_line_35",
          "block_type": "paragraph",
          "text": "29",
          "bbox": [
            7.0967,
            5.1278,
            7.2754,
            5.2751
          ]
        },
        {
          "block_id": "p7_line_36",
          "block_type": "paragraph",
          "text": "16.3.1",
          "bbox": [
            1.5963,
            5.4381,
            2.0151,
            5.5892
          ]
        },
        {
          "block_id": "p7_line_37",
          "block_type": "paragraph",
          "text": "CRFs for deaths, other serious adverse events and",
          "bbox": [
            2.1672,
            5.4249,
            5.7397,
            5.6058
          ]
        },
        {
          "block_id": "p7_line_38",
          "block_type": "paragraph",
          "text": "withdrawals for AE",
          "bbox": [
            2.1635,
            5.6103,
            3.5719,
            5.7811
          ]
        },
        {
          "block_id": "p7_line_39",
          "block_type": "paragraph",
          "text": "29",
          "bbox": [
            7.0986,
            5.6189,
            7.2761,
            5.7681
          ]
        },
        {
          "block_id": "p7_line_40",
          "block_type": "paragraph",
          "text": "16.3.2",
          "bbox": [
            1.5955,
            5.9285,
            2.0248,
            6.082
          ]
        },
        {
          "block_id": "p7_line_41",
          "block_type": "paragraph",
          "text": "Other CRFs submitted",
          "bbox": [
            2.1055,
            5.9215,
            3.7939,
            6.0885
          ]
        },
        {
          "block_id": "p7_line_42",
          "block_type": "paragraph",
          "text": "29",
          "bbox": [
            7.0963,
            5.9272,
            7.2774,
            6.0772
          ]
        },
        {
          "block_id": "p7_line_43",
          "block_type": "paragraph",
          "text": "16.4. INDIVIDUAL PATIENT DATA LISTINGS (US ARCHIVAL LISTINGS)",
          "bbox": [
            1.1786,
            6.2153,
            6.6875,
            6.4024
          ]
        },
        {
          "block_id": "p7_line_44",
          "block_type": "paragraph",
          "text": "29",
          "bbox": [
            7.0938,
            6.2364,
            7.2748,
            6.3825
          ]
        },
        {
          "block_id": "p7_line_45",
          "block_type": "paragraph",
          "text": "ANNEX I",
          "bbox": [
            1.1633,
            6.5357,
            1.8815,
            6.7006
          ]
        },
        {
          "block_id": "p7_line_46",
          "block_type": "paragraph",
          "text": "Synopsis (Example)",
          "bbox": [
            2.1644,
            6.534,
            3.5737,
            6.7226
          ]
        },
        {
          "block_id": "p7_line_47",
          "block_type": "paragraph",
          "text": "30",
          "bbox": [
            7.0964,
            6.5457,
            7.2767,
            6.6938
          ]
        },
        {
          "block_id": "p7_line_48",
          "block_type": "paragraph",
          "text": "ANNEX II",
          "bbox": [
            1.1636,
            6.8422,
            1.9414,
            7.008
          ]
        },
        {
          "block_id": "p7_line_49",
          "block_type": "paragraph",
          "text": "Principal or Coordinating Investigator(s) Signature(s) or Sponsor's",
          "bbox": [
            2.1657,
            6.8409,
            6.8702,
            7.0309
          ]
        },
        {
          "block_id": "p7_line_50",
          "block_type": "paragraph",
          "text": "Responsible Medical Officer (Example)",
          "bbox": [
            2.1628,
            7.0268,
            4.9095,
            7.2125
          ]
        },
        {
          "block_id": "p7_line_51",
          "block_type": "paragraph",
          "text": "32",
          "bbox": [
            7.096,
            7.0358,
            7.2743,
            7.182
          ]
        },
        {
          "block_id": "p7_line_52",
          "block_type": "paragraph",
          "text": "ANNEX IIIa Study Design and Schedule of Assessments (Example)",
          "bbox": [
            1.1623,
            7.328,
            5.9642,
            7.5203
          ]
        },
        {
          "block_id": "p7_line_53",
          "block_type": "paragraph",
          "text": "33",
          "bbox": [
            7.0923,
            7.3446,
            7.2716,
            7.4899
          ]
        },
        {
          "block_id": "p7_line_54",
          "block_type": "paragraph",
          "text": "ANNEX IIIb Study Design and Schedule of Assessments (Example)",
          "bbox": [
            1.1654,
            7.6345,
            5.9627,
            7.8297
          ]
        },
        {
          "block_id": "p7_line_55",
          "block_type": "paragraph",
          "text": "34",
          "bbox": [
            7.0945,
            7.6547,
            7.2769,
            7.8005
          ]
        },
        {
          "block_id": "p7_line_56",
          "block_type": "paragraph",
          "text": "ANNEX IVa Disposition of Patients (Example)",
          "bbox": [
            1.1631,
            7.9446,
            4.5359,
            8.137
          ]
        },
        {
          "block_id": "p7_line_57",
          "block_type": "paragraph",
          "text": "35",
          "bbox": [
            7.0943,
            7.9587,
            7.2746,
            8.1076
          ]
        },
        {
          "block_id": "p7_line_58",
          "block_type": "paragraph",
          "text": "ANNEX IVb Disposition of Patients (Example)",
          "bbox": [
            1.1617,
            8.2588,
            4.541,
            8.45
          ]
        },
        {
          "block_id": "p7_line_59",
          "block_type": "paragraph",
          "text": "36",
          "bbox": [
            7.0954,
            8.2757,
            7.2771,
            8.4225
          ]
        },
        {
          "block_id": "p7_line_60",
          "block_type": "paragraph",
          "text": "ANNEX V",
          "bbox": [
            1.1625,
            8.5746,
            1.9394,
            8.7362
          ]
        },
        {
          "block_id": "p7_line_61",
          "block_type": "paragraph",
          "text": "Listing of Patients Who Discontinued Therapy (Example)",
          "bbox": [
            2.1598,
            8.5653,
            6.1971,
            8.76
          ]
        },
        {
          "block_id": "p7_line_62",
          "block_type": "paragraph",
          "text": "37",
          "bbox": [
            7.0928,
            8.582,
            7.2726,
            8.7319
          ]
        },
        {
          "block_id": "p7_line_63",
          "block_type": "paragraph",
          "text": "ANNEX VI",
          "bbox": [
            1.1611,
            8.8846,
            1.989,
            9.0441
          ]
        },
        {
          "block_id": "p7_line_64",
          "block_type": "paragraph",
          "text": "Listing of Patients and Observations Excluded from",
          "bbox": [
            2.1657,
            8.8806,
            5.8183,
            9.0614
          ]
        },
        {
          "block_id": "p7_line_65",
          "block_type": "paragraph",
          "text": "Efficacy Analysis",
          "bbox": [
            2.1677,
            9.0678,
            3.3946,
            9.2466
          ]
        },
        {
          "block_id": "p7_line_66",
          "block_type": "paragraph",
          "text": "38",
          "bbox": [
            7.0964,
            9.0782,
            7.278,
            9.2205
          ]
        },
        {
          "block_id": "p7_line_67",
          "block_type": "paragraph",
          "text": "ANNEX VII Number of Patients Excluded from Efficacy Analysis (Example).",
          "bbox": [
            1.1649,
            9.3647,
            6.6343,
            9.5614
          ]
        },
        {
          "block_id": "p7_line_68",
          "block_type": "paragraph",
          "text": "39",
          "bbox": [
            7.0939,
            9.3848,
            7.273,
            9.5284
          ]
        },
        {
          "block_id": "p7_line_69",
          "block_type": "paragraph",
          "text": "ANNEX VIII Guidance for Section 11.4.2 - Statistical/ Analytical Issues and",
          "bbox": [
            1.1634,
            9.6788,
            6.6158,
            9.8572
          ]
        },
        {
          "block_id": "p7_line_70",
          "block_type": "paragraph",
          "text": "Appendix 16.1.9.",
          "bbox": [
            2.1588,
            9.8705,
            3.3403,
            10.0449
          ]
        },
        {
          "block_id": "p7_line_71",
          "block_type": "paragraph",
          "text": "40",
          "bbox": [
            7.1033,
            9.8795,
            7.2767,
            10.0199
          ]
        },
        {
          "block_id": "p7_line_72",
          "block_type": "paragraph",
          "text": "v",
          "bbox": [
            4.1936,
            11.0001,
            4.2719,
            11.072
          ]
        },
        {
          "block_id": "table_3",
          "block_type": "table",
          "page_number": 7,
          "bbox": [
            1.0924,
            0.919,
            7.3507,
            10.0915
          ],
          "headers": [],
          "rows": [
            [
              "16.1.10 Documentation of inter-laboratory standardisation methods and quality assurance procedures if used 29",
              ""
            ],
            [
              "16.1.11 Publications based on the study 29",
              ""
            ],
            [
              "16.1.12 Important publications referenced in the report 29",
              ""
            ],
            [
              "16.2. PATIENT DATA LISTINGS 29",
              ""
            ],
            [
              "16.2.1",
              "Discontinued patients 29"
            ],
            [
              "16.2.2",
              "Protocol deviations 29"
            ],
            [
              "16.2.3",
              "Patients excluded from the efficacy analysis 29"
            ],
            [
              "16.2.4",
              "Demographic data 29"
            ],
            [
              "16.2.5",
              "Compliance and/or drug concentration data (if available) 29"
            ],
            [
              "16.2.6",
              "Individual efficacy response data 29"
            ],
            [
              "16.2.7",
              "Adverse event listings (each patient) 29"
            ],
            [
              "16.2.8.",
              "Listing of individual laboratory measurements by patient, when required by regulatory authorities 29"
            ],
            [
              "16.3 CASE REPORT FORMS 29",
              ""
            ],
            [
              "16.3.1",
              "CRFs for deaths, other serious adverse events and withdrawals for AE 29"
            ],
            [
              "16.3.2",
              "Other CRFs submitted 29"
            ],
            [
              "16.4. INDIVIDUAL PATIENT DATA LISTINGS (US ARCHIVAL LISTINGS) 29",
              ""
            ],
            [
              "ANNEX I",
              "Synopsis (Example) 30"
            ],
            [
              "ANNEX II",
              "Principal or Coordinating Investigator(s) Signature(s) or Sponsor's Responsible Medical Officer (Example) 32"
            ],
            [
              "ANNEX IIIa",
              "Study Design and Schedule of Assessments (Example) 33"
            ],
            [
              "ANNEX IIIb",
              "Study Design and Schedule of Assessments (Example) 34"
            ],
            [
              "ANNEX IVa",
              "Disposition of Patients (Example) 35"
            ],
            [
              "ANNEX IVb",
              "Disposition of Patients (Example) 36"
            ],
            [
              "ANNEX V",
              "Listing of Patients Who Discontinued Therapy (Example) 37"
            ],
            [
              "ANNEX VI",
              "Listing of Patients and Observations Excluded from Efficacy Analysis 38"
            ],
            [
              "ANNEX VII",
              "Number of Patients Excluded from Efficacy Analysis (Example). 39"
            ],
            [
              "ANNEX VIII",
              "Guidance for Section 11.4.2 - Statistical/ Analytical Issues and Appendix 16.1.9. 40"
            ]
          ]
        }
      ]
    },
    {
      "page_number": 8,
      "width": 8.2639,
      "height": 11.6944,
      "unit": "inch",
      "blocks": []
    },
    {
      "page_number": 9,
      "width": 8.2639,
      "height": 11.6944,
      "unit": "inch",
      "blocks": [
        {
          "block_id": "p9_line_0",
          "block_type": "paragraph",
          "text": "STRUCTURE AND CONTENT OF CLINICAL STUDY REPORTS",
          "bbox": [
            1.6454,
            1.0467,
            6.807,
            1.2403
          ]
        },
        {
          "block_id": "p9_line_1",
          "block_type": "paragraph",
          "text": "INTRODUCTION TO THE GUIDELINE",
          "bbox": [
            2.6786,
            1.5075,
            5.7686,
            1.6753
          ]
        },
        {
          "block_id": "p9_line_2",
          "block_type": "paragraph",
          "text": "The objective of this guideline is to allow the compilation of a single core clinical study",
          "bbox": [
            1.1677,
            2.0714,
            7.2895,
            2.2625
          ]
        },
        {
          "block_id": "p9_line_3",
          "block_type": "paragraph",
          "text": "report acceptable to all regulatory authorities of the ICH regions. The regulatory",
          "bbox": [
            1.1649,
            2.2648,
            7.2866,
            2.4533
          ]
        },
        {
          "block_id": "p9_line_4",
          "block_type": "paragraph",
          "text": "authority specific additions will consist of modules to be considered as appendices,",
          "bbox": [
            1.1696,
            2.4455,
            7.2804,
            2.6366
          ]
        },
        {
          "block_id": "p9_line_5",
          "block_type": "paragraph",
          "text": "available upon request according to regional regulatory requirements.",
          "bbox": [
            1.1698,
            2.6335,
            6.1186,
            2.8163
          ]
        },
        {
          "block_id": "p9_line_6",
          "block_type": "paragraph",
          "text": "The clinical study report described in this guideline is an \"integrated\" full report of an",
          "bbox": [
            1.1668,
            2.935,
            7.2896,
            3.1235
          ]
        },
        {
          "block_id": "p9_line_7",
          "block_type": "paragraph",
          "text": "individual study of any therapeutic, prophylactic or diagnostic agent (referred to",
          "bbox": [
            1.1601,
            3.1211,
            7.2878,
            3.3108
          ]
        },
        {
          "block_id": "p9_line_8",
          "block_type": "paragraph",
          "text": "herein as drug or treatment) conducted in patients, in which the clinical and",
          "bbox": [
            1.1607,
            3.2972,
            7.2924,
            3.4889
          ]
        },
        {
          "block_id": "p9_line_9",
          "block_type": "paragraph",
          "text": "statistical description, presentations, and analyses are integrated into a single report,",
          "bbox": [
            1.167,
            3.4889,
            7.2801,
            3.6746
          ]
        },
        {
          "block_id": "p9_line_10",
          "block_type": "paragraph",
          "text": "incorporating tables and figures into the main text of the report, or at the end of the",
          "bbox": [
            1.16,
            3.6659,
            7.2873,
            3.857
          ]
        },
        {
          "block_id": "p9_line_11",
          "block_type": "paragraph",
          "text": "text, and with appendices containing the protocol, sample case report forms,",
          "bbox": [
            1.1654,
            3.8521,
            7.2778,
            4.0396
          ]
        },
        {
          "block_id": "p9_line_12",
          "block_type": "paragraph",
          "text": "investigator related information, information related to the test drugs/investigational",
          "bbox": [
            1.1613,
            4.0307,
            7.2907,
            4.2198
          ]
        },
        {
          "block_id": "p9_line_13",
          "block_type": "paragraph",
          "text": "products including active control/comparators, technical statistical documentation,",
          "bbox": [
            1.1642,
            4.2232,
            7.2778,
            4.4071
          ]
        },
        {
          "block_id": "p9_line_14",
          "block_type": "paragraph",
          "text": "related publications, patient data listings, and technical statistical details such as",
          "bbox": [
            1.1649,
            4.4043,
            7.2904,
            4.5902
          ]
        },
        {
          "block_id": "p9_line_15",
          "block_type": "paragraph",
          "text": "derivations, computations, analyses, and computer output etc. The integrated full",
          "bbox": [
            1.1723,
            4.587,
            7.2911,
            4.7762
          ]
        },
        {
          "block_id": "p9_line_16",
          "block_type": "paragraph",
          "text": "report of a study should not be derived by simply joining a separate clinical and",
          "bbox": [
            1.1646,
            4.768,
            7.292,
            4.9621
          ]
        },
        {
          "block_id": "p9_line_17",
          "block_type": "paragraph",
          "text": "statistical report. Although this guideline is mainly aimed at efficacy and safety",
          "bbox": [
            1.171,
            4.9531,
            7.2893,
            5.1409
          ]
        },
        {
          "block_id": "p9_line_18",
          "block_type": "paragraph",
          "text": "trials, the basic principles and structure described can be applied to other kinds of",
          "bbox": [
            1.1664,
            5.1315,
            7.2977,
            5.3235
          ]
        },
        {
          "block_id": "p9_line_19",
          "block_type": "paragraph",
          "text": "trials, such as clinical pharmacology studies. Depending on the nature and",
          "bbox": [
            1.1665,
            5.317,
            7.2936,
            5.5058
          ]
        },
        {
          "block_id": "p9_line_20",
          "block_type": "paragraph",
          "text": "importance of such studies, a less detailed report might be appropriate.",
          "bbox": [
            1.164,
            5.4992,
            6.2081,
            5.693
          ]
        },
        {
          "block_id": "p9_line_21",
          "block_type": "paragraph",
          "text": "The guideline is intended to assist sponsors in the development of a report that is",
          "bbox": [
            1.1676,
            5.8055,
            7.2867,
            5.9988
          ]
        },
        {
          "block_id": "p9_line_22",
          "block_type": "paragraph",
          "text": "complete, free from ambiguity, well organised and easy to review. The report should",
          "bbox": [
            1.1681,
            5.9919,
            7.2912,
            6.184
          ]
        },
        {
          "block_id": "p9_line_23",
          "block_type": "paragraph",
          "text": "provide a clear explanation of how the critical design features of the study were",
          "bbox": [
            1.1646,
            6.1806,
            7.2876,
            6.3721
          ]
        },
        {
          "block_id": "p9_line_24",
          "block_type": "paragraph",
          "text": "chosen and enough information on the plan, methods and conduct of the study so that",
          "bbox": [
            1.1678,
            6.3631,
            7.2904,
            6.5496
          ]
        },
        {
          "block_id": "p9_line_25",
          "block_type": "paragraph",
          "text": "there is no ambiguity in how the study was carried out. The report with its",
          "bbox": [
            1.1682,
            6.5461,
            7.292,
            6.7337
          ]
        },
        {
          "block_id": "p9_line_26",
          "block_type": "paragraph",
          "text": "appendices should also provide enough individual patient data, including the",
          "bbox": [
            1.1684,
            6.7276,
            7.2889,
            6.9188
          ]
        },
        {
          "block_id": "p9_line_27",
          "block_type": "paragraph",
          "text": "demographic and baseline data, and details of analytical methods, to allow replication",
          "bbox": [
            1.1712,
            6.9109,
            7.2889,
            7.0978
          ]
        },
        {
          "block_id": "p9_line_28",
          "block_type": "paragraph",
          "text": "of the critical analyses when authorities wish to do so. It is also particularly",
          "bbox": [
            1.1701,
            7.092,
            7.2868,
            7.2829
          ]
        },
        {
          "block_id": "p9_line_29",
          "block_type": "paragraph",
          "text": "important that all analyses, tables, and figures carry, in text or as part of the table,",
          "bbox": [
            1.1615,
            7.2815,
            7.2815,
            7.4658
          ]
        },
        {
          "block_id": "p9_line_30",
          "block_type": "paragraph",
          "text": "clear identification of the set of patients from which they were generated.",
          "bbox": [
            1.1668,
            7.4612,
            6.3531,
            7.6455
          ]
        },
        {
          "block_id": "p9_line_31",
          "block_type": "paragraph",
          "text": "Depending on the regulatory authority's review policy, abbreviated reports using",
          "bbox": [
            1.1617,
            7.7662,
            7.2907,
            7.9588
          ]
        },
        {
          "block_id": "p9_line_32",
          "block_type": "paragraph",
          "text": "summarised data or with some sections deleted, may be acceptable for uncontrolled",
          "bbox": [
            1.1667,
            7.9509,
            7.2914,
            8.137
          ]
        },
        {
          "block_id": "p9_line_33",
          "block_type": "paragraph",
          "text": "studies or other studies not designed to establish efficacy (but a controlled safety",
          "bbox": [
            1.1674,
            8.1322,
            7.2879,
            8.3197
          ]
        },
        {
          "block_id": "p9_line_34",
          "block_type": "paragraph",
          "text": "study should be reported in full), for seriously flawed or aborted studies, or for",
          "bbox": [
            1.167,
            8.3209,
            7.2876,
            8.5052
          ]
        },
        {
          "block_id": "p9_line_35",
          "block_type": "paragraph",
          "text": "controlled studies that examine conditions clearly unrelated to those for which a claim",
          "bbox": [
            1.1684,
            8.5048,
            7.2875,
            8.6852
          ]
        },
        {
          "block_id": "p9_line_36",
          "block_type": "paragraph",
          "text": "is made. However, a full description of safety aspects should be included in these",
          "bbox": [
            1.1643,
            8.6887,
            7.2877,
            8.8709
          ]
        },
        {
          "block_id": "p9_line_37",
          "block_type": "paragraph",
          "text": "cases. If an abbreviated report is submitted, there should be enough detail of design",
          "bbox": [
            1.1682,
            8.87,
            7.2878,
            9.0526
          ]
        },
        {
          "block_id": "p9_line_38",
          "block_type": "paragraph",
          "text": "and results to allow the regulatory authority to determine whether a full report is",
          "bbox": [
            1.1685,
            9.0563,
            7.2886,
            9.2363
          ]
        },
        {
          "block_id": "p9_line_39",
          "block_type": "paragraph",
          "text": "needed. If there is any question regarding whether the reports are needed, it may be",
          "bbox": [
            1.165,
            9.2403,
            7.2889,
            9.4208
          ]
        },
        {
          "block_id": "p9_line_40",
          "block_type": "paragraph",
          "text": "useful to consult the regulatory authority.",
          "bbox": [
            1.1671,
            9.4199,
            4.1456,
            9.6045
          ]
        },
        {
          "block_id": "p9_line_41",
          "block_type": "paragraph",
          "text": "In presenting the detailed description of how the study was carried out, it may be",
          "bbox": [
            1.1628,
            9.7285,
            7.2872,
            9.9092
          ]
        },
        {
          "block_id": "p9_line_42",
          "block_type": "paragraph",
          "text": "possible simply to restate the description in the initial protocol. Often, however, it is",
          "bbox": [
            1.1633,
            9.9089,
            7.2881,
            10.0951
          ]
        },
        {
          "block_id": "p9_line_43",
          "block_type": "paragraph",
          "text": "possible to present the methodology of the study more concisely in a separate",
          "bbox": [
            1.1643,
            10.099,
            7.2857,
            10.2771
          ]
        },
        {
          "block_id": "p9_line_44",
          "block_type": "paragraph",
          "text": "document. In each section describing the design and conduct of the study, it is",
          "bbox": [
            1.1729,
            10.2808,
            7.2862,
            10.4637
          ]
        },
        {
          "block_id": "p9_line_45",
          "block_type": "paragraph",
          "text": "particularly important to clarify features of the study that are not well-described in",
          "bbox": [
            1.1647,
            10.4668,
            7.2867,
            10.6503
          ]
        },
        {
          "block_id": "p9_line_46",
          "block_type": "paragraph",
          "text": "1",
          "bbox": [
            4.1892,
            10.957,
            4.2675,
            11.0785
          ]
        }
      ]
    },
    {
      "page_number": 10,
      "width": 8.2639,
      "height": 11.6944,
      "unit": "inch",
      "blocks": [
        {
          "block_id": "p10_line_0",
          "block_type": "paragraph",
          "text": "Structure and Content of Clinical Study Reports",
          "bbox": [
            0.9738,
            0.7138,
            4.0778,
            0.8866
          ]
        },
        {
          "block_id": "p10_line_1",
          "block_type": "paragraph",
          "text": "the protocol and identify ways in which the study as conducted differed from the",
          "bbox": [
            0.9737,
            1.045,
            7.0894,
            1.2306
          ]
        },
        {
          "block_id": "p10_line_2",
          "block_type": "paragraph",
          "text": "protocol, and to discuss the statistical methods and analyses used to account for these",
          "bbox": [
            0.9691,
            1.2334,
            7.0902,
            1.4145
          ]
        },
        {
          "block_id": "p10_line_3",
          "block_type": "paragraph",
          "text": "deviations from the planned protocol.",
          "bbox": [
            0.9744,
            1.4196,
            3.6127,
            1.602
          ]
        },
        {
          "block_id": "p10_line_4",
          "block_type": "paragraph",
          "text": "The full integrated report of the individual study should include the most detailed",
          "bbox": [
            0.9717,
            1.7236,
            7.0928,
            1.9085
          ]
        },
        {
          "block_id": "p10_line_5",
          "block_type": "paragraph",
          "text": "discussion of individual adverse events or laboratory abnormalities, but these should",
          "bbox": [
            0.9781,
            1.9089,
            7.092,
            2.0937
          ]
        },
        {
          "block_id": "p10_line_6",
          "block_type": "paragraph",
          "text": "usually be reexamined as part of an overall safety analysis of all available data in any",
          "bbox": [
            0.9712,
            2.0932,
            7.0892,
            2.2802
          ]
        },
        {
          "block_id": "p10_line_7",
          "block_type": "paragraph",
          "text": "application.",
          "bbox": [
            0.9741,
            2.2857,
            1.8104,
            2.4573
          ]
        },
        {
          "block_id": "p10_line_8",
          "block_type": "paragraph",
          "text": "The report should describe demographic and other potentially predictive",
          "bbox": [
            0.9707,
            2.581,
            7.0909,
            2.7723
          ]
        },
        {
          "block_id": "p10_line_9",
          "block_type": "paragraph",
          "text": "characteristics of the study population and, where the study is large enough to permit",
          "bbox": [
            0.9729,
            2.7648,
            7.0907,
            2.9531
          ]
        },
        {
          "block_id": "p10_line_10",
          "block_type": "paragraph",
          "text": "this, present data for demographic (e.g., age, sex, race, weight) and other (e.g., renal",
          "bbox": [
            0.9714,
            2.9512,
            7.0918,
            3.1388
          ]
        },
        {
          "block_id": "p10_line_11",
          "block_type": "paragraph",
          "text": "or hepatic function) subgroups so that possible differences in efficacy or safety can be",
          "bbox": [
            0.9727,
            3.1341,
            7.0892,
            3.3176
          ]
        },
        {
          "block_id": "p10_line_12",
          "block_type": "paragraph",
          "text": "identified. Usually, however, subgroup responses should be examined in the larger",
          "bbox": [
            0.9688,
            3.3122,
            7.093,
            3.5048
          ]
        },
        {
          "block_id": "p10_line_13",
          "block_type": "paragraph",
          "text": "database used in the overall analysis.",
          "bbox": [
            0.974,
            3.4962,
            3.6384,
            3.6803
          ]
        },
        {
          "block_id": "p10_line_14",
          "block_type": "paragraph",
          "text": "The data listings requested as part of the report (usually in an appendix) are those",
          "bbox": [
            0.9697,
            3.8042,
            7.0942,
            3.9952
          ]
        },
        {
          "block_id": "p10_line_15",
          "block_type": "paragraph",
          "text": "needed to support critical analyses. Data listings that are part of the report should be",
          "bbox": [
            0.9689,
            3.994,
            7.0914,
            4.1799
          ]
        },
        {
          "block_id": "p10_line_16",
          "block_type": "paragraph",
          "text": "readily usable by the reviewer. Thus, although it may be desirable to include many",
          "bbox": [
            0.9667,
            4.1744,
            7.0909,
            4.3652
          ]
        },
        {
          "block_id": "p10_line_17",
          "block_type": "paragraph",
          "text": "variables in a single listing to limit size, this should not be at the expense of clarity.",
          "bbox": [
            0.9689,
            4.3607,
            7.0842,
            4.5454
          ]
        },
        {
          "block_id": "p10_line_18",
          "block_type": "paragraph",
          "text": "An excess of data should not be allowed to lead to overuse of symbols instead of words",
          "bbox": [
            0.9725,
            4.5409,
            7.0898,
            4.7248
          ]
        },
        {
          "block_id": "p10_line_19",
          "block_type": "paragraph",
          "text": "or easily understood abbreviations or to too small displays etc. In this case, it is",
          "bbox": [
            0.9719,
            4.7243,
            7.0918,
            4.9108
          ]
        },
        {
          "block_id": "p10_line_20",
          "block_type": "paragraph",
          "text": "preferable to produce several listings.",
          "bbox": [
            0.9672,
            4.9121,
            3.6353,
            5.0971
          ]
        },
        {
          "block_id": "p10_line_21",
          "block_type": "paragraph",
          "text": "Data should be presented in the report at different levels of detail: overall summary",
          "bbox": [
            0.9684,
            5.2077,
            7.0924,
            5.4067
          ]
        },
        {
          "block_id": "p10_line_22",
          "block_type": "paragraph",
          "text": "figures and tables for important demographic, efficacy and safety variables may be",
          "bbox": [
            0.9688,
            5.3996,
            7.0937,
            5.5885
          ]
        },
        {
          "block_id": "p10_line_23",
          "block_type": "paragraph",
          "text": "placed in the text to illustrate important points; other summary figures, tables and",
          "bbox": [
            0.9685,
            5.5792,
            7.0955,
            5.7723
          ]
        },
        {
          "block_id": "p10_line_24",
          "block_type": "paragraph",
          "text": "listings for demographic, efficacy and safety variables should be provided in section",
          "bbox": [
            0.9677,
            5.7618,
            7.0926,
            5.9546
          ]
        },
        {
          "block_id": "p10_line_25",
          "block_type": "paragraph",
          "text": "14; individual patient data for specified groups of patients should be provided as",
          "bbox": [
            0.9784,
            5.9523,
            7.0913,
            6.1431
          ]
        },
        {
          "block_id": "p10_line_26",
          "block_type": "paragraph",
          "text": "listings in Appendix 16.2; and all individual patient data (archival listings requested",
          "bbox": [
            0.9679,
            6.1339,
            7.094,
            6.3243
          ]
        },
        {
          "block_id": "p10_line_27",
          "block_type": "paragraph",
          "text": "only in the US) should be provided in Appendix 16.4.",
          "bbox": [
            0.9733,
            6.3176,
            4.7091,
            6.5048
          ]
        },
        {
          "block_id": "p10_line_28",
          "block_type": "paragraph",
          "text": "In any table, figure or data listing, estimated or derived values, if used, should be",
          "bbox": [
            0.9687,
            6.6217,
            7.091,
            6.8155
          ]
        },
        {
          "block_id": "p10_line_29",
          "block_type": "paragraph",
          "text": "identified in a conspicuous fashion. Detailed explanations should be provided as to",
          "bbox": [
            0.9699,
            6.8081,
            7.0891,
            6.9948
          ]
        },
        {
          "block_id": "p10_line_30",
          "block_type": "paragraph",
          "text": "how such values were estimated or derived and what underlying assumptions were",
          "bbox": [
            0.9684,
            6.9912,
            7.0908,
            7.1805
          ]
        },
        {
          "block_id": "p10_line_31",
          "block_type": "paragraph",
          "text": "made.",
          "bbox": [
            0.9737,
            7.1877,
            1.4071,
            7.343
          ]
        },
        {
          "block_id": "p10_line_32",
          "block_type": "paragraph",
          "text": "The guidance provided below is detailed and is intended to notify the applicant of",
          "bbox": [
            0.9739,
            7.4775,
            7.1042,
            7.6669
          ]
        },
        {
          "block_id": "p10_line_33",
          "block_type": "paragraph",
          "text": "virtually all of the information that should routinely be provided so that post-",
          "bbox": [
            0.9725,
            7.6644,
            7.0836,
            7.8503
          ]
        },
        {
          "block_id": "p10_line_34",
          "block_type": "paragraph",
          "text": "submission requests for further data clarification and analyses can be reduced as",
          "bbox": [
            0.9734,
            7.8487,
            7.0908,
            8.0322
          ]
        },
        {
          "block_id": "p10_line_35",
          "block_type": "paragraph",
          "text": "much as possible. Nonetheless, specific requirements for data presentation and/ or",
          "bbox": [
            0.9731,
            8.03,
            7.0924,
            8.2169
          ]
        },
        {
          "block_id": "p10_line_36",
          "block_type": "paragraph",
          "text": "analysis may depend on specific situations, may evolve over time, may vary from drug",
          "bbox": [
            0.9739,
            8.2158,
            7.0946,
            8.4014
          ]
        },
        {
          "block_id": "p10_line_37",
          "block_type": "paragraph",
          "text": "class to drug class, may differ among regions and cannot be described in general",
          "bbox": [
            0.975,
            8.3989,
            7.0911,
            8.5881
          ]
        },
        {
          "block_id": "p10_line_38",
          "block_type": "paragraph",
          "text": "terms; it is therefore important to refer to specific clinical guidelines and to discuss",
          "bbox": [
            0.9733,
            8.5845,
            7.0897,
            8.7708
          ]
        },
        {
          "block_id": "p10_line_39",
          "block_type": "paragraph",
          "text": "data presentation and analyses with the reviewing authority, whenever possible.",
          "bbox": [
            0.9756,
            8.7693,
            7.0798,
            8.9536
          ]
        },
        {
          "block_id": "p10_line_40",
          "block_type": "paragraph",
          "text": "Detailed written guidance on statistical approaches is available from some",
          "bbox": [
            0.971,
            8.9519,
            7.0891,
            9.1376
          ]
        },
        {
          "block_id": "p10_line_41",
          "block_type": "paragraph",
          "text": "authorities.",
          "bbox": [
            0.9727,
            9.1481,
            1.8009,
            9.2983
          ]
        },
        {
          "block_id": "p10_line_42",
          "block_type": "paragraph",
          "text": "Each report should consider all of the topics described (unless clearly not relevant)",
          "bbox": [
            0.976,
            9.4385,
            7.0835,
            9.6244
          ]
        },
        {
          "block_id": "p10_line_43",
          "block_type": "paragraph",
          "text": "although the specific sequence and grouping of topics may be changed if alternatives",
          "bbox": [
            0.9765,
            9.6261,
            7.0899,
            9.8115
          ]
        },
        {
          "block_id": "p10_line_44",
          "block_type": "paragraph",
          "text": "are more logical for a particular study. Some data in the appendices are specific",
          "bbox": [
            0.9746,
            9.8115,
            7.091,
            9.9892
          ]
        },
        {
          "block_id": "p10_line_45",
          "block_type": "paragraph",
          "text": "requirements of individual regulatory authorities and should be submitted as",
          "bbox": [
            0.9697,
            9.9897,
            7.0908,
            10.1721
          ]
        },
        {
          "block_id": "p10_line_46",
          "block_type": "paragraph",
          "text": "appropriate. The numbering should then be adapted accordingly.",
          "bbox": [
            0.9733,
            10.1771,
            5.6109,
            10.3575
          ]
        },
        {
          "block_id": "p10_line_47",
          "block_type": "paragraph",
          "text": "2",
          "bbox": [
            3.9837,
            10.9526,
            4.0755,
            11.08
          ]
        }
      ]
    },
    {
      "page_number": 11,
      "width": 8.2639,
      "height": 11.6944,
      "unit": "inch",
      "blocks": [
        {
          "block_id": "p11_line_0",
          "block_type": "paragraph",
          "text": "Structure and Content of Clinical Study Reports",
          "bbox": [
            4.1842,
            0.7138,
            7.2866,
            0.8881
          ]
        },
        {
          "block_id": "p11_line_1",
          "block_type": "paragraph",
          "text": "In the case of very large trials, some of the provisions of this guideline may be",
          "bbox": [
            1.1638,
            1.0476,
            7.287,
            1.2321
          ]
        },
        {
          "block_id": "p11_line_2",
          "block_type": "paragraph",
          "text": "impractical or inappropriate. When planning and when reporting such trials, contact",
          "bbox": [
            1.164,
            1.2344,
            7.2874,
            1.4192
          ]
        },
        {
          "block_id": "p11_line_3",
          "block_type": "paragraph",
          "text": "with regulatory authorities to discuss an appropriate report format is encouraged.",
          "bbox": [
            1.1663,
            1.4259,
            6.9657,
            1.6046
          ]
        },
        {
          "block_id": "p11_line_4",
          "block_type": "paragraph",
          "text": "The provisions of this guideline should be used in conjunction with other ICH",
          "bbox": [
            1.1662,
            1.7228,
            7.2889,
            1.9125
          ]
        },
        {
          "block_id": "p11_line_5",
          "block_type": "paragraph",
          "text": "guidelines.",
          "bbox": [
            1.1657,
            1.9193,
            1.9473,
            2.0936
          ]
        },
        {
          "block_id": "p11_line_6",
          "block_type": "paragraph",
          "text": "STRUCTURE AND CONTENT OF CLINICAL STUDY REPORTS",
          "bbox": [
            1.1658,
            2.606,
            6.5841,
            2.7935
          ]
        },
        {
          "block_id": "p11_line_7",
          "block_type": "paragraph",
          "text": "1. TITLE PAGE",
          "bbox": [
            1.1786,
            2.9318,
            2.7176,
            3.1025
          ]
        },
        {
          "block_id": "p11_line_8",
          "block_type": "paragraph",
          "text": "The title page should contain the following information:",
          "bbox": [
            1.1691,
            3.1534,
            5.1183,
            3.3398
          ]
        },
        {
          "block_id": "p11_line_9",
          "block_type": "paragraph",
          "text": "- study title",
          "bbox": [
            1.3696,
            3.3947,
            2.3128,
            3.5613
          ]
        },
        {
          "block_id": "p11_line_10",
          "block_type": "paragraph",
          "text": "- name of test drug/ investigational product",
          "bbox": [
            1.3693,
            3.6662,
            4.5486,
            3.839
          ]
        },
        {
          "block_id": "p11_line_11",
          "block_type": "paragraph",
          "text": "- indication studied",
          "bbox": [
            1.3738,
            3.9332,
            2.8584,
            4.0942
          ]
        },
        {
          "block_id": "p11_line_12",
          "block_type": "paragraph",
          "text": "- if not apparent from the title, a brief (1 to 2 sentences) description giving design",
          "bbox": [
            1.3764,
            4.197,
            7.2886,
            4.382
          ]
        },
        {
          "block_id": "p11_line_13",
          "block_type": "paragraph",
          "text": "(parallel, cross-over, blinding, randomised) comparison (placebo, active,",
          "bbox": [
            1.5678,
            4.3764,
            7.283,
            4.5696
          ]
        },
        {
          "block_id": "p11_line_14",
          "block_type": "paragraph",
          "text": "dose/response), duration, dose, and patient population",
          "bbox": [
            1.567,
            4.5681,
            5.3987,
            4.7546
          ]
        },
        {
          "block_id": "p11_line_15",
          "block_type": "paragraph",
          "text": "- name of the sponsor",
          "bbox": [
            1.3736,
            4.8525,
            2.9998,
            5.011
          ]
        },
        {
          "block_id": "p11_line_16",
          "block_type": "paragraph",
          "text": "- protocol identification (code or number)",
          "bbox": [
            1.3715,
            5.1062,
            4.353,
            5.2887
          ]
        },
        {
          "block_id": "p11_line_17",
          "block_type": "paragraph",
          "text": "- development phase of study",
          "bbox": [
            1.3726,
            5.3777,
            3.5421,
            5.5548
          ]
        },
        {
          "block_id": "p11_line_18",
          "block_type": "paragraph",
          "text": "- study initiation date (first patient enrolled, or any other verifiable definition)",
          "bbox": [
            1.3717,
            5.6448,
            7.0125,
            5.8301
          ]
        },
        {
          "block_id": "p11_line_19",
          "block_type": "paragraph",
          "text": "- date of early study termination, if any",
          "bbox": [
            1.3717,
            5.916,
            4.2696,
            6.0973
          ]
        },
        {
          "block_id": "p11_line_20",
          "block_type": "paragraph",
          "text": "- study completion date (last patient completed)",
          "bbox": [
            1.3725,
            6.1856,
            4.8451,
            6.3658
          ]
        },
        {
          "block_id": "p11_line_21",
          "block_type": "paragraph",
          "text": "- name and affiliation of principal or coordinating investigator(s) or sponsor's",
          "bbox": [
            1.3715,
            6.4604,
            7.2905,
            6.6429
          ]
        },
        {
          "block_id": "p11_line_22",
          "block_type": "paragraph",
          "text": "responsible medical officer",
          "bbox": [
            1.5536,
            6.6412,
            3.4572,
            6.823
          ]
        },
        {
          "block_id": "p11_line_23",
          "block_type": "paragraph",
          "text": "- name of company/sponsor signatory (the person responsible for the study report",
          "bbox": [
            1.3719,
            6.9115,
            7.2904,
            7.0957
          ]
        },
        {
          "block_id": "p11_line_24",
          "block_type": "paragraph",
          "text": "within the company/sponsor. The name, telephone number and fax number of",
          "bbox": [
            1.5622,
            7.0863,
            7.3026,
            7.2796
          ]
        },
        {
          "block_id": "p11_line_25",
          "block_type": "paragraph",
          "text": "the company/sponsor contact persons for questions arising during review of the",
          "bbox": [
            1.5628,
            7.2723,
            7.2886,
            7.4632
          ]
        },
        {
          "block_id": "p11_line_26",
          "block_type": "paragraph",
          "text": "study report should be indicated on this page or in the letter of application.)",
          "bbox": [
            1.5593,
            7.4547,
            6.9206,
            7.6432
          ]
        },
        {
          "block_id": "p11_line_27",
          "block_type": "paragraph",
          "text": "- statement indicating whether the study was performed in compliance with Good",
          "bbox": [
            1.3721,
            7.7284,
            7.2927,
            7.9143
          ]
        },
        {
          "block_id": "p11_line_28",
          "block_type": "paragraph",
          "text": "Clinical Practices (GCP), including the archiving of essential documents",
          "bbox": [
            1.5684,
            7.9104,
            6.6619,
            8.097
          ]
        },
        {
          "block_id": "p11_line_29",
          "block_type": "paragraph",
          "text": "- date of the report (identify any earlier reports from the same study by title and",
          "bbox": [
            1.3745,
            8.1816,
            7.2935,
            8.3654
          ]
        },
        {
          "block_id": "p11_line_30",
          "block_type": "paragraph",
          "text": "date).",
          "bbox": [
            1.5637,
            8.3717,
            1.9754,
            8.536
          ]
        },
        {
          "block_id": "p11_line_31",
          "block_type": "paragraph",
          "text": "2. SYNOPSIS",
          "bbox": [
            1.1714,
            8.708,
            2.5369,
            8.8811
          ]
        },
        {
          "block_id": "p11_line_32",
          "block_type": "paragraph",
          "text": "A brief synopsis (usually limited to 3 pages) that summarises the study should be",
          "bbox": [
            1.1634,
            8.9358,
            7.2884,
            9.1249
          ]
        },
        {
          "block_id": "p11_line_33",
          "block_type": "paragraph",
          "text": "provided (see Annex I of the guideline for an example of a synopsis format used in",
          "bbox": [
            1.1587,
            9.1231,
            7.2909,
            9.3076
          ]
        },
        {
          "block_id": "p11_line_34",
          "block_type": "paragraph",
          "text": "Europe). The synopsis should include numerical data to illustrate results, not just",
          "bbox": [
            1.168,
            9.3031,
            7.2915,
            9.4891
          ]
        },
        {
          "block_id": "p11_line_35",
          "block_type": "paragraph",
          "text": "text or p-values.",
          "bbox": [
            1.1643,
            9.5032,
            2.3243,
            9.6656
          ]
        },
        {
          "block_id": "p11_line_36",
          "block_type": "paragraph",
          "text": "3",
          "bbox": [
            4.1851,
            10.9508,
            4.2715,
            11.0799
          ]
        }
      ]
    },
    {
      "page_number": 12,
      "width": 8.2639,
      "height": 11.6944,
      "unit": "inch",
      "blocks": [
        {
          "block_id": "p12_line_0",
          "block_type": "paragraph",
          "text": "Structure and Content of Clinical Study Reports",
          "bbox": [
            0.9746,
            0.7138,
            4.0765,
            0.8841
          ]
        },
        {
          "block_id": "p12_line_1",
          "block_type": "paragraph",
          "text": "3.",
          "bbox": [
            0.978,
            1.0706,
            1.1088,
            1.209
          ]
        },
        {
          "block_id": "p12_line_2",
          "block_type": "paragraph",
          "text": "TABLE OF CONTENTS FOR THE INDIVIDUAL CLINICAL STUDY",
          "bbox": [
            1.4668,
            1.0476,
            6.7223,
            1.2207
          ]
        },
        {
          "block_id": "p12_line_3",
          "block_type": "paragraph",
          "text": "REPORT",
          "bbox": [
            1.4702,
            1.2397,
            2.2084,
            1.3958
          ]
        },
        {
          "block_id": "p12_line_4",
          "block_type": "paragraph",
          "text": "The table of contents should include:",
          "bbox": [
            0.9698,
            1.4585,
            3.5748,
            1.6298
          ]
        },
        {
          "block_id": "p12_line_5",
          "block_type": "paragraph",
          "text": "- the page number or other locating information of each section, including",
          "bbox": [
            1.1737,
            1.7702,
            7.0971,
            1.9545
          ]
        },
        {
          "block_id": "p12_line_6",
          "block_type": "paragraph",
          "text": "summary tables, figures and graphs;",
          "bbox": [
            1.3633,
            1.9629,
            3.971,
            2.1431
          ]
        },
        {
          "block_id": "p12_line_7",
          "block_type": "paragraph",
          "text": "- a list and the locations of appendices, tabulations and any case report forms",
          "bbox": [
            1.1699,
            2.1886,
            7.0899,
            2.3661
          ]
        },
        {
          "block_id": "p12_line_8",
          "block_type": "paragraph",
          "text": "provided.",
          "bbox": [
            1.3606,
            2.3737,
            2.0359,
            2.5467
          ]
        },
        {
          "block_id": "p12_line_9",
          "block_type": "paragraph",
          "text": "4.",
          "bbox": [
            0.98,
            2.7365,
            1.1111,
            2.8744
          ]
        },
        {
          "block_id": "p12_line_10",
          "block_type": "paragraph",
          "text": "LIST OF ABBREVIATIONS AND DEFINITION OF TERMS",
          "bbox": [
            1.4599,
            2.7083,
            6.0591,
            2.887
          ]
        },
        {
          "block_id": "p12_line_11",
          "block_type": "paragraph",
          "text": "A list of the abbreviations, and lists and definitions of specialised or unusual terms or",
          "bbox": [
            0.9731,
            2.9354,
            7.0916,
            3.116
          ]
        },
        {
          "block_id": "p12_line_12",
          "block_type": "paragraph",
          "text": "measurements units used in the report should be provided. Abbreviated terms should",
          "bbox": [
            0.9701,
            3.1192,
            7.0923,
            3.3005
          ]
        },
        {
          "block_id": "p12_line_13",
          "block_type": "paragraph",
          "text": "be spelled out and the abbreviation indicated in parentheses at first appearance in the",
          "bbox": [
            0.967,
            3.3094,
            7.0919,
            3.4926
          ]
        },
        {
          "block_id": "p12_line_14",
          "block_type": "paragraph",
          "text": "text.",
          "bbox": [
            0.9709,
            3.5114,
            1.3036,
            3.6527
          ]
        },
        {
          "block_id": "p12_line_15",
          "block_type": "paragraph",
          "text": "5. ETHICS",
          "bbox": [
            0.9761,
            3.8802,
            2.1351,
            4.0485
          ]
        },
        {
          "block_id": "p12_line_16",
          "block_type": "paragraph",
          "text": "5.1",
          "bbox": [
            0.9777,
            4.2023,
            1.1927,
            4.35
          ]
        },
        {
          "block_id": "p12_line_17",
          "block_type": "paragraph",
          "text": "INDEPENDENT ETHICS COMMITTEE (IEC) OR INSTITUTIONAL",
          "bbox": [
            1.458,
            4.1802,
            6.7297,
            4.3625
          ]
        },
        {
          "block_id": "p12_line_18",
          "block_type": "paragraph",
          "text": "REVIEW BOARD (IRB)",
          "bbox": [
            1.4702,
            4.3686,
            3.2984,
            4.5567
          ]
        },
        {
          "block_id": "p12_line_19",
          "block_type": "paragraph",
          "text": "It should be confirmed that the study and any amendments were reviewed by an",
          "bbox": [
            0.9679,
            4.5967,
            7.0909,
            4.7851
          ]
        },
        {
          "block_id": "p12_line_20",
          "block_type": "paragraph",
          "text": "Independent Ethics Committee or Institutional Review Board. A list of all IECs or",
          "bbox": [
            0.9664,
            4.7786,
            7.09,
            4.9615
          ]
        },
        {
          "block_id": "p12_line_21",
          "block_type": "paragraph",
          "text": "IRBs consulted should be given in appendix 16.1.3 and, if required by the regulatory",
          "bbox": [
            0.9668,
            4.9621,
            7.0915,
            5.1547
          ]
        },
        {
          "block_id": "p12_line_22",
          "block_type": "paragraph",
          "text": "authority, the name of the committee Chair should be provided.",
          "bbox": [
            0.9736,
            5.1482,
            5.4776,
            5.331
          ]
        },
        {
          "block_id": "p12_line_23",
          "block_type": "paragraph",
          "text": "5.2",
          "bbox": [
            0.9766,
            5.5526,
            1.2013,
            5.7023
          ]
        },
        {
          "block_id": "p12_line_24",
          "block_type": "paragraph",
          "text": "ETHICAL CONDUCT OF THE STUDY",
          "bbox": [
            1.4207,
            5.5352,
            4.4627,
            5.7109
          ]
        },
        {
          "block_id": "p12_line_25",
          "block_type": "paragraph",
          "text": "It should be confirmed that the study was conducted in accordance with the ethical",
          "bbox": [
            0.9675,
            5.7599,
            7.0938,
            5.9443
          ]
        },
        {
          "block_id": "p12_line_26",
          "block_type": "paragraph",
          "text": "principles that have their origins in the Declaration of Helsinki.",
          "bbox": [
            0.9685,
            5.9443,
            5.4965,
            6.1394
          ]
        },
        {
          "block_id": "p12_line_27",
          "block_type": "paragraph",
          "text": "5.3",
          "bbox": [
            0.9788,
            6.3527,
            1.1975,
            6.5025
          ]
        },
        {
          "block_id": "p12_line_28",
          "block_type": "paragraph",
          "text": "PATIENT INFORMATION AND CONSENT",
          "bbox": [
            1.4579,
            6.3346,
            4.8312,
            6.5109
          ]
        },
        {
          "block_id": "p12_line_29",
          "block_type": "paragraph",
          "text": "How and when informed consent was obtained in relation to patient enrolment, (e.g.,",
          "bbox": [
            0.9696,
            6.561,
            7.0826,
            6.754
          ]
        },
        {
          "block_id": "p12_line_30",
          "block_type": "paragraph",
          "text": "at allocation, pre-screening) should be described.",
          "bbox": [
            0.9722,
            6.7482,
            4.4229,
            6.9307
          ]
        },
        {
          "block_id": "p12_line_31",
          "block_type": "paragraph",
          "text": "Representative written information for the patient (if any) and a sample patient",
          "bbox": [
            0.9694,
            7.0531,
            7.0924,
            7.2405
          ]
        },
        {
          "block_id": "p12_line_32",
          "block_type": "paragraph",
          "text": "consent form should be provided in appendix 16.1.3.",
          "bbox": [
            0.9725,
            7.2424,
            4.6495,
            7.4199
          ]
        },
        {
          "block_id": "p12_line_33",
          "block_type": "paragraph",
          "text": "6.",
          "bbox": [
            0.9791,
            7.6479,
            1.1072,
            7.7906
          ]
        },
        {
          "block_id": "p12_line_34",
          "block_type": "paragraph",
          "text": "INVESTIGATORS AND STUDY ADMINISTRATIVE STRUCTURE",
          "bbox": [
            1.4617,
            7.6244,
            6.5957,
            7.8038
          ]
        },
        {
          "block_id": "p12_line_35",
          "block_type": "paragraph",
          "text": "The administrative structure of the study (e.g., principal investigator, coordinating",
          "bbox": [
            0.9713,
            7.8539,
            7.0936,
            8.0399
          ]
        },
        {
          "block_id": "p12_line_36",
          "block_type": "paragraph",
          "text": "investigator, steering committee, administration, monitoring and evaluation",
          "bbox": [
            0.966,
            8.0437,
            7.0919,
            8.2277
          ]
        },
        {
          "block_id": "p12_line_37",
          "block_type": "paragraph",
          "text": "committees, institutions, statistician, central laboratory facilities, contract research",
          "bbox": [
            0.9721,
            8.2272,
            7.0889,
            8.4054
          ]
        },
        {
          "block_id": "p12_line_38",
          "block_type": "paragraph",
          "text": "organisation (C.R.O.), clinical trial supply management) should be described briefly in",
          "bbox": [
            0.9728,
            8.4098,
            7.0905,
            8.5936
          ]
        },
        {
          "block_id": "p12_line_39",
          "block_type": "paragraph",
          "text": "the body of the report.",
          "bbox": [
            0.9698,
            8.5941,
            2.5471,
            8.7736
          ]
        },
        {
          "block_id": "p12_line_40",
          "block_type": "paragraph",
          "text": "There should be provided in appendix 16.1.4 a list of the investigators with their",
          "bbox": [
            0.9717,
            8.8983,
            7.0889,
            9.0785
          ]
        },
        {
          "block_id": "p12_line_41",
          "block_type": "paragraph",
          "text": "affiliations, their role in the study and their qualifications (curriculum vitae or",
          "bbox": [
            0.977,
            9.0823,
            7.0903,
            9.2649
          ]
        },
        {
          "block_id": "p12_line_42",
          "block_type": "paragraph",
          "text": "equivalent). A similar list for other persons whose participation materially affected",
          "bbox": [
            0.973,
            9.2676,
            7.0925,
            9.4489
          ]
        },
        {
          "block_id": "p12_line_43",
          "block_type": "paragraph",
          "text": "the conduct of the study should also be provided in appendix 16.1.4. In the case of",
          "bbox": [
            0.9718,
            9.4485,
            7.1027,
            9.6282
          ]
        },
        {
          "block_id": "p12_line_44",
          "block_type": "paragraph",
          "text": "large trials with many investigators the above requirements may be abbreviated to",
          "bbox": [
            0.9679,
            9.6327,
            7.0884,
            9.8134
          ]
        },
        {
          "block_id": "p12_line_45",
          "block_type": "paragraph",
          "text": "consist of general statements of qualifications for persons carrying out particular roles",
          "bbox": [
            0.9733,
            9.8193,
            7.0884,
            9.9945
          ]
        },
        {
          "block_id": "p12_line_46",
          "block_type": "paragraph",
          "text": "in the study with only the name, degree and institutional affiliation and roles of each",
          "bbox": [
            0.9687,
            9.9979,
            7.0871,
            10.1764
          ]
        },
        {
          "block_id": "p12_line_47",
          "block_type": "paragraph",
          "text": "investigator or other participant.",
          "bbox": [
            0.9648,
            10.1952,
            3.3061,
            10.3657
          ]
        },
        {
          "block_id": "p12_line_48",
          "block_type": "paragraph",
          "text": "The listing should include:",
          "bbox": [
            0.9685,
            10.4954,
            2.8642,
            10.6659
          ]
        },
        {
          "block_id": "p12_line_49",
          "block_type": "paragraph",
          "text": "4",
          "bbox": [
            3.9876,
            10.953,
            4.0772,
            11.0826
          ]
        }
      ]
    },
    {
      "page_number": 13,
      "width": 8.2639,
      "height": 11.6944,
      "unit": "inch",
      "blocks": [
        {
          "block_id": "p13_line_0",
          "block_type": "paragraph",
          "text": "Structure and Content of Clinical Study Reports",
          "bbox": [
            4.1833,
            0.7138,
            7.2879,
            0.8869
          ]
        },
        {
          "block_id": "p13_line_1",
          "block_type": "paragraph",
          "text": "a) Investigators",
          "bbox": [
            1.564,
            1.0613,
            2.8073,
            1.2277
          ]
        },
        {
          "block_id": "p13_line_2",
          "block_type": "paragraph",
          "text": "b)",
          "bbox": [
            1.5617,
            1.2901,
            1.7029,
            1.4445
          ]
        },
        {
          "block_id": "p13_line_3",
          "block_type": "paragraph",
          "text": "Any other person carrying out observations of primary or other major",
          "bbox": [
            1.8515,
            1.2797,
            7.289,
            1.4618
          ]
        },
        {
          "block_id": "p13_line_4",
          "block_type": "paragraph",
          "text": "efficacy variables, such as a nurse, physician's assistant, clinical",
          "bbox": [
            1.8584,
            1.4599,
            7.2918,
            1.6445
          ]
        },
        {
          "block_id": "p13_line_5",
          "block_type": "paragraph",
          "text": "psychologist, clinical pharmacist, or house staff physician. It is not",
          "bbox": [
            1.8524,
            1.6388,
            7.2895,
            1.8328
          ]
        },
        {
          "block_id": "p13_line_6",
          "block_type": "paragraph",
          "text": "necessary to include in this list a person with only an occasional role, e.g.,",
          "bbox": [
            1.851,
            1.8273,
            7.2778,
            2.0113
          ]
        },
        {
          "block_id": "p13_line_7",
          "block_type": "paragraph",
          "text": "an on-call physician who dealt with a possible adverse effect or a temporary",
          "bbox": [
            1.8559,
            2.01,
            7.2851,
            2.1996
          ]
        },
        {
          "block_id": "p13_line_8",
          "block_type": "paragraph",
          "text": "substitute for any of the above",
          "bbox": [
            1.8557,
            2.1959,
            4.0232,
            2.368
          ]
        },
        {
          "block_id": "p13_line_9",
          "block_type": "paragraph",
          "text": "c) The author(s) of the report, including the responsible biostatistician(s).",
          "bbox": [
            1.568,
            2.4165,
            6.8679,
            2.6048
          ]
        },
        {
          "block_id": "p13_line_10",
          "block_type": "paragraph",
          "text": "Where signatures of the principal or coordinating investigators are required by",
          "bbox": [
            1.1703,
            2.7245,
            7.2884,
            2.915
          ]
        },
        {
          "block_id": "p13_line_11",
          "block_type": "paragraph",
          "text": "regulatory authorities, these should be included in appendix 16.1.5 (see Annex II for a",
          "bbox": [
            1.1622,
            2.91,
            7.2884,
            3.0935
          ]
        },
        {
          "block_id": "p13_line_12",
          "block_type": "paragraph",
          "text": "sample form). Where these are not required, the signature of the sponsor's",
          "bbox": [
            1.1704,
            3.0912,
            7.29,
            3.2814
          ]
        },
        {
          "block_id": "p13_line_13",
          "block_type": "paragraph",
          "text": "responsible medical officer should be provided in appendix 16.1.5.",
          "bbox": [
            1.1608,
            3.2744,
            5.8083,
            3.4637
          ]
        },
        {
          "block_id": "p13_line_14",
          "block_type": "paragraph",
          "text": "7.",
          "bbox": [
            1.1793,
            3.6819,
            1.3084,
            3.8274
          ]
        },
        {
          "block_id": "p13_line_15",
          "block_type": "paragraph",
          "text": "INTRODUCTION",
          "bbox": [
            1.6571,
            3.6664,
            3.0429,
            3.8367
          ]
        },
        {
          "block_id": "p13_line_16",
          "block_type": "paragraph",
          "text": "The introduction should contain a brief statement (maximum: 1 page) placing the",
          "bbox": [
            1.1648,
            3.8871,
            7.2874,
            4.0816
          ]
        },
        {
          "block_id": "p13_line_17",
          "block_type": "paragraph",
          "text": "study in the context of the development of the test drug/investigational product,",
          "bbox": [
            1.1663,
            4.0754,
            7.28,
            4.2609
          ]
        },
        {
          "block_id": "p13_line_18",
          "block_type": "paragraph",
          "text": "relating the critical features of the study (e.g., rationale and aims, target population,",
          "bbox": [
            1.1636,
            4.2547,
            7.279,
            4.4468
          ]
        },
        {
          "block_id": "p13_line_19",
          "block_type": "paragraph",
          "text": "treatment, duration, primary endpoints) to that development. Any guidelines that",
          "bbox": [
            1.1645,
            4.4398,
            7.2903,
            4.6293
          ]
        },
        {
          "block_id": "p13_line_20",
          "block_type": "paragraph",
          "text": "were followed in the development of the protocol or any other agreements/meetings",
          "bbox": [
            1.1674,
            4.6252,
            7.2885,
            4.8105
          ]
        },
        {
          "block_id": "p13_line_21",
          "block_type": "paragraph",
          "text": "between the sponsor/company and regulatory authorities that are relevant to the",
          "bbox": [
            1.163,
            4.8104,
            7.2884,
            4.9984
          ]
        },
        {
          "block_id": "p13_line_22",
          "block_type": "paragraph",
          "text": "particular study, should be identified or described.",
          "bbox": [
            1.1634,
            4.9907,
            4.7402,
            5.1846
          ]
        },
        {
          "block_id": "p13_line_23",
          "block_type": "paragraph",
          "text": "8.",
          "bbox": [
            1.177,
            5.3934,
            1.3067,
            5.5433
          ]
        },
        {
          "block_id": "p13_line_24",
          "block_type": "paragraph",
          "text": "STUDY OBJECTIVES",
          "bbox": [
            1.6584,
            5.3783,
            3.3931,
            5.5522
          ]
        },
        {
          "block_id": "p13_line_25",
          "block_type": "paragraph",
          "text": "A statement describing the overall purpose(s) of the study should be provided.",
          "bbox": [
            1.1654,
            5.6075,
            6.6789,
            5.7985
          ]
        },
        {
          "block_id": "p13_line_26",
          "block_type": "paragraph",
          "text": "9.",
          "bbox": [
            1.1752,
            6.0107,
            1.3051,
            6.1595
          ]
        },
        {
          "block_id": "p13_line_27",
          "block_type": "paragraph",
          "text": "INVESTIGATIONAL PLAN",
          "bbox": [
            1.6586,
            5.9925,
            3.8026,
            6.1698
          ]
        },
        {
          "block_id": "p13_line_28",
          "block_type": "paragraph",
          "text": "9.1",
          "bbox": [
            1.1747,
            6.3199,
            1.3891,
            6.4671
          ]
        },
        {
          "block_id": "p13_line_29",
          "block_type": "paragraph",
          "text": "OVERALL STUDY DESIGN AND PLAN - DESCRIPTION",
          "bbox": [
            1.6658,
            6.2967,
            6.1005,
            6.4805
          ]
        },
        {
          "block_id": "p13_line_30",
          "block_type": "paragraph",
          "text": "The overall study plan and design (configuration) of the study (e.g., parallel, cross-",
          "bbox": [
            1.168,
            6.531,
            7.2823,
            6.7247
          ]
        },
        {
          "block_id": "p13_line_31",
          "block_type": "paragraph",
          "text": "over) should be described briefly but clearly, using charts and diagrams as needed. If",
          "bbox": [
            1.1684,
            6.7149,
            7.3006,
            6.9078
          ]
        },
        {
          "block_id": "p13_line_32",
          "block_type": "paragraph",
          "text": "other studies used a very similar protocol, it may be useful to note this and describe",
          "bbox": [
            1.1714,
            6.8967,
            7.2881,
            7.089
          ]
        },
        {
          "block_id": "p13_line_33",
          "block_type": "paragraph",
          "text": "any important differences. The actual protocol and any changes should be included as",
          "bbox": [
            1.1668,
            7.0806,
            7.2888,
            7.2733
          ]
        },
        {
          "block_id": "p13_line_34",
          "block_type": "paragraph",
          "text": "appendix 16.1.1 and a sample case report form (unique pages only; i.e., it is not",
          "bbox": [
            1.1682,
            7.2693,
            7.291,
            7.457
          ]
        },
        {
          "block_id": "p13_line_35",
          "block_type": "paragraph",
          "text": "necessary to include identical pages from forms for different evaluations or visits) as",
          "bbox": [
            1.1654,
            7.4472,
            7.2886,
            7.6357
          ]
        },
        {
          "block_id": "p13_line_36",
          "block_type": "paragraph",
          "text": "appendix 16.1.2. If any of the information in this section comes from sources other",
          "bbox": [
            1.1671,
            7.6294,
            7.2895,
            7.8171
          ]
        },
        {
          "block_id": "p13_line_37",
          "block_type": "paragraph",
          "text": "than the protocol, these should be identified.",
          "bbox": [
            1.167,
            7.8125,
            4.3244,
            7.9961
          ]
        },
        {
          "block_id": "p13_line_38",
          "block_type": "paragraph",
          "text": "The information provided should include:",
          "bbox": [
            1.1668,
            8.1201,
            4.1026,
            8.3011
          ]
        },
        {
          "block_id": "p13_line_39",
          "block_type": "paragraph",
          "text": "- treatments studied (specific drugs, doses and procedures);",
          "bbox": [
            1.5672,
            8.3553,
            5.8602,
            8.5362
          ]
        },
        {
          "block_id": "p13_line_40",
          "block_type": "paragraph",
          "text": "- patient population studied and the number of patients to be included;",
          "bbox": [
            1.5682,
            8.5824,
            6.6829,
            8.7615
          ]
        },
        {
          "block_id": "p13_line_41",
          "block_type": "paragraph",
          "text": "- level and method of blinding/masking (e.g., open, double-blind, single-blind,",
          "bbox": [
            1.5712,
            8.81,
            7.2791,
            8.9913
          ]
        },
        {
          "block_id": "p13_line_42",
          "block_type": "paragraph",
          "text": "blinded evaluators and unblinded patients and/or investigators);",
          "bbox": [
            1.7504,
            8.9893,
            6.3216,
            9.1763
          ]
        },
        {
          "block_id": "p13_line_43",
          "block_type": "paragraph",
          "text": "- kind of control(s) (e.g., placebo, no treatment, active drug, dose-response,",
          "bbox": [
            1.5694,
            9.2219,
            7.2796,
            9.407
          ]
        },
        {
          "block_id": "p13_line_44",
          "block_type": "paragraph",
          "text": "historical) and study configuration (parallel, cross-over);",
          "bbox": [
            1.7504,
            9.4056,
            5.7425,
            9.5965
          ]
        },
        {
          "block_id": "p13_line_45",
          "block_type": "paragraph",
          "text": "- method of assignment to treatment (randomisation, stratification);",
          "bbox": [
            1.5703,
            9.6425,
            6.4807,
            9.8156
          ]
        },
        {
          "block_id": "p13_line_46",
          "block_type": "paragraph",
          "text": "- sequence and duration of all study periods, including pre-randomisation and",
          "bbox": [
            1.5713,
            9.8683,
            7.2911,
            10.0442
          ]
        },
        {
          "block_id": "p13_line_47",
          "block_type": "paragraph",
          "text": "post-treatment periods, therapy withdrawal periods and single- and double-",
          "bbox": [
            1.7506,
            10.0475,
            7.2817,
            10.2326
          ]
        },
        {
          "block_id": "p13_line_48",
          "block_type": "paragraph",
          "text": "blind treatment periods. When patients are randomised should be specified.",
          "bbox": [
            1.753,
            10.2324,
            7.2776,
            10.4092
          ]
        },
        {
          "block_id": "p13_line_49",
          "block_type": "paragraph",
          "text": "5",
          "bbox": [
            4.1848,
            10.9506,
            4.2718,
            11.0831
          ]
        }
      ]
    },
    {
      "page_number": 14,
      "width": 8.2639,
      "height": 11.6944,
      "unit": "inch",
      "blocks": [
        {
          "block_id": "p14_line_0",
          "block_type": "paragraph",
          "text": "Structure and Content of Clinical Study Reports",
          "bbox": [
            0.973,
            0.7138,
            4.0781,
            0.886
          ]
        },
        {
          "block_id": "p14_line_1",
          "block_type": "paragraph",
          "text": "It is usually helpful to display the design graphically with a flow chart which",
          "bbox": [
            1.5618,
            1.0469,
            7.0861,
            1.2296
          ]
        },
        {
          "block_id": "p14_line_2",
          "block_type": "paragraph",
          "text": "includes timing of assessments (see Annexes IIIa and IIIb for an example);",
          "bbox": [
            1.5563,
            1.2334,
            6.8501,
            1.4152
          ]
        },
        {
          "block_id": "p14_line_3",
          "block_type": "paragraph",
          "text": "- any safety, data monitoring or special steering or evaluation committees;",
          "bbox": [
            1.3732,
            1.4675,
            6.7268,
            1.6425
          ]
        },
        {
          "block_id": "p14_line_4",
          "block_type": "paragraph",
          "text": "- any interim analyses.",
          "bbox": [
            1.3737,
            1.7052,
            3.1022,
            1.8672
          ]
        },
        {
          "block_id": "p14_line_5",
          "block_type": "paragraph",
          "text": "9.2 DISCUSSION OF STUDY DESIGN, INCLUDING THE CHOICE OF",
          "bbox": [
            0.9837,
            2.0321,
            6.6518,
            2.2149
          ]
        },
        {
          "block_id": "p14_line_6",
          "block_type": "paragraph",
          "text": "CONTROL GROUPS",
          "bbox": [
            1.4753,
            2.2217,
            3.0958,
            2.3917
          ]
        },
        {
          "block_id": "p14_line_7",
          "block_type": "paragraph",
          "text": "The specific control chosen and the study design used should be discussed, as",
          "bbox": [
            0.9693,
            2.444,
            7.0944,
            2.6315
          ]
        },
        {
          "block_id": "p14_line_8",
          "block_type": "paragraph",
          "text": "necessary. Examples of design issues meriting discussion follow.",
          "bbox": [
            0.9687,
            2.6324,
            5.569,
            2.8199
          ]
        },
        {
          "block_id": "p14_line_9",
          "block_type": "paragraph",
          "text": "Generally, the control (comparison) groups that are recognised are placebo concurrent",
          "bbox": [
            0.9733,
            2.9365,
            7.0956,
            3.1235
          ]
        },
        {
          "block_id": "p14_line_10",
          "block_type": "paragraph",
          "text": "control, no treatment concurrent control, active treatment concurrent control, dose",
          "bbox": [
            0.9728,
            3.1241,
            7.0927,
            3.3034
          ]
        },
        {
          "block_id": "p14_line_11",
          "block_type": "paragraph",
          "text": "comparison concurrent control, and historical control. In addition to the type of",
          "bbox": [
            0.9726,
            3.3062,
            7.1046,
            3.4958
          ]
        },
        {
          "block_id": "p14_line_12",
          "block_type": "paragraph",
          "text": "control, other critical design features that may need discussion are use of a cross-over",
          "bbox": [
            0.9725,
            3.4933,
            7.0946,
            3.6741
          ]
        },
        {
          "block_id": "p14_line_13",
          "block_type": "paragraph",
          "text": "design and selection of patients with particular prior history, such as response or non-",
          "bbox": [
            0.9757,
            3.6746,
            7.0828,
            3.8631
          ]
        },
        {
          "block_id": "p14_line_14",
          "block_type": "paragraph",
          "text": "response to a specific drug or member of a drug class. If randomisation was not used,",
          "bbox": [
            0.9671,
            3.8544,
            7.0812,
            4.0485
          ]
        },
        {
          "block_id": "p14_line_15",
          "block_type": "paragraph",
          "text": "it is important to explain how other techniques, if any, guarded against systematic",
          "bbox": [
            0.9682,
            4.0373,
            7.0941,
            4.2312
          ]
        },
        {
          "block_id": "p14_line_16",
          "block_type": "paragraph",
          "text": "selection bias.",
          "bbox": [
            0.971,
            4.2296,
            1.9746,
            4.3948
          ]
        },
        {
          "block_id": "p14_line_17",
          "block_type": "paragraph",
          "text": "Known or potential problems associated with the study design or control group",
          "bbox": [
            0.9707,
            4.5282,
            7.0886,
            4.7276
          ]
        },
        {
          "block_id": "p14_line_18",
          "block_type": "paragraph",
          "text": "chosen, should be discussed in light of the specific disease and therapies being",
          "bbox": [
            0.9734,
            4.7109,
            7.0968,
            4.9028
          ]
        },
        {
          "block_id": "p14_line_19",
          "block_type": "paragraph",
          "text": "studied. For a crossover design, for example, there should be consideration, among",
          "bbox": [
            0.974,
            4.8936,
            7.0944,
            5.0886
          ]
        },
        {
          "block_id": "p14_line_20",
          "block_type": "paragraph",
          "text": "other things, of the likelihood of spontaneous change in the disease and of carry-over",
          "bbox": [
            0.9732,
            5.081,
            7.0937,
            5.2664
          ]
        },
        {
          "block_id": "p14_line_21",
          "block_type": "paragraph",
          "text": "effects of treatment during the study.",
          "bbox": [
            0.9736,
            5.2648,
            3.6219,
            5.4553
          ]
        },
        {
          "block_id": "p14_line_22",
          "block_type": "paragraph",
          "text": "If efficacy was to be demonstrated by showing equivalence, i.e., the absence of a",
          "bbox": [
            0.9694,
            5.5706,
            7.0903,
            5.764
          ]
        },
        {
          "block_id": "p14_line_23",
          "block_type": "paragraph",
          "text": "specified degree of inferiority of the new treatment compared to an established",
          "bbox": [
            0.9731,
            5.7538,
            7.0932,
            5.9496
          ]
        },
        {
          "block_id": "p14_line_24",
          "block_type": "paragraph",
          "text": "treatment, problems associated with such study designs should be addressed.",
          "bbox": [
            0.9709,
            5.9344,
            7.0852,
            6.1327
          ]
        },
        {
          "block_id": "p14_line_25",
          "block_type": "paragraph",
          "text": "Specifically there should be provided a basis for considering the study capable of",
          "bbox": [
            0.9717,
            6.1176,
            7.102,
            6.314
          ]
        },
        {
          "block_id": "p14_line_26",
          "block_type": "paragraph",
          "text": "distinguishing active from inactive therapy. Support may be provided by an analysis",
          "bbox": [
            0.9733,
            6.3037,
            7.0926,
            6.4996
          ]
        },
        {
          "block_id": "p14_line_27",
          "block_type": "paragraph",
          "text": "of previous studies similar to the present study with respect to important design",
          "bbox": [
            0.9727,
            6.491,
            7.0924,
            6.6785
          ]
        },
        {
          "block_id": "p14_line_28",
          "block_type": "paragraph",
          "text": "characteristics (patient selection, study endpoints, duration, dose of active control,",
          "bbox": [
            0.9736,
            6.6707,
            7.0827,
            6.8614
          ]
        },
        {
          "block_id": "p14_line_29",
          "block_type": "paragraph",
          "text": "concomitant therapy etc.) showing a consistent ability to demonstrate superiority of",
          "bbox": [
            0.9737,
            6.8556,
            7.1025,
            7.0419
          ]
        },
        {
          "block_id": "p14_line_30",
          "block_type": "paragraph",
          "text": "the active control to placebo. How to assess the ability of the present study to",
          "bbox": [
            0.9715,
            7.0349,
            7.0908,
            7.2248
          ]
        },
        {
          "block_id": "p14_line_31",
          "block_type": "paragraph",
          "text": "distinguish effective from ineffective therapy should also be discussed. For example,",
          "bbox": [
            0.9756,
            7.2157,
            7.0826,
            7.4088
          ]
        },
        {
          "block_id": "p14_line_32",
          "block_type": "paragraph",
          "text": "it may be possible to identify a treatment response (based on past studies) that would",
          "bbox": [
            0.9677,
            7.4068,
            7.0945,
            7.5977
          ]
        },
        {
          "block_id": "p14_line_33",
          "block_type": "paragraph",
          "text": "clearly distinguish between the treated population and an untreated group. Such a",
          "bbox": [
            0.9726,
            7.5899,
            7.0906,
            7.7773
          ]
        },
        {
          "block_id": "p14_line_34",
          "block_type": "paragraph",
          "text": "response could be the change of a measure from baseline or some other specified",
          "bbox": [
            0.969,
            7.7744,
            7.0941,
            7.96
          ]
        },
        {
          "block_id": "p14_line_35",
          "block_type": "paragraph",
          "text": "outcome like healing rate or survival rate. Attainment of such a response would",
          "bbox": [
            0.9723,
            7.9572,
            7.0943,
            8.1392
          ]
        },
        {
          "block_id": "p14_line_36",
          "block_type": "paragraph",
          "text": "support the expectation that the study could have distinguished the active drug from",
          "bbox": [
            0.9715,
            8.1376,
            7.0908,
            8.3273
          ]
        },
        {
          "block_id": "p14_line_37",
          "block_type": "paragraph",
          "text": "an inactive drug. There should also be a discussion of the degree of inferiority of the",
          "bbox": [
            0.9727,
            8.3231,
            7.0927,
            8.5046
          ]
        },
        {
          "block_id": "p14_line_38",
          "block_type": "paragraph",
          "text": "therapy (often referred to as the delta value) the study was intended to show was not",
          "bbox": [
            0.9704,
            8.5043,
            7.0925,
            8.6896
          ]
        },
        {
          "block_id": "p14_line_39",
          "block_type": "paragraph",
          "text": "exceeded.",
          "bbox": [
            0.9729,
            8.6966,
            1.6576,
            8.8565
          ]
        },
        {
          "block_id": "p14_line_40",
          "block_type": "paragraph",
          "text": "The limitations of historical controls are well known (difficulty of assuring",
          "bbox": [
            0.9702,
            8.9935,
            7.0934,
            9.1845
          ]
        },
        {
          "block_id": "p14_line_41",
          "block_type": "paragraph",
          "text": "comparability of treated groups, inability to blind investigators to treatment, change",
          "bbox": [
            0.9724,
            9.1831,
            7.0887,
            9.364
          ]
        },
        {
          "block_id": "p14_line_42",
          "block_type": "paragraph",
          "text": "in therapy/disease, difference due to placebo effect etc.) and deserve particular",
          "bbox": [
            0.9678,
            9.3698,
            7.0931,
            9.5505
          ]
        },
        {
          "block_id": "p14_line_43",
          "block_type": "paragraph",
          "text": "attention.",
          "bbox": [
            0.9724,
            9.5666,
            1.6757,
            9.7158
          ]
        },
        {
          "block_id": "p14_line_44",
          "block_type": "paragraph",
          "text": "Other specific features of the design may also deserve discussion, including presence",
          "bbox": [
            0.9753,
            9.8566,
            7.088,
            10.0426
          ]
        },
        {
          "block_id": "p14_line_45",
          "block_type": "paragraph",
          "text": "or absence of washout periods and the duration of the treatment period, especially for",
          "bbox": [
            0.9751,
            10.0467,
            7.0909,
            10.2218
          ]
        },
        {
          "block_id": "p14_line_46",
          "block_type": "paragraph",
          "text": "a chronic illness. The rationale for dose and dose-interval selection should be",
          "bbox": [
            0.9769,
            10.2265,
            7.0886,
            10.3982
          ]
        },
        {
          "block_id": "p14_line_47",
          "block_type": "paragraph",
          "text": "explained, if it is not obvious. For example, once daily dosing with a short half-life",
          "bbox": [
            0.9726,
            10.4097,
            7.0889,
            10.592
          ]
        },
        {
          "block_id": "p14_line_48",
          "block_type": "paragraph",
          "text": "6",
          "bbox": [
            3.9858,
            10.9529,
            4.0739,
            11.0784
          ]
        }
      ]
    },
    {
      "page_number": 15,
      "width": 8.2639,
      "height": 11.6944,
      "unit": "inch",
      "blocks": [
        {
          "block_id": "p15_line_0",
          "block_type": "paragraph",
          "text": "Structure and Content of Clinical Study Reports",
          "bbox": [
            4.1843,
            0.7138,
            7.2867,
            0.8882
          ]
        },
        {
          "block_id": "p15_line_1",
          "block_type": "paragraph",
          "text": "drug whose effect is closely related in time to blood level is not usually effective; if the",
          "bbox": [
            1.1727,
            1.0446,
            7.285,
            1.2281
          ]
        },
        {
          "block_id": "p15_line_2",
          "block_type": "paragraph",
          "text": "study design uses such dosing, this should be explained, e.g., by pointing to",
          "bbox": [
            1.1683,
            1.2334,
            7.2847,
            1.4171
          ]
        },
        {
          "block_id": "p15_line_3",
          "block_type": "paragraph",
          "text": "pharmacodynamic evidence that effect is prolonged compared to blood levels. The",
          "bbox": [
            1.1623,
            1.4178,
            7.2856,
            1.6065
          ]
        },
        {
          "block_id": "p15_line_4",
          "block_type": "paragraph",
          "text": "procedures used to seek evidence of \"escape\" from drug effect at the end of the dose-",
          "bbox": [
            1.1632,
            1.6003,
            7.2815,
            1.7873
          ]
        },
        {
          "block_id": "p15_line_5",
          "block_type": "paragraph",
          "text": "interval, such as measurements of effect just prior to dosing, should be described.",
          "bbox": [
            1.1631,
            1.7846,
            7.2762,
            1.97
          ]
        },
        {
          "block_id": "p15_line_6",
          "block_type": "paragraph",
          "text": "Similarly, in a parallel design dose-response study, the choice of doses should be",
          "bbox": [
            1.1679,
            1.9669,
            7.2887,
            2.1526
          ]
        },
        {
          "block_id": "p15_line_7",
          "block_type": "paragraph",
          "text": "explained.",
          "bbox": [
            1.169,
            2.1572,
            1.9083,
            2.3316
          ]
        },
        {
          "block_id": "p15_line_8",
          "block_type": "paragraph",
          "text": "9.3 SELECTION OF STUDY POPULATION",
          "bbox": [
            1.1763,
            2.5367,
            4.7633,
            2.7164
          ]
        },
        {
          "block_id": "p15_line_9",
          "block_type": "paragraph",
          "text": "9.3.1 Inclusion Criteria",
          "bbox": [
            1.1705,
            2.8528,
            3.1099,
            3.0238
          ]
        },
        {
          "block_id": "p15_line_10",
          "block_type": "paragraph",
          "text": "The patient population and the selection criteria used to enter the patients into the",
          "bbox": [
            1.1662,
            3.0728,
            7.2866,
            3.2591
          ]
        },
        {
          "block_id": "p15_line_11",
          "block_type": "paragraph",
          "text": "study should be described, and the suitability of the population for the purposes of the",
          "bbox": [
            1.1668,
            3.2581,
            7.2871,
            3.4448
          ]
        },
        {
          "block_id": "p15_line_12",
          "block_type": "paragraph",
          "text": "study discussed. Specific diagnostic criteria used, as well as specific disease",
          "bbox": [
            1.1676,
            3.4392,
            7.2896,
            3.6284
          ]
        },
        {
          "block_id": "p15_line_13",
          "block_type": "paragraph",
          "text": "requirements (e.g., disease of a particular severity or duration, results of a particular",
          "bbox": [
            1.1625,
            3.6251,
            7.2892,
            3.8127
          ]
        },
        {
          "block_id": "p15_line_14",
          "block_type": "paragraph",
          "text": "test or rating scale(s) or physical examination, particular features of clinical history,",
          "bbox": [
            1.1656,
            3.8035,
            7.2782,
            3.9969
          ]
        },
        {
          "block_id": "p15_line_15",
          "block_type": "paragraph",
          "text": "such as failure or success on prior therapy, or other potential prognostic factors and",
          "bbox": [
            1.1684,
            3.9936,
            7.2932,
            4.1834
          ]
        },
        {
          "block_id": "p15_line_16",
          "block_type": "paragraph",
          "text": "any age, sex or ethnic factors) should be presented.",
          "bbox": [
            1.1648,
            4.1799,
            4.7738,
            4.3668
          ]
        },
        {
          "block_id": "p15_line_17",
          "block_type": "paragraph",
          "text": "Screening criteria and any additional criteria for randomisation or entry into the test",
          "bbox": [
            1.1663,
            4.4812,
            7.2903,
            4.6708
          ]
        },
        {
          "block_id": "p15_line_18",
          "block_type": "paragraph",
          "text": "drug/investigational product treatment part of the trial should be described. If there",
          "bbox": [
            1.1713,
            4.662,
            7.2901,
            4.8575
          ]
        },
        {
          "block_id": "p15_line_19",
          "block_type": "paragraph",
          "text": "is reason to believe that there were additional entry criteria, not defined in the",
          "bbox": [
            1.1637,
            4.8471,
            7.2874,
            5.0364
          ]
        },
        {
          "block_id": "p15_line_20",
          "block_type": "paragraph",
          "text": "protocol, the implications of these should be discussed. For example, some",
          "bbox": [
            1.1632,
            5.0287,
            7.2869,
            5.2245
          ]
        },
        {
          "block_id": "p15_line_21",
          "block_type": "paragraph",
          "text": "investigators may have excluded, or entered into other studies, patients who were",
          "bbox": [
            1.1608,
            5.2143,
            7.2882,
            5.4028
          ]
        },
        {
          "block_id": "p15_line_22",
          "block_type": "paragraph",
          "text": "particularly ill or who had particular baseline characteristics.",
          "bbox": [
            1.1603,
            5.3961,
            5.5327,
            5.59
          ]
        },
        {
          "block_id": "p15_line_23",
          "block_type": "paragraph",
          "text": "9.3.2 Exclusion Criteria",
          "bbox": [
            1.1677,
            5.7884,
            3.1454,
            5.9685
          ]
        },
        {
          "block_id": "p15_line_24",
          "block_type": "paragraph",
          "text": "The criteria for exclusion at entry into the study should be specified and the rationale",
          "bbox": [
            1.1676,
            6.0097,
            7.2864,
            6.2013
          ]
        },
        {
          "block_id": "p15_line_25",
          "block_type": "paragraph",
          "text": "(e.g., safety concerns, administrative reasons or lack of suitability for the trial)",
          "bbox": [
            1.1765,
            6.1924,
            7.2819,
            6.389
          ]
        },
        {
          "block_id": "p15_line_26",
          "block_type": "paragraph",
          "text": "provided. The impact of exclusions on the generalisability of the study should be",
          "bbox": [
            1.1621,
            6.3774,
            7.2897,
            6.5716
          ]
        },
        {
          "block_id": "p15_line_27",
          "block_type": "paragraph",
          "text": "discussed in section 13 of the study report, or in an overview of safety and efficacy.",
          "bbox": [
            1.1742,
            6.5667,
            6.9995,
            6.7631
          ]
        },
        {
          "block_id": "p15_line_28",
          "block_type": "paragraph",
          "text": "9.3.3 Removal of Patients from Therapy or Assessment",
          "bbox": [
            1.1731,
            6.9511,
            5.5966,
            7.1425
          ]
        },
        {
          "block_id": "p15_line_29",
          "block_type": "paragraph",
          "text": "The predetermined reasons for removing patients from therapy or assessment",
          "bbox": [
            1.5635,
            7.1834,
            7.2902,
            7.3748
          ]
        },
        {
          "block_id": "p15_line_30",
          "block_type": "paragraph",
          "text": "observation, if any, should be described, as should the nature and duration of",
          "bbox": [
            1.5621,
            7.3641,
            7.3012,
            7.5546
          ]
        },
        {
          "block_id": "p15_line_31",
          "block_type": "paragraph",
          "text": "any planned follow-up observations in those patients.",
          "bbox": [
            1.5598,
            7.555,
            5.3407,
            7.7396
          ]
        },
        {
          "block_id": "p15_line_32",
          "block_type": "paragraph",
          "text": "9.4 TREATMENTS",
          "bbox": [
            1.1712,
            7.9371,
            2.8625,
            8.1092
          ]
        },
        {
          "block_id": "p15_line_33",
          "block_type": "paragraph",
          "text": "9.4.1 Treatments Administered",
          "bbox": [
            1.1721,
            8.249,
            3.7221,
            8.4201
          ]
        },
        {
          "block_id": "p15_line_34",
          "block_type": "paragraph",
          "text": "The precise treatments or diagnostic agents to be administered in each arm of the",
          "bbox": [
            1.1661,
            8.4717,
            7.2856,
            8.6607
          ]
        },
        {
          "block_id": "p15_line_35",
          "block_type": "paragraph",
          "text": "study, and for each period of the study, should be described including route and mode",
          "bbox": [
            1.1693,
            8.6558,
            7.2876,
            8.8451
          ]
        },
        {
          "block_id": "p15_line_36",
          "block_type": "paragraph",
          "text": "of administration, dose and dosage schedule.",
          "bbox": [
            1.17,
            8.8439,
            4.3302,
            9.0221
          ]
        },
        {
          "block_id": "p15_line_37",
          "block_type": "paragraph",
          "text": "9.4.2 Identity of Investigational Product(s)",
          "bbox": [
            1.1716,
            9.2335,
            4.645,
            9.4207
          ]
        },
        {
          "block_id": "p15_line_38",
          "block_type": "paragraph",
          "text": "In the text of the report, a brief description of the test drug(s)/investigational",
          "bbox": [
            1.1644,
            9.4573,
            7.2896,
            9.644
          ]
        },
        {
          "block_id": "p15_line_39",
          "block_type": "paragraph",
          "text": "product(s) (formulation, strength, batch number(s)) should be given. If more than one",
          "bbox": [
            1.1637,
            9.6392,
            7.2882,
            9.8285
          ]
        },
        {
          "block_id": "p15_line_40",
          "block_type": "paragraph",
          "text": "batch of test drug/investigational product was used, patients receiving each batch",
          "bbox": [
            1.1652,
            9.8261,
            7.2854,
            10.0074
          ]
        },
        {
          "block_id": "p15_line_41",
          "block_type": "paragraph",
          "text": "should be identified in appendix 16.1.6.",
          "bbox": [
            1.1686,
            10.0068,
            3.9563,
            10.1856
          ]
        },
        {
          "block_id": "p15_line_42",
          "block_type": "paragraph",
          "text": "The source of placebos and active control/comparator product(s) should be provided.",
          "bbox": [
            1.1717,
            10.2747,
            7.2735,
            10.4559
          ]
        },
        {
          "block_id": "p15_line_43",
          "block_type": "paragraph",
          "text": "Any modification of comparator product(s) from their usual commercial state should",
          "bbox": [
            1.1668,
            10.4589,
            7.2889,
            10.6381
          ]
        },
        {
          "block_id": "p15_line_44",
          "block_type": "paragraph",
          "text": "7",
          "bbox": [
            4.1852,
            10.9489,
            4.2688,
            11.0807
          ]
        }
      ]
    },
    {
      "page_number": 16,
      "width": 8.2639,
      "height": 11.6944,
      "unit": "inch",
      "blocks": [
        {
          "block_id": "p16_line_0",
          "block_type": "paragraph",
          "text": "Structure and Content of Clinical Study Reports",
          "bbox": [
            0.9742,
            0.7138,
            4.0777,
            0.8872
          ]
        },
        {
          "block_id": "p16_line_1",
          "block_type": "paragraph",
          "text": "be noted, and the steps taken to assure that their bioavailability was unaltered should",
          "bbox": [
            0.9686,
            1.0463,
            7.0897,
            1.2253
          ]
        },
        {
          "block_id": "p16_line_2",
          "block_type": "paragraph",
          "text": "be described.",
          "bbox": [
            0.9673,
            1.2329,
            1.8934,
            1.3999
          ]
        },
        {
          "block_id": "p16_line_3",
          "block_type": "paragraph",
          "text": "For long-duration trials of investigational products with limited shelf-lives or",
          "bbox": [
            0.9734,
            1.4966,
            7.091,
            1.6811
          ]
        },
        {
          "block_id": "p16_line_4",
          "block_type": "paragraph",
          "text": "incomplete stability data, the logistics of resupply of the materials should be",
          "bbox": [
            0.9684,
            1.6812,
            7.089,
            1.8664
          ]
        },
        {
          "block_id": "p16_line_5",
          "block_type": "paragraph",
          "text": "described. Any use of test materials past their expiry date should be noted, and",
          "bbox": [
            0.9768,
            1.863,
            7.0919,
            2.0493
          ]
        },
        {
          "block_id": "p16_line_6",
          "block_type": "paragraph",
          "text": "patients receiving them identified. If there were specific storage requirements, these",
          "bbox": [
            0.968,
            2.0557,
            7.0916,
            2.2368
          ]
        },
        {
          "block_id": "p16_line_7",
          "block_type": "paragraph",
          "text": "should also be described.",
          "bbox": [
            0.9723,
            2.2353,
            2.7282,
            2.4081
          ]
        },
        {
          "block_id": "p16_line_8",
          "block_type": "paragraph",
          "text": "9.4.3 Method of Assigning Patients to Treatment Groups",
          "bbox": [
            0.9775,
            2.581,
            5.5319,
            2.7682
          ]
        },
        {
          "block_id": "p16_line_9",
          "block_type": "paragraph",
          "text": "The specific methods used to assign patients to treatment groups, e.g., centralised",
          "bbox": [
            0.9704,
            2.806,
            7.0922,
            2.9918
          ]
        },
        {
          "block_id": "p16_line_10",
          "block_type": "paragraph",
          "text": "allocation, allocation within sites, adaptive allocation (that is, assignment on the basis",
          "bbox": [
            0.9746,
            2.9918,
            7.089,
            3.1726
          ]
        },
        {
          "block_id": "p16_line_11",
          "block_type": "paragraph",
          "text": "of earlier assignment or outcome) should be described in the text of the report,",
          "bbox": [
            0.9738,
            3.1768,
            7.0809,
            3.3629
          ]
        },
        {
          "block_id": "p16_line_12",
          "block_type": "paragraph",
          "text": "including any stratification or blocking procedures. Any unusual features should be",
          "bbox": [
            0.9673,
            3.3594,
            7.0891,
            3.5499
          ]
        },
        {
          "block_id": "p16_line_13",
          "block_type": "paragraph",
          "text": "explained.",
          "bbox": [
            0.9733,
            3.549,
            1.7098,
            3.7271
          ]
        },
        {
          "block_id": "p16_line_14",
          "block_type": "paragraph",
          "text": "A detailed description of the randomisation method, including how it was executed,",
          "bbox": [
            0.9731,
            3.8015,
            7.0786,
            3.9914
          ]
        },
        {
          "block_id": "p16_line_15",
          "block_type": "paragraph",
          "text": "should be given in appendix 16.1.7 with references cited if necessary. A table",
          "bbox": [
            0.9707,
            3.994,
            7.0911,
            4.179
          ]
        },
        {
          "block_id": "p16_line_16",
          "block_type": "paragraph",
          "text": "exhibiting the randomisation codes, patient identifier, and treatment assigned should",
          "bbox": [
            0.9739,
            4.1752,
            7.091,
            4.3626
          ]
        },
        {
          "block_id": "p16_line_17",
          "block_type": "paragraph",
          "text": "also be presented in the appendix. For a multicentre study, the information should be",
          "bbox": [
            0.9741,
            4.3571,
            7.0921,
            4.5453
          ]
        },
        {
          "block_id": "p16_line_18",
          "block_type": "paragraph",
          "text": "given by centre. The method of generating random numbers should be explained.",
          "bbox": [
            0.9714,
            4.5404,
            6.744,
            4.7329
          ]
        },
        {
          "block_id": "p16_line_19",
          "block_type": "paragraph",
          "text": "For a historically controlled trial, it is important to explain how the particular control",
          "bbox": [
            0.9745,
            4.8053,
            7.0931,
            4.9995
          ]
        },
        {
          "block_id": "p16_line_20",
          "block_type": "paragraph",
          "text": "was selected and what other historical experiences were examined, if any, and how",
          "bbox": [
            0.9715,
            4.9964,
            7.0903,
            5.1791
          ]
        },
        {
          "block_id": "p16_line_21",
          "block_type": "paragraph",
          "text": "their results compared to the control used.",
          "bbox": [
            0.973,
            5.1767,
            3.9791,
            5.3587
          ]
        },
        {
          "block_id": "p16_line_22",
          "block_type": "paragraph",
          "text": "9.4.4 Selection of Doses in the Study",
          "bbox": [
            0.9775,
            5.5657,
            3.9391,
            5.755
          ]
        },
        {
          "block_id": "p16_line_23",
          "block_type": "paragraph",
          "text": "The doses or dose ranges used in the study should be given for all treatments and the",
          "bbox": [
            0.9731,
            5.7902,
            7.0904,
            5.9784
          ]
        },
        {
          "block_id": "p16_line_24",
          "block_type": "paragraph",
          "text": "basis for choosing them described (e.g., prior experience in humans, animal data).",
          "bbox": [
            0.9663,
            5.9713,
            6.7423,
            6.167
          ]
        },
        {
          "block_id": "p16_line_25",
          "block_type": "paragraph",
          "text": "9.4.5 Selection and Timing of Dose for each Patient",
          "bbox": [
            0.9767,
            6.3662,
            5.1279,
            6.5542
          ]
        },
        {
          "block_id": "p16_line_26",
          "block_type": "paragraph",
          "text": "Procedures for selecting each patient's dose of test drug/investigational product and",
          "bbox": [
            0.9732,
            6.5881,
            7.094,
            6.7786
          ]
        },
        {
          "block_id": "p16_line_27",
          "block_type": "paragraph",
          "text": "active control/comparator should be described. These procedures can vary from",
          "bbox": [
            0.9743,
            6.7735,
            7.0889,
            6.9612
          ]
        },
        {
          "block_id": "p16_line_28",
          "block_type": "paragraph",
          "text": "simple random assignment to a selected fixed drug/dose regimen, to some specified",
          "bbox": [
            0.9725,
            6.9577,
            7.092,
            7.1458
          ]
        },
        {
          "block_id": "p16_line_29",
          "block_type": "paragraph",
          "text": "titration procedure, to more elaborate response-determined selection procedures, e.g.,",
          "bbox": [
            0.9731,
            7.1434,
            7.0798,
            7.3309
          ]
        },
        {
          "block_id": "p16_line_30",
          "block_type": "paragraph",
          "text": "where dose is titrated upward at intervals until intolerance or some specified",
          "bbox": [
            0.9732,
            7.3253,
            7.0914,
            7.5053
          ]
        },
        {
          "block_id": "p16_line_31",
          "block_type": "paragraph",
          "text": "endpoint is achieved. Procedures for back-titration, if any, should also be described.",
          "bbox": [
            0.9742,
            7.5032,
            6.9173,
            7.6916
          ]
        },
        {
          "block_id": "p16_line_32",
          "block_type": "paragraph",
          "text": "The timing (time of day, interval) of dosing and the relation of dosing to meals should",
          "bbox": [
            0.9714,
            7.81,
            7.0923,
            8.0009
          ]
        },
        {
          "block_id": "p16_line_33",
          "block_type": "paragraph",
          "text": "be described, and if it was not specified, this should be noted.",
          "bbox": [
            0.9676,
            7.9998,
            5.2947,
            8.1862
          ]
        },
        {
          "block_id": "p16_line_34",
          "block_type": "paragraph",
          "text": "Any specific instructions to patients about when or how to take the dose(s) should be",
          "bbox": [
            0.9716,
            8.3062,
            7.0898,
            8.4967
          ]
        },
        {
          "block_id": "p16_line_35",
          "block_type": "paragraph",
          "text": "described.",
          "bbox": [
            0.9732,
            8.4982,
            1.6915,
            8.6623
          ]
        },
        {
          "block_id": "p16_line_36",
          "block_type": "paragraph",
          "text": "9.4.6 Blinding",
          "bbox": [
            0.9731,
            8.885,
            2.1816,
            9.0602
          ]
        },
        {
          "block_id": "p16_line_37",
          "block_type": "paragraph",
          "text": "A description of the specific procedures used to carry out blinding should be provided",
          "bbox": [
            0.9724,
            9.1065,
            7.0922,
            9.2962
          ]
        },
        {
          "block_id": "p16_line_38",
          "block_type": "paragraph",
          "text": "(e.g., how bottles were labelled, labels that reveal blind-breakage, sealed code",
          "bbox": [
            0.9774,
            9.2905,
            7.09,
            9.4769
          ]
        },
        {
          "block_id": "p16_line_39",
          "block_type": "paragraph",
          "text": "list/envelopes, double dummy techniques), including the circumstances in which the",
          "bbox": [
            0.9692,
            9.4781,
            7.0933,
            9.6584
          ]
        },
        {
          "block_id": "p16_line_40",
          "block_type": "paragraph",
          "text": "blind would be broken for an individual or for all patients, e.g., for serious adverse",
          "bbox": [
            0.9702,
            9.6599,
            7.0912,
            9.8386
          ]
        },
        {
          "block_id": "p16_line_41",
          "block_type": "paragraph",
          "text": "events, the procedures used and who had access to patient codes. If the study allowed",
          "bbox": [
            0.9745,
            9.8428,
            7.0931,
            10.0214
          ]
        },
        {
          "block_id": "p16_line_42",
          "block_type": "paragraph",
          "text": "for some investigators to remain unblinded (e.g., to allow them to adjust medication),",
          "bbox": [
            0.9705,
            10.0272,
            7.0811,
            10.2063
          ]
        },
        {
          "block_id": "p16_line_43",
          "block_type": "paragraph",
          "text": "the means of shielding other investigators should be explained. Measures taken to",
          "bbox": [
            0.9727,
            10.2103,
            7.0871,
            10.3838
          ]
        },
        {
          "block_id": "p16_line_44",
          "block_type": "paragraph",
          "text": "ensure that test drug/investigational product and placebo were indistinguishable and",
          "bbox": [
            0.9758,
            10.3925,
            7.0921,
            10.5695
          ]
        },
        {
          "block_id": "p16_line_45",
          "block_type": "paragraph",
          "text": "8",
          "bbox": [
            3.9859,
            10.9521,
            4.0765,
            11.0803
          ]
        }
      ]
    },
    {
      "page_number": 17,
      "width": 8.2639,
      "height": 11.6944,
      "unit": "inch",
      "blocks": [
        {
          "block_id": "p17_line_0",
          "block_type": "paragraph",
          "text": "Structure and Content of Clinical Study Reports",
          "bbox": [
            4.1835,
            0.7138,
            7.2868,
            0.8879
          ]
        },
        {
          "block_id": "p17_line_1",
          "block_type": "paragraph",
          "text": "evidence that they were indistinguishable, should be described, as should the",
          "bbox": [
            1.1702,
            1.045,
            7.2865,
            1.2266
          ]
        },
        {
          "block_id": "p17_line_2",
          "block_type": "paragraph",
          "text": "appearance, shape, smell, and taste of the test material. Measures to prevent",
          "bbox": [
            1.169,
            1.2294,
            7.2907,
            1.4205
          ]
        },
        {
          "block_id": "p17_line_3",
          "block_type": "paragraph",
          "text": "unblinding by laboratory measurements, if used, should be described. If there was a",
          "bbox": [
            1.1664,
            1.4192,
            7.2878,
            1.6034
          ]
        },
        {
          "block_id": "p17_line_4",
          "block_type": "paragraph",
          "text": "data monitoring committee with access to unblinded data, procedures to ensure",
          "bbox": [
            1.1727,
            1.6058,
            7.2872,
            1.7824
          ]
        },
        {
          "block_id": "p17_line_5",
          "block_type": "paragraph",
          "text": "maintenance of overall study blinding should be described. The procedure to",
          "bbox": [
            1.1687,
            1.7836,
            7.2863,
            1.9672
          ]
        },
        {
          "block_id": "p17_line_6",
          "block_type": "paragraph",
          "text": "maintain the blinding when interim analyses are performed should also be explained.",
          "bbox": [
            1.1676,
            1.9679,
            7.2285,
            2.1527
          ]
        },
        {
          "block_id": "p17_line_7",
          "block_type": "paragraph",
          "text": "If blinding was considered unnecessary to reduce bias for some or all of the",
          "bbox": [
            1.165,
            2.2698,
            7.2864,
            2.4562
          ]
        },
        {
          "block_id": "p17_line_8",
          "block_type": "paragraph",
          "text": "observations, this should be explained; e.g., use of a random-zero sphygmomanometer",
          "bbox": [
            1.1703,
            2.4569,
            7.2882,
            2.6438
          ]
        },
        {
          "block_id": "p17_line_9",
          "block_type": "paragraph",
          "text": "eliminates possible observer bias in reading blood pressure and Holter tapes are often",
          "bbox": [
            1.1724,
            2.6406,
            7.2894,
            2.8247
          ]
        },
        {
          "block_id": "p17_line_10",
          "block_type": "paragraph",
          "text": "read by automated systems that are presumably immune to observer bias. If blinding",
          "bbox": [
            1.1637,
            2.8228,
            7.2905,
            3.0079
          ]
        },
        {
          "block_id": "p17_line_11",
          "block_type": "paragraph",
          "text": "was considered desirable but not feasible, the reasons and implications should be",
          "bbox": [
            1.167,
            3.0071,
            7.2895,
            3.1881
          ]
        },
        {
          "block_id": "p17_line_12",
          "block_type": "paragraph",
          "text": "discussed. Sometimes blinding is attempted but is known to be imperfect because of",
          "bbox": [
            1.1739,
            3.1844,
            7.2984,
            3.3743
          ]
        },
        {
          "block_id": "p17_line_13",
          "block_type": "paragraph",
          "text": "obvious drug effects in at least some patients (dry mouth, bradycardia, fever, injection",
          "bbox": [
            1.1691,
            3.3779,
            7.2879,
            3.5646
          ]
        },
        {
          "block_id": "p17_line_14",
          "block_type": "paragraph",
          "text": "site reactions, changes in laboratory data). Such problems or potential problems",
          "bbox": [
            1.168,
            3.5574,
            7.2878,
            3.75
          ]
        },
        {
          "block_id": "p17_line_15",
          "block_type": "paragraph",
          "text": "should be identified and if there were any attempts to assess the magnitude of the",
          "bbox": [
            1.1698,
            3.7418,
            7.289,
            3.9274
          ]
        },
        {
          "block_id": "p17_line_16",
          "block_type": "paragraph",
          "text": "problem or manage it (e.g., by having some endpoint measurements carried out by",
          "bbox": [
            1.1636,
            3.9276,
            7.2878,
            4.1144
          ]
        },
        {
          "block_id": "p17_line_17",
          "block_type": "paragraph",
          "text": "people shielded from information that might reveal treatment assignment), they",
          "bbox": [
            1.1623,
            4.1056,
            7.2877,
            4.3026
          ]
        },
        {
          "block_id": "p17_line_18",
          "block_type": "paragraph",
          "text": "should be described.",
          "bbox": [
            1.1658,
            4.2899,
            2.6048,
            4.4665
          ]
        },
        {
          "block_id": "p17_line_19",
          "block_type": "paragraph",
          "text": "9.4.7 Prior and Concomitant Therapy",
          "bbox": [
            1.1703,
            4.6766,
            4.2356,
            4.8765
          ]
        },
        {
          "block_id": "p17_line_20",
          "block_type": "paragraph",
          "text": "Which drugs or procedures were allowed before and during the study, whether and",
          "bbox": [
            1.1683,
            4.9013,
            7.2918,
            5.0935
          ]
        },
        {
          "block_id": "p17_line_21",
          "block_type": "paragraph",
          "text": "how their use was recorded, and any other specific rules and procedures related to",
          "bbox": [
            1.163,
            5.0878,
            7.288,
            5.2768
          ]
        },
        {
          "block_id": "p17_line_22",
          "block_type": "paragraph",
          "text": "permitted or forbidden concomitant therapy should be described. How allowed",
          "bbox": [
            1.1638,
            5.2684,
            7.2929,
            5.4628
          ]
        },
        {
          "block_id": "p17_line_23",
          "block_type": "paragraph",
          "text": "concomitant therapy might affect the outcome due either to drug-drug interaction or",
          "bbox": [
            1.168,
            5.4569,
            7.2893,
            5.6414
          ]
        },
        {
          "block_id": "p17_line_24",
          "block_type": "paragraph",
          "text": "to direct effects on the study endpoints should be discussed, and how the independent",
          "bbox": [
            1.1686,
            5.6429,
            7.2901,
            5.829
          ]
        },
        {
          "block_id": "p17_line_25",
          "block_type": "paragraph",
          "text": "effects of concomitant and study therapies could be ascertained should be explained.",
          "bbox": [
            1.1724,
            5.8258,
            7.1228,
            6.014
          ]
        },
        {
          "block_id": "p17_line_26",
          "block_type": "paragraph",
          "text": "9.4.8 Treatment Compliance",
          "bbox": [
            1.1731,
            6.2148,
            3.5067,
            6.3975
          ]
        },
        {
          "block_id": "p17_line_27",
          "block_type": "paragraph",
          "text": "The measures taken to ensure and document treatment compliance should be",
          "bbox": [
            1.1687,
            6.4403,
            7.2877,
            6.6278
          ]
        },
        {
          "block_id": "p17_line_28",
          "block_type": "paragraph",
          "text": "described, e.g., drug accountability, diary cards, blood, urine or other body fluid drug",
          "bbox": [
            1.173,
            6.6229,
            7.2908,
            6.8161
          ]
        },
        {
          "block_id": "p17_line_29",
          "block_type": "paragraph",
          "text": "level measurements, or medication event monitoring.",
          "bbox": [
            1.1607,
            6.8077,
            4.9396,
            6.9966
          ]
        },
        {
          "block_id": "p17_line_30",
          "block_type": "paragraph",
          "text": "9.5 EFFICACY AND SAFETY VARIABLES",
          "bbox": [
            1.172,
            7.1948,
            4.6969,
            7.3759
          ]
        },
        {
          "block_id": "p17_line_31",
          "block_type": "paragraph",
          "text": "9.5.1 Efficacy and Safety Measurements Assessed and Flow Chart",
          "bbox": [
            1.1718,
            7.5067,
            6.454,
            7.6916
          ]
        },
        {
          "block_id": "p17_line_32",
          "block_type": "paragraph",
          "text": "The specific efficacy and safety variables to be assessed and laboratory tests to be",
          "bbox": [
            1.1681,
            7.7305,
            7.2862,
            7.917
          ]
        },
        {
          "block_id": "p17_line_33",
          "block_type": "paragraph",
          "text": "conducted, their schedule (days of study, time of day, relation to meals, and the timing",
          "bbox": [
            1.1671,
            7.9143,
            7.2921,
            8.1028
          ]
        },
        {
          "block_id": "p17_line_34",
          "block_type": "paragraph",
          "text": "of critical measures in relation to test drug administration, e.g., just prior to next",
          "bbox": [
            1.1681,
            8.0996,
            7.2892,
            8.2855
          ]
        },
        {
          "block_id": "p17_line_35",
          "block_type": "paragraph",
          "text": "dose, two hours after dose), the methods for measuring them, and the persons",
          "bbox": [
            1.1713,
            8.2809,
            7.2895,
            8.4676
          ]
        },
        {
          "block_id": "p17_line_36",
          "block_type": "paragraph",
          "text": "responsible for the measurements should be described. If there were changes in",
          "bbox": [
            1.1637,
            8.466,
            7.2885,
            8.6486
          ]
        },
        {
          "block_id": "p17_line_37",
          "block_type": "paragraph",
          "text": "personnel carrying out critical measurements, these should be reported.",
          "bbox": [
            1.1629,
            8.6501,
            6.2566,
            8.8348
          ]
        },
        {
          "block_id": "p17_line_38",
          "block_type": "paragraph",
          "text": "It is usually helpful to display graphically in a flow chart (see Annex III of the",
          "bbox": [
            1.1634,
            8.9507,
            7.2864,
            9.1418
          ]
        },
        {
          "block_id": "p17_line_39",
          "block_type": "paragraph",
          "text": "guideline) the frequency and timing of efficacy and safety measurements; visit",
          "bbox": [
            1.1669,
            9.1409,
            7.2904,
            9.3247
          ]
        },
        {
          "block_id": "p17_line_40",
          "block_type": "paragraph",
          "text": "numbers and times should be shown, or, alternatively, times alone can be used (visit",
          "bbox": [
            1.1638,
            9.3278,
            7.2892,
            9.5095
          ]
        },
        {
          "block_id": "p17_line_41",
          "block_type": "paragraph",
          "text": "numbers alone are more difficult to interpret). Any specific instructions (e.g.,",
          "bbox": [
            1.1628,
            9.5074,
            7.2789,
            9.6977
          ]
        },
        {
          "block_id": "p17_line_42",
          "block_type": "paragraph",
          "text": "guidance or use of a diary) to the patients should also be noted.",
          "bbox": [
            1.1677,
            9.6902,
            5.6381,
            9.8786
          ]
        },
        {
          "block_id": "p17_line_43",
          "block_type": "paragraph",
          "text": "Any definitions used to characterise outcome (e.g., criteria for determining occurrence",
          "bbox": [
            1.1647,
            10.0016,
            7.2874,
            10.1812
          ]
        },
        {
          "block_id": "p17_line_44",
          "block_type": "paragraph",
          "text": "of acute myocardial infarction, designation of the location of the infarction,",
          "bbox": [
            1.1699,
            10.188,
            7.277,
            10.3613
          ]
        },
        {
          "block_id": "p17_line_45",
          "block_type": "paragraph",
          "text": "characterisation of a stroke as thrombotic or haemorrhagic, distinction between TIA",
          "bbox": [
            1.1696,
            10.3685,
            7.2845,
            10.5438
          ]
        },
        {
          "block_id": "p17_line_46",
          "block_type": "paragraph",
          "text": "9",
          "bbox": [
            4.1822,
            10.9533,
            4.2695,
            11.0806
          ]
        }
      ]
    },
    {
      "page_number": 18,
      "width": 8.2639,
      "height": 11.6944,
      "unit": "inch",
      "blocks": [
        {
          "block_id": "p18_line_0",
          "block_type": "paragraph",
          "text": "Structure and Content of Clinical Study Reports",
          "bbox": [
            0.9733,
            0.7138,
            4.0779,
            0.8871
          ]
        },
        {
          "block_id": "p18_line_1",
          "block_type": "paragraph",
          "text": "and stroke, assignment of cause of death) should be explained in full. Any techniques",
          "bbox": [
            0.9754,
            1.0456,
            7.0884,
            1.2297
          ]
        },
        {
          "block_id": "p18_line_2",
          "block_type": "paragraph",
          "text": "used to standardise or compare results of laboratory tests or other clinical",
          "bbox": [
            0.9732,
            1.2337,
            7.0922,
            1.4143
          ]
        },
        {
          "block_id": "p18_line_3",
          "block_type": "paragraph",
          "text": "measurements (e.g., ECG, chest X-ray) should also be described. This is particularly",
          "bbox": [
            0.973,
            1.4173,
            7.0893,
            1.6064
          ]
        },
        {
          "block_id": "p18_line_4",
          "block_type": "paragraph",
          "text": "important in multicentre studies.",
          "bbox": [
            0.9642,
            1.6014,
            3.3394,
            1.7844
          ]
        },
        {
          "block_id": "p18_line_5",
          "block_type": "paragraph",
          "text": "If anyone other than the investigator was responsible for evaluation of clinical",
          "bbox": [
            0.9695,
            1.9051,
            7.0921,
            2.0955
          ]
        },
        {
          "block_id": "p18_line_6",
          "block_type": "paragraph",
          "text": "outcomes (e.g., the sponsor or an external committee to review X-rays or ECG's or to",
          "bbox": [
            0.9719,
            2.0899,
            7.0874,
            2.2784
          ]
        },
        {
          "block_id": "p18_line_7",
          "block_type": "paragraph",
          "text": "determine whether the patient had a stroke, acute infarction, or sudden death) the",
          "bbox": [
            0.9743,
            2.272,
            7.0914,
            2.4595
          ]
        },
        {
          "block_id": "p18_line_8",
          "block_type": "paragraph",
          "text": "person or group should be identified. The procedures, including means of maintaining",
          "bbox": [
            0.9643,
            2.4572,
            7.0956,
            2.6471
          ]
        },
        {
          "block_id": "p18_line_9",
          "block_type": "paragraph",
          "text": "blindness, and centralising readings and measurements, should be described fully.",
          "bbox": [
            0.9647,
            2.639,
            6.8148,
            2.8276
          ]
        },
        {
          "block_id": "p18_line_10",
          "block_type": "paragraph",
          "text": "The means of obtaining adverse event data should be described (volunteered,",
          "bbox": [
            0.9694,
            2.9441,
            7.0783,
            3.1298
          ]
        },
        {
          "block_id": "p18_line_11",
          "block_type": "paragraph",
          "text": "checklist, or, questioning), as should any specific rating scale(s) used and any",
          "bbox": [
            0.9717,
            3.1314,
            7.0903,
            3.3225
          ]
        },
        {
          "block_id": "p18_line_12",
          "block_type": "paragraph",
          "text": "specifically planned follow-up procedures for adverse events or any planned",
          "bbox": [
            0.9713,
            3.3163,
            7.094,
            3.5033
          ]
        },
        {
          "block_id": "p18_line_13",
          "block_type": "paragraph",
          "text": "rechallenge procedure.",
          "bbox": [
            0.9666,
            3.5052,
            2.5812,
            3.679
          ]
        },
        {
          "block_id": "p18_line_14",
          "block_type": "paragraph",
          "text": "Any rating of adverse events by the investigator, sponsor or external group, (e.g.,",
          "bbox": [
            0.9705,
            3.8043,
            7.0829,
            4.0002
          ]
        },
        {
          "block_id": "p18_line_15",
          "block_type": "paragraph",
          "text": "rating by severity or, likelihood of drug causation) should be described. The criteria",
          "bbox": [
            0.9669,
            3.9914,
            7.0883,
            4.1799
          ]
        },
        {
          "block_id": "p18_line_16",
          "block_type": "paragraph",
          "text": "for such ratings, if any, should be given and the parties responsible for the ratings",
          "bbox": [
            0.9687,
            4.1776,
            7.0937,
            4.3654
          ]
        },
        {
          "block_id": "p18_line_17",
          "block_type": "paragraph",
          "text": "should be clearly identified. If efficacy or safety was to be assessed in terms of",
          "bbox": [
            0.9719,
            4.3539,
            7.1051,
            4.5453
          ]
        },
        {
          "block_id": "p18_line_18",
          "block_type": "paragraph",
          "text": "categorical ratings, numerical scores etc., the criteria used for point assignment (e.g.,",
          "bbox": [
            0.972,
            4.5453,
            7.0816,
            4.7315
          ]
        },
        {
          "block_id": "p18_line_19",
          "block_type": "paragraph",
          "text": "definitions of point scores) should be provided. For multicentre studies, indicate how",
          "bbox": [
            0.9769,
            4.7228,
            7.0905,
            4.9108
          ]
        },
        {
          "block_id": "p18_line_20",
          "block_type": "paragraph",
          "text": "methods were standardised.",
          "bbox": [
            0.9683,
            4.9123,
            2.9669,
            5.0838
          ]
        },
        {
          "block_id": "p18_line_21",
          "block_type": "paragraph",
          "text": "9.5.2 Appropriateness of Measurements",
          "bbox": [
            0.9768,
            5.3016,
            4.2064,
            5.4844
          ]
        },
        {
          "block_id": "p18_line_22",
          "block_type": "paragraph",
          "text": "If any of the efficacy or safety assessments was not standard, i.e., widely used and",
          "bbox": [
            0.9686,
            5.5196,
            7.0927,
            5.7115
          ]
        },
        {
          "block_id": "p18_line_23",
          "block_type": "paragraph",
          "text": "generally recognised as reliable, accurate, and relevant (able to discriminate between",
          "bbox": [
            0.9709,
            5.7045,
            7.0916,
            5.8963
          ]
        },
        {
          "block_id": "p18_line_24",
          "block_type": "paragraph",
          "text": "effective and ineffective agents), its reliability, accuracy and relevance should be",
          "bbox": [
            0.9755,
            5.8892,
            7.0921,
            6.075
          ]
        },
        {
          "block_id": "p18_line_25",
          "block_type": "paragraph",
          "text": "documented. It may be helpful to describe alternatives considered but rejected.",
          "bbox": [
            0.9751,
            6.069,
            6.5881,
            6.2584
          ]
        },
        {
          "block_id": "p18_line_26",
          "block_type": "paragraph",
          "text": "If a surrogate end point (a laboratory measurement or physical measurement or sign",
          "bbox": [
            0.968,
            6.3788,
            7.0901,
            6.5715
          ]
        },
        {
          "block_id": "p18_line_27",
          "block_type": "paragraph",
          "text": "that is not a direct measure of clinical benefit) was used as a study end point, this",
          "bbox": [
            0.9706,
            6.5667,
            7.0897,
            6.7563
          ]
        },
        {
          "block_id": "p18_line_28",
          "block_type": "paragraph",
          "text": "should be justified e.g., by reference to clinical data, publications, guidelines or",
          "bbox": [
            0.9723,
            6.7519,
            7.0925,
            6.9379
          ]
        },
        {
          "block_id": "p18_line_29",
          "block_type": "paragraph",
          "text": "previous actions by regulatory authorities.",
          "bbox": [
            0.9651,
            6.9379,
            3.9806,
            7.1274
          ]
        },
        {
          "block_id": "p18_line_30",
          "block_type": "paragraph",
          "text": "9.5.3 Primary Efficacy Variable(s)",
          "bbox": [
            0.9746,
            7.3147,
            3.7526,
            7.51
          ]
        },
        {
          "block_id": "p18_line_31",
          "block_type": "paragraph",
          "text": "The primary measurements and endpoints used to determine efficacy should be",
          "bbox": [
            0.9709,
            7.5444,
            7.0919,
            7.7373
          ]
        },
        {
          "block_id": "p18_line_32",
          "block_type": "paragraph",
          "text": "clearly specified. Although the critical efficacy measurements may seem obvious,",
          "bbox": [
            0.97,
            7.7319,
            7.0831,
            7.9209
          ]
        },
        {
          "block_id": "p18_line_33",
          "block_type": "paragraph",
          "text": "when there are multiple variables, or when variables are measured repeatedly, the",
          "bbox": [
            0.9709,
            7.9143,
            7.0915,
            8.1013
          ]
        },
        {
          "block_id": "p18_line_34",
          "block_type": "paragraph",
          "text": "protocol should identify the primary ones, with an explanation of why they were",
          "bbox": [
            0.9681,
            8.1022,
            7.0913,
            8.2874
          ]
        },
        {
          "block_id": "p18_line_35",
          "block_type": "paragraph",
          "text": "chosen, or designate the pattern of significant findings or other method of combining",
          "bbox": [
            0.9712,
            8.283,
            7.0949,
            8.4681
          ]
        },
        {
          "block_id": "p18_line_36",
          "block_type": "paragraph",
          "text": "information that would be interpreted as supporting efficacy. If the protocol did not",
          "bbox": [
            0.9675,
            8.4652,
            7.0921,
            8.6511
          ]
        },
        {
          "block_id": "p18_line_37",
          "block_type": "paragraph",
          "text": "identify the primary variables, the study report should explain how these critical",
          "bbox": [
            0.9667,
            8.6453,
            7.093,
            8.8336
          ]
        },
        {
          "block_id": "p18_line_38",
          "block_type": "paragraph",
          "text": "variables were selected (e.g., by reference to publications, guidelines or previous",
          "bbox": [
            0.97,
            8.8346,
            7.0913,
            9.0145
          ]
        },
        {
          "block_id": "p18_line_39",
          "block_type": "paragraph",
          "text": "actions by regulatory authorities) and when they were identified (i.e., before or after",
          "bbox": [
            0.9735,
            9.0172,
            7.0926,
            9.2036
          ]
        },
        {
          "block_id": "p18_line_40",
          "block_type": "paragraph",
          "text": "the study was completed and unblinded). If an efficacy threshold was defined in the",
          "bbox": [
            0.9709,
            9.1992,
            7.0904,
            9.3818
          ]
        },
        {
          "block_id": "p18_line_41",
          "block_type": "paragraph",
          "text": "protocol, this should be described.",
          "bbox": [
            0.9644,
            9.3818,
            3.368,
            9.5719
          ]
        },
        {
          "block_id": "p18_line_42",
          "block_type": "paragraph",
          "text": "9.5.4 Drug Concentration Measurements",
          "bbox": [
            0.976,
            9.7815,
            4.2848,
            9.9528
          ]
        },
        {
          "block_id": "p18_line_43",
          "block_type": "paragraph",
          "text": "Any drug concentrations to be measured, and the sample collection times and periods",
          "bbox": [
            0.9711,
            10.0009,
            7.0883,
            10.1818
          ]
        },
        {
          "block_id": "p18_line_44",
          "block_type": "paragraph",
          "text": "in relation to the timing of drug administration, should be described. Any relation of",
          "bbox": [
            0.9673,
            10.1852,
            7.0994,
            10.3637
          ]
        },
        {
          "block_id": "p18_line_45",
          "block_type": "paragraph",
          "text": "drug administration and sampling to ingestion of food, posture and the possible",
          "bbox": [
            0.9747,
            10.3705,
            7.089,
            10.5497
          ]
        },
        {
          "block_id": "p18_line_46",
          "block_type": "paragraph",
          "text": "10",
          "bbox": [
            3.9469,
            10.9484,
            4.1187,
            11.0838
          ]
        }
      ]
    },
    {
      "page_number": 19,
      "width": 8.2639,
      "height": 11.6944,
      "unit": "inch",
      "blocks": [
        {
          "block_id": "p19_line_0",
          "block_type": "paragraph",
          "text": "Structure and Content of Clinical Study Reports",
          "bbox": [
            4.184,
            0.7138,
            7.2873,
            0.8868
          ]
        },
        {
          "block_id": "p19_line_1",
          "block_type": "paragraph",
          "text": "effects of concomitant medication/alcohol/caffeine/nicotine should also be addressed.",
          "bbox": [
            1.1713,
            1.0452,
            7.275,
            1.224
          ]
        },
        {
          "block_id": "p19_line_2",
          "block_type": "paragraph",
          "text": "The biological sample measured the handling of samples and the method of",
          "bbox": [
            1.171,
            1.2307,
            7.298,
            1.4135
          ]
        },
        {
          "block_id": "p19_line_3",
          "block_type": "paragraph",
          "text": "measurement used should be described, referring to published and/or internal assay",
          "bbox": [
            1.1691,
            1.4218,
            7.2878,
            1.6036
          ]
        },
        {
          "block_id": "p19_line_4",
          "block_type": "paragraph",
          "text": "validation documentation for methodological details. Where other factors are believed",
          "bbox": [
            1.1676,
            1.6013,
            7.293,
            1.7816
          ]
        },
        {
          "block_id": "p19_line_5",
          "block_type": "paragraph",
          "text": "important in assessing pharmacokinetics (e.g., soluble circulating receptors, renal or",
          "bbox": [
            1.1623,
            1.7873,
            7.2896,
            1.9725
          ]
        },
        {
          "block_id": "p19_line_6",
          "block_type": "paragraph",
          "text": "hepatic function), the timing and plans to measure these factors should also be",
          "bbox": [
            1.1612,
            1.9647,
            7.2895,
            2.1566
          ]
        },
        {
          "block_id": "p19_line_7",
          "block_type": "paragraph",
          "text": "specified.",
          "bbox": [
            1.1651,
            2.1562,
            1.8376,
            2.3354
          ]
        },
        {
          "block_id": "p19_line_8",
          "block_type": "paragraph",
          "text": "9.6 DATA QUALITY ASSURANCE",
          "bbox": [
            1.1809,
            2.5369,
            4.0545,
            2.7203
          ]
        },
        {
          "block_id": "p19_line_9",
          "block_type": "paragraph",
          "text": "The quality assurance and quality control systems implemented to assure the quality",
          "bbox": [
            1.1668,
            2.7648,
            7.2884,
            2.9545
          ]
        },
        {
          "block_id": "p19_line_10",
          "block_type": "paragraph",
          "text": "of the data should be described in brief. If none were used, this should be stated.",
          "bbox": [
            1.1708,
            2.9467,
            7.2797,
            3.1268
          ]
        },
        {
          "block_id": "p19_line_11",
          "block_type": "paragraph",
          "text": "Documentation of inter-laboratory standardisation methods and quality assurance",
          "bbox": [
            1.1627,
            3.1292,
            7.2882,
            3.3195
          ]
        },
        {
          "block_id": "p19_line_12",
          "block_type": "paragraph",
          "text": "procedures, if used, should be provided under appendix 16.1.10.",
          "bbox": [
            1.1624,
            3.3119,
            5.6702,
            3.506
          ]
        },
        {
          "block_id": "p19_line_13",
          "block_type": "paragraph",
          "text": "Any steps taken at the investigation site or centrally to ensure the use of standard",
          "bbox": [
            1.1637,
            3.6187,
            7.293,
            3.8087
          ]
        },
        {
          "block_id": "p19_line_14",
          "block_type": "paragraph",
          "text": "terminology and the collection of accurate, consistent, complete, and reliable data,",
          "bbox": [
            1.1652,
            3.8059,
            7.2799,
            3.9934
          ]
        },
        {
          "block_id": "p19_line_15",
          "block_type": "paragraph",
          "text": "such as training sessions, monitoring of investigators by sponsor personnel,",
          "bbox": [
            1.1693,
            3.9971,
            7.2797,
            4.1831
          ]
        },
        {
          "block_id": "p19_line_16",
          "block_type": "paragraph",
          "text": "instruction manuals, data verification, cross-checking, use of a central laboratory for",
          "bbox": [
            1.1659,
            4.1792,
            7.2892,
            4.3605
          ]
        },
        {
          "block_id": "p19_line_17",
          "block_type": "paragraph",
          "text": "certain tests, centralised ECG reading, or data audits, should be described. It should",
          "bbox": [
            1.1673,
            4.3569,
            7.2922,
            4.5449
          ]
        },
        {
          "block_id": "p19_line_18",
          "block_type": "paragraph",
          "text": "be noted whether investigator meetings or other steps were taken to prepare",
          "bbox": [
            1.1647,
            4.5416,
            7.2897,
            4.7337
          ]
        },
        {
          "block_id": "p19_line_19",
          "block_type": "paragraph",
          "text": "investigators and standardise performance.",
          "bbox": [
            1.1644,
            4.7309,
            4.2508,
            4.907
          ]
        },
        {
          "block_id": "p19_line_20",
          "block_type": "paragraph",
          "text": "If the sponsor used an independent internal or external auditing procedure, it should",
          "bbox": [
            1.1627,
            5.0283,
            7.2924,
            5.2188
          ]
        },
        {
          "block_id": "p19_line_21",
          "block_type": "paragraph",
          "text": "be mentioned here and described in appendix 16.1.8; and audit certificates, if",
          "bbox": [
            1.1646,
            5.2123,
            7.3026,
            5.4018
          ]
        },
        {
          "block_id": "p19_line_22",
          "block_type": "paragraph",
          "text": "available, should be provided in the same appendix.",
          "bbox": [
            1.167,
            5.4018,
            4.8383,
            5.5843
          ]
        },
        {
          "block_id": "p19_line_23",
          "block_type": "paragraph",
          "text": "9.7",
          "bbox": [
            1.1735,
            5.8013,
            1.3966,
            5.9557
          ]
        },
        {
          "block_id": "p19_line_24",
          "block_type": "paragraph",
          "text": "STATISTICAL METHODS PLANNED IN THE PROTOCOL AND",
          "bbox": [
            1.6592,
            5.7844,
            6.6546,
            5.9638
          ]
        },
        {
          "block_id": "p19_line_25",
          "block_type": "paragraph",
          "text": "DETERMINATION OF SAMPLE SIZE",
          "bbox": [
            1.665,
            5.971,
            4.6306,
            6.1445
          ]
        },
        {
          "block_id": "p19_line_26",
          "block_type": "paragraph",
          "text": "9.7.1 Statistical and Analytical Plans",
          "bbox": [
            1.1727,
            6.2824,
            4.1875,
            6.4638
          ]
        },
        {
          "block_id": "p19_line_27",
          "block_type": "paragraph",
          "text": "The statistical analyses planned in the protocol and any changes made before outcome",
          "bbox": [
            1.1689,
            6.5039,
            7.2882,
            6.692
          ]
        },
        {
          "block_id": "p19_line_28",
          "block_type": "paragraph",
          "text": "results were available should be described. In this section emphasis should be on",
          "bbox": [
            1.1639,
            6.6885,
            7.288,
            6.8711
          ]
        },
        {
          "block_id": "p19_line_29",
          "block_type": "paragraph",
          "text": "which analyses, comparisons and statistical tests were planned, not on which ones",
          "bbox": [
            1.1683,
            6.8785,
            7.2901,
            7.0626
          ]
        },
        {
          "block_id": "p19_line_30",
          "block_type": "paragraph",
          "text": "were actually used. If critical measurements were made more than once, the",
          "bbox": [
            1.1664,
            7.0611,
            7.2878,
            7.244
          ]
        },
        {
          "block_id": "p19_line_31",
          "block_type": "paragraph",
          "text": "particular measurements (e.g., average of several measurements over the entire",
          "bbox": [
            1.1633,
            7.2435,
            7.2884,
            7.4307
          ]
        },
        {
          "block_id": "p19_line_32",
          "block_type": "paragraph",
          "text": "study, values at particular times, values only from study completers, or last on-",
          "bbox": [
            1.1697,
            7.4261,
            7.2834,
            7.6117
          ]
        },
        {
          "block_id": "p19_line_33",
          "block_type": "paragraph",
          "text": "therapy value) planned as the basis for comparison of test drug/investigational",
          "bbox": [
            1.1661,
            7.6076,
            7.2906,
            7.7972
          ]
        },
        {
          "block_id": "p19_line_34",
          "block_type": "paragraph",
          "text": "product and control should be specified. Similarly, if more than one analytical",
          "bbox": [
            1.163,
            7.787,
            7.2924,
            7.9786
          ]
        },
        {
          "block_id": "p19_line_35",
          "block_type": "paragraph",
          "text": "approach is plausible, e.g., changes from baseline response, slope analysis, life table",
          "bbox": [
            1.1692,
            7.9714,
            7.2897,
            8.1644
          ]
        },
        {
          "block_id": "p19_line_36",
          "block_type": "paragraph",
          "text": "analysis, the planned approach should be identified. Also, whether the primary",
          "bbox": [
            1.1691,
            8.1541,
            7.288,
            8.3504
          ]
        },
        {
          "block_id": "p19_line_37",
          "block_type": "paragraph",
          "text": "analysis is to include adjustment for covariates should be specified.",
          "bbox": [
            1.1655,
            8.3381,
            5.9232,
            8.5252
          ]
        },
        {
          "block_id": "p19_line_38",
          "block_type": "paragraph",
          "text": "If there were any planned reasons for excluding from analysis patients for whom data",
          "bbox": [
            1.1639,
            8.6456,
            7.2886,
            8.8309
          ]
        },
        {
          "block_id": "p19_line_39",
          "block_type": "paragraph",
          "text": "are available, these should be described. If there were any subgroups whose results",
          "bbox": [
            1.1674,
            8.8336,
            7.2907,
            9.0122
          ]
        },
        {
          "block_id": "p19_line_40",
          "block_type": "paragraph",
          "text": "were to be examined separately, these should be identified. If categorical responses",
          "bbox": [
            1.166,
            9.0221,
            7.2916,
            9.2039
          ]
        },
        {
          "block_id": "p19_line_41",
          "block_type": "paragraph",
          "text": "(global scales, severity scores, responses of a certain size) were to be used in analysing",
          "bbox": [
            1.1769,
            9.2004,
            7.2914,
            9.3912
          ]
        },
        {
          "block_id": "p19_line_42",
          "block_type": "paragraph",
          "text": "responses, they should be clearly defined.",
          "bbox": [
            1.1632,
            9.3833,
            4.105,
            9.5727
          ]
        },
        {
          "block_id": "p19_line_43",
          "block_type": "paragraph",
          "text": "Planned monitoring of the results of the study should be described. If there was a",
          "bbox": [
            1.1654,
            9.6945,
            7.2866,
            9.8677
          ]
        },
        {
          "block_id": "p19_line_44",
          "block_type": "paragraph",
          "text": "data monitoring committee, either within or outside the sponsor's control, its",
          "bbox": [
            1.172,
            9.8801,
            7.2896,
            10.0565
          ]
        },
        {
          "block_id": "p19_line_45",
          "block_type": "paragraph",
          "text": "composition and operating procedures should be described and procedures to maintain",
          "bbox": [
            1.1693,
            10.0577,
            7.2886,
            10.241
          ]
        },
        {
          "block_id": "p19_line_46",
          "block_type": "paragraph",
          "text": "study blinding should be given. The frequency and nature of any planned interim",
          "bbox": [
            1.1685,
            10.2444,
            7.288,
            10.4216
          ]
        },
        {
          "block_id": "p19_line_47",
          "block_type": "paragraph",
          "text": "analysis, any specified circumstances in which the study would be terminated and any",
          "bbox": [
            1.1675,
            10.4284,
            7.288,
            10.6066
          ]
        },
        {
          "block_id": "p19_line_48",
          "block_type": "paragraph",
          "text": "11",
          "bbox": [
            4.144,
            10.9516,
            4.308,
            11.0818
          ]
        }
      ]
    },
    {
      "page_number": 20,
      "width": 8.2639,
      "height": 11.6944,
      "unit": "inch",
      "blocks": [
        {
          "block_id": "p20_line_0",
          "block_type": "paragraph",
          "text": "Structure and Content of Clinical Study Reports",
          "bbox": [
            0.9742,
            0.7138,
            4.0776,
            0.8872
          ]
        },
        {
          "block_id": "p20_line_1",
          "block_type": "paragraph",
          "text": "statistical adjustments to be employed because of interim analyses should be",
          "bbox": [
            0.9747,
            1.0471,
            7.0914,
            1.2299
          ]
        },
        {
          "block_id": "p20_line_2",
          "block_type": "paragraph",
          "text": "described.",
          "bbox": [
            0.9737,
            1.2343,
            1.691,
            1.3958
          ]
        },
        {
          "block_id": "p20_line_3",
          "block_type": "paragraph",
          "text": "9.7.2 Determination of Sample Size",
          "bbox": [
            0.9752,
            1.6189,
            3.8495,
            1.8086
          ]
        },
        {
          "block_id": "p20_line_4",
          "block_type": "paragraph",
          "text": "The planned sample size and the basis for it, such as statistical considerations or",
          "bbox": [
            0.9692,
            1.8444,
            7.093,
            2.0321
          ]
        },
        {
          "block_id": "p20_line_5",
          "block_type": "paragraph",
          "text": "practical limitations, should be provided. Methods for sample size calculation should",
          "bbox": [
            0.9673,
            2.0328,
            7.0923,
            2.22
          ]
        },
        {
          "block_id": "p20_line_6",
          "block_type": "paragraph",
          "text": "be given together with their derivations or source of reference. Estimates used in the",
          "bbox": [
            0.9672,
            2.2164,
            7.0901,
            2.4016
          ]
        },
        {
          "block_id": "p20_line_7",
          "block_type": "paragraph",
          "text": "calculations should be given and explanations provided as to how they were obtained.",
          "bbox": [
            0.9721,
            2.4018,
            7.082,
            2.5853
          ]
        },
        {
          "block_id": "p20_line_8",
          "block_type": "paragraph",
          "text": "For a study intended to show a difference between treatments, the difference the",
          "bbox": [
            0.9725,
            2.5839,
            7.0928,
            2.7637
          ]
        },
        {
          "block_id": "p20_line_9",
          "block_type": "paragraph",
          "text": "study is designed to detect should be specified. For a positive control study intended",
          "bbox": [
            0.9733,
            2.7658,
            7.0927,
            2.9507
          ]
        },
        {
          "block_id": "p20_line_10",
          "block_type": "paragraph",
          "text": "to show that a new therapy is at least as effective as the standard therapy, the sample",
          "bbox": [
            0.9707,
            2.9503,
            7.0892,
            3.1327
          ]
        },
        {
          "block_id": "p20_line_11",
          "block_type": "paragraph",
          "text": "size determination should specify the difference between treatments that would be",
          "bbox": [
            0.9718,
            3.1306,
            7.0886,
            3.3135
          ]
        },
        {
          "block_id": "p20_line_12",
          "block_type": "paragraph",
          "text": "considered unacceptably large and therefore the difference the study is designed to be",
          "bbox": [
            0.9721,
            3.3139,
            7.0903,
            3.4996
          ]
        },
        {
          "block_id": "p20_line_13",
          "block_type": "paragraph",
          "text": "able to exclude.",
          "bbox": [
            0.9735,
            3.5034,
            2.0726,
            3.6686
          ]
        },
        {
          "block_id": "p20_line_14",
          "block_type": "paragraph",
          "text": "9.8",
          "bbox": [
            0.9799,
            3.9038,
            1.2045,
            4.0517
          ]
        },
        {
          "block_id": "p20_line_15",
          "block_type": "paragraph",
          "text": "CHANGES IN THE CONDUCT OF THE STUDY OR PLANNED",
          "bbox": [
            1.4729,
            3.8816,
            6.34,
            4.0654
          ]
        },
        {
          "block_id": "p20_line_16",
          "block_type": "paragraph",
          "text": "ANALYSES",
          "bbox": [
            1.4704,
            4.076,
            2.3824,
            4.2356
          ]
        },
        {
          "block_id": "p20_line_17",
          "block_type": "paragraph",
          "text": "Any change in the conduct of the study or planned analyses (e.g., dropping a",
          "bbox": [
            0.9704,
            4.2998,
            7.09,
            4.4958
          ]
        },
        {
          "block_id": "p20_line_18",
          "block_type": "paragraph",
          "text": "treatment group, changing the entry criteria or drug dosages, adjusting the sample",
          "bbox": [
            0.97,
            4.485,
            7.0918,
            4.6766
          ]
        },
        {
          "block_id": "p20_line_19",
          "block_type": "paragraph",
          "text": "size etc.) instituted after the start of the study should be described. The time(s) and",
          "bbox": [
            0.971,
            4.6646,
            7.0943,
            4.8533
          ]
        },
        {
          "block_id": "p20_line_20",
          "block_type": "paragraph",
          "text": "reason(s) for the change(s), the procedure used to decide on the change(s), the",
          "bbox": [
            0.9683,
            4.8504,
            7.095,
            5.0382
          ]
        },
        {
          "block_id": "p20_line_21",
          "block_type": "paragraph",
          "text": "person(s) or group(s) responsible for the change(s) and the nature and content of the",
          "bbox": [
            0.969,
            5.0307,
            7.0938,
            5.2248
          ]
        },
        {
          "block_id": "p20_line_22",
          "block_type": "paragraph",
          "text": "data available (and to whom they were available) when the change was made should",
          "bbox": [
            0.9744,
            5.2134,
            7.0954,
            5.4018
          ]
        },
        {
          "block_id": "p20_line_23",
          "block_type": "paragraph",
          "text": "also be described, whether the change was documented as a formal protocol",
          "bbox": [
            0.9723,
            5.3982,
            7.0955,
            5.584
          ]
        },
        {
          "block_id": "p20_line_24",
          "block_type": "paragraph",
          "text": "amendment or not (Personnel changes need not be included). Any possible",
          "bbox": [
            0.9711,
            5.5781,
            7.0923,
            5.7673
          ]
        },
        {
          "block_id": "p20_line_25",
          "block_type": "paragraph",
          "text": "implications of the change(s) for the interpretation of the study should be discussed",
          "bbox": [
            0.9649,
            5.7579,
            7.0933,
            5.9523
          ]
        },
        {
          "block_id": "p20_line_26",
          "block_type": "paragraph",
          "text": "briefly in this section and more fully in other appropriate sections of the report. In",
          "bbox": [
            0.966,
            5.9435,
            7.0907,
            6.1361
          ]
        },
        {
          "block_id": "p20_line_27",
          "block_type": "paragraph",
          "text": "every section of the report, a clear distinction between conditions (procedures)",
          "bbox": [
            0.9716,
            6.1332,
            7.0838,
            6.3234
          ]
        },
        {
          "block_id": "p20_line_28",
          "block_type": "paragraph",
          "text": "planned in the protocol and amendments or additions should be made. In general,",
          "bbox": [
            0.9672,
            6.3155,
            7.0815,
            6.5064
          ]
        },
        {
          "block_id": "p20_line_29",
          "block_type": "paragraph",
          "text": "changes in planned analyses made prior to breaking the blind have limited",
          "bbox": [
            0.9702,
            6.495,
            7.0946,
            6.6914
          ]
        },
        {
          "block_id": "p20_line_30",
          "block_type": "paragraph",
          "text": "implications for study interpretation. It is therefore particularly critical that the",
          "bbox": [
            0.9653,
            6.6802,
            7.093,
            6.8721
          ]
        },
        {
          "block_id": "p20_line_31",
          "block_type": "paragraph",
          "text": "timing of changes relative to blind breaking and availability of outcome results be",
          "bbox": [
            0.9715,
            6.8656,
            7.0939,
            7.0531
          ]
        },
        {
          "block_id": "p20_line_32",
          "block_type": "paragraph",
          "text": "well characterised.",
          "bbox": [
            0.9722,
            7.0521,
            2.306,
            7.2213
          ]
        },
        {
          "block_id": "p20_line_33",
          "block_type": "paragraph",
          "text": "10. STUDY PATIENTS",
          "bbox": [
            0.9858,
            7.4401,
            2.9647,
            7.6142
          ]
        },
        {
          "block_id": "p20_line_34",
          "block_type": "paragraph",
          "text": "10.1 DISPOSITION OF PATIENTS",
          "bbox": [
            0.9826,
            7.746,
            3.8105,
            7.9212
          ]
        },
        {
          "block_id": "p20_line_35",
          "block_type": "paragraph",
          "text": "There should be a clear accounting of all patients who entered the study, using figures",
          "bbox": [
            0.9687,
            7.9712,
            7.0895,
            8.1612
          ]
        },
        {
          "block_id": "p20_line_36",
          "block_type": "paragraph",
          "text": "or tables in the text of the report. The numbers of patients who were randomised, and",
          "bbox": [
            0.9716,
            8.1558,
            7.0996,
            8.3407
          ]
        },
        {
          "block_id": "p20_line_37",
          "block_type": "paragraph",
          "text": "who entered and completed each phase of the study, (or each week/month of the",
          "bbox": [
            0.974,
            8.3385,
            7.0933,
            8.524
          ]
        },
        {
          "block_id": "p20_line_38",
          "block_type": "paragraph",
          "text": "study) should be provided, as well as the reasons for all post-randomisation",
          "bbox": [
            0.9729,
            8.5241,
            7.0901,
            8.7048
          ]
        },
        {
          "block_id": "p20_line_39",
          "block_type": "paragraph",
          "text": "discontinuations, grouped by treatment and by major reason (lost to follow-up,",
          "bbox": [
            0.9743,
            8.7084,
            7.0801,
            8.9
          ]
        },
        {
          "block_id": "p20_line_40",
          "block_type": "paragraph",
          "text": "adverse event, poor compliance etc.). It may also be relevant to provide the number of",
          "bbox": [
            0.973,
            8.8927,
            7.1012,
            9.0792
          ]
        },
        {
          "block_id": "p20_line_41",
          "block_type": "paragraph",
          "text": "patients screened for inclusion and a breakdown of the reasons for excluding patients",
          "bbox": [
            0.9681,
            9.0759,
            7.0896,
            9.2587
          ]
        },
        {
          "block_id": "p20_line_42",
          "block_type": "paragraph",
          "text": "during screening, if this could help clarify the appropriate patient population for",
          "bbox": [
            0.974,
            9.258,
            7.0897,
            9.4461
          ]
        },
        {
          "block_id": "p20_line_43",
          "block_type": "paragraph",
          "text": "eventual drug use. A flow chart is often helpful (see Annexes IVa and IVb of the",
          "bbox": [
            0.9736,
            9.4425,
            7.0902,
            9.6211
          ]
        },
        {
          "block_id": "p20_line_44",
          "block_type": "paragraph",
          "text": "guideline for example). Whether patients are followed for the duration of the study,",
          "bbox": [
            0.9719,
            9.6216,
            7.0843,
            9.8106
          ]
        },
        {
          "block_id": "p20_line_45",
          "block_type": "paragraph",
          "text": "even if drug is discontinued, should be made clear.",
          "bbox": [
            0.973,
            9.8101,
            4.5481,
            9.9884
          ]
        },
        {
          "block_id": "p20_line_46",
          "block_type": "paragraph",
          "text": "In appendix 16.2.1, there should also be a listing of all patients discontinued from the",
          "bbox": [
            0.9679,
            10.1145,
            7.0903,
            10.2939
          ]
        },
        {
          "block_id": "p20_line_47",
          "block_type": "paragraph",
          "text": "study after enrolment, broken down by centre and treatment group, giving a patient",
          "bbox": [
            0.9715,
            10.3044,
            7.0916,
            10.4793
          ]
        },
        {
          "block_id": "p20_line_48",
          "block_type": "paragraph",
          "text": "identifier, the specific reason for discontinuation, the treatment (drug and dose),",
          "bbox": [
            0.9673,
            10.4839,
            7.0804,
            10.6653
          ]
        },
        {
          "block_id": "p20_line_49",
          "block_type": "paragraph",
          "text": "12",
          "bbox": [
            3.9474,
            10.9488,
            4.1199,
            11.0814
          ]
        }
      ]
    },
    {
      "page_number": 21,
      "width": 8.2639,
      "height": 11.6944,
      "unit": "inch",
      "blocks": [
        {
          "block_id": "p21_line_0",
          "block_type": "paragraph",
          "text": "Structure and Content of Clinical Study Reports",
          "bbox": [
            4.1842,
            0.7138,
            7.2872,
            0.8878
          ]
        },
        {
          "block_id": "p21_line_1",
          "block_type": "paragraph",
          "text": "cumulative dose, (where appropriate), and the duration of treatment before",
          "bbox": [
            1.1676,
            1.045,
            7.2872,
            1.2313
          ]
        },
        {
          "block_id": "p21_line_2",
          "block_type": "paragraph",
          "text": "discontinuation. Whether or not the blind for the patient was broken at the time of",
          "bbox": [
            1.1741,
            1.2315,
            7.2984,
            1.4095
          ]
        },
        {
          "block_id": "p21_line_3",
          "block_type": "paragraph",
          "text": "discontinuation should be noted. It may also be useful to include other information,",
          "bbox": [
            1.173,
            1.4181,
            7.279,
            1.5988
          ]
        },
        {
          "block_id": "p21_line_4",
          "block_type": "paragraph",
          "text": "such as critical demographic data (e.g., age, sex, race), concomitant medication, and",
          "bbox": [
            1.1672,
            1.6071,
            7.293,
            1.7861
          ]
        },
        {
          "block_id": "p21_line_5",
          "block_type": "paragraph",
          "text": "the major response variable(s) at termination. See Annex V for an example of such a",
          "bbox": [
            1.1669,
            1.7863,
            7.2883,
            1.968
          ]
        },
        {
          "block_id": "p21_line_6",
          "block_type": "paragraph",
          "text": "listing.",
          "bbox": [
            1.1593,
            1.9726,
            1.6753,
            2.1511
          ]
        },
        {
          "block_id": "p21_line_7",
          "block_type": "paragraph",
          "text": "10.2 PROTOCOL DEVIATIONS",
          "bbox": [
            1.1785,
            2.3568,
            3.7569,
            2.5305
          ]
        },
        {
          "block_id": "p21_line_8",
          "block_type": "paragraph",
          "text": "All important deviations related to study inclusion or exclusion criteria, conduct of the",
          "bbox": [
            1.167,
            2.5837,
            7.2888,
            2.7654
          ]
        },
        {
          "block_id": "p21_line_9",
          "block_type": "paragraph",
          "text": "trial, patient management or patient assessment should be described.",
          "bbox": [
            1.1642,
            2.7673,
            6.1047,
            2.9545
          ]
        },
        {
          "block_id": "p21_line_10",
          "block_type": "paragraph",
          "text": "In the body of the text, protocol deviations should be appropriately summarised by",
          "bbox": [
            1.1626,
            3.067,
            7.2869,
            3.2643
          ]
        },
        {
          "block_id": "p21_line_11",
          "block_type": "paragraph",
          "text": "centre and grouped into different categories, such as:",
          "bbox": [
            1.1663,
            3.2605,
            4.9222,
            3.4426
          ]
        },
        {
          "block_id": "p21_line_12",
          "block_type": "paragraph",
          "text": "- those who entered the study even though they did not satisfy the entry",
          "bbox": [
            1.57,
            3.4846,
            7.2885,
            3.6741
          ]
        },
        {
          "block_id": "p21_line_13",
          "block_type": "paragraph",
          "text": "criteria;",
          "bbox": [
            1.7533,
            3.6797,
            2.3365,
            3.8426
          ]
        },
        {
          "block_id": "p21_line_14",
          "block_type": "paragraph",
          "text": "- those who developed withdrawal criteria during the study but were not",
          "bbox": [
            1.5679,
            3.8978,
            7.2918,
            4.0828
          ]
        },
        {
          "block_id": "p21_line_15",
          "block_type": "paragraph",
          "text": "withdrawn;",
          "bbox": [
            1.7533,
            4.0885,
            2.5871,
            4.2566
          ]
        },
        {
          "block_id": "p21_line_16",
          "block_type": "paragraph",
          "text": "- those who received the wrong treatment or incorrect dose;",
          "bbox": [
            1.5686,
            4.3145,
            5.8678,
            4.4896
          ]
        },
        {
          "block_id": "p21_line_17",
          "block_type": "paragraph",
          "text": "- those who received an excluded concomitant treatment.",
          "bbox": [
            1.5712,
            4.5441,
            5.6876,
            4.7087
          ]
        },
        {
          "block_id": "p21_line_18",
          "block_type": "paragraph",
          "text": "In appendix 16.2.2, individual patients with these protocol deviations should be listed,",
          "bbox": [
            1.1611,
            4.801,
            7.2774,
            4.9919
          ]
        },
        {
          "block_id": "p21_line_19",
          "block_type": "paragraph",
          "text": "broken down by centre for multicentre studies.",
          "bbox": [
            1.1638,
            4.9891,
            4.4785,
            5.1677
          ]
        },
        {
          "block_id": "p21_line_20",
          "block_type": "paragraph",
          "text": "11. EFFICACY EVALUATION",
          "bbox": [
            1.1782,
            5.3768,
            3.7271,
            5.5526
          ]
        },
        {
          "block_id": "p21_line_21",
          "block_type": "paragraph",
          "text": "11.1 DATA SETS ANALYSED",
          "bbox": [
            1.1764,
            5.6877,
            3.5838,
            5.8586
          ]
        },
        {
          "block_id": "p21_line_22",
          "block_type": "paragraph",
          "text": "Exactly which patients were included in each efficacy analysis should be precisely",
          "bbox": [
            1.1701,
            5.909,
            7.2883,
            6.1016
          ]
        },
        {
          "block_id": "p21_line_23",
          "block_type": "paragraph",
          "text": "defined, e.g., all patients receiving any test drugs/investigational products, all",
          "bbox": [
            1.1728,
            6.0952,
            7.2903,
            6.2849
          ]
        },
        {
          "block_id": "p21_line_24",
          "block_type": "paragraph",
          "text": "patients with any efficacy observation or with a certain minimum number of",
          "bbox": [
            1.1647,
            6.2755,
            7.3017,
            6.4682
          ]
        },
        {
          "block_id": "p21_line_25",
          "block_type": "paragraph",
          "text": "observations, only patients completing the trial, all patients with an observation",
          "bbox": [
            1.1684,
            6.4614,
            7.2897,
            6.6487
          ]
        },
        {
          "block_id": "p21_line_26",
          "block_type": "paragraph",
          "text": "during a particular time window, only patients with a specified degree of compliance",
          "bbox": [
            1.1725,
            6.6477,
            7.2897,
            6.8382
          ]
        },
        {
          "block_id": "p21_line_27",
          "block_type": "paragraph",
          "text": "etc. It should be clear, if not defined in the study protocol, when, (relative to study",
          "bbox": [
            1.1726,
            6.8328,
            7.2878,
            7.0187
          ]
        },
        {
          "block_id": "p21_line_28",
          "block_type": "paragraph",
          "text": "unblinding), and how inclusion/exclusion criteria for the data sets analysed were",
          "bbox": [
            1.1654,
            7.0162,
            7.2886,
            7.1965
          ]
        },
        {
          "block_id": "p21_line_29",
          "block_type": "paragraph",
          "text": "developed. Generally, even if the applicant's proposed primary analysis is based on a",
          "bbox": [
            1.1722,
            7.1966,
            7.2842,
            7.3872
          ]
        },
        {
          "block_id": "p21_line_30",
          "block_type": "paragraph",
          "text": "reduced subset of the patients with data, there should also be for any trial intended to",
          "bbox": [
            1.1651,
            7.3796,
            7.2862,
            7.5657
          ]
        },
        {
          "block_id": "p21_line_31",
          "block_type": "paragraph",
          "text": "establish efficacy an additional analysis using all randomised (or otherwise entered)",
          "bbox": [
            1.1728,
            7.5621,
            7.2817,
            7.7544
          ]
        },
        {
          "block_id": "p21_line_32",
          "block_type": "paragraph",
          "text": "patients with any on-treatment data.",
          "bbox": [
            1.1629,
            7.7487,
            3.7992,
            7.9344
          ]
        },
        {
          "block_id": "p21_line_33",
          "block_type": "paragraph",
          "text": "There should be a tabular listing of all patients, visits and observations excluded from",
          "bbox": [
            1.1676,
            8.0514,
            7.287,
            8.2339
          ]
        },
        {
          "block_id": "p21_line_34",
          "block_type": "paragraph",
          "text": "the efficacy analysis provided in appendix 16.2.3 (see Annex VI of the guideline for an",
          "bbox": [
            1.1651,
            8.2365,
            7.2885,
            8.4217
          ]
        },
        {
          "block_id": "p21_line_35",
          "block_type": "paragraph",
          "text": "example). The reasons for exclusions should also be analysed for the whole treatment",
          "bbox": [
            1.169,
            8.4181,
            7.2911,
            8.6041
          ]
        },
        {
          "block_id": "p21_line_36",
          "block_type": "paragraph",
          "text": "group over time (see Annex VII of the guideline for an example).",
          "bbox": [
            1.1661,
            8.6027,
            5.7074,
            8.7919
          ]
        },
        {
          "block_id": "p21_line_37",
          "block_type": "paragraph",
          "text": "11.2 DEMOGRAPHIC AND OTHER BASELINE CHARACTERISTICS",
          "bbox": [
            1.1779,
            8.9902,
            6.6731,
            9.1648
          ]
        },
        {
          "block_id": "p21_line_38",
          "block_type": "paragraph",
          "text": "Group data for the critical demographic and baseline characteristics of the patients,",
          "bbox": [
            1.1719,
            9.2145,
            7.2769,
            9.4017
          ]
        },
        {
          "block_id": "p21_line_39",
          "block_type": "paragraph",
          "text": "as well as other factors arising during the study that could affect response, should be",
          "bbox": [
            1.1703,
            9.4084,
            7.2855,
            9.5874
          ]
        },
        {
          "block_id": "p21_line_40",
          "block_type": "paragraph",
          "text": "presented in this section and comparability of the treatment groups for all relevant",
          "bbox": [
            1.1633,
            9.5914,
            7.287,
            9.7736
          ]
        },
        {
          "block_id": "p21_line_41",
          "block_type": "paragraph",
          "text": "characteristics should be displayed by use of tables or graphs in section 14.1. The",
          "bbox": [
            1.1683,
            9.7723,
            7.2889,
            9.9528
          ]
        },
        {
          "block_id": "p21_line_42",
          "block_type": "paragraph",
          "text": "data for the patient sample included in the \"all patients with data\" analysis should be",
          "bbox": [
            1.1733,
            9.9531,
            7.2865,
            10.1356
          ]
        },
        {
          "block_id": "p21_line_43",
          "block_type": "paragraph",
          "text": "given first. This can then be followed by data on other groups used in principal",
          "bbox": [
            1.1706,
            10.1403,
            7.2899,
            10.324
          ]
        },
        {
          "block_id": "p21_line_44",
          "block_type": "paragraph",
          "text": "analyses, such as the \"per-protocol\" analysis or other analyses, e.g., groups defined by",
          "bbox": [
            1.1704,
            10.3268,
            7.2877,
            10.5055
          ]
        },
        {
          "block_id": "p21_line_45",
          "block_type": "paragraph",
          "text": "compliance, concomitant disease/therapy, or demographic/baseline characteristics.",
          "bbox": [
            1.1693,
            10.5069,
            7.2786,
            10.6895
          ]
        },
        {
          "block_id": "p21_line_46",
          "block_type": "paragraph",
          "text": "13",
          "bbox": [
            4.1441,
            10.9505,
            4.3171,
            11.0827
          ]
        }
      ]
    },
    {
      "page_number": 22,
      "width": 8.2639,
      "height": 11.6944,
      "unit": "inch",
      "blocks": [
        {
          "block_id": "p22_line_0",
          "block_type": "paragraph",
          "text": "Structure and Content of Clinical Study Reports",
          "bbox": [
            0.973,
            0.7138,
            4.0775,
            0.8873
          ]
        },
        {
          "block_id": "p22_line_1",
          "block_type": "paragraph",
          "text": "When such groups are used, data for the complementary excluded group should also",
          "bbox": [
            0.9747,
            1.0482,
            7.0872,
            1.23
          ]
        },
        {
          "block_id": "p22_line_2",
          "block_type": "paragraph",
          "text": "be shown. In a multicentre study where appropriate, comparability should be",
          "bbox": [
            0.9676,
            1.2322,
            7.0905,
            1.4161
          ]
        },
        {
          "block_id": "p22_line_3",
          "block_type": "paragraph",
          "text": "assessed by centre, and centres should be compared.",
          "bbox": [
            0.9717,
            1.4246,
            4.6723,
            1.6022
          ]
        },
        {
          "block_id": "p22_line_4",
          "block_type": "paragraph",
          "text": "A diagram showing the relationship between the entire sample and any other analysis",
          "bbox": [
            0.9714,
            1.726,
            7.0885,
            1.9136
          ]
        },
        {
          "block_id": "p22_line_5",
          "block_type": "paragraph",
          "text": "groups should be provided.",
          "bbox": [
            0.968,
            1.9129,
            2.8729,
            2.1038
          ]
        },
        {
          "block_id": "p22_line_6",
          "block_type": "paragraph",
          "text": "The critical variables will depend on the specific nature of the disease and on the",
          "bbox": [
            0.969,
            2.2183,
            7.0936,
            2.3983
          ]
        },
        {
          "block_id": "p22_line_7",
          "block_type": "paragraph",
          "text": "protocol but will usually include:",
          "bbox": [
            0.9663,
            2.4013,
            3.2925,
            2.5913
          ]
        },
        {
          "block_id": "p22_line_8",
          "block_type": "paragraph",
          "text": "> demographic variables",
          "bbox": [
            1.3763,
            2.7164,
            3.1807,
            2.8907
          ]
        },
        {
          "block_id": "p22_line_9",
          "block_type": "paragraph",
          "text": "- age",
          "bbox": [
            1.6637,
            2.9812,
            2.1199,
            3.1107
          ]
        },
        {
          "block_id": "p22_line_10",
          "block_type": "paragraph",
          "text": "- sex",
          "bbox": [
            1.6665,
            3.2128,
            2.1083,
            3.3252
          ]
        },
        {
          "block_id": "p22_line_11",
          "block_type": "paragraph",
          "text": "- race",
          "bbox": [
            1.6656,
            3.4396,
            2.1741,
            3.5552
          ]
        },
        {
          "block_id": "p22_line_12",
          "block_type": "paragraph",
          "text": "> disease factors",
          "bbox": [
            1.3764,
            3.6234,
            2.6165,
            3.7875
          ]
        },
        {
          "block_id": "p22_line_13",
          "block_type": "paragraph",
          "text": "- specific entry criteria (if not uniform), duration, stage and severity of",
          "bbox": [
            1.6646,
            3.8504,
            7.1064,
            4.0313
          ]
        },
        {
          "block_id": "p22_line_14",
          "block_type": "paragraph",
          "text": "disease and other clinical classifications and sub-groupings in common",
          "bbox": [
            1.8612,
            4.0257,
            7.0911,
            4.2179
          ]
        },
        {
          "block_id": "p22_line_15",
          "block_type": "paragraph",
          "text": "usage or of known prognostic significance",
          "bbox": [
            1.8552,
            4.2195,
            4.8022,
            4.398
          ]
        },
        {
          "block_id": "p22_line_16",
          "block_type": "paragraph",
          "text": "- baseline values for critical clinical measurements carried out during the",
          "bbox": [
            1.6688,
            4.4428,
            7.0915,
            4.621
          ]
        },
        {
          "block_id": "p22_line_17",
          "block_type": "paragraph",
          "text": "study or identified as important indicators of prognosis or response to",
          "bbox": [
            1.8556,
            4.6258,
            7.0906,
            4.8102
          ]
        },
        {
          "block_id": "p22_line_18",
          "block_type": "paragraph",
          "text": "therapy",
          "bbox": [
            1.8527,
            4.8196,
            2.425,
            4.997
          ]
        },
        {
          "block_id": "p22_line_19",
          "block_type": "paragraph",
          "text": "- concomitant illness at trial initiation, such as renal disease, diabetes,",
          "bbox": [
            1.6696,
            5.0421,
            7.0834,
            5.2215
          ]
        },
        {
          "block_id": "p22_line_20",
          "block_type": "paragraph",
          "text": "heart failure",
          "bbox": [
            1.8504,
            5.2259,
            2.7704,
            5.3912
          ]
        },
        {
          "block_id": "p22_line_21",
          "block_type": "paragraph",
          "text": "- relevant previous illness",
          "bbox": [
            1.6662,
            5.4622,
            3.6104,
            5.6294
          ]
        },
        {
          "block_id": "p22_line_22",
          "block_type": "paragraph",
          "text": "- relevant previous treatment for illness treated in the study",
          "bbox": [
            1.6681,
            5.6853,
            6.0507,
            5.8596
          ]
        },
        {
          "block_id": "p22_line_23",
          "block_type": "paragraph",
          "text": "- concomitant treatment maintained, even if the dose was changed during",
          "bbox": [
            1.669,
            5.91,
            7.0972,
            6.0948
          ]
        },
        {
          "block_id": "p22_line_24",
          "block_type": "paragraph",
          "text": "the study, including oral contraceptive and hormone replacement",
          "bbox": [
            1.8573,
            6.0934,
            7.0927,
            6.2769
          ]
        },
        {
          "block_id": "p22_line_25",
          "block_type": "paragraph",
          "text": "therapy; treatments stopped at entry into the study period (or changed at",
          "bbox": [
            1.858,
            6.2732,
            7.0948,
            6.4639
          ]
        },
        {
          "block_id": "p22_line_26",
          "block_type": "paragraph",
          "text": "study initiation)",
          "bbox": [
            1.8577,
            6.4617,
            3.0126,
            6.6366
          ]
        },
        {
          "block_id": "p22_line_27",
          "block_type": "paragraph",
          "text": "> other factors that might affect response to therapy (e.g., weight, renin status,",
          "bbox": [
            1.3749,
            6.6782,
            7.0839,
            6.8722
          ]
        },
        {
          "block_id": "p22_line_28",
          "block_type": "paragraph",
          "text": "antibody levels, metabolic status)",
          "bbox": [
            1.5616,
            6.8644,
            3.9316,
            7.0441
          ]
        },
        {
          "block_id": "p22_line_29",
          "block_type": "paragraph",
          "text": "> other possibly relevant variables (e.g., smoking, alcohol intake, special diets)",
          "bbox": [
            1.375,
            7.1695,
            7.0831,
            7.3568
          ]
        },
        {
          "block_id": "p22_line_30",
          "block_type": "paragraph",
          "text": "and, for women, menstrual status and date of last menstrual period, if",
          "bbox": [
            1.5634,
            7.3554,
            7.104,
            7.5453
          ]
        },
        {
          "block_id": "p22_line_31",
          "block_type": "paragraph",
          "text": "pertinent for the study.",
          "bbox": [
            1.556,
            7.5457,
            3.2209,
            7.7285
          ]
        },
        {
          "block_id": "p22_line_32",
          "block_type": "paragraph",
          "text": "In addition to tables and graphs giving group data for these baseline variables,",
          "bbox": [
            0.969,
            7.8459,
            7.0826,
            8.0366
          ]
        },
        {
          "block_id": "p22_line_33",
          "block_type": "paragraph",
          "text": "relevant individual patient demographic and baseline data, including laboratory",
          "bbox": [
            0.9686,
            8.031,
            7.0907,
            8.2158
          ]
        },
        {
          "block_id": "p22_line_34",
          "block_type": "paragraph",
          "text": "values, and all concomitant medication for all individual patients randomised (broken",
          "bbox": [
            0.9706,
            8.2166,
            7.0908,
            8.3954
          ]
        },
        {
          "block_id": "p22_line_35",
          "block_type": "paragraph",
          "text": "down by treatment and by centre for multicentre studies) should be presented in by-",
          "bbox": [
            0.9754,
            8.3974,
            7.0832,
            8.5801
          ]
        },
        {
          "block_id": "p22_line_36",
          "block_type": "paragraph",
          "text": "patient tabular listings in appendix 16.2.4. Although some regulatory authorities will",
          "bbox": [
            0.966,
            8.5798,
            7.0906,
            8.7651
          ]
        },
        {
          "block_id": "p22_line_37",
          "block_type": "paragraph",
          "text": "require all baseline data to be presented elsewhere in tabular listings, the appendix to",
          "bbox": [
            0.9664,
            8.7651,
            7.0882,
            8.9437
          ]
        },
        {
          "block_id": "p22_line_38",
          "block_type": "paragraph",
          "text": "the study report should be limited to only the most relevant data, generally the",
          "bbox": [
            0.97,
            8.9447,
            7.09,
            9.1304
          ]
        },
        {
          "block_id": "p22_line_39",
          "block_type": "paragraph",
          "text": "variables listed above.",
          "bbox": [
            0.9696,
            9.1358,
            2.5525,
            9.2984
          ]
        },
        {
          "block_id": "p22_line_40",
          "block_type": "paragraph",
          "text": "14",
          "bbox": [
            3.9466,
            10.9498,
            4.1234,
            11.0835
          ]
        }
      ]
    },
    {
      "page_number": 23,
      "width": 8.2639,
      "height": 11.6944,
      "unit": "inch",
      "blocks": [
        {
          "block_id": "p23_line_0",
          "block_type": "paragraph",
          "text": "Structure and Content of Clinical Study Reports",
          "bbox": [
            4.1848,
            0.7138,
            7.2872,
            0.8857
          ]
        },
        {
          "block_id": "p23_line_1",
          "block_type": "paragraph",
          "text": "11.3 MEASUREMENTS OF TREATMENT COMPLIANCE",
          "bbox": [
            1.1785,
            1.0477,
            5.754,
            1.2202
          ]
        },
        {
          "block_id": "p23_line_2",
          "block_type": "paragraph",
          "text": "Any measurements of compliance of individual patients with the treatment regimen",
          "bbox": [
            1.1653,
            1.2793,
            7.2868,
            1.4541
          ]
        },
        {
          "block_id": "p23_line_3",
          "block_type": "paragraph",
          "text": "under study and drug concentrations in body fluids should be summarised, analysed",
          "bbox": [
            1.1656,
            1.463,
            7.2919,
            1.641
          ]
        },
        {
          "block_id": "p23_line_4",
          "block_type": "paragraph",
          "text": "by treatment group and time interval, and tabulated in Appendix 16.2.5.",
          "bbox": [
            1.1638,
            1.6422,
            6.3038,
            1.8272
          ]
        },
        {
          "block_id": "p23_line_5",
          "block_type": "paragraph",
          "text": "11.4 EFFICACY RESULTS AND TABULATIONS OF INDIVIDUAL PATIENT",
          "bbox": [
            1.1772,
            2.0272,
            7.2547,
            2.2055
          ]
        },
        {
          "block_id": "p23_line_6",
          "block_type": "paragraph",
          "text": "DATA",
          "bbox": [
            1.6648,
            2.2224,
            2.1551,
            2.3784
          ]
        },
        {
          "block_id": "p23_line_7",
          "block_type": "paragraph",
          "text": "11.4.1 Analysis of Efficacy",
          "bbox": [
            1.1729,
            2.5296,
            3.2396,
            2.711
          ]
        },
        {
          "block_id": "p23_line_8",
          "block_type": "paragraph",
          "text": "Treatment groups should be compared for all critical measures of efficacy (primary",
          "bbox": [
            1.1664,
            2.7466,
            7.2878,
            2.9404
          ]
        },
        {
          "block_id": "p23_line_9",
          "block_type": "paragraph",
          "text": "and secondary end-points; any pharmacodynamic end points studied), as well as",
          "bbox": [
            1.1678,
            2.9338,
            7.2911,
            3.1185
          ]
        },
        {
          "block_id": "p23_line_10",
          "block_type": "paragraph",
          "text": "benefit/risk assessment(s) in each patient where these are utilised. In general, the",
          "bbox": [
            1.1633,
            3.1145,
            7.2888,
            3.2988
          ]
        },
        {
          "block_id": "p23_line_11",
          "block_type": "paragraph",
          "text": "results of all analyses contemplated in the protocol and an analysis including all",
          "bbox": [
            1.164,
            3.2958,
            7.2926,
            3.4832
          ]
        },
        {
          "block_id": "p23_line_12",
          "block_type": "paragraph",
          "text": "patients with on-study data should be performed in studies intended to establish",
          "bbox": [
            1.1634,
            3.4777,
            7.2884,
            3.6743
          ]
        },
        {
          "block_id": "p23_line_13",
          "block_type": "paragraph",
          "text": "efficacy. The analysis should show the size (point estimate) of the difference between",
          "bbox": [
            1.1693,
            3.6668,
            7.2897,
            3.8518
          ]
        },
        {
          "block_id": "p23_line_14",
          "block_type": "paragraph",
          "text": "the treatments, the associated confidence interval, and where utilised, the results of",
          "bbox": [
            1.1661,
            3.8466,
            7.3017,
            4.037
          ]
        },
        {
          "block_id": "p23_line_15",
          "block_type": "paragraph",
          "text": "hypothesis testing.",
          "bbox": [
            1.1599,
            4.0369,
            2.5071,
            4.2231
          ]
        },
        {
          "block_id": "p23_line_16",
          "block_type": "paragraph",
          "text": "Analyses based on continuous variables (e.g., mean blood pressure or depression scale",
          "bbox": [
            1.1648,
            4.3394,
            7.2875,
            4.5294
          ]
        },
        {
          "block_id": "p23_line_17",
          "block_type": "paragraph",
          "text": "score) and categorical responses (e.g., cure of an infection) can be equally valid;",
          "bbox": [
            1.1668,
            4.5251,
            7.2846,
            4.7166
          ]
        },
        {
          "block_id": "p23_line_18",
          "block_type": "paragraph",
          "text": "ordinarily both should be presented if both were planned and are available. If",
          "bbox": [
            1.1718,
            4.7052,
            7.3006,
            4.8953
          ]
        },
        {
          "block_id": "p23_line_19",
          "block_type": "paragraph",
          "text": "categories are newly created, (i.e., not in the statistical plan) the basis for them",
          "bbox": [
            1.1682,
            4.8879,
            7.2887,
            5.0821
          ]
        },
        {
          "block_id": "p23_line_20",
          "block_type": "paragraph",
          "text": "should be explained. Even if one variable receives primary attention (e.g., in a blood",
          "bbox": [
            1.1695,
            5.0702,
            7.2932,
            5.2636
          ]
        },
        {
          "block_id": "p23_line_21",
          "block_type": "paragraph",
          "text": "pressure study, supine blood pressure at week x), other reasonable measures (e.g.,",
          "bbox": [
            1.1649,
            5.2591,
            7.2791,
            5.4477
          ]
        },
        {
          "block_id": "p23_line_22",
          "block_type": "paragraph",
          "text": "standing blood pressure and blood pressures at other particular times) should be",
          "bbox": [
            1.1683,
            5.435,
            7.2873,
            5.63
          ]
        },
        {
          "block_id": "p23_line_23",
          "block_type": "paragraph",
          "text": "assessed, at least briefly. In addition, the time course of response should be",
          "bbox": [
            1.1693,
            5.6261,
            7.2883,
            5.813
          ]
        },
        {
          "block_id": "p23_line_24",
          "block_type": "paragraph",
          "text": "described, if possible. For a multicentre study, where appropriate, data display and",
          "bbox": [
            1.1738,
            5.8077,
            7.2926,
            6.0014
          ]
        },
        {
          "block_id": "p23_line_25",
          "block_type": "paragraph",
          "text": "analysis of individual centres should be included for critical variables to give a clear",
          "bbox": [
            1.1685,
            5.9927,
            7.2896,
            6.1774
          ]
        },
        {
          "block_id": "p23_line_26",
          "block_type": "paragraph",
          "text": "picture of the results at each site, especially the larger sites.",
          "bbox": [
            1.161,
            6.1784,
            5.4301,
            6.3638
          ]
        },
        {
          "block_id": "p23_line_27",
          "block_type": "paragraph",
          "text": "If any critical measurements or assessments of efficacy or safety outcomes were made",
          "bbox": [
            1.1642,
            6.481,
            7.2866,
            6.6683
          ]
        },
        {
          "block_id": "p23_line_28",
          "block_type": "paragraph",
          "text": "by more than one party (e.g., both the investigator and an expert committee may offer",
          "bbox": [
            1.1642,
            6.6667,
            7.2877,
            6.8563
          ]
        },
        {
          "block_id": "p23_line_29",
          "block_type": "paragraph",
          "text": "an opinion on whether a patient had an acute infarction), overall differences between",
          "bbox": [
            1.1691,
            6.8494,
            7.2882,
            7.0356
          ]
        },
        {
          "block_id": "p23_line_30",
          "block_type": "paragraph",
          "text": "the ratings should be shown, and each patient having disparate assessments should",
          "bbox": [
            1.1679,
            7.0309,
            7.2911,
            7.2198
          ]
        },
        {
          "block_id": "p23_line_31",
          "block_type": "paragraph",
          "text": "be identified. The assessments used should be clear in all analyses.",
          "bbox": [
            1.1651,
            7.2099,
            5.9594,
            7.4004
          ]
        },
        {
          "block_id": "p23_line_32",
          "block_type": "paragraph",
          "text": "In many cases, efficacy and safety endpoints are difficult to distinguish, (e.g., deaths",
          "bbox": [
            1.1626,
            7.5203,
            7.2879,
            7.7106
          ]
        },
        {
          "block_id": "p23_line_33",
          "block_type": "paragraph",
          "text": "in a fatal disease study). Many of the principles addressed below should be adopted",
          "bbox": [
            1.1633,
            7.7022,
            7.2919,
            7.8918
          ]
        },
        {
          "block_id": "p23_line_34",
          "block_type": "paragraph",
          "text": "for critical safety measures as well.",
          "bbox": [
            1.1612,
            7.8958,
            3.6694,
            8.0742
          ]
        },
        {
          "block_id": "p23_line_35",
          "block_type": "paragraph",
          "text": "11.4.2 Statistical/Analytical Issues",
          "bbox": [
            1.1739,
            8.281,
            3.8874,
            8.4619
          ]
        },
        {
          "block_id": "p23_line_36",
          "block_type": "paragraph",
          "text": "The statistical analysis used should be described for clinical and statistical reviewers",
          "bbox": [
            1.1673,
            8.509,
            7.2887,
            8.6883
          ]
        },
        {
          "block_id": "p23_line_37",
          "block_type": "paragraph",
          "text": "in the text of the report, with detailed documentation of statistical methods (see",
          "bbox": [
            1.1622,
            8.6926,
            7.2887,
            8.8736
          ]
        },
        {
          "block_id": "p23_line_38",
          "block_type": "paragraph",
          "text": "section Annex IX) presented in appendix 16.1.9. Important features of the analysis",
          "bbox": [
            1.1659,
            8.8759,
            7.2884,
            9.0605
          ]
        },
        {
          "block_id": "p23_line_39",
          "block_type": "paragraph",
          "text": "including the particular methods used, adjustments made for demographic or baseline",
          "bbox": [
            1.1607,
            9.0581,
            7.2873,
            9.2439
          ]
        },
        {
          "block_id": "p23_line_40",
          "block_type": "paragraph",
          "text": "measurements or concomitant therapy, handling of drop-outs and missing data,",
          "bbox": [
            1.1664,
            9.2448,
            7.2773,
            9.4292
          ]
        },
        {
          "block_id": "p23_line_41",
          "block_type": "paragraph",
          "text": "adjustments for multiple comparisons, special analyses of multicentre studies, and",
          "bbox": [
            1.1684,
            9.4264,
            7.2905,
            9.6097
          ]
        },
        {
          "block_id": "p23_line_42",
          "block_type": "paragraph",
          "text": "adjustments for interim analyses, should be discussed. Any changes in the analysis",
          "bbox": [
            1.1684,
            9.6045,
            7.2891,
            9.7915
          ]
        },
        {
          "block_id": "p23_line_43",
          "block_type": "paragraph",
          "text": "made after blind-breaking should be identified.",
          "bbox": [
            1.1675,
            9.791,
            4.505,
            9.9671
          ]
        },
        {
          "block_id": "p23_line_44",
          "block_type": "paragraph",
          "text": "15",
          "bbox": [
            4.1449,
            10.9495,
            4.3154,
            11.0841
          ]
        }
      ]
    },
    {
      "page_number": 24,
      "width": 8.2639,
      "height": 11.6944,
      "unit": "inch",
      "blocks": [
        {
          "block_id": "p24_line_0",
          "block_type": "paragraph",
          "text": "Structure and Content of Clinical Study Reports",
          "bbox": [
            0.9734,
            0.7138,
            4.0783,
            0.8871
          ]
        },
        {
          "block_id": "p24_line_1",
          "block_type": "paragraph",
          "text": "In addition to the general discussion the following specific issues should be addressed",
          "bbox": [
            0.9702,
            1.0443,
            7.092,
            1.2299
          ]
        },
        {
          "block_id": "p24_line_2",
          "block_type": "paragraph",
          "text": "(unless not applicable):",
          "bbox": [
            0.9777,
            1.2361,
            2.6157,
            1.412
          ]
        },
        {
          "block_id": "p24_line_3",
          "block_type": "paragraph",
          "text": "11.4.2.1 Adjustments for Covariates",
          "bbox": [
            0.9809,
            1.6255,
            3.9489,
            1.8017
          ]
        },
        {
          "block_id": "p24_line_4",
          "block_type": "paragraph",
          "text": "Selection of, and adjustments for, demographic or baseline measurements,",
          "bbox": [
            0.9712,
            1.8444,
            7.083,
            2.0314
          ]
        },
        {
          "block_id": "p24_line_5",
          "block_type": "paragraph",
          "text": "concomitant therapy, or any other covariate or prognostic factor should be explained",
          "bbox": [
            0.9714,
            2.0343,
            7.0921,
            2.2241
          ]
        },
        {
          "block_id": "p24_line_6",
          "block_type": "paragraph",
          "text": "in the report, and methods of adjustment, results of analyses, and supportive",
          "bbox": [
            0.9684,
            2.2162,
            7.0909,
            2.4055
          ]
        },
        {
          "block_id": "p24_line_7",
          "block_type": "paragraph",
          "text": "information (e.g., ANCOVA or Cox regression output) should be included in the",
          "bbox": [
            0.9661,
            2.3992,
            7.0894,
            2.5854
          ]
        },
        {
          "block_id": "p24_line_8",
          "block_type": "paragraph",
          "text": "detailed documentation of statistical methods. If the covariates or methods used in",
          "bbox": [
            0.9738,
            2.5811,
            7.0901,
            2.7621
          ]
        },
        {
          "block_id": "p24_line_9",
          "block_type": "paragraph",
          "text": "these analyses differed from those planned in the protocol, the differences should be",
          "bbox": [
            0.9702,
            2.7637,
            7.089,
            2.9499
          ]
        },
        {
          "block_id": "p24_line_10",
          "block_type": "paragraph",
          "text": "explained and where possible and relevant, the results of planned analyses should",
          "bbox": [
            0.9732,
            2.9454,
            7.091,
            3.1359
          ]
        },
        {
          "block_id": "p24_line_11",
          "block_type": "paragraph",
          "text": "also be presented. Although not part of the individual study report, comparisons of",
          "bbox": [
            0.974,
            3.1301,
            7.1035,
            3.3178
          ]
        },
        {
          "block_id": "p24_line_12",
          "block_type": "paragraph",
          "text": "covariate adjustments and prognostic factors across individual studies may be an",
          "bbox": [
            0.9721,
            3.3153,
            7.0914,
            3.5011
          ]
        },
        {
          "block_id": "p24_line_13",
          "block_type": "paragraph",
          "text": "informative analysis in a summary of clinical efficacy data.",
          "bbox": [
            0.9663,
            3.4963,
            5.1478,
            3.6842
          ]
        },
        {
          "block_id": "p24_line_14",
          "block_type": "paragraph",
          "text": "11.4.2.2 Handling of Dropouts or Missing Data",
          "bbox": [
            0.9796,
            3.8853,
            4.7965,
            4.0819
          ]
        },
        {
          "block_id": "p24_line_15",
          "block_type": "paragraph",
          "text": "There are several factors that may affect dropout rates. These include the duration of",
          "bbox": [
            0.9686,
            4.1073,
            7.1068,
            4.2996
          ]
        },
        {
          "block_id": "p24_line_16",
          "block_type": "paragraph",
          "text": "the study, the nature of the disease, the efficacy and toxicity of the drug under study,",
          "bbox": [
            0.9702,
            4.2998,
            7.0817,
            4.4918
          ]
        },
        {
          "block_id": "p24_line_17",
          "block_type": "paragraph",
          "text": "and other factors that are not therapy related. Ignoring the patients who dropped out",
          "bbox": [
            0.972,
            4.4839,
            7.0927,
            4.6735
          ]
        },
        {
          "block_id": "p24_line_18",
          "block_type": "paragraph",
          "text": "of the study and drawing conclusions based only on patients who completed the study",
          "bbox": [
            0.972,
            4.6673,
            7.0904,
            4.8554
          ]
        },
        {
          "block_id": "p24_line_19",
          "block_type": "paragraph",
          "text": "can be misleading. A large number of dropouts, however, even if included in an",
          "bbox": [
            0.9716,
            4.8498,
            7.0925,
            5.0364
          ]
        },
        {
          "block_id": "p24_line_20",
          "block_type": "paragraph",
          "text": "analysis, may introduce bias, particularly if there are more early dropouts in one",
          "bbox": [
            0.9716,
            5.0315,
            7.0937,
            5.224
          ]
        },
        {
          "block_id": "p24_line_21",
          "block_type": "paragraph",
          "text": "treatment group or the reasons for dropping out are treatment or outcome related.",
          "bbox": [
            0.9703,
            5.2152,
            7.0832,
            5.4055
          ]
        },
        {
          "block_id": "p24_line_22",
          "block_type": "paragraph",
          "text": "Although the effects of early dropouts, and sometimes even the direction of bias, can",
          "bbox": [
            0.9713,
            5.395,
            7.0945,
            5.5861
          ]
        },
        {
          "block_id": "p24_line_23",
          "block_type": "paragraph",
          "text": "be difficult to determine, possible effects should be explored as fully as possible. It",
          "bbox": [
            0.9663,
            5.576,
            7.0915,
            5.7702
          ]
        },
        {
          "block_id": "p24_line_24",
          "block_type": "paragraph",
          "text": "may be helpful to examine the observed cases at various time points or, if dropouts",
          "bbox": [
            0.9708,
            5.7655,
            7.0922,
            5.955
          ]
        },
        {
          "block_id": "p24_line_25",
          "block_type": "paragraph",
          "text": "were very frequent, to concentrate on analyses at time points when most of the",
          "bbox": [
            0.9716,
            5.946,
            7.093,
            6.1384
          ]
        },
        {
          "block_id": "p24_line_26",
          "block_type": "paragraph",
          "text": "patients were still under observation and when the full effect of the drug was realised.",
          "bbox": [
            0.9685,
            6.1292,
            7.0869,
            6.3234
          ]
        },
        {
          "block_id": "p24_line_27",
          "block_type": "paragraph",
          "text": "It may also be helpful to examine modelling approaches to the evaluation of such",
          "bbox": [
            0.9694,
            6.314,
            7.0904,
            6.5087
          ]
        },
        {
          "block_id": "p24_line_28",
          "block_type": "paragraph",
          "text": "incomplete data sets.",
          "bbox": [
            0.9647,
            6.505,
            2.475,
            6.6836
          ]
        },
        {
          "block_id": "p24_line_29",
          "block_type": "paragraph",
          "text": "The results of a clinical trial should be assessed not only for the subset of patients",
          "bbox": [
            0.9695,
            6.8031,
            7.0911,
            6.995
          ]
        },
        {
          "block_id": "p24_line_30",
          "block_type": "paragraph",
          "text": "who completed the study, but also for the entire patient population as randomised or",
          "bbox": [
            0.9732,
            6.9924,
            7.092,
            7.177
          ]
        },
        {
          "block_id": "p24_line_31",
          "block_type": "paragraph",
          "text": "at least for all those with any on-study measurements. Several factors need to be",
          "bbox": [
            0.9759,
            7.1742,
            7.0927,
            7.3604
          ]
        },
        {
          "block_id": "p24_line_32",
          "block_type": "paragraph",
          "text": "considered and compared for the treatment groups in analysing the effects of",
          "bbox": [
            0.9746,
            7.3572,
            7.1059,
            7.5451
          ]
        },
        {
          "block_id": "p24_line_33",
          "block_type": "paragraph",
          "text": "dropouts: the reasons for the dropouts, the time to dropout, and the proportion of",
          "bbox": [
            0.9742,
            7.5393,
            7.1064,
            7.728
          ]
        },
        {
          "block_id": "p24_line_34",
          "block_type": "paragraph",
          "text": "dropouts among treatment groups at various time points.",
          "bbox": [
            0.9745,
            7.7297,
            5.0278,
            7.9105
          ]
        },
        {
          "block_id": "p24_line_35",
          "block_type": "paragraph",
          "text": "Procedures for dealing with missing data, e.g., use of estimated or derived data,",
          "bbox": [
            0.9685,
            8.0268,
            7.0774,
            8.216
          ]
        },
        {
          "block_id": "p24_line_36",
          "block_type": "paragraph",
          "text": "should be described. Detailed explanation should be provided as to how such",
          "bbox": [
            0.9723,
            8.21,
            7.0855,
            8.394
          ]
        },
        {
          "block_id": "p24_line_37",
          "block_type": "paragraph",
          "text": "estimations or derivations were done and what underlying assumptions were made.",
          "bbox": [
            0.9739,
            8.4038,
            6.8906,
            8.5871
          ]
        },
        {
          "block_id": "p24_line_38",
          "block_type": "paragraph",
          "text": "11.4.2.3 Interim Analyses and Data Monitoring",
          "bbox": [
            0.9826,
            8.788,
            4.8366,
            8.9735
          ]
        },
        {
          "block_id": "p24_line_39",
          "block_type": "paragraph",
          "text": "The process of examining and analysing data accumulating in a clinical trial, either",
          "bbox": [
            0.9701,
            9.0156,
            7.0941,
            9.2035
          ]
        },
        {
          "block_id": "p24_line_40",
          "block_type": "paragraph",
          "text": "formally or informally, can introduce bias and/or increase type I error. Therefore, all",
          "bbox": [
            0.9688,
            9.1988,
            7.0918,
            9.3854
          ]
        },
        {
          "block_id": "p24_line_41",
          "block_type": "paragraph",
          "text": "interim analyses, formal or informal, pre-planned or ad hoc, by any study participant,",
          "bbox": [
            0.9672,
            9.3832,
            7.0817,
            9.5722
          ]
        },
        {
          "block_id": "p24_line_42",
          "block_type": "paragraph",
          "text": "sponsor staff member, or data monitoring group should be described in full, even if",
          "bbox": [
            0.9718,
            9.5652,
            7.1004,
            9.7522
          ]
        },
        {
          "block_id": "p24_line_43",
          "block_type": "paragraph",
          "text": "the treatment groups were not identified. The need for statistical adjustment because",
          "bbox": [
            0.9705,
            9.7533,
            7.0915,
            9.9283
          ]
        },
        {
          "block_id": "p24_line_44",
          "block_type": "paragraph",
          "text": "of such analyses should be addressed. Any operating instructions or procedures used",
          "bbox": [
            0.9727,
            9.9375,
            7.093,
            10.1125
          ]
        },
        {
          "block_id": "p24_line_45",
          "block_type": "paragraph",
          "text": "for such analyses should be described. The minutes of meetings of any data",
          "bbox": [
            0.9691,
            10.1133,
            7.0869,
            10.2959
          ]
        },
        {
          "block_id": "p24_line_46",
          "block_type": "paragraph",
          "text": "monitoring group and any data reports reviewed at those meetings, particularly a",
          "bbox": [
            0.9712,
            10.3029,
            7.0874,
            10.48
          ]
        },
        {
          "block_id": "p24_line_47",
          "block_type": "paragraph",
          "text": "meeting that led to a change in the protocol or early termination of the study, may be",
          "bbox": [
            0.9712,
            10.4852,
            7.0899,
            10.6626
          ]
        },
        {
          "block_id": "p24_line_48",
          "block_type": "paragraph",
          "text": "16",
          "bbox": [
            3.9465,
            10.9488,
            4.1201,
            11.0814
          ]
        }
      ]
    },
    {
      "page_number": 25,
      "width": 8.2639,
      "height": 11.6944,
      "unit": "inch",
      "blocks": [
        {
          "block_id": "p25_line_0",
          "block_type": "paragraph",
          "text": "Structure and Content of Clinical Study Reports",
          "bbox": [
            4.1842,
            0.7138,
            7.2875,
            0.8871
          ]
        },
        {
          "block_id": "p25_line_1",
          "block_type": "paragraph",
          "text": "helpful and should be provided in appendix 16.1.9. Data monitoring without code-",
          "bbox": [
            1.1615,
            1.0474,
            7.2801,
            1.23
          ]
        },
        {
          "block_id": "p25_line_2",
          "block_type": "paragraph",
          "text": "breaking should also be described, even if this kind of monitoring is considered to",
          "bbox": [
            1.1652,
            1.2318,
            7.2878,
            1.4123
          ]
        },
        {
          "block_id": "p25_line_3",
          "block_type": "paragraph",
          "text": "cause no increase in type I error.",
          "bbox": [
            1.1675,
            1.4318,
            3.4897,
            1.598
          ]
        },
        {
          "block_id": "p25_line_4",
          "block_type": "paragraph",
          "text": "11.4.2.4 Multicentre Studies",
          "bbox": [
            1.1756,
            1.8052,
            3.5476,
            1.9829
          ]
        },
        {
          "block_id": "p25_line_5",
          "block_type": "paragraph",
          "text": "A multicentre study is a single study under a common protocol, involving several",
          "bbox": [
            1.1667,
            2.0333,
            7.291,
            2.221
          ]
        },
        {
          "block_id": "p25_line_6",
          "block_type": "paragraph",
          "text": "centres (e.g., clinics, practices, hospitals) where the data collected are intended to be",
          "bbox": [
            1.168,
            2.2155,
            7.2895,
            2.4075
          ]
        },
        {
          "block_id": "p25_line_7",
          "block_type": "paragraph",
          "text": "analysed as a whole (as opposed to a post-hoc decision to combine data or results from",
          "bbox": [
            1.1697,
            2.3983,
            7.2877,
            2.5867
          ]
        },
        {
          "block_id": "p25_line_8",
          "block_type": "paragraph",
          "text": "separate studies). Individual centre results should be presented, however, where",
          "bbox": [
            1.1686,
            2.5823,
            7.2894,
            2.7696
          ]
        },
        {
          "block_id": "p25_line_9",
          "block_type": "paragraph",
          "text": "appropriate, e.g., when the centres have sufficient numbers of patients to make such",
          "bbox": [
            1.1708,
            2.7637,
            7.2878,
            2.9579
          ]
        },
        {
          "block_id": "p25_line_10",
          "block_type": "paragraph",
          "text": "analysis potentially valuable, the possibility of qualitative or quantitative treatment-",
          "bbox": [
            1.1684,
            2.9522,
            7.282,
            3.1356
          ]
        },
        {
          "block_id": "p25_line_11",
          "block_type": "paragraph",
          "text": "by-centre interaction should be explored. Any extreme or opposite results among",
          "bbox": [
            1.1611,
            3.1292,
            7.2911,
            3.3237
          ]
        },
        {
          "block_id": "p25_line_12",
          "block_type": "paragraph",
          "text": "centres should be noted and discussed, considering such possibilities as differences in",
          "bbox": [
            1.1691,
            3.3155,
            7.2896,
            3.4984
          ]
        },
        {
          "block_id": "p25_line_13",
          "block_type": "paragraph",
          "text": "study conduct, patient characteristics, or clinical settings. Treatment comparison",
          "bbox": [
            1.1692,
            3.4982,
            7.2879,
            3.6853
          ]
        },
        {
          "block_id": "p25_line_14",
          "block_type": "paragraph",
          "text": "should include analyses that allow for centre differences with respect to response. If",
          "bbox": [
            1.1716,
            3.6831,
            7.2995,
            3.8715
          ]
        },
        {
          "block_id": "p25_line_15",
          "block_type": "paragraph",
          "text": "appropriate, demographic, baseline, and post-baseline data, as well as efficacy data,",
          "bbox": [
            1.1693,
            3.8693,
            7.2809,
            4.0622
          ]
        },
        {
          "block_id": "p25_line_16",
          "block_type": "paragraph",
          "text": "should be presented by centre, even though the combined analysis is the primary one.",
          "bbox": [
            1.1706,
            4.0485,
            7.2312,
            4.2441
          ]
        },
        {
          "block_id": "p25_line_17",
          "block_type": "paragraph",
          "text": "11.4.2.5 Multiple Comparison/Multiplicity",
          "bbox": [
            1.175,
            4.4376,
            4.631,
            4.6367
          ]
        },
        {
          "block_id": "p25_line_18",
          "block_type": "paragraph",
          "text": "False positive findings increase in number as the number of significance tests",
          "bbox": [
            1.1651,
            4.6646,
            7.2907,
            4.8537
          ]
        },
        {
          "block_id": "p25_line_19",
          "block_type": "paragraph",
          "text": "(number of comparisons) performed increases. If there was more than one primary",
          "bbox": [
            1.1752,
            4.8479,
            7.2869,
            5.0441
          ]
        },
        {
          "block_id": "p25_line_20",
          "block_type": "paragraph",
          "text": "endpoint (outcome variable), more than one analysis of particular endpoint, or if there",
          "bbox": [
            1.1702,
            5.0293,
            7.2883,
            5.2248
          ]
        },
        {
          "block_id": "p25_line_21",
          "block_type": "paragraph",
          "text": "were multiple treatment groups, or subsets of the patient population being examined,",
          "bbox": [
            1.1673,
            5.2144,
            7.2803,
            5.4075
          ]
        },
        {
          "block_id": "p25_line_22",
          "block_type": "paragraph",
          "text": "the statistical analysis should reflect awareness of this and either explain the",
          "bbox": [
            1.1667,
            5.3967,
            7.2883,
            5.5849
          ]
        },
        {
          "block_id": "p25_line_23",
          "block_type": "paragraph",
          "text": "statistical adjustment used for type I error criteria or give reasons why it was",
          "bbox": [
            1.1679,
            5.5815,
            7.2882,
            5.773
          ]
        },
        {
          "block_id": "p25_line_24",
          "block_type": "paragraph",
          "text": "considered unnecessary.",
          "bbox": [
            1.167,
            5.773,
            2.8955,
            5.95
          ]
        },
        {
          "block_id": "p25_line_25",
          "block_type": "paragraph",
          "text": "11.4.2.6 Use of an \"Efficacy Subset\" of Patients",
          "bbox": [
            1.1759,
            6.1521,
            4.9798,
            6.3419
          ]
        },
        {
          "block_id": "p25_line_26",
          "block_type": "paragraph",
          "text": "Particular attention should be devoted to the effects of dropping patients with",
          "bbox": [
            1.1665,
            6.3742,
            7.2892,
            6.5694
          ]
        },
        {
          "block_id": "p25_line_27",
          "block_type": "paragraph",
          "text": "available data from analyses because of poor compliance, missed visits, ineligibility,",
          "bbox": [
            1.17,
            6.5667,
            7.2779,
            6.7621
          ]
        },
        {
          "block_id": "p25_line_28",
          "block_type": "paragraph",
          "text": "or any other reason. As noted above, an analysis using all available data should be",
          "bbox": [
            1.171,
            6.748,
            7.2871,
            6.9379
          ]
        },
        {
          "block_id": "p25_line_29",
          "block_type": "paragraph",
          "text": "carried out for all studies intended to establish efficacy, even if it is not the analysis",
          "bbox": [
            1.1716,
            6.9337,
            7.2875,
            7.1198
          ]
        },
        {
          "block_id": "p25_line_30",
          "block_type": "paragraph",
          "text": "proposed as the primary analysis by the applicant. In general, it is advantageous to",
          "bbox": [
            1.1647,
            7.1174,
            7.2869,
            7.3103
          ]
        },
        {
          "block_id": "p25_line_31",
          "block_type": "paragraph",
          "text": "demonstrate robustness of the principal trial conclusions with respect to alternative",
          "bbox": [
            1.1736,
            7.2988,
            7.2895,
            7.486
          ]
        },
        {
          "block_id": "p25_line_32",
          "block_type": "paragraph",
          "text": "choices of patient populations for analysis. Any substantial differences resulting from",
          "bbox": [
            1.1726,
            7.4847,
            7.2872,
            7.6677
          ]
        },
        {
          "block_id": "p25_line_33",
          "block_type": "paragraph",
          "text": "the choice of patient population for analysis should be the subject of explicit",
          "bbox": [
            1.1696,
            7.6633,
            7.2903,
            7.8538
          ]
        },
        {
          "block_id": "p25_line_34",
          "block_type": "paragraph",
          "text": "discussion.",
          "bbox": [
            1.1728,
            7.8581,
            1.947,
            8.0185
          ]
        },
        {
          "block_id": "p25_line_35",
          "block_type": "paragraph",
          "text": "11.4.2.7 Active-Control Studies Intended to Show Equivalence",
          "bbox": [
            1.1764,
            8.1998,
            6.239,
            8.3872
          ]
        },
        {
          "block_id": "p25_line_36",
          "block_type": "paragraph",
          "text": "If an active control study is intended to show equivalence (i.e., lack of a difference",
          "bbox": [
            1.1664,
            8.4222,
            7.2895,
            8.6074
          ]
        },
        {
          "block_id": "p25_line_37",
          "block_type": "paragraph",
          "text": "greater than a specified size) between the test drug/investigational product and the",
          "bbox": [
            1.1674,
            8.6087,
            7.2869,
            8.7928
          ]
        },
        {
          "block_id": "p25_line_38",
          "block_type": "paragraph",
          "text": "active control/comparator, the analysis should show the confidence interval for the",
          "bbox": [
            1.1693,
            8.7913,
            7.2889,
            8.9705
          ]
        },
        {
          "block_id": "p25_line_39",
          "block_type": "paragraph",
          "text": "comparison between the two agents for critical end points and the relation of that",
          "bbox": [
            1.1682,
            8.9735,
            7.2899,
            9.1591
          ]
        },
        {
          "block_id": "p25_line_40",
          "block_type": "paragraph",
          "text": "interval to the prespecified degree of inferiority that would be considered",
          "bbox": [
            1.1651,
            9.154,
            7.2922,
            9.3361
          ]
        },
        {
          "block_id": "p25_line_41",
          "block_type": "paragraph",
          "text": "unacceptable. (See 9.2, for important considerations when using the active control",
          "bbox": [
            1.1659,
            9.3419,
            7.2906,
            9.5229
          ]
        },
        {
          "block_id": "p25_line_42",
          "block_type": "paragraph",
          "text": "equivalence design.)",
          "bbox": [
            1.1698,
            9.5357,
            2.605,
            9.7121
          ]
        },
        {
          "block_id": "p25_line_43",
          "block_type": "paragraph",
          "text": "17",
          "bbox": [
            4.1444,
            10.9481,
            4.3161,
            11.0825
          ]
        }
      ]
    },
    {
      "page_number": 26,
      "width": 8.2639,
      "height": 11.6944,
      "unit": "inch",
      "blocks": [
        {
          "block_id": "p26_line_0",
          "block_type": "paragraph",
          "text": "Structure and Content of Clinical Study Reports",
          "bbox": [
            0.9737,
            0.7138,
            4.0783,
            0.888
          ]
        },
        {
          "block_id": "p26_line_1",
          "block_type": "paragraph",
          "text": "11.4.2.8 Examination of Subgroups",
          "bbox": [
            0.981,
            1.0507,
            3.8923,
            1.2388
          ]
        },
        {
          "block_id": "p26_line_2",
          "block_type": "paragraph",
          "text": "If the size of the study permits, important demographic or baseline value-defined",
          "bbox": [
            0.9698,
            1.2729,
            7.0911,
            1.4593
          ]
        },
        {
          "block_id": "p26_line_3",
          "block_type": "paragraph",
          "text": "subgroups should be examined for unusually large or small responses and the results",
          "bbox": [
            0.9728,
            1.4585,
            7.0903,
            1.6414
          ]
        },
        {
          "block_id": "p26_line_4",
          "block_type": "paragraph",
          "text": "presented, e.g., comparison of effects by age, sex, or race, by severity or prognostic",
          "bbox": [
            0.9673,
            1.6473,
            7.0931,
            1.8304
          ]
        },
        {
          "block_id": "p26_line_5",
          "block_type": "paragraph",
          "text": "groups, by history of prior treatment with a drug of the same class etc. If these",
          "bbox": [
            0.971,
            1.8215,
            7.0917,
            2.0148
          ]
        },
        {
          "block_id": "p26_line_6",
          "block_type": "paragraph",
          "text": "analyses were not carried out because the study was too small it should be noted.",
          "bbox": [
            0.973,
            2.0049,
            7.0813,
            2.1927
          ]
        },
        {
          "block_id": "p26_line_7",
          "block_type": "paragraph",
          "text": "These analyses are not intended to \"salvage\" an otherwise non-supportive study but",
          "bbox": [
            0.9718,
            2.1896,
            7.0907,
            2.3744
          ]
        },
        {
          "block_id": "p26_line_8",
          "block_type": "paragraph",
          "text": "may suggest hypotheses worth examining in other studies or be helpful in refining",
          "bbox": [
            0.9709,
            2.3743,
            7.094,
            2.5605
          ]
        },
        {
          "block_id": "p26_line_9",
          "block_type": "paragraph",
          "text": "labelling information, patient selection, dose selection etc. Where there is a prior",
          "bbox": [
            0.9651,
            2.561,
            7.0916,
            2.7452
          ]
        },
        {
          "block_id": "p26_line_10",
          "block_type": "paragraph",
          "text": "hypothesis of a differential effect in a particular subgroup, this hypothesis and its",
          "bbox": [
            0.9653,
            2.7446,
            7.0922,
            2.932
          ]
        },
        {
          "block_id": "p26_line_11",
          "block_type": "paragraph",
          "text": "assessment should be part of the planned statistical analysis.",
          "bbox": [
            0.9739,
            2.927,
            5.3215,
            3.1131
          ]
        },
        {
          "block_id": "p26_line_12",
          "block_type": "paragraph",
          "text": "11.4.3 Tabulation of Individual Response Data",
          "bbox": [
            0.9779,
            3.2725,
            4.6528,
            3.4561
          ]
        },
        {
          "block_id": "p26_line_13",
          "block_type": "paragraph",
          "text": "In addition to tables and graphs representing group data, individual response data",
          "bbox": [
            0.9674,
            3.4946,
            7.086,
            3.6873
          ]
        },
        {
          "block_id": "p26_line_14",
          "block_type": "paragraph",
          "text": "and other relevant study information should be presented in tables. Some regulatory",
          "bbox": [
            0.9729,
            3.6831,
            7.0912,
            3.8761
          ]
        },
        {
          "block_id": "p26_line_15",
          "block_type": "paragraph",
          "text": "authorities may require all individual data in archival case report tabulations. What",
          "bbox": [
            0.9741,
            3.8684,
            7.093,
            4.0523
          ]
        },
        {
          "block_id": "p26_line_16",
          "block_type": "paragraph",
          "text": "needs to be included in the report will vary from study to study and from one drug",
          "bbox": [
            0.9697,
            4.0531,
            7.0954,
            4.2373
          ]
        },
        {
          "block_id": "p26_line_17",
          "block_type": "paragraph",
          "text": "class to another and the applicant must decide, if possible after consultation with the",
          "bbox": [
            0.9732,
            4.2323,
            7.0915,
            4.4192
          ]
        },
        {
          "block_id": "p26_line_18",
          "block_type": "paragraph",
          "text": "regulatory authority, what to include in appendix to the study report. The study",
          "bbox": [
            0.9684,
            4.4172,
            7.0917,
            4.6055
          ]
        },
        {
          "block_id": "p26_line_19",
          "block_type": "paragraph",
          "text": "report should indicate what material is included as an appendix, what is in the more",
          "bbox": [
            0.968,
            4.5977,
            7.0918,
            4.7851
          ]
        },
        {
          "block_id": "p26_line_20",
          "block_type": "paragraph",
          "text": "extensive archival case report tabulations, if required by the regulatory authority, and",
          "bbox": [
            0.9752,
            4.7825,
            7.0952,
            4.9719
          ]
        },
        {
          "block_id": "p26_line_21",
          "block_type": "paragraph",
          "text": "what is available on request.",
          "bbox": [
            0.9726,
            4.9679,
            3.0125,
            5.1487
          ]
        },
        {
          "block_id": "p26_line_22",
          "block_type": "paragraph",
          "text": "For a controlled study in which critical efficacy measurements or assessments (e.g.,",
          "bbox": [
            0.9722,
            5.2305,
            7.0788,
            5.4218
          ]
        },
        {
          "block_id": "p26_line_23",
          "block_type": "paragraph",
          "text": "blood or urine cultures, pulmonary function tests, angina frequency, or global",
          "bbox": [
            0.9664,
            5.4122,
            7.0914,
            5.6074
          ]
        },
        {
          "block_id": "p26_line_24",
          "block_type": "paragraph",
          "text": "evaluations) are repeated at intervals, the data listings accompanying the report",
          "bbox": [
            0.9734,
            5.6006,
            7.0928,
            5.7869
          ]
        },
        {
          "block_id": "p26_line_25",
          "block_type": "paragraph",
          "text": "should include, for each patient, a patient identifier, all measured or observed values",
          "bbox": [
            0.9734,
            5.7803,
            7.0916,
            5.9666
          ]
        },
        {
          "block_id": "p26_line_26",
          "block_type": "paragraph",
          "text": "of critical measurements, including baseline measurements, with notation of the time",
          "bbox": [
            0.9736,
            5.9632,
            7.0916,
            6.1487
          ]
        },
        {
          "block_id": "p26_line_27",
          "block_type": "paragraph",
          "text": "during the study (e.g., days on therapy and time of day, if relevant) when the",
          "bbox": [
            0.9753,
            6.1479,
            7.0919,
            6.3462
          ]
        },
        {
          "block_id": "p26_line_28",
          "block_type": "paragraph",
          "text": "measurements were made, the drug/dose at the time (if useful, given as mg/kg), any",
          "bbox": [
            0.9719,
            6.3326,
            7.0933,
            6.5279
          ]
        },
        {
          "block_id": "p26_line_29",
          "block_type": "paragraph",
          "text": "measurements of compliance, and any concomitant medications at the time of, or close",
          "bbox": [
            0.972,
            6.5198,
            7.0953,
            6.7059
          ]
        },
        {
          "block_id": "p26_line_30",
          "block_type": "paragraph",
          "text": "to the time of, measurement or assessment. If, aside from repeated assessments, the",
          "bbox": [
            0.9725,
            6.7008,
            7.0911,
            6.8865
          ]
        },
        {
          "block_id": "p26_line_31",
          "block_type": "paragraph",
          "text": "study included some overall responder vs non-responder evaluation(s), (bacteriologic",
          "bbox": [
            0.9733,
            6.8826,
            7.094,
            7.0749
          ]
        },
        {
          "block_id": "p26_line_32",
          "block_type": "paragraph",
          "text": "cure or failure), it should also be included. In addition to critical measurements, the",
          "bbox": [
            0.9725,
            7.0674,
            7.0922,
            7.2459
          ]
        },
        {
          "block_id": "p26_line_33",
          "block_type": "paragraph",
          "text": "tabulation should note whether the patient was included in the efficacy evaluation",
          "bbox": [
            0.9727,
            7.2477,
            7.092,
            7.4325
          ]
        },
        {
          "block_id": "p26_line_34",
          "block_type": "paragraph",
          "text": "(and which evaluation, if more than one), provide patient compliance information, if",
          "bbox": [
            0.9788,
            7.4296,
            7.1015,
            7.6226
          ]
        },
        {
          "block_id": "p26_line_35",
          "block_type": "paragraph",
          "text": "collected, and a reference to the location of the case report form, if included. Critical",
          "bbox": [
            0.9742,
            7.6126,
            7.0937,
            7.8001
          ]
        },
        {
          "block_id": "p26_line_36",
          "block_type": "paragraph",
          "text": "baseline information such as age, sex, weight, disease being treated (if more than one",
          "bbox": [
            0.966,
            7.7965,
            7.0912,
            7.9836
          ]
        },
        {
          "block_id": "p26_line_37",
          "block_type": "paragraph",
          "text": "in study), and disease stage or severity, is also helpful. The baseline values for",
          "bbox": [
            0.9667,
            7.9815,
            7.0924,
            8.1744
          ]
        },
        {
          "block_id": "p26_line_38",
          "block_type": "paragraph",
          "text": "critical measurements would ordinarily be included as zero time values for each",
          "bbox": [
            0.9733,
            8.166,
            7.0892,
            8.3519
          ]
        },
        {
          "block_id": "p26_line_39",
          "block_type": "paragraph",
          "text": "efficacy measurement.",
          "bbox": [
            0.9741,
            8.3598,
            2.5651,
            8.5274
          ]
        },
        {
          "block_id": "p26_line_40",
          "block_type": "paragraph",
          "text": "The tabulation described should usually be included in appendix 16.2.6 of the study",
          "bbox": [
            0.9699,
            8.6173,
            7.0906,
            8.8007
          ]
        },
        {
          "block_id": "p26_line_41",
          "block_type": "paragraph",
          "text": "report, rather than in the more extensive case report tabulations required by some",
          "bbox": [
            0.9688,
            8.8051,
            7.0911,
            8.9864
          ]
        },
        {
          "block_id": "p26_line_42",
          "block_type": "paragraph",
          "text": "regulatory authorities, because it represents the basic efficacy data supporting",
          "bbox": [
            0.9684,
            8.9878,
            7.0933,
            9.1732
          ]
        },
        {
          "block_id": "p26_line_43",
          "block_type": "paragraph",
          "text": "summary tables. Such a thorough tabulation can be unwieldy for review purposes,",
          "bbox": [
            0.9699,
            9.1705,
            7.0845,
            9.3563
          ]
        },
        {
          "block_id": "p26_line_44",
          "block_type": "paragraph",
          "text": "however, and it is expected that more targeted displays will be developed as well. For",
          "bbox": [
            0.9636,
            9.3507,
            7.0904,
            9.5343
          ]
        },
        {
          "block_id": "p26_line_45",
          "block_type": "paragraph",
          "text": "example, if there are many measurements reported, tabulations of the most critical",
          "bbox": [
            0.9746,
            9.5346,
            7.0924,
            9.7178
          ]
        },
        {
          "block_id": "p26_line_46",
          "block_type": "paragraph",
          "text": "measurements for each patient (e.g., the blood pressure value at certain visits might",
          "bbox": [
            0.9719,
            9.7212,
            7.092,
            9.8972
          ]
        },
        {
          "block_id": "p26_line_47",
          "block_type": "paragraph",
          "text": "be more important than others) will be useful in providing an overview of each",
          "bbox": [
            0.9667,
            9.9008,
            7.0875,
            10.0797
          ]
        },
        {
          "block_id": "p26_line_48",
          "block_type": "paragraph",
          "text": "individual's results in a study, with each patient's response summarised on a single",
          "bbox": [
            0.9675,
            10.0856,
            7.0896,
            10.2646
          ]
        },
        {
          "block_id": "p26_line_49",
          "block_type": "paragraph",
          "text": "line or small number of lines.",
          "bbox": [
            0.9643,
            10.2708,
            3.0532,
            10.4345
          ]
        },
        {
          "block_id": "p26_line_50",
          "block_type": "paragraph",
          "text": "18",
          "bbox": [
            3.9459,
            10.948,
            4.1232,
            11.0831
          ]
        }
      ]
    },
    {
      "page_number": 27,
      "width": 8.2639,
      "height": 11.6944,
      "unit": "inch",
      "blocks": [
        {
          "block_id": "p27_line_0",
          "block_type": "paragraph",
          "text": "Structure and Content of Clinical Study Reports",
          "bbox": [
            4.1845,
            0.7138,
            7.2868,
            0.8864
          ]
        },
        {
          "block_id": "p27_line_1",
          "block_type": "paragraph",
          "text": "11.4.4 Drug Dose, Drug Concentration, and Relationships to Response",
          "bbox": [
            1.1755,
            1.0524,
            6.7218,
            1.2391
          ]
        },
        {
          "block_id": "p27_line_2",
          "block_type": "paragraph",
          "text": "When the dose in each patient can vary, the actual doses received by patients should",
          "bbox": [
            1.1706,
            1.2726,
            7.2904,
            1.4581
          ]
        },
        {
          "block_id": "p27_line_3",
          "block_type": "paragraph",
          "text": "be shown and individual patient's doses should be tabulated. Although studies not",
          "bbox": [
            1.1639,
            1.4575,
            7.2878,
            1.6388
          ]
        },
        {
          "block_id": "p27_line_4",
          "block_type": "paragraph",
          "text": "designed as dose-response studies may have limited ability to contribute dose-",
          "bbox": [
            1.1731,
            1.6418,
            7.2836,
            1.8248
          ]
        },
        {
          "block_id": "p27_line_5",
          "block_type": "paragraph",
          "text": "response information, the available data should be examined for whatever",
          "bbox": [
            1.164,
            1.8224,
            7.2884,
            2.0073
          ]
        },
        {
          "block_id": "p27_line_6",
          "block_type": "paragraph",
          "text": "information they can yield. In examining the dose response, it may be helpful to",
          "bbox": [
            1.1624,
            2.0058,
            7.286,
            2.1948
          ]
        },
        {
          "block_id": "p27_line_7",
          "block_type": "paragraph",
          "text": "calculate dose as mg/kg body weight or mg/m2 body surface.",
          "bbox": [
            1.1672,
            2.1932,
            5.3756,
            2.3773
          ]
        },
        {
          "block_id": "p27_line_8",
          "block_type": "paragraph",
          "text": "Drug concentration information, if available, should also be tabulated (Appendix",
          "bbox": [
            1.1638,
            2.4518,
            7.2907,
            2.6438
          ]
        },
        {
          "block_id": "p27_line_9",
          "block_type": "paragraph",
          "text": "16.2.5), analysed in pharmacokinetic terms and, if possible, related to response.",
          "bbox": [
            1.1781,
            2.64,
            6.7965,
            2.8306
          ]
        },
        {
          "block_id": "p27_line_10",
          "block_type": "paragraph",
          "text": "Further guidance on the design and analysis of studies exploring dose-response or",
          "bbox": [
            1.1655,
            2.9065,
            7.2861,
            3.0981
          ]
        },
        {
          "block_id": "p27_line_11",
          "block_type": "paragraph",
          "text": "concentration response can be found in the ICH Guideline \"Dose-Response",
          "bbox": [
            1.1677,
            3.0899,
            7.2882,
            3.278
          ]
        },
        {
          "block_id": "p27_line_12",
          "block_type": "paragraph",
          "text": "Information to Support Drug Registration\".",
          "bbox": [
            1.161,
            3.2734,
            4.2397,
            3.4604
          ]
        },
        {
          "block_id": "p27_line_13",
          "block_type": "paragraph",
          "text": "11.4.5 Drug-Drug and Drug-Disease Interactions",
          "bbox": [
            1.1735,
            3.6206,
            5.0118,
            3.8113
          ]
        },
        {
          "block_id": "p27_line_14",
          "block_type": "paragraph",
          "text": "Any apparent relationship between response and concomitant therapy and between",
          "bbox": [
            1.1648,
            3.8511,
            7.2891,
            4.0386
          ]
        },
        {
          "block_id": "p27_line_15",
          "block_type": "paragraph",
          "text": "response and past and/or concurrent illness should be described.",
          "bbox": [
            1.1611,
            4.0314,
            5.7192,
            4.2243
          ]
        },
        {
          "block_id": "p27_line_16",
          "block_type": "paragraph",
          "text": "11.4.6 By-Patient Displays",
          "bbox": [
            1.1731,
            4.3797,
            3.2584,
            4.5715
          ]
        },
        {
          "block_id": "p27_line_17",
          "block_type": "paragraph",
          "text": "While individual patient data ordinarily can be displayed in tabular listings, it has on",
          "bbox": [
            1.1713,
            4.6049,
            7.2865,
            4.7965
          ]
        },
        {
          "block_id": "p27_line_18",
          "block_type": "paragraph",
          "text": "occasion been helpful to construct individual patient profiles in other formats, such as",
          "bbox": [
            1.1708,
            4.7945,
            7.2876,
            4.9793
          ]
        },
        {
          "block_id": "p27_line_19",
          "block_type": "paragraph",
          "text": "graphic displays. These might, for example, show the value of (a) particular",
          "bbox": [
            1.1679,
            4.9736,
            7.2901,
            5.1695
          ]
        },
        {
          "block_id": "p27_line_20",
          "block_type": "paragraph",
          "text": "parameter(s) over time, the drug dose over the same period, and the times of",
          "bbox": [
            1.1653,
            5.1563,
            7.3002,
            5.3504
          ]
        },
        {
          "block_id": "p27_line_21",
          "block_type": "paragraph",
          "text": "particular events (e.g., an adverse event or change in concomitant therapy). Where",
          "bbox": [
            1.1646,
            5.3404,
            7.2895,
            5.5324
          ]
        },
        {
          "block_id": "p27_line_22",
          "block_type": "paragraph",
          "text": "group mean data represent the principal analyses, this kind of \"case report extract\"",
          "bbox": [
            1.1686,
            5.5217,
            7.2844,
            5.7159
          ]
        },
        {
          "block_id": "p27_line_23",
          "block_type": "paragraph",
          "text": "may offer little advantage; it may be helpful, however, if overall evaluation of",
          "bbox": [
            1.1689,
            5.7045,
            7.3008,
            5.8986
          ]
        },
        {
          "block_id": "p27_line_24",
          "block_type": "paragraph",
          "text": "individual responses is a critical part of the analysis.",
          "bbox": [
            1.1633,
            5.8906,
            4.9062,
            6.0791
          ]
        },
        {
          "block_id": "p27_line_25",
          "block_type": "paragraph",
          "text": "11.4.7 Efficacy Conclusions",
          "bbox": [
            1.1718,
            6.2812,
            3.3441,
            6.4649
          ]
        },
        {
          "block_id": "p27_line_26",
          "block_type": "paragraph",
          "text": "The important conclusions concerning efficacy should be concisely described,",
          "bbox": [
            1.1702,
            6.4973,
            7.2768,
            6.698
          ]
        },
        {
          "block_id": "p27_line_27",
          "block_type": "paragraph",
          "text": "considering primary and secondary end points, pre-specified and alternative",
          "bbox": [
            1.168,
            6.6853,
            7.2894,
            6.8808
          ]
        },
        {
          "block_id": "p27_line_28",
          "block_type": "paragraph",
          "text": "statistical approaches and results of exploratory analyses.",
          "bbox": [
            1.1686,
            6.8737,
            5.2766,
            7.0614
          ]
        },
        {
          "block_id": "p27_line_29",
          "block_type": "paragraph",
          "text": "12. SAFETY EVALUATION",
          "bbox": [
            1.1804,
            7.221,
            3.5285,
            7.3963
          ]
        },
        {
          "block_id": "p27_line_30",
          "block_type": "paragraph",
          "text": "Analysis of safety-related data can be considered at three levels. First, the extent of",
          "bbox": [
            1.1659,
            7.4451,
            7.3019,
            7.6325
          ]
        },
        {
          "block_id": "p27_line_31",
          "block_type": "paragraph",
          "text": "exposure (dose, duration, number of patients) should be examined to determine the",
          "bbox": [
            1.169,
            7.6284,
            7.2895,
            7.8208
          ]
        },
        {
          "block_id": "p27_line_32",
          "block_type": "paragraph",
          "text": "degree to which safety can be assessed from the study. Second, the more common",
          "bbox": [
            1.1715,
            7.8124,
            7.2891,
            8.0
          ]
        },
        {
          "block_id": "p27_line_33",
          "block_type": "paragraph",
          "text": "adverse events, laboratory test changes etc. should be identified, classified in some",
          "bbox": [
            1.1685,
            8.001,
            7.2876,
            8.1884
          ]
        },
        {
          "block_id": "p27_line_34",
          "block_type": "paragraph",
          "text": "reasonable way, compared for treatment groups, and analysed, as appropriate, for",
          "bbox": [
            1.1646,
            8.1912,
            7.2856,
            8.3733
          ]
        },
        {
          "block_id": "p27_line_35",
          "block_type": "paragraph",
          "text": "factors that may affect the frequency of adverse reactions/events, such as time",
          "bbox": [
            1.1633,
            8.3684,
            7.2875,
            8.5522
          ]
        },
        {
          "block_id": "p27_line_36",
          "block_type": "paragraph",
          "text": "dependence, relation to demographic characteristics, relation to dose or drug",
          "bbox": [
            1.1702,
            8.5492,
            7.2894,
            8.7377
          ]
        },
        {
          "block_id": "p27_line_37",
          "block_type": "paragraph",
          "text": "concentration etc. Finally, serious adverse events and other significant adverse",
          "bbox": [
            1.1694,
            8.7333,
            7.2893,
            8.916
          ]
        },
        {
          "block_id": "p27_line_38",
          "block_type": "paragraph",
          "text": "events should be identified, usually by close examination of patients who left the",
          "bbox": [
            1.1703,
            8.9166,
            7.2882,
            9.1013
          ]
        },
        {
          "block_id": "p27_line_39",
          "block_type": "paragraph",
          "text": "study prematurely because of an adverse event, whether or not identified as drug",
          "bbox": [
            1.1666,
            9.102,
            7.2903,
            9.2817
          ]
        },
        {
          "block_id": "p27_line_40",
          "block_type": "paragraph",
          "text": "related, or who died.",
          "bbox": [
            1.1621,
            9.2848,
            2.6273,
            9.4581
          ]
        },
        {
          "block_id": "p27_line_41",
          "block_type": "paragraph",
          "text": "The ICH Guideline on Clinical Safety Data Management, Definitions and Standards",
          "bbox": [
            1.1665,
            9.5464,
            7.2874,
            9.7298
          ]
        },
        {
          "block_id": "p27_line_42",
          "block_type": "paragraph",
          "text": "for Expedited Reporting defines serious adverse events as follows: a \"serious adverse",
          "bbox": [
            1.1641,
            9.7331,
            7.2879,
            9.9156
          ]
        },
        {
          "block_id": "p27_line_43",
          "block_type": "paragraph",
          "text": "event\" (experience) or reaction is any untoward medical occurrence that at any dose:",
          "bbox": [
            1.1717,
            9.9207,
            7.2854,
            10.0966
          ]
        },
        {
          "block_id": "p27_line_44",
          "block_type": "paragraph",
          "text": "results in death, is life-threatening, requires inpatient hospitalisation or prolongation",
          "bbox": [
            1.1664,
            10.1013,
            7.2862,
            10.2832
          ]
        },
        {
          "block_id": "p27_line_45",
          "block_type": "paragraph",
          "text": "of existing hospitalisation, results in persistent or significant disability/incapacity, or",
          "bbox": [
            1.1705,
            10.284,
            7.2869,
            10.4703
          ]
        },
        {
          "block_id": "p27_line_46",
          "block_type": "paragraph",
          "text": "is a congenital anomaly/birth defect.",
          "bbox": [
            1.1626,
            10.4709,
            3.7487,
            10.6438
          ]
        },
        {
          "block_id": "p27_line_47",
          "block_type": "paragraph",
          "text": "19",
          "bbox": [
            4.1442,
            10.9517,
            4.3143,
            11.083
          ]
        }
      ]
    },
    {
      "page_number": 28,
      "width": 8.2639,
      "height": 11.6944,
      "unit": "inch",
      "blocks": [
        {
          "block_id": "p28_line_0",
          "block_type": "paragraph",
          "text": "Structure and Content of Clinical Study Reports",
          "bbox": [
            0.9743,
            0.7138,
            4.0773,
            0.8871
          ]
        },
        {
          "block_id": "p28_line_1",
          "block_type": "paragraph",
          "text": "For the purpose of this guideline, \"other significant adverse events\" are marked",
          "bbox": [
            0.9727,
            1.0471,
            7.0903,
            1.2315
          ]
        },
        {
          "block_id": "p28_line_2",
          "block_type": "paragraph",
          "text": "haematological and other laboratory abnormalities and any adverse events that led to",
          "bbox": [
            0.9682,
            1.2311,
            7.0876,
            1.4134
          ]
        },
        {
          "block_id": "p28_line_3",
          "block_type": "paragraph",
          "text": "an intervention, including withdrawal of drug treatment, dose reduction or significant",
          "bbox": [
            0.9749,
            1.4222,
            7.0906,
            1.6045
          ]
        },
        {
          "block_id": "p28_line_4",
          "block_type": "paragraph",
          "text": "additional concomitant therapy.",
          "bbox": [
            0.9732,
            1.6046,
            3.2424,
            1.7868
          ]
        },
        {
          "block_id": "p28_line_5",
          "block_type": "paragraph",
          "text": "In the following sections, three kinds of analysis and display are called for:",
          "bbox": [
            0.9692,
            1.8609,
            6.2597,
            2.0498
          ]
        },
        {
          "block_id": "p28_line_6",
          "block_type": "paragraph",
          "text": "1) summarised data, often using tables and graphical presentations presented",
          "bbox": [
            1.38,
            2.0919,
            7.093,
            2.2817
          ]
        },
        {
          "block_id": "p28_line_7",
          "block_type": "paragraph",
          "text": "in the main body of the report",
          "bbox": [
            1.6068,
            2.2784,
            3.7455,
            2.4608
          ]
        },
        {
          "block_id": "p28_line_8",
          "block_type": "paragraph",
          "text": "2) listings of individual patient data, and",
          "bbox": [
            1.367,
            2.4963,
            4.3532,
            2.6876
          ]
        },
        {
          "block_id": "p28_line_9",
          "block_type": "paragraph",
          "text": "3) narrative statements of events of particular interest.",
          "bbox": [
            1.3694,
            2.7321,
            5.3505,
            2.9072
          ]
        },
        {
          "block_id": "p28_line_10",
          "block_type": "paragraph",
          "text": "In all tabulations and analyses, events associated with both test drug and control",
          "bbox": [
            0.9673,
            2.9848,
            7.0934,
            3.1721
          ]
        },
        {
          "block_id": "p28_line_11",
          "block_type": "paragraph",
          "text": "treatment should be displayed.",
          "bbox": [
            0.9684,
            3.1757,
            3.168,
            3.3595
          ]
        },
        {
          "block_id": "p28_line_12",
          "block_type": "paragraph",
          "text": "12.1 EXTENT OF EXPOSURE",
          "bbox": [
            0.9819,
            3.5214,
            3.4373,
            3.6945
          ]
        },
        {
          "block_id": "p28_line_13",
          "block_type": "paragraph",
          "text": "The extent of exposure to test drugs/investigational products (and to active control",
          "bbox": [
            0.9701,
            3.7468,
            7.0927,
            3.9342
          ]
        },
        {
          "block_id": "p28_line_14",
          "block_type": "paragraph",
          "text": "and placebo) should be characterised according to the number of patients exposed, the",
          "bbox": [
            0.9721,
            3.93,
            7.0926,
            4.119
          ]
        },
        {
          "block_id": "p28_line_15",
          "block_type": "paragraph",
          "text": "duration of exposure, and the dose to which they were exposed.",
          "bbox": [
            0.9751,
            4.1138,
            5.4367,
            4.3032
          ]
        },
        {
          "block_id": "p28_line_16",
          "block_type": "paragraph",
          "text": " Duration: Duration of exposure to any dose can be expressed as a median or",
          "bbox": [
            1.3752,
            4.3918,
            7.0933,
            4.5705
          ]
        },
        {
          "block_id": "p28_line_17",
          "block_type": "paragraph",
          "text": "mean, but it is also helpful to describe the number of patients exposed for",
          "bbox": [
            1.6124,
            4.5697,
            7.0925,
            4.7547
          ]
        },
        {
          "block_id": "p28_line_18",
          "block_type": "paragraph",
          "text": "specified periods of time, such as for one day or less, 2 days to one week,",
          "bbox": [
            1.6123,
            4.7532,
            7.0828,
            4.942
          ]
        },
        {
          "block_id": "p28_line_19",
          "block_type": "paragraph",
          "text": "more than one week to one month, more than one month to 6 months etc.",
          "bbox": [
            1.6145,
            4.9353,
            7.0846,
            5.1215
          ]
        },
        {
          "block_id": "p28_line_20",
          "block_type": "paragraph",
          "text": "The numbers exposed to test drug(s)/investigational product(s) for the",
          "bbox": [
            1.6186,
            5.116,
            7.0927,
            5.3048
          ]
        },
        {
          "block_id": "p28_line_21",
          "block_type": "paragraph",
          "text": "various durations should also be broken down into age, sex, and racial",
          "bbox": [
            1.6157,
            5.2995,
            7.0959,
            5.4851
          ]
        },
        {
          "block_id": "p28_line_22",
          "block_type": "paragraph",
          "text": "subgroups, and any other pertinent subgroups, such as disease (if more than",
          "bbox": [
            1.6131,
            5.4824,
            7.0941,
            5.6775
          ]
        },
        {
          "block_id": "p28_line_23",
          "block_type": "paragraph",
          "text": "one is represented), disease severity, concurrent illness.",
          "bbox": [
            1.6155,
            5.6733,
            5.5639,
            5.855
          ]
        },
        {
          "block_id": "p28_line_24",
          "block_type": "paragraph",
          "text": " Dose: The mean or median dose used and the number of patients exposed to",
          "bbox": [
            1.3782,
            5.9843,
            7.09,
            6.1641
          ]
        },
        {
          "block_id": "p28_line_25",
          "block_type": "paragraph",
          "text": "specified daily dose levels should be given; the daily dose levels used could be",
          "bbox": [
            1.6126,
            6.1625,
            7.0908,
            6.3516
          ]
        },
        {
          "block_id": "p28_line_26",
          "block_type": "paragraph",
          "text": "the maximum dose for each patient, the dose with longest exposure for each",
          "bbox": [
            1.6149,
            6.3471,
            7.0898,
            6.5349
          ]
        },
        {
          "block_id": "p28_line_27",
          "block_type": "paragraph",
          "text": "patient, or the mean daily dose. It is often useful to provide combined dose-",
          "bbox": [
            1.6089,
            6.527,
            7.0863,
            6.7188
          ]
        },
        {
          "block_id": "p28_line_28",
          "block_type": "paragraph",
          "text": "duration information, such as the numbers exposed for a given duration (e.g.,",
          "bbox": [
            1.6189,
            6.7101,
            7.083,
            6.9036
          ]
        },
        {
          "block_id": "p28_line_29",
          "block_type": "paragraph",
          "text": "at least one month) to the most common dose, the highest dose, the",
          "bbox": [
            1.6168,
            6.8988,
            7.0928,
            7.0896
          ]
        },
        {
          "block_id": "p28_line_30",
          "block_type": "paragraph",
          "text": "maximum recommended dose etc. In some cases, cumulative dose might be",
          "bbox": [
            1.6158,
            7.0846,
            7.0927,
            7.2691
          ]
        },
        {
          "block_id": "p28_line_31",
          "block_type": "paragraph",
          "text": "pertinent. Dosage may be given as the actual daily dose or on a mg/kg or",
          "bbox": [
            1.6133,
            7.2656,
            7.0934,
            7.4575
          ]
        },
        {
          "block_id": "p28_line_32",
          "block_type": "paragraph",
          "text": "mg/m2 basis as appropriate. The numbers of patients exposed to various",
          "bbox": [
            1.6153,
            7.4511,
            7.092,
            7.6385
          ]
        },
        {
          "block_id": "p28_line_33",
          "block_type": "paragraph",
          "text": "doses should be broken down into age, sex, and racial subgroups, and any",
          "bbox": [
            1.6187,
            7.6288,
            7.0906,
            7.8253
          ]
        },
        {
          "block_id": "p28_line_34",
          "block_type": "paragraph",
          "text": "other pertinent subgroups.",
          "bbox": [
            1.615,
            7.821,
            3.5176,
            8.005
          ]
        },
        {
          "block_id": "p28_line_35",
          "block_type": "paragraph",
          "text": " Drug concentration: If available, drug concentration data (e.g., concentration",
          "bbox": [
            1.3771,
            8.1313,
            7.0907,
            8.3106
          ]
        },
        {
          "block_id": "p28_line_36",
          "block_type": "paragraph",
          "text": "at the time of an event, maximum plasma concentration, area under curve)",
          "bbox": [
            1.6155,
            8.3136,
            7.0854,
            8.4955
          ]
        },
        {
          "block_id": "p28_line_37",
          "block_type": "paragraph",
          "text": "may be helpful in individual patients for correlation with adverse events or",
          "bbox": [
            1.6142,
            8.494,
            7.0929,
            8.6771
          ]
        },
        {
          "block_id": "p28_line_38",
          "block_type": "paragraph",
          "text": "changes in laboratory variables. (Appendix 16.2.5.)",
          "bbox": [
            1.6165,
            8.6782,
            5.2579,
            8.8627
          ]
        },
        {
          "block_id": "p28_line_39",
          "block_type": "paragraph",
          "text": "It is assumed that all patients entered into treatment who received at least",
          "bbox": [
            1.6564,
            8.985,
            7.0911,
            9.1625
          ]
        },
        {
          "block_id": "p28_line_40",
          "block_type": "paragraph",
          "text": "one dose of the treatment are included in the safety analysis; if that is not",
          "bbox": [
            1.6617,
            9.1691,
            7.0927,
            9.3497
          ]
        },
        {
          "block_id": "p28_line_41",
          "block_type": "paragraph",
          "text": "so, an explanation should be provided.",
          "bbox": [
            1.6599,
            9.3531,
            4.3744,
            9.5401
          ]
        },
        {
          "block_id": "p28_line_42",
          "block_type": "paragraph",
          "text": "20",
          "bbox": [
            3.939,
            10.9463,
            4.1192,
            11.0847
          ]
        }
      ]
    },
    {
      "page_number": 29,
      "width": 8.2639,
      "height": 11.6944,
      "unit": "inch",
      "blocks": [
        {
          "block_id": "p29_line_0",
          "block_type": "paragraph",
          "text": "Structure and Content of Clinical Study Reports",
          "bbox": [
            4.1842,
            0.7138,
            7.2866,
            0.8863
          ]
        },
        {
          "block_id": "p29_line_1",
          "block_type": "paragraph",
          "text": "12.2 ADVERSE EVENTS (AEs)",
          "bbox": [
            1.1765,
            1.0507,
            3.6927,
            1.232
          ]
        },
        {
          "block_id": "p29_line_2",
          "block_type": "paragraph",
          "text": "12.2.1 Brief Summary of Adverse Events",
          "bbox": [
            1.1738,
            1.3625,
            4.3619,
            1.539
          ]
        },
        {
          "block_id": "p29_line_3",
          "block_type": "paragraph",
          "text": "The overall adverse event experience in the study should be described in a brief",
          "bbox": [
            1.1666,
            1.583,
            7.2991,
            1.7657
          ]
        },
        {
          "block_id": "p29_line_4",
          "block_type": "paragraph",
          "text": "narrative, supported by the following more detailed tabulations and analyses. In",
          "bbox": [
            1.1639,
            1.7669,
            7.2875,
            1.9517
          ]
        },
        {
          "block_id": "p29_line_5",
          "block_type": "paragraph",
          "text": "these tabulations and analyses, events associated with both the test drug and control",
          "bbox": [
            1.1664,
            1.952,
            7.2903,
            2.1315
          ]
        },
        {
          "block_id": "p29_line_6",
          "block_type": "paragraph",
          "text": "treatment should be displayed.",
          "bbox": [
            1.1633,
            2.1342,
            3.3638,
            2.3152
          ]
        },
        {
          "block_id": "p29_line_7",
          "block_type": "paragraph",
          "text": "12.2.2 Display of Adverse Events",
          "bbox": [
            1.1738,
            2.5262,
            3.7547,
            2.7071
          ]
        },
        {
          "block_id": "p29_line_8",
          "block_type": "paragraph",
          "text": "All adverse events occurring after initiation of study treatments (including events",
          "bbox": [
            1.1661,
            2.7488,
            7.2885,
            2.935
          ]
        },
        {
          "block_id": "p29_line_9",
          "block_type": "paragraph",
          "text": "likely to be related to the underlying disease or likely to represent concomitant",
          "bbox": [
            1.1596,
            2.9309,
            7.2897,
            3.1178
          ]
        },
        {
          "block_id": "p29_line_10",
          "block_type": "paragraph",
          "text": "illness, unless there is a prior agreement with the regulatory authority to consider",
          "bbox": [
            1.1628,
            3.117,
            7.2885,
            3.3005
          ]
        },
        {
          "block_id": "p29_line_11",
          "block_type": "paragraph",
          "text": "specified events as disease related) should be displayed in summary tables (section",
          "bbox": [
            1.1664,
            3.2969,
            7.2874,
            3.4843
          ]
        },
        {
          "block_id": "p29_line_12",
          "block_type": "paragraph",
          "text": "14.3.1). The tables should include changes in vital signs and any laboratory changes",
          "bbox": [
            1.177,
            3.4832,
            7.2896,
            3.6774
          ]
        },
        {
          "block_id": "p29_line_13",
          "block_type": "paragraph",
          "text": "that were considered serious adverse events or other significant adverse events.",
          "bbox": [
            1.1666,
            3.6662,
            6.812,
            3.8544
          ]
        },
        {
          "block_id": "p29_line_14",
          "block_type": "paragraph",
          "text": "In most cases, it will also be useful to identify in such tables \"treatment emergent",
          "bbox": [
            1.1624,
            3.9743,
            7.29,
            4.1626
          ]
        },
        {
          "block_id": "p29_line_15",
          "block_type": "paragraph",
          "text": "signs and symptoms\" (TESS; those not seen at baseline and those that worsened even",
          "bbox": [
            1.1662,
            4.157,
            7.2894,
            4.3502
          ]
        },
        {
          "block_id": "p29_line_16",
          "block_type": "paragraph",
          "text": "if present at baseline).",
          "bbox": [
            1.1601,
            4.345,
            2.7553,
            4.5293
          ]
        },
        {
          "block_id": "p29_line_17",
          "block_type": "paragraph",
          "text": "The tables should list each adverse event, the number of patients in each treatment",
          "bbox": [
            1.1676,
            4.6451,
            7.2928,
            4.8365
          ]
        },
        {
          "block_id": "p29_line_18",
          "block_type": "paragraph",
          "text": "group in whom the event occurred, and the rate of occurrence. When treatments are",
          "bbox": [
            1.1699,
            4.8328,
            7.2901,
            5.0208
          ]
        },
        {
          "block_id": "p29_line_19",
          "block_type": "paragraph",
          "text": "cyclical, e.g., cancer chemotherapy, it may also be helpful to list results separately for",
          "bbox": [
            1.1704,
            5.0145,
            7.2892,
            5.2062
          ]
        },
        {
          "block_id": "p29_line_20",
          "block_type": "paragraph",
          "text": "each cycle. Adverse events should be grouped by body system. Each event may then",
          "bbox": [
            1.1731,
            5.2003,
            7.2889,
            5.3868
          ]
        },
        {
          "block_id": "p29_line_21",
          "block_type": "paragraph",
          "text": "be divided into defined severity categories (e.g., mild, moderate, severe) if these were",
          "bbox": [
            1.1644,
            5.3784,
            7.2891,
            5.5712
          ]
        },
        {
          "block_id": "p29_line_22",
          "block_type": "paragraph",
          "text": "used. The tables may also divide the adverse events into those considered at least",
          "bbox": [
            1.1685,
            5.5617,
            7.2892,
            5.7491
          ]
        },
        {
          "block_id": "p29_line_23",
          "block_type": "paragraph",
          "text": "possibly related to drug use and those considered not related, or use some other",
          "bbox": [
            1.1649,
            5.7444,
            7.2888,
            5.9379
          ]
        },
        {
          "block_id": "p29_line_24",
          "block_type": "paragraph",
          "text": "causality scheme (e.g., unrelated or possibly, probably, or definitely related). Even",
          "bbox": [
            1.169,
            5.9329,
            7.2888,
            6.127
          ]
        },
        {
          "block_id": "p29_line_25",
          "block_type": "paragraph",
          "text": "when such a causality assessment is used, the tables should include all adverse",
          "bbox": [
            1.1693,
            6.1156,
            7.2878,
            6.304
          ]
        },
        {
          "block_id": "p29_line_26",
          "block_type": "paragraph",
          "text": "events, whether or not considered drug related, including events thought to represent",
          "bbox": [
            1.1718,
            6.3012,
            7.2881,
            6.4873
          ]
        },
        {
          "block_id": "p29_line_27",
          "block_type": "paragraph",
          "text": "intercurrent illnesses. Subsequent analyses of the study or of the overall safety data",
          "bbox": [
            1.1646,
            6.483,
            7.286,
            6.6695
          ]
        },
        {
          "block_id": "p29_line_28",
          "block_type": "paragraph",
          "text": "base may help to distinguish between adverse events that are, or are not, considered",
          "bbox": [
            1.1657,
            6.6665,
            7.2908,
            6.852
          ]
        },
        {
          "block_id": "p29_line_29",
          "block_type": "paragraph",
          "text": "drug related. So that it is possible to analyse and evaluate the data in these tables, it",
          "bbox": [
            1.1739,
            6.8474,
            7.2906,
            7.0349
          ]
        },
        {
          "block_id": "p29_line_30",
          "block_type": "paragraph",
          "text": "is important to identify each patient having each adverse event. An example of such a",
          "bbox": [
            1.1651,
            7.0328,
            7.289,
            7.222
          ]
        },
        {
          "block_id": "p29_line_31",
          "block_type": "paragraph",
          "text": "tabular presentation is shown below.",
          "bbox": [
            1.1664,
            7.2179,
            3.7846,
            7.3977
          ]
        },
        {
          "block_id": "p29_line_32",
          "block_type": "paragraph",
          "text": "21",
          "bbox": [
            4.1378,
            10.947,
            4.3074,
            11.0818
          ]
        }
      ]
    },
    {
      "page_number": 30,
      "width": 8.2639,
      "height": 11.6944,
      "unit": "inch",
      "blocks": [
        {
          "block_id": "p30_line_0",
          "block_type": "paragraph",
          "text": "Structure and Content of Clinical Study Reports",
          "bbox": [
            0.9725,
            0.7138,
            4.078,
            0.8878
          ]
        },
        {
          "block_id": "p30_line_1",
          "block_type": "paragraph",
          "text": "ADVERSE EVENTS: NUMBER OBSERVED AND RATE,",
          "bbox": [
            2.0567,
            1.0564,
            5.9986,
            1.2399
          ]
        },
        {
          "block_id": "p30_line_2",
          "block_type": "paragraph",
          "text": "WITH PATIENT IDENTIFICATIONS",
          "bbox": [
            2.7543,
            1.3055,
            5.301,
            1.4729
          ]
        },
        {
          "block_id": "p30_line_3",
          "block_type": "paragraph",
          "text": "Treatment Group X",
          "bbox": [
            1.361,
            1.6146,
            2.9316,
            1.7941
          ]
        },
        {
          "block_id": "p30_line_4",
          "block_type": "paragraph",
          "text": "N=50",
          "bbox": [
            4.9649,
            1.6188,
            5.3766,
            1.7722
          ]
        },
        {
          "block_id": "p30_line_5",
          "block_type": "paragraph",
          "text": "Mild",
          "bbox": [
            2.178,
            2.0003,
            2.5009,
            2.1441
          ]
        },
        {
          "block_id": "p30_line_6",
          "block_type": "paragraph",
          "text": "Moderate",
          "bbox": [
            3.3312,
            2.0015,
            3.9711,
            2.1479
          ]
        },
        {
          "block_id": "p30_line_7",
          "block_type": "paragraph",
          "text": "Severe",
          "bbox": [
            4.7196,
            2.0009,
            5.166,
            2.147
          ]
        },
        {
          "block_id": "p30_line_8",
          "block_type": "paragraph",
          "text": "Total",
          "bbox": [
            6.1112,
            1.9997,
            6.4618,
            2.1441
          ]
        },
        {
          "block_id": "p30_line_9",
          "block_type": "paragraph",
          "text": "Total",
          "bbox": [
            7.1515,
            1.9991,
            7.5081,
            2.1453
          ]
        },
        {
          "block_id": "p30_line_10",
          "block_type": "paragraph",
          "text": "Related*",
          "bbox": [
            1.7414,
            2.2568,
            2.3226,
            2.4084
          ]
        },
        {
          "block_id": "p30_line_11",
          "block_type": "paragraph",
          "text": "NR*",
          "bbox": [
            2.5304,
            2.262,
            2.8303,
            2.4057
          ]
        },
        {
          "block_id": "p30_line_12",
          "block_type": "paragraph",
          "text": "Related",
          "bbox": [
            3.0816,
            2.2592,
            3.6029,
            2.4091
          ]
        },
        {
          "block_id": "p30_line_13",
          "block_type": "paragraph",
          "text": "NR",
          "bbox": [
            3.948,
            2.2632,
            4.1808,
            2.404
          ]
        },
        {
          "block_id": "p30_line_14",
          "block_type": "paragraph",
          "text": "Related",
          "bbox": [
            4.3629,
            2.2591,
            4.8855,
            2.4084
          ]
        },
        {
          "block_id": "p30_line_15",
          "block_type": "paragraph",
          "text": "NR",
          "bbox": [
            5.2722,
            2.2657,
            5.5064,
            2.4048
          ]
        },
        {
          "block_id": "p30_line_16",
          "block_type": "paragraph",
          "text": "Related",
          "bbox": [
            5.6532,
            2.2596,
            6.1774,
            2.4082
          ]
        },
        {
          "block_id": "p30_line_17",
          "block_type": "paragraph",
          "text": "NR",
          "bbox": [
            6.6399,
            2.2634,
            6.8713,
            2.4037
          ]
        },
        {
          "block_id": "p30_line_18",
          "block_type": "paragraph",
          "text": "R+NR",
          "bbox": [
            7.1168,
            2.2607,
            7.5373,
            2.4055
          ]
        },
        {
          "block_id": "p30_line_19",
          "block_type": "paragraph",
          "text": "Body System A",
          "bbox": [
            0.6448,
            2.5147,
            1.4849,
            2.6797
          ]
        },
        {
          "block_id": "p30_line_20",
          "block_type": "paragraph",
          "text": "Event 1",
          "bbox": [
            0.6486,
            2.7277,
            1.1585,
            2.8779
          ]
        },
        {
          "block_id": "p30_line_21",
          "block_type": "paragraph",
          "text": "6 (12%)",
          "bbox": [
            1.7471,
            2.7315,
            2.2353,
            2.8872
          ]
        },
        {
          "block_id": "p30_line_22",
          "block_type": "paragraph",
          "text": "2 (4%)",
          "bbox": [
            2.4422,
            2.7322,
            2.8574,
            2.8878
          ]
        },
        {
          "block_id": "p30_line_23",
          "block_type": "paragraph",
          "text": "3 (6%)",
          "bbox": [
            3.0863,
            2.734,
            3.4964,
            2.8877
          ]
        },
        {
          "block_id": "p30_line_24",
          "block_type": "paragraph",
          "text": "1 (2%)",
          "bbox": [
            3.7357,
            2.732,
            4.1403,
            2.8875
          ]
        },
        {
          "block_id": "p30_line_25",
          "block_type": "paragraph",
          "text": "3 (6%)",
          "bbox": [
            4.3717,
            2.7329,
            4.783,
            2.8879
          ]
        },
        {
          "block_id": "p30_line_26",
          "block_type": "paragraph",
          "text": "1 (2%)",
          "bbox": [
            5.0497,
            2.7313,
            5.4585,
            2.8874
          ]
        },
        {
          "block_id": "p30_line_27",
          "block_type": "paragraph",
          "text": "12 (24%)",
          "bbox": [
            5.6716,
            2.7295,
            6.2352,
            2.8891
          ]
        },
        {
          "block_id": "p30_line_28",
          "block_type": "paragraph",
          "text": "4 (8%)",
          "bbox": [
            6.4497,
            2.7334,
            6.8579,
            2.8872
          ]
        },
        {
          "block_id": "p30_line_29",
          "block_type": "paragraph",
          "text": "N11 **",
          "bbox": [
            1.7419,
            3.0136,
            2.1645,
            3.1634
          ]
        },
        {
          "block_id": "p30_line_30",
          "block_type": "paragraph",
          "text": "N21",
          "bbox": [
            2.4455,
            3.0222,
            2.7219,
            3.165
          ]
        },
        {
          "block_id": "p30_line_31",
          "block_type": "paragraph",
          "text": "N31",
          "bbox": [
            3.086,
            3.022,
            3.3625,
            3.1648
          ]
        },
        {
          "block_id": "p30_line_32",
          "block_type": "paragraph",
          "text": "N41",
          "bbox": [
            3.7275,
            3.0229,
            4.0061,
            3.1642
          ]
        },
        {
          "block_id": "p30_line_33",
          "block_type": "paragraph",
          "text": "N51",
          "bbox": [
            4.372,
            3.0217,
            4.6482,
            3.1656
          ]
        },
        {
          "block_id": "p30_line_34",
          "block_type": "paragraph",
          "text": "N61",
          "bbox": [
            5.0456,
            3.0219,
            5.3219,
            3.166
          ]
        },
        {
          "block_id": "p30_line_35",
          "block_type": "paragraph",
          "text": "N12",
          "bbox": [
            1.7411,
            3.2306,
            2.0253,
            3.376
          ]
        },
        {
          "block_id": "p30_line_36",
          "block_type": "paragraph",
          "text": "N22",
          "bbox": [
            2.4435,
            3.2325,
            2.7275,
            3.3771
          ]
        },
        {
          "block_id": "p30_line_37",
          "block_type": "paragraph",
          "text": "N32",
          "bbox": [
            3.0824,
            3.2332,
            3.3698,
            3.3775
          ]
        },
        {
          "block_id": "p30_line_38",
          "block_type": "paragraph",
          "text": "N52",
          "bbox": [
            4.37,
            3.2346,
            4.6534,
            3.3768
          ]
        },
        {
          "block_id": "p30_line_39",
          "block_type": "paragraph",
          "text": "N13",
          "bbox": [
            1.7412,
            3.4376,
            2.0247,
            3.5849
          ]
        },
        {
          "block_id": "p30_line_40",
          "block_type": "paragraph",
          "text": "N33",
          "bbox": [
            3.0843,
            3.4389,
            3.3683,
            3.584
          ]
        },
        {
          "block_id": "p30_line_41",
          "block_type": "paragraph",
          "text": "N53",
          "bbox": [
            4.3726,
            3.4377,
            4.6545,
            3.5851
          ]
        },
        {
          "block_id": "p30_line_42",
          "block_type": "paragraph",
          "text": "N14",
          "bbox": [
            1.7427,
            3.6506,
            2.0264,
            3.7933
          ]
        },
        {
          "block_id": "p30_line_43",
          "block_type": "paragraph",
          "text": "N15",
          "bbox": [
            1.7419,
            3.8532,
            2.0234,
            4.0016
          ]
        },
        {
          "block_id": "p30_line_44",
          "block_type": "paragraph",
          "text": "N16",
          "bbox": [
            1.7426,
            4.0597,
            2.0286,
            4.2062
          ]
        },
        {
          "block_id": "p30_line_45",
          "block_type": "paragraph",
          "text": "Event 2",
          "bbox": [
            0.6497,
            4.3545,
            1.1639,
            4.5058
          ]
        },
        {
          "block_id": "p30_line_46",
          "block_type": "paragraph",
          "text": "*NR = not related; related could be expanded, e.g., as definite, probable, possible",
          "bbox": [
            0.5872,
            4.7546,
            6.2047,
            4.9484
          ]
        },
        {
          "block_id": "p30_line_47",
          "block_type": "paragraph",
          "text": "** Patient identification number",
          "bbox": [
            0.5842,
            4.9326,
            2.8307,
            5.122
          ]
        },
        {
          "block_id": "p30_line_48",
          "block_type": "paragraph",
          "text": "In addition to these complete tables provided in 14.3.1, an additional summary table",
          "bbox": [
            0.9677,
            5.2474,
            7.0901,
            5.4377
          ]
        },
        {
          "block_id": "p30_line_49",
          "block_type": "paragraph",
          "text": "comparing treatment and control groups, without the patient identifying numbers",
          "bbox": [
            0.971,
            5.433,
            7.0905,
            5.6245
          ]
        },
        {
          "block_id": "p30_line_50",
          "block_type": "paragraph",
          "text": "limited to relatively common adverse events (e.g., those in at least 1% of the treated",
          "bbox": [
            0.9687,
            5.6134,
            7.0932,
            5.8036
          ]
        },
        {
          "block_id": "p30_line_51",
          "block_type": "paragraph",
          "text": "group), should be provided in the body of the report.",
          "bbox": [
            0.9685,
            5.8017,
            4.6478,
            5.9996
          ]
        },
        {
          "block_id": "p30_line_52",
          "block_type": "paragraph",
          "text": "In presenting adverse events, it is important both to display the original terms used",
          "bbox": [
            0.9675,
            6.1048,
            7.0952,
            6.304
          ]
        },
        {
          "block_id": "p30_line_53",
          "block_type": "paragraph",
          "text": "by the investigator and to attempt to group related events (i.e., events that probably",
          "bbox": [
            0.9652,
            6.292,
            7.0918,
            6.4868
          ]
        },
        {
          "block_id": "p30_line_54",
          "block_type": "paragraph",
          "text": "represent the same phenomena) so that the true occurrence rate is not obscured. One",
          "bbox": [
            0.9678,
            6.4758,
            7.0931,
            6.667
          ]
        },
        {
          "block_id": "p30_line_55",
          "block_type": "paragraph",
          "text": "way to do this is with a standard adverse reaction/events dictionary.",
          "bbox": [
            0.9725,
            6.662,
            5.805,
            6.8486
          ]
        },
        {
          "block_id": "p30_line_56",
          "block_type": "paragraph",
          "text": "12.2.3 Analysis of Adverse Events",
          "bbox": [
            0.9776,
            7.0525,
            3.6295,
            7.2346
          ]
        },
        {
          "block_id": "p30_line_57",
          "block_type": "paragraph",
          "text": "The basic display of adverse event rates described in section 12.2.2 (and located in",
          "bbox": [
            0.9697,
            7.2728,
            7.0908,
            7.4615
          ]
        },
        {
          "block_id": "p30_line_58",
          "block_type": "paragraph",
          "text": "section 14.3.1) of the report, should be used to compare rates in treatment and control",
          "bbox": [
            0.9709,
            7.4587,
            7.0963,
            7.6459
          ]
        },
        {
          "block_id": "p30_line_59",
          "block_type": "paragraph",
          "text": "groups. For this analysis it may be helpful to combine the event severity categories",
          "bbox": [
            0.972,
            7.6419,
            7.0933,
            7.8325
          ]
        },
        {
          "block_id": "p30_line_60",
          "block_type": "paragraph",
          "text": "and the causality categories, leading to a simpler side-by-side comparison of",
          "bbox": [
            0.9723,
            7.8242,
            7.1031,
            8.016
          ]
        },
        {
          "block_id": "p30_line_61",
          "block_type": "paragraph",
          "text": "treatment groups. In addition, although this is usually best done in an integrated",
          "bbox": [
            0.9712,
            8.0063,
            7.0969,
            8.1969
          ]
        },
        {
          "block_id": "p30_line_62",
          "block_type": "paragraph",
          "text": "analysis of safety, if study size and design permit, it may be useful to examine the",
          "bbox": [
            0.9728,
            8.1887,
            7.0937,
            8.3812
          ]
        },
        {
          "block_id": "p30_line_63",
          "block_type": "paragraph",
          "text": "more common adverse events that seem to be drug related for relationship to dosage",
          "bbox": [
            0.9714,
            8.3747,
            7.0933,
            8.5597
          ]
        },
        {
          "block_id": "p30_line_64",
          "block_type": "paragraph",
          "text": "and to mg/kg or mg/m2 dose, to dose regimen, to duration of treatment, to total dose,",
          "bbox": [
            0.9724,
            8.5655,
            7.0815,
            8.7479
          ]
        },
        {
          "block_id": "p30_line_65",
          "block_type": "paragraph",
          "text": "to demographic characteristics such as age, sex, race, to other baseline features such",
          "bbox": [
            0.9709,
            8.7454,
            7.0886,
            8.9307
          ]
        },
        {
          "block_id": "p30_line_66",
          "block_type": "paragraph",
          "text": "as renal status, to efficacy outcomes, and to drug concentration. It may also be useful",
          "bbox": [
            0.9739,
            8.9282,
            7.0947,
            9.1134
          ]
        },
        {
          "block_id": "p30_line_67",
          "block_type": "paragraph",
          "text": "to examine time of onset and duration of adverse events. A variety of additional",
          "bbox": [
            0.9712,
            9.1078,
            7.0941,
            9.2905
          ]
        },
        {
          "block_id": "p30_line_68",
          "block_type": "paragraph",
          "text": "analyses may be suggested by the study results or by the pharmacology of the test",
          "bbox": [
            0.9723,
            9.2929,
            7.0942,
            9.4844
          ]
        },
        {
          "block_id": "p30_line_69",
          "block_type": "paragraph",
          "text": "drug/investigational product.",
          "bbox": [
            0.9729,
            9.4817,
            3.036,
            9.658
          ]
        },
        {
          "block_id": "p30_line_70",
          "block_type": "paragraph",
          "text": "It is not intended that every adverse event be subjected to rigorous statistical",
          "bbox": [
            0.9682,
            9.7845,
            7.0946,
            9.9666
          ]
        },
        {
          "block_id": "p30_line_71",
          "block_type": "paragraph",
          "text": "evaluation. It may be apparent from initial display and inspection of the data that a",
          "bbox": [
            0.9725,
            9.9697,
            7.09,
            10.1492
          ]
        },
        {
          "block_id": "p30_line_72",
          "block_type": "paragraph",
          "text": "significant relation to demographic or other baseline features is not present. If the",
          "bbox": [
            0.971,
            10.1528,
            7.0935,
            10.3295
          ]
        },
        {
          "block_id": "p30_line_73",
          "block_type": "paragraph",
          "text": "studies are small and if the number of events is relatively small, it may be sufficient",
          "bbox": [
            0.9709,
            10.3336,
            7.0917,
            10.5124
          ]
        },
        {
          "block_id": "p30_line_74",
          "block_type": "paragraph",
          "text": "to limit analyses to a comparison of treatment and control.",
          "bbox": [
            0.9716,
            10.5248,
            5.1215,
            10.7006
          ]
        },
        {
          "block_id": "p30_line_75",
          "block_type": "paragraph",
          "text": "22",
          "bbox": [
            3.9385,
            10.9465,
            4.1203,
            11.0845
          ]
        },
        {
          "block_id": "table_4",
          "block_type": "table",
          "page_number": 30,
          "bbox": [
            0.5637,
            1.912,
            7.6965,
            4.6615
          ],
          "headers": [
            "",
            "Mild",
            "",
            "Moderate",
            "",
            "Severe",
            "",
            "Total",
            "",
            "Total"
          ],
          "rows": [
            [
              "",
              "Related*",
              "NR*",
              "Related",
              "NR",
              "Related",
              "NR",
              "Related",
              "NR",
              "R+NR"
            ],
            [
              "Body System A Event 1",
              "",
              "",
              "",
              "",
              "",
              "",
              "",
              "",
              ""
            ],
            [
              "",
              "6 (12%)",
              "2 (4%)",
              "3 (6%)",
              "1 (2%)",
              "3 (6%)",
              "1 (2%)",
              "12 (24%)",
              "4 (8%)",
              ""
            ],
            [
              "",
              "N11 **",
              "N21",
              "N31",
              "N41",
              "N51",
              "N61",
              "",
              "",
              ""
            ],
            [
              "",
              "N12",
              "N22",
              "N32",
              "",
              "N52",
              "",
              "",
              "",
              ""
            ],
            [
              "",
              "N13",
              "",
              "N33",
              "",
              "N53",
              "",
              "",
              "",
              ""
            ],
            [
              "",
              "N14",
              "",
              "",
              "",
              "",
              "",
              "",
              "",
              ""
            ],
            [
              "",
              "N15",
              "",
              "",
              "",
              "",
              "",
              "",
              "",
              ""
            ],
            [
              "",
              "N16",
              "",
              "",
              "",
              "",
              "",
              "",
              "",
              ""
            ],
            [
              "Event 2",
              "",
              "",
              "",
              "",
              "",
              "",
              "",
              "",
              ""
            ]
          ]
        }
      ]
    },
    {
      "page_number": 31,
      "width": 8.2639,
      "height": 11.6944,
      "unit": "inch",
      "blocks": [
        {
          "block_id": "p31_line_0",
          "block_type": "paragraph",
          "text": "Structure and Content of Clinical Study Reports",
          "bbox": [
            4.1844,
            0.7138,
            7.2866,
            0.8877
          ]
        },
        {
          "block_id": "p31_line_1",
          "block_type": "paragraph",
          "text": "Under certain circumstances, life table or similar analyses may be more informative",
          "bbox": [
            1.1706,
            1.047,
            7.2863,
            1.2267
          ]
        },
        {
          "block_id": "p31_line_2",
          "block_type": "paragraph",
          "text": "than reporting of crude adverse event rates. When treatments are cyclical, e.g.,",
          "bbox": [
            1.1674,
            1.2277,
            7.2813,
            1.4236
          ]
        },
        {
          "block_id": "p31_line_3",
          "block_type": "paragraph",
          "text": "cancer chemotherapy, it may also be helpful to analyse results separately for each",
          "bbox": [
            1.1704,
            1.4218,
            7.2869,
            1.6083
          ]
        },
        {
          "block_id": "p31_line_4",
          "block_type": "paragraph",
          "text": "cycle.",
          "bbox": [
            1.1673,
            1.6133,
            1.5633,
            1.7799
          ]
        },
        {
          "block_id": "p31_line_5",
          "block_type": "paragraph",
          "text": "12.2.4 Listing of Adverse Events by Patient",
          "bbox": [
            1.1734,
            1.9871,
            4.5892,
            2.1733
          ]
        },
        {
          "block_id": "p31_line_6",
          "block_type": "paragraph",
          "text": "All adverse events for each patient, including the same event on several occasions",
          "bbox": [
            1.1665,
            2.2167,
            7.2873,
            2.4011
          ]
        },
        {
          "block_id": "p31_line_7",
          "block_type": "paragraph",
          "text": "should be listed in appendix 16.2.7, giving both preferred term and the original term",
          "bbox": [
            1.1684,
            2.4014,
            7.2867,
            2.5866
          ]
        },
        {
          "block_id": "p31_line_8",
          "block_type": "paragraph",
          "text": "used by the investigator. The listing should be by investigator and by treatment",
          "bbox": [
            1.1667,
            2.5823,
            7.2902,
            2.7693
          ]
        },
        {
          "block_id": "p31_line_9",
          "block_type": "paragraph",
          "text": "group and should include:",
          "bbox": [
            1.1671,
            2.7664,
            3.0128,
            2.9571
          ]
        },
        {
          "block_id": "p31_line_10",
          "block_type": "paragraph",
          "text": "- Patient identifier",
          "bbox": [
            1.5689,
            3.003,
            3.0034,
            3.1616
          ]
        },
        {
          "block_id": "p31_line_11",
          "block_type": "paragraph",
          "text": "- Age, race, sex, weight (height, if relevant)",
          "bbox": [
            1.5665,
            3.2282,
            4.7096,
            3.411
          ]
        },
        {
          "block_id": "p31_line_12",
          "block_type": "paragraph",
          "text": "- Location of CRFs, if provided",
          "bbox": [
            1.5685,
            3.4547,
            3.8363,
            3.6307
          ]
        },
        {
          "block_id": "p31_line_13",
          "block_type": "paragraph",
          "text": "- The adverse event (preferred term, reported term)",
          "bbox": [
            1.5671,
            3.6831,
            5.3095,
            3.8653
          ]
        },
        {
          "block_id": "p31_line_14",
          "block_type": "paragraph",
          "text": "- Duration of the adverse event",
          "bbox": [
            1.5678,
            3.9173,
            3.8805,
            4.0798
          ]
        },
        {
          "block_id": "p31_line_15",
          "block_type": "paragraph",
          "text": "- Severity (e.g., mild, moderate, severe)",
          "bbox": [
            1.5692,
            4.1426,
            4.4347,
            4.3212
          ]
        },
        {
          "block_id": "p31_line_16",
          "block_type": "paragraph",
          "text": "- Seriousness (serious/non-serious)",
          "bbox": [
            1.5718,
            4.372,
            4.1198,
            4.5452
          ]
        },
        {
          "block_id": "p31_line_17",
          "block_type": "paragraph",
          "text": "- Action taken (none, dose reduced, treatment stopped, specific treatment",
          "bbox": [
            1.5715,
            4.5977,
            7.2912,
            4.7783
          ]
        },
        {
          "block_id": "p31_line_18",
          "block_type": "paragraph",
          "text": "instituted etc.)",
          "bbox": [
            1.7516,
            4.7795,
            2.8079,
            4.9555
          ]
        },
        {
          "block_id": "p31_line_19",
          "block_type": "paragraph",
          "text": "- Outcome (e.g., CIOMS format)",
          "bbox": [
            1.5692,
            5.0089,
            3.9187,
            5.1848
          ]
        },
        {
          "block_id": "p31_line_20",
          "block_type": "paragraph",
          "text": "- Causality assessment (e.g., related/not related). How this was determined",
          "bbox": [
            1.5742,
            5.2327,
            7.2938,
            5.4132
          ]
        },
        {
          "block_id": "p31_line_21",
          "block_type": "paragraph",
          "text": "should be described in the table or elsewhere",
          "bbox": [
            1.7584,
            5.4157,
            4.9473,
            5.5934
          ]
        },
        {
          "block_id": "p31_line_22",
          "block_type": "paragraph",
          "text": "- Date of onset or date of clinic visit at which the event was discovered",
          "bbox": [
            1.5695,
            5.6468,
            6.6379,
            5.8192
          ]
        },
        {
          "block_id": "p31_line_23",
          "block_type": "paragraph",
          "text": "- Timing of onset of the adverse event in relation to last dose of test",
          "bbox": [
            1.5719,
            5.8736,
            7.2917,
            6.0525
          ]
        },
        {
          "block_id": "p31_line_24",
          "block_type": "paragraph",
          "text": "drug/investigational product (when applicable)",
          "bbox": [
            1.7592,
            6.0559,
            5.0683,
            6.2481
          ]
        },
        {
          "block_id": "p31_line_25",
          "block_type": "paragraph",
          "text": "- Study treatment at time of event or most recent study treatment taken",
          "bbox": [
            1.5703,
            6.2945,
            6.792,
            6.4619
          ]
        },
        {
          "block_id": "p31_line_26",
          "block_type": "paragraph",
          "text": "- Test drug/investigational product dose in absolute amount, mg/kg or mg/m2 at",
          "bbox": [
            1.5744,
            6.5163,
            7.2915,
            6.6976
          ]
        },
        {
          "block_id": "p31_line_27",
          "block_type": "paragraph",
          "text": "time of event",
          "bbox": [
            1.7556,
            6.7018,
            2.6986,
            6.8684
          ]
        },
        {
          "block_id": "p31_line_28",
          "block_type": "paragraph",
          "text": "- Drug concentration (if known)",
          "bbox": [
            1.5661,
            6.9325,
            3.898,
            7.106
          ]
        },
        {
          "block_id": "p31_line_29",
          "block_type": "paragraph",
          "text": "- Duration of test drug/investigational product treatment",
          "bbox": [
            1.569,
            7.1583,
            5.7064,
            7.3334
          ]
        },
        {
          "block_id": "p31_line_30",
          "block_type": "paragraph",
          "text": "- Concomitant treatment during study.",
          "bbox": [
            1.5687,
            7.3855,
            4.4228,
            7.5632
          ]
        },
        {
          "block_id": "p31_line_31",
          "block_type": "paragraph",
          "text": "Any abbreviations and codes should be clearly explained at the beginning of the",
          "bbox": [
            1.1648,
            7.6058,
            7.2873,
            7.7944
          ]
        },
        {
          "block_id": "p31_line_32",
          "block_type": "paragraph",
          "text": "listing or, preferably, on each page.",
          "bbox": [
            1.1602,
            7.7944,
            3.6615,
            7.9842
          ]
        },
        {
          "block_id": "p31_line_33",
          "block_type": "paragraph",
          "text": "12.3 DEATHS, OTHER SERIOUS ADVERSE EVENTS, AND OTHER",
          "bbox": [
            1.1801,
            8.1777,
            6.591,
            8.3602
          ]
        },
        {
          "block_id": "p31_line_34",
          "block_type": "paragraph",
          "text": "SIGNIFICANT ADVERSE EVENTS",
          "bbox": [
            1.663,
            8.3646,
            4.4114,
            8.5357
          ]
        },
        {
          "block_id": "p31_line_35",
          "block_type": "paragraph",
          "text": "Deaths, other serious adverse events, and other significant adverse events deserve",
          "bbox": [
            1.1608,
            8.5914,
            7.288,
            8.7724
          ]
        },
        {
          "block_id": "p31_line_36",
          "block_type": "paragraph",
          "text": "special attention.",
          "bbox": [
            1.164,
            8.7836,
            2.3997,
            8.9574
          ]
        },
        {
          "block_id": "p31_line_37",
          "block_type": "paragraph",
          "text": "12.3.1 Listing of Deaths, other Serious Adverse Events and Other Significant",
          "bbox": [
            1.177,
            9.1673,
            7.2454,
            9.3476
          ]
        },
        {
          "block_id": "p31_line_38",
          "block_type": "paragraph",
          "text": "Adverse Events",
          "bbox": [
            1.6614,
            9.3556,
            2.9119,
            9.5193
          ]
        },
        {
          "block_id": "p31_line_39",
          "block_type": "paragraph",
          "text": "Listings, containing the same information as called for in section 12.2.4 above, should",
          "bbox": [
            1.1602,
            9.5707,
            7.2905,
            9.753
          ]
        },
        {
          "block_id": "p31_line_40",
          "block_type": "paragraph",
          "text": "be provided for the following events.",
          "bbox": [
            1.1615,
            9.7587,
            3.7351,
            9.9387
          ]
        },
        {
          "block_id": "p31_line_41",
          "block_type": "paragraph",
          "text": "12.3.1.1",
          "bbox": [
            1.1815,
            10.1634,
            1.7439,
            10.3069
          ]
        },
        {
          "block_id": "p31_line_42",
          "block_type": "paragraph",
          "text": "Deaths",
          "bbox": [
            1.949,
            10.1584,
            2.5239,
            10.3103
          ]
        },
        {
          "block_id": "p31_line_43",
          "block_type": "paragraph",
          "text": "23",
          "bbox": [
            4.1377,
            10.9463,
            4.3171,
            11.0839
          ]
        }
      ]
    },
    {
      "page_number": 32,
      "width": 8.2639,
      "height": 11.6944,
      "unit": "inch",
      "blocks": [
        {
          "block_id": "p32_line_0",
          "block_type": "paragraph",
          "text": "Structure and Content of Clinical Study Reports",
          "bbox": [
            0.9735,
            0.7138,
            4.0779,
            0.8863
          ]
        },
        {
          "block_id": "p32_line_1",
          "block_type": "paragraph",
          "text": "All deaths during the study, including the post treatment follow-up period, and deaths",
          "bbox": [
            0.9734,
            1.0467,
            7.0862,
            1.231
          ]
        },
        {
          "block_id": "p32_line_2",
          "block_type": "paragraph",
          "text": "that resulted from a process that began during the study, should be listed by patient",
          "bbox": [
            0.9724,
            1.2332,
            7.0883,
            1.4157
          ]
        },
        {
          "block_id": "p32_line_3",
          "block_type": "paragraph",
          "text": "in section 14.3.2.",
          "bbox": [
            0.965,
            1.4256,
            2.1664,
            1.5866
          ]
        },
        {
          "block_id": "p32_line_4",
          "block_type": "paragraph",
          "text": "12.3.1.2 Other Serious Adverse Events",
          "bbox": [
            0.9793,
            1.8076,
            4.1556,
            1.9799
          ]
        },
        {
          "block_id": "p32_line_5",
          "block_type": "paragraph",
          "text": "All serious adverse events (other than death but including the serious adverse events",
          "bbox": [
            0.9724,
            2.0329,
            7.0911,
            2.2151
          ]
        },
        {
          "block_id": "p32_line_6",
          "block_type": "paragraph",
          "text": "temporally associated with or preceding the deaths) should be listed in section 14.3.2.",
          "bbox": [
            0.9677,
            2.2155,
            7.077,
            2.4027
          ]
        },
        {
          "block_id": "p32_line_7",
          "block_type": "paragraph",
          "text": "The listing should include laboratory abnormalities, abnormal vital signs and",
          "bbox": [
            0.9703,
            2.4009,
            7.098,
            2.5826
          ]
        },
        {
          "block_id": "p32_line_8",
          "block_type": "paragraph",
          "text": "abnormal physical observations that were considered serious adverse events.",
          "bbox": [
            0.973,
            2.585,
            6.4134,
            2.7677
          ]
        },
        {
          "block_id": "p32_line_9",
          "block_type": "paragraph",
          "text": "12.3.1.3 Other Significant Adverse Events",
          "bbox": [
            0.9792,
            2.9721,
            4.4306,
            3.1634
          ]
        },
        {
          "block_id": "p32_line_10",
          "block_type": "paragraph",
          "text": "Marked haematological and other laboratory abnormalities (other than those meeting",
          "bbox": [
            0.9634,
            3.192,
            7.0941,
            3.3887
          ]
        },
        {
          "block_id": "p32_line_11",
          "block_type": "paragraph",
          "text": "the definition of serious) and any events that led to an intervention, including",
          "bbox": [
            0.9695,
            3.3804,
            7.0935,
            3.5728
          ]
        },
        {
          "block_id": "p32_line_12",
          "block_type": "paragraph",
          "text": "withdrawal of test drug/investigational product treatment, dose reduction, or",
          "bbox": [
            0.9723,
            3.5655,
            7.092,
            3.7507
          ]
        },
        {
          "block_id": "p32_line_13",
          "block_type": "paragraph",
          "text": "significant additional concomitant therapy, other than those reported as serious",
          "bbox": [
            0.971,
            3.7488,
            7.0922,
            3.9367
          ]
        },
        {
          "block_id": "p32_line_14",
          "block_type": "paragraph",
          "text": "adverse events, should be listed in section 14.3.2.",
          "bbox": [
            0.9735,
            3.9302,
            4.4514,
            4.1107
          ]
        },
        {
          "block_id": "p32_line_15",
          "block_type": "paragraph",
          "text": "12.3.2 Narratives of Deaths, Other Serious Adverse Events and Certain",
          "bbox": [
            0.9772,
            4.3198,
            6.595,
            4.5047
          ]
        },
        {
          "block_id": "p32_line_16",
          "block_type": "paragraph",
          "text": "Other Significant Adverse Events",
          "bbox": [
            1.4695,
            4.5066,
            4.1423,
            4.6904
          ]
        },
        {
          "block_id": "p32_line_17",
          "block_type": "paragraph",
          "text": "There should be brief narratives describing each death, each other serious adverse",
          "bbox": [
            0.9685,
            4.7256,
            7.0911,
            4.9142
          ]
        },
        {
          "block_id": "p32_line_18",
          "block_type": "paragraph",
          "text": "event, and those of the other significant adverse events that are judged to be of special",
          "bbox": [
            0.9729,
            4.9177,
            7.092,
            5.1089
          ]
        },
        {
          "block_id": "p32_line_19",
          "block_type": "paragraph",
          "text": "interest because of clinical importance. These narratives can be placed either in the",
          "bbox": [
            0.9666,
            5.0979,
            7.0906,
            5.2876
          ]
        },
        {
          "block_id": "p32_line_20",
          "block_type": "paragraph",
          "text": "text of the report or in section 14.3.3, depending on their number. Events that were",
          "bbox": [
            0.9705,
            5.2835,
            7.0905,
            5.4704
          ]
        },
        {
          "block_id": "p32_line_21",
          "block_type": "paragraph",
          "text": "clearly unrelated to the test drug/investigational product may be omitted or described",
          "bbox": [
            0.9723,
            5.4646,
            7.0938,
            5.6544
          ]
        },
        {
          "block_id": "p32_line_22",
          "block_type": "paragraph",
          "text": "very briefly. In general, the narrative should describe the following:",
          "bbox": [
            0.971,
            5.6502,
            5.8062,
            5.8376
          ]
        },
        {
          "block_id": "p32_line_23",
          "block_type": "paragraph",
          "text": "the nature and intensity of event, the clinical course leading up to event, with an",
          "bbox": [
            1.3638,
            5.8707,
            7.0916,
            6.0567
          ]
        },
        {
          "block_id": "p32_line_24",
          "block_type": "paragraph",
          "text": "indication of timing relevant to test drug/investigational product administration;",
          "bbox": [
            1.3623,
            6.0535,
            7.0885,
            6.246
          ]
        },
        {
          "block_id": "p32_line_25",
          "block_type": "paragraph",
          "text": "relevant laboratory measurements, whether the drug was stopped, and when;",
          "bbox": [
            1.3626,
            6.2465,
            7.0881,
            6.4316
          ]
        },
        {
          "block_id": "p32_line_26",
          "block_type": "paragraph",
          "text": "countermeasures; post mortem findings; investigator's opinion on causality, and",
          "bbox": [
            1.3662,
            6.4297,
            7.0938,
            6.6181
          ]
        },
        {
          "block_id": "p32_line_27",
          "block_type": "paragraph",
          "text": "sponsor's opinion on causality, if appropriate.",
          "bbox": [
            1.3654,
            6.6173,
            4.5809,
            6.7981
          ]
        },
        {
          "block_id": "p32_line_28",
          "block_type": "paragraph",
          "text": "In addition, the following information should be included:",
          "bbox": [
            0.968,
            6.9135,
            5.0485,
            7.0988
          ]
        },
        {
          "block_id": "p32_line_29",
          "block_type": "paragraph",
          "text": "- Patient identifier",
          "bbox": [
            1.3682,
            7.1529,
            2.8072,
            7.3133
          ]
        },
        {
          "block_id": "p32_line_30",
          "block_type": "paragraph",
          "text": "- Age and sex of patient; general clinical condition of patient, if appropriate",
          "bbox": [
            1.3688,
            7.3781,
            6.7843,
            7.5594
          ]
        },
        {
          "block_id": "p32_line_31",
          "block_type": "paragraph",
          "text": "- Disease being treated (if the same for all patients this is not required) with",
          "bbox": [
            1.3723,
            7.6036,
            7.0878,
            7.7874
          ]
        },
        {
          "block_id": "p32_line_32",
          "block_type": "paragraph",
          "text": "duration (of current episode) of illness",
          "bbox": [
            1.5657,
            7.7868,
            4.2646,
            7.9692
          ]
        },
        {
          "block_id": "p32_line_33",
          "block_type": "paragraph",
          "text": "- Relevant concomitant/previous illnesses with details of occurrence/duration",
          "bbox": [
            1.371,
            8.0201,
            6.9085,
            8.1904
          ]
        },
        {
          "block_id": "p32_line_34",
          "block_type": "paragraph",
          "text": "- Relevant concomitant/previous medication with details of dosage",
          "bbox": [
            1.3734,
            8.2473,
            6.1552,
            8.421
          ]
        },
        {
          "block_id": "p32_line_35",
          "block_type": "paragraph",
          "text": "- Test drug/investigational product administered, drug dose, if this varied",
          "bbox": [
            1.3714,
            8.4703,
            7.0928,
            8.6566
          ]
        },
        {
          "block_id": "p32_line_36",
          "block_type": "paragraph",
          "text": "among patients, and length of time administered.",
          "bbox": [
            1.5592,
            8.6566,
            5.0689,
            8.8418
          ]
        },
        {
          "block_id": "p32_line_37",
          "block_type": "paragraph",
          "text": "12.3.3 Analysis and Discussion of Deaths, Other Serious Adverse Events and",
          "bbox": [
            0.9784,
            9.0428,
            7.0054,
            9.2265
          ]
        },
        {
          "block_id": "p32_line_38",
          "block_type": "paragraph",
          "text": "Other Significant Adverse Events",
          "bbox": [
            1.4727,
            9.2304,
            4.1425,
            9.406
          ]
        },
        {
          "block_id": "p32_line_39",
          "block_type": "paragraph",
          "text": "The significance of the deaths, other serious adverse events and other significant",
          "bbox": [
            0.9701,
            9.4506,
            7.0901,
            9.6328
          ]
        },
        {
          "block_id": "p32_line_40",
          "block_type": "paragraph",
          "text": "adverse events leading to withdrawal, dose reduction or institution of concomitant",
          "bbox": [
            0.9755,
            9.6388,
            7.0902,
            9.8142
          ]
        },
        {
          "block_id": "p32_line_41",
          "block_type": "paragraph",
          "text": "therapy should be assessed with respect to the safety of the test drug/investigational",
          "bbox": [
            0.9735,
            9.82,
            7.092,
            10.0003
          ]
        },
        {
          "block_id": "p32_line_42",
          "block_type": "paragraph",
          "text": "product. Particular attention should be paid to whether any of these events may",
          "bbox": [
            0.97,
            10.0042,
            7.0902,
            10.186
          ]
        },
        {
          "block_id": "p32_line_43",
          "block_type": "paragraph",
          "text": "represent a previously unsuspected important adverse effect of the test",
          "bbox": [
            0.9679,
            10.187,
            7.0926,
            10.3724
          ]
        },
        {
          "block_id": "p32_line_44",
          "block_type": "paragraph",
          "text": "drug/investigational product. For serious adverse events that appear of particular",
          "bbox": [
            0.9729,
            10.3758,
            7.0884,
            10.5538
          ]
        },
        {
          "block_id": "p32_line_45",
          "block_type": "paragraph",
          "text": "24",
          "bbox": [
            3.9353,
            10.9474,
            4.1234,
            11.0868
          ]
        }
      ]
    },
    {
      "page_number": 33,
      "width": 8.2639,
      "height": 11.6944,
      "unit": "inch",
      "blocks": [
        {
          "block_id": "p33_line_0",
          "block_type": "paragraph",
          "text": "Structure and Content of Clinical Study Reports",
          "bbox": [
            4.1865,
            0.7138,
            7.2867,
            0.8869
          ]
        },
        {
          "block_id": "p33_line_1",
          "block_type": "paragraph",
          "text": "importance, it may be useful to use life table or similar analyses to show their relation",
          "bbox": [
            1.1637,
            1.045,
            7.2866,
            1.2316
          ]
        },
        {
          "block_id": "p33_line_2",
          "block_type": "paragraph",
          "text": "to time on test drug/investigational product and to assess their risk over time.",
          "bbox": [
            1.167,
            1.2341,
            6.6785,
            1.4117
          ]
        },
        {
          "block_id": "p33_line_3",
          "block_type": "paragraph",
          "text": "12.4 CLINICAL LABORATORY EVALUATION",
          "bbox": [
            1.1767,
            1.6194,
            4.9206,
            1.793
          ]
        },
        {
          "block_id": "p33_line_4",
          "block_type": "paragraph",
          "text": "12.4.1 Listing of Individual Laboratory Measurements by Patient (16.2.8) and",
          "bbox": [
            1.1762,
            1.931,
            7.2763,
            2.116
          ]
        },
        {
          "block_id": "p33_line_5",
          "block_type": "paragraph",
          "text": "Each Abnormal Laboratory Value (14.3.4)",
          "bbox": [
            1.6684,
            2.1124,
            4.9472,
            2.299
          ]
        },
        {
          "block_id": "p33_line_6",
          "block_type": "paragraph",
          "text": "When required by regulatory authorities, the results of all safety-related laboratory",
          "bbox": [
            1.1707,
            2.3412,
            7.286,
            2.5301
          ]
        },
        {
          "block_id": "p33_line_7",
          "block_type": "paragraph",
          "text": "tests should be available in tabular listings, using a display similar to the following,",
          "bbox": [
            1.1677,
            2.5248,
            7.2738,
            2.7153
          ]
        },
        {
          "block_id": "p33_line_8",
          "block_type": "paragraph",
          "text": "where each row represents a patient visit at which a laboratory study was done, with",
          "bbox": [
            1.1704,
            2.7137,
            7.2876,
            2.8919
          ]
        },
        {
          "block_id": "p33_line_9",
          "block_type": "paragraph",
          "text": "patients grouped by investigator (if more than one) and treatment group, and columns",
          "bbox": [
            1.1658,
            2.8951,
            7.2884,
            3.0822
          ]
        },
        {
          "block_id": "p33_line_10",
          "block_type": "paragraph",
          "text": "include critical demographic data, drug dose data, and the results of the laboratory",
          "bbox": [
            1.1636,
            3.0762,
            7.2875,
            3.2589
          ]
        },
        {
          "block_id": "p33_line_11",
          "block_type": "paragraph",
          "text": "tests. As not all tests can be displayed in a single table, they should be grouped",
          "bbox": [
            1.1689,
            3.2583,
            7.2927,
            3.4452
          ]
        },
        {
          "block_id": "p33_line_12",
          "block_type": "paragraph",
          "text": "logically (haematological tests, liver chemistries, electrolytes, urinalysis etc.).",
          "bbox": [
            1.1634,
            3.4388,
            7.2785,
            3.6299
          ]
        },
        {
          "block_id": "p33_line_13",
          "block_type": "paragraph",
          "text": "Abnormal values should be identified, e.g., by underlining, bracketing etc. These",
          "bbox": [
            1.1697,
            3.6191,
            7.2882,
            3.8113
          ]
        },
        {
          "block_id": "p33_line_14",
          "block_type": "paragraph",
          "text": "listings should be submitted as part of the registration/marketing application, when",
          "bbox": [
            1.163,
            3.8055,
            7.2885,
            3.9942
          ]
        },
        {
          "block_id": "p33_line_15",
          "block_type": "paragraph",
          "text": "this is required, or may be available on request.",
          "bbox": [
            1.1677,
            3.9971,
            4.5499,
            4.1808
          ]
        },
        {
          "block_id": "p33_line_16",
          "block_type": "paragraph",
          "text": "LIST OF LABORATORY MEASUREMENTS",
          "bbox": [
            2.7062,
            4.3483,
            5.7421,
            4.5258
          ]
        },
        {
          "block_id": "p33_line_17",
          "block_type": "paragraph",
          "text": "Laboratory Tests",
          "bbox": [
            5.88,
            4.6188,
            7.101,
            4.7931
          ]
        },
        {
          "block_id": "p33_line_18",
          "block_type": "paragraph",
          "text": "Patient",
          "bbox": [
            1.2976,
            4.9353,
            1.65,
            5.0661
          ]
        },
        {
          "block_id": "p33_line_19",
          "block_type": "paragraph",
          "text": "Time",
          "bbox": [
            1.8912,
            4.9368,
            2.1968,
            5.0686
          ]
        },
        {
          "block_id": "p33_line_20",
          "block_type": "paragraph",
          "text": "Age",
          "bbox": [
            2.4774,
            4.9422,
            2.7117,
            5.0808
          ]
        },
        {
          "block_id": "p33_line_21",
          "block_type": "paragraph",
          "text": "Sex",
          "bbox": [
            3.0695,
            4.9407,
            3.2911,
            5.0682
          ]
        },
        {
          "block_id": "p33_line_22",
          "block_type": "paragraph",
          "text": "Race",
          "bbox": [
            3.6572,
            4.9365,
            3.9504,
            5.0696
          ]
        },
        {
          "block_id": "p33_line_23",
          "block_type": "paragraph",
          "text": "Weight",
          "bbox": [
            4.2521,
            4.9313,
            4.6807,
            5.0804
          ]
        },
        {
          "block_id": "p33_line_24",
          "block_type": "paragraph",
          "text": "Dose",
          "bbox": [
            4.8344,
            4.9393,
            5.1342,
            5.0722
          ]
        },
        {
          "block_id": "p33_line_25",
          "block_type": "paragraph",
          "text": "SGOT",
          "bbox": [
            5.4312,
            4.9354,
            5.796,
            5.0668
          ]
        },
        {
          "block_id": "p33_line_26",
          "block_type": "paragraph",
          "text": "SGPT",
          "bbox": [
            6.0223,
            4.936,
            6.3745,
            5.0647
          ]
        },
        {
          "block_id": "p33_line_27",
          "block_type": "paragraph",
          "text": "AP",
          "bbox": [
            6.616,
            4.94,
            6.7918,
            5.0581
          ]
        },
        {
          "block_id": "p33_line_28",
          "block_type": "paragraph",
          "text": "X",
          "bbox": [
            7.1337,
            4.9401,
            7.2333,
            5.0553
          ]
        },
        {
          "block_id": "p33_line_29",
          "block_type": "paragraph",
          "text": "# 1",
          "bbox": [
            1.2907,
            5.2698,
            1.4788,
            5.3904
          ]
        },
        {
          "block_id": "p33_line_30",
          "block_type": "paragraph",
          "text": "T0",
          "bbox": [
            1.8904,
            5.265,
            2.0503,
            5.3904
          ]
        },
        {
          "block_id": "p33_line_31",
          "block_type": "paragraph",
          "text": "70",
          "bbox": [
            2.4869,
            5.2683,
            2.6251,
            5.388
          ]
        },
        {
          "block_id": "p33_line_32",
          "block_type": "paragraph",
          "text": "M",
          "bbox": [
            3.0673,
            5.2637,
            3.2027,
            5.3863
          ]
        },
        {
          "block_id": "p33_line_33",
          "block_type": "paragraph",
          "text": "W",
          "bbox": [
            3.6617,
            5.2601,
            3.7912,
            5.3841
          ]
        },
        {
          "block_id": "p33_line_34",
          "block_type": "paragraph",
          "text": "70 kg",
          "bbox": [
            4.2547,
            5.2591,
            4.5803,
            5.4085
          ]
        },
        {
          "block_id": "p33_line_35",
          "block_type": "paragraph",
          "text": "400mg",
          "bbox": [
            4.843,
            5.2668,
            5.2403,
            5.4074
          ]
        },
        {
          "block_id": "p33_line_36",
          "block_type": "paragraph",
          "text": "V1*",
          "bbox": [
            5.4293,
            5.2615,
            5.6584,
            5.387
          ]
        },
        {
          "block_id": "p33_line_37",
          "block_type": "paragraph",
          "text": "V5",
          "bbox": [
            6.0216,
            5.2636,
            6.189,
            5.3886
          ]
        },
        {
          "block_id": "p33_line_38",
          "block_type": "paragraph",
          "text": "V9",
          "bbox": [
            6.6135,
            5.2639,
            6.7786,
            5.3854
          ]
        },
        {
          "block_id": "p33_line_39",
          "block_type": "paragraph",
          "text": "T1",
          "bbox": [
            1.8912,
            5.4577,
            2.0459,
            5.5819
          ]
        },
        {
          "block_id": "p33_line_40",
          "block_type": "paragraph",
          "text": "V2",
          "bbox": [
            5.4278,
            5.4551,
            5.6021,
            5.5814
          ]
        },
        {
          "block_id": "p33_line_41",
          "block_type": "paragraph",
          "text": "V6",
          "bbox": [
            6.0194,
            5.4548,
            6.1908,
            5.5833
          ]
        },
        {
          "block_id": "p33_line_42",
          "block_type": "paragraph",
          "text": "V10",
          "bbox": [
            6.611,
            5.4557,
            6.8499,
            5.5864
          ]
        },
        {
          "block_id": "p33_line_43",
          "block_type": "paragraph",
          "text": "T2",
          "bbox": [
            1.8925,
            5.6462,
            2.0516,
            5.7718
          ]
        },
        {
          "block_id": "p33_line_44",
          "block_type": "paragraph",
          "text": "V3",
          "bbox": [
            5.428,
            5.6447,
            5.6016,
            5.7721
          ]
        },
        {
          "block_id": "p33_line_45",
          "block_type": "paragraph",
          "text": "V7",
          "bbox": [
            6.0178,
            5.6417,
            6.1893,
            5.7699
          ]
        },
        {
          "block_id": "p33_line_46",
          "block_type": "paragraph",
          "text": "V11",
          "bbox": [
            6.6094,
            5.6449,
            6.8455,
            5.7744
          ]
        },
        {
          "block_id": "p33_line_47",
          "block_type": "paragraph",
          "text": "T3",
          "bbox": [
            1.8904,
            5.8409,
            2.0522,
            5.9636
          ]
        },
        {
          "block_id": "p33_line_48",
          "block_type": "paragraph",
          "text": "V4",
          "bbox": [
            5.4268,
            5.8394,
            5.6023,
            5.9637
          ]
        },
        {
          "block_id": "p33_line_49",
          "block_type": "paragraph",
          "text": "V8",
          "bbox": [
            6.0194,
            5.8381,
            6.1935,
            5.9654
          ]
        },
        {
          "block_id": "p33_line_50",
          "block_type": "paragraph",
          "text": "V12",
          "bbox": [
            6.611,
            5.8388,
            6.85,
            5.966
          ]
        },
        {
          "block_id": "p33_line_51",
          "block_type": "paragraph",
          "text": "# 2",
          "bbox": [
            1.291,
            6.117,
            1.4849,
            6.2401
          ]
        },
        {
          "block_id": "p33_line_52",
          "block_type": "paragraph",
          "text": "T10",
          "bbox": [
            1.8882,
            6.114,
            2.1204,
            6.2441
          ]
        },
        {
          "block_id": "p33_line_53",
          "block_type": "paragraph",
          "text": "65",
          "bbox": [
            2.4872,
            6.1217,
            2.6252,
            6.2373
          ]
        },
        {
          "block_id": "p33_line_54",
          "block_type": "paragraph",
          "text": "F",
          "bbox": [
            3.0693,
            6.1162,
            3.1649,
            6.2355
          ]
        },
        {
          "block_id": "p33_line_55",
          "block_type": "paragraph",
          "text": "B",
          "bbox": [
            3.6597,
            6.1163,
            3.7599,
            6.2355
          ]
        },
        {
          "block_id": "p33_line_56",
          "block_type": "paragraph",
          "text": "50 kg",
          "bbox": [
            4.2499,
            6.1083,
            4.5831,
            6.2615
          ]
        },
        {
          "block_id": "p33_line_57",
          "block_type": "paragraph",
          "text": "300mg",
          "bbox": [
            4.8398,
            6.1161,
            5.2415,
            6.2596
          ]
        },
        {
          "block_id": "p33_line_58",
          "block_type": "paragraph",
          "text": "V13",
          "bbox": [
            5.427,
            6.1131,
            5.6673,
            6.2437
          ]
        },
        {
          "block_id": "p33_line_59",
          "block_type": "paragraph",
          "text": "V16",
          "bbox": [
            6.0194,
            6.1124,
            6.2593,
            6.2428
          ]
        },
        {
          "block_id": "p33_line_60",
          "block_type": "paragraph",
          "text": "V19",
          "bbox": [
            6.6102,
            6.113,
            6.8475,
            6.2418
          ]
        },
        {
          "block_id": "p33_line_61",
          "block_type": "paragraph",
          "text": "T21",
          "bbox": [
            1.8931,
            6.3085,
            2.116,
            6.4354
          ]
        },
        {
          "block_id": "p33_line_62",
          "block_type": "paragraph",
          "text": "V14",
          "bbox": [
            5.4287,
            6.308,
            5.6697,
            6.4371
          ]
        },
        {
          "block_id": "p33_line_63",
          "block_type": "paragraph",
          "text": "V17",
          "bbox": [
            6.0222,
            6.3053,
            6.2584,
            6.4354
          ]
        },
        {
          "block_id": "p33_line_64",
          "block_type": "paragraph",
          "text": "V20",
          "bbox": [
            6.6135,
            6.3064,
            6.846,
            6.4369
          ]
        },
        {
          "block_id": "p33_line_65",
          "block_type": "paragraph",
          "text": "T32",
          "bbox": [
            1.8925,
            6.4957,
            2.1222,
            6.6227
          ]
        },
        {
          "block_id": "p33_line_66",
          "block_type": "paragraph",
          "text": "V15",
          "bbox": [
            5.4312,
            6.4956,
            5.6654,
            6.6255
          ]
        },
        {
          "block_id": "p33_line_67",
          "block_type": "paragraph",
          "text": "V18",
          "bbox": [
            6.0252,
            6.4953,
            6.2619,
            6.6254
          ]
        },
        {
          "block_id": "p33_line_68",
          "block_type": "paragraph",
          "text": "V21",
          "bbox": [
            6.6117,
            6.4955,
            6.8418,
            6.6234
          ]
        },
        {
          "block_id": "p33_line_69",
          "block_type": "paragraph",
          "text": "* Vn = value of a particular test",
          "bbox": [
            1.1748,
            6.7543,
            3.429,
            6.9379
          ]
        },
        {
          "block_id": "p33_line_70",
          "block_type": "paragraph",
          "text": "For all regulatory authorities, there should be a by-patient listing of all abnormal",
          "bbox": [
            1.1693,
            7.0621,
            7.2911,
            7.2532
          ]
        },
        {
          "block_id": "p33_line_71",
          "block_type": "paragraph",
          "text": "laboratory values in section 14.3.4, using the format described above. For laboratory",
          "bbox": [
            1.1639,
            7.2474,
            7.2872,
            7.434
          ]
        },
        {
          "block_id": "p33_line_72",
          "block_type": "paragraph",
          "text": "abnormalities of special interest (abnormal laboratory values of potential clinical",
          "bbox": [
            1.174,
            7.4303,
            7.2911,
            7.6174
          ]
        },
        {
          "block_id": "p33_line_73",
          "block_type": "paragraph",
          "text": "importance), it may also be useful to provide additional data, such as normal values",
          "bbox": [
            1.1635,
            7.619,
            7.2899,
            7.8058
          ]
        },
        {
          "block_id": "p33_line_74",
          "block_type": "paragraph",
          "text": "before and after the abnormal value, and values of related laboratory tests. In some",
          "bbox": [
            1.1677,
            7.802,
            7.288,
            7.9862
          ]
        },
        {
          "block_id": "p33_line_75",
          "block_type": "paragraph",
          "text": "cases, it may be desirable to exclude certain abnormal values from further analysis.",
          "bbox": [
            1.1727,
            7.9865,
            7.2758,
            8.1684
          ]
        },
        {
          "block_id": "p33_line_76",
          "block_type": "paragraph",
          "text": "For example, single, non-replicated, small abnormalities of some tests (e.g., uric acid",
          "bbox": [
            1.1712,
            8.1693,
            7.2923,
            8.3544
          ]
        },
        {
          "block_id": "p33_line_77",
          "block_type": "paragraph",
          "text": "or electrolytes) or occasional low values of some tests (e.g., transaminase, alkaline",
          "bbox": [
            1.1734,
            8.3552,
            7.2881,
            8.5334
          ]
        },
        {
          "block_id": "p33_line_78",
          "block_type": "paragraph",
          "text": "phosphatase, BUN etc.) can probably be defined as clinically insignificant and",
          "bbox": [
            1.1669,
            8.5327,
            7.2917,
            8.7202
          ]
        },
        {
          "block_id": "p33_line_79",
          "block_type": "paragraph",
          "text": "excluded. Any such decisions should be clearly explained, however, and the complete",
          "bbox": [
            1.174,
            8.7185,
            7.2872,
            8.8986
          ]
        },
        {
          "block_id": "p33_line_80",
          "block_type": "paragraph",
          "text": "list of values provided (or available to authorities on request) should identify every",
          "bbox": [
            1.1642,
            8.8965,
            7.286,
            9.0915
          ]
        },
        {
          "block_id": "p33_line_81",
          "block_type": "paragraph",
          "text": "abnormal value.",
          "bbox": [
            1.1701,
            9.0881,
            2.323,
            9.2505
          ]
        },
        {
          "block_id": "p33_line_82",
          "block_type": "paragraph",
          "text": "12.4.2 Evaluation of Each Laboratory Parameter",
          "bbox": [
            1.1753,
            9.4784,
            5.0305,
            9.6532
          ]
        },
        {
          "block_id": "p33_line_83",
          "block_type": "paragraph",
          "text": "The necessary evaluation of laboratory values must in part be determined by the",
          "bbox": [
            1.1708,
            9.6992,
            7.2861,
            9.8802
          ]
        },
        {
          "block_id": "p33_line_84",
          "block_type": "paragraph",
          "text": "results seen, but, in general, the following analyses should be provided. For each",
          "bbox": [
            1.1662,
            9.8843,
            7.286,
            10.0613
          ]
        },
        {
          "block_id": "p33_line_85",
          "block_type": "paragraph",
          "text": "analysis, comparison of the treatment and control groups should be carried out, as",
          "bbox": [
            1.1724,
            10.0741,
            7.2878,
            10.2496
          ]
        },
        {
          "block_id": "p33_line_86",
          "block_type": "paragraph",
          "text": "appropriate, and as compatible with study size. In addition, normal laboratory ranges",
          "bbox": [
            1.1741,
            10.2579,
            7.2868,
            10.4371
          ]
        },
        {
          "block_id": "p33_line_87",
          "block_type": "paragraph",
          "text": "should be given for each analysis.",
          "bbox": [
            1.1711,
            10.4417,
            3.5487,
            10.6134
          ]
        },
        {
          "block_id": "p33_line_88",
          "block_type": "paragraph",
          "text": "25",
          "bbox": [
            4.1394,
            10.9469,
            4.3127,
            11.0841
          ]
        },
        {
          "block_id": "table_5",
          "block_type": "table",
          "page_number": 33,
          "bbox": [
            1.1824,
            4.5613,
            7.4195,
            6.7043
          ],
          "headers": [
            "",
            "Laboratory Tests",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            ""
          ],
          "rows": [
            [
              "Patient",
              "Time",
              "Age",
              "Sex",
              "Race",
              "Weight",
              "Dose",
              "SGOT",
              "SGPT",
              "AP X"
            ],
            [
              "# 1",
              "T0",
              "70",
              "M",
              "W",
              "70 kg",
              "400mg",
              "V1*",
              "V5",
              "V9"
            ],
            [
              "",
              "T1",
              "",
              "",
              "",
              "",
              "",
              "V2",
              "V6",
              "V10"
            ],
            [
              "",
              "T2",
              "",
              "",
              "",
              "",
              "",
              "V3",
              "V7",
              "V11"
            ],
            [
              "",
              "T3",
              "",
              "",
              "",
              "",
              "",
              "V4",
              "V8",
              "V12"
            ],
            [
              "# 2",
              "T10",
              "65",
              "F",
              "B",
              "50 kg",
              "300mg",
              "V13",
              "V16",
              "V19"
            ],
            [
              "",
              "T21",
              "",
              "",
              "",
              "",
              "",
              "V14",
              "V17",
              "V20"
            ],
            [
              "",
              "T32",
              "",
              "",
              "",
              "",
              "",
              "V15",
              "V18",
              "V21"
            ]
          ]
        }
      ]
    },
    {
      "page_number": 34,
      "width": 8.2639,
      "height": 11.6944,
      "unit": "inch",
      "blocks": [
        {
          "block_id": "p34_line_0",
          "block_type": "paragraph",
          "text": "Structure and Content of Clinical Study Reports",
          "bbox": [
            0.974,
            0.7138,
            4.0775,
            0.8863
          ]
        },
        {
          "block_id": "p34_line_1",
          "block_type": "paragraph",
          "text": "12.4.2.1 Laboratory Values Over Time",
          "bbox": [
            0.9829,
            1.0559,
            4.1236,
            1.23
          ]
        },
        {
          "block_id": "p34_line_2",
          "block_type": "paragraph",
          "text": "For each parameter at each time over the course of the study (e.g., at each visit) the",
          "bbox": [
            0.9724,
            1.2743,
            7.0901,
            1.459
          ]
        },
        {
          "block_id": "p34_line_3",
          "block_type": "paragraph",
          "text": "following should be described: the group mean or median values, the range of values,",
          "bbox": [
            0.9692,
            1.4609,
            7.0807,
            1.6434
          ]
        },
        {
          "block_id": "p34_line_4",
          "block_type": "paragraph",
          "text": "and the number of patients with abnormal values, or with abnormal values that are of",
          "bbox": [
            0.9725,
            1.6405,
            7.103,
            1.8215
          ]
        },
        {
          "block_id": "p34_line_5",
          "block_type": "paragraph",
          "text": "a certain size (e.g., twice the upper limit of normal, 5 times the upper limit; choices",
          "bbox": [
            0.9738,
            1.8287,
            7.0912,
            2.0074
          ]
        },
        {
          "block_id": "p34_line_6",
          "block_type": "paragraph",
          "text": "should be explained). Graphs may be used.",
          "bbox": [
            0.971,
            2.0084,
            4.0456,
            2.1922
          ]
        },
        {
          "block_id": "p34_line_7",
          "block_type": "paragraph",
          "text": "12.4.2.2 Individual Patient Changes",
          "bbox": [
            0.9801,
            2.3983,
            3.9607,
            2.5832
          ]
        },
        {
          "block_id": "p34_line_8",
          "block_type": "paragraph",
          "text": "An analysis of individual patient changes by treatment group should be given. A",
          "bbox": [
            0.9718,
            2.6248,
            7.0927,
            2.8121
          ]
        },
        {
          "block_id": "p34_line_9",
          "block_type": "paragraph",
          "text": "variety of approaches may be used, including:",
          "bbox": [
            0.9687,
            2.8097,
            4.2037,
            2.9957
          ]
        },
        {
          "block_id": "p34_line_10",
          "block_type": "paragraph",
          "text": "I. \"Shift tables\" - These tables show the number of patients who are low, normal, or",
          "bbox": [
            0.9699,
            3.1112,
            7.0949,
            3.3019
          ]
        },
        {
          "block_id": "p34_line_11",
          "block_type": "paragraph",
          "text": "high at baseline and then at selected time intervals.",
          "bbox": [
            1.2136,
            3.2978,
            4.9032,
            3.4802
          ]
        },
        {
          "block_id": "p34_line_12",
          "block_type": "paragraph",
          "text": "II. Tables showing the number or fraction of patients who had a change in parameter",
          "bbox": [
            0.9683,
            3.6021,
            7.0899,
            3.7962
          ]
        },
        {
          "block_id": "p34_line_13",
          "block_type": "paragraph",
          "text": "of a predetermined size at selected time intervals. For example, for BUN, it might",
          "bbox": [
            1.2218,
            3.7944,
            7.0906,
            3.9789
          ]
        },
        {
          "block_id": "p34_line_14",
          "block_type": "paragraph",
          "text": "be decided that a change of more than 10 mg/dL BUN should be noted. For this",
          "bbox": [
            1.2177,
            3.9748,
            7.091,
            4.1621
          ]
        },
        {
          "block_id": "p34_line_15",
          "block_type": "paragraph",
          "text": "parameter, the number of patients having a change less than this or greater than",
          "bbox": [
            1.2176,
            4.1591,
            7.0922,
            4.3512
          ]
        },
        {
          "block_id": "p34_line_16",
          "block_type": "paragraph",
          "text": "this would be shown for one or more visits, usually grouping patients separately",
          "bbox": [
            1.2207,
            4.3418,
            7.0891,
            4.5339
          ]
        },
        {
          "block_id": "p34_line_17",
          "block_type": "paragraph",
          "text": "depending on baseline BUN (normal or elevated). The possible advantage of this",
          "bbox": [
            1.2249,
            4.5244,
            7.0917,
            4.7123
          ]
        },
        {
          "block_id": "p34_line_18",
          "block_type": "paragraph",
          "text": "display, compared to the usual shift table, is that changes of a certain size are",
          "bbox": [
            1.2262,
            4.7099,
            7.0923,
            4.8954
          ]
        },
        {
          "block_id": "p34_line_19",
          "block_type": "paragraph",
          "text": "noted, even if the final value is not abnormal.",
          "bbox": [
            1.2178,
            4.8922,
            4.4433,
            5.0715
          ]
        },
        {
          "block_id": "p34_line_20",
          "block_type": "paragraph",
          "text": "III. A graph comparing the initial value and the on-treatment values of a laboratory",
          "bbox": [
            0.9672,
            5.1939,
            7.0918,
            5.3888
          ]
        },
        {
          "block_id": "p34_line_21",
          "block_type": "paragraph",
          "text": "measurement for each patient by locating the point defined by the initial value on",
          "bbox": [
            1.2227,
            5.3814,
            7.0916,
            5.5723
          ]
        },
        {
          "block_id": "p34_line_22",
          "block_type": "paragraph",
          "text": "the abscissa and a subsequent value on the ordinate. If no changes occur, the",
          "bbox": [
            1.2233,
            5.565,
            7.0923,
            5.7484
          ]
        },
        {
          "block_id": "p34_line_23",
          "block_type": "paragraph",
          "text": "point representing each patient will be located on the 45 line. A general shift to",
          "bbox": [
            1.2169,
            5.7444,
            7.09,
            5.939
          ]
        },
        {
          "block_id": "p34_line_24",
          "block_type": "paragraph",
          "text": "higher values will show a clustering of points above the 45 line. As this display",
          "bbox": [
            1.2167,
            5.9329,
            7.0934,
            6.1244
          ]
        },
        {
          "block_id": "p34_line_25",
          "block_type": "paragraph",
          "text": "usually shows only a single time point for a single treatment, interpretation",
          "bbox": [
            1.2208,
            6.1235,
            7.0923,
            6.3062
          ]
        },
        {
          "block_id": "p34_line_26",
          "block_type": "paragraph",
          "text": "requires a time series of these plots for treatment and control groups.",
          "bbox": [
            1.2165,
            6.304,
            7.0845,
            6.4892
          ]
        },
        {
          "block_id": "p34_line_27",
          "block_type": "paragraph",
          "text": "Alternatively the display could show baseline and most extreme on-treatment",
          "bbox": [
            1.2208,
            6.4818,
            7.0913,
            6.6695
          ]
        },
        {
          "block_id": "p34_line_28",
          "block_type": "paragraph",
          "text": "value. These displays identify outliers readily (it is useful to include patient",
          "bbox": [
            1.2201,
            6.6671,
            7.0934,
            6.8522
          ]
        },
        {
          "block_id": "p34_line_29",
          "block_type": "paragraph",
          "text": "identifiers for the outliers).",
          "bbox": [
            1.2138,
            6.8483,
            3.1417,
            7.0267
          ]
        },
        {
          "block_id": "p34_line_30",
          "block_type": "paragraph",
          "text": "12.4.2.3 Individual Clinically Significant Abnormalities",
          "bbox": [
            0.981,
            7.2366,
            5.5133,
            7.4278
          ]
        },
        {
          "block_id": "p34_line_31",
          "block_type": "paragraph",
          "text": "Clinically significant changes (defined by the applicant) should be discussed. A",
          "bbox": [
            0.978,
            7.4586,
            7.0911,
            7.6516
          ]
        },
        {
          "block_id": "p34_line_32",
          "block_type": "paragraph",
          "text": "narrative of each patient whose laboratory abnormality was considered a serious",
          "bbox": [
            0.9693,
            7.6505,
            7.0917,
            7.8334
          ]
        },
        {
          "block_id": "p34_line_33",
          "block_type": "paragraph",
          "text": "adverse event and, in certain cases, considered an other significant adverse event,",
          "bbox": [
            0.9729,
            7.8341,
            7.0828,
            8.0155
          ]
        },
        {
          "block_id": "p34_line_34",
          "block_type": "paragraph",
          "text": "should be provided under sections 12.3.2 or 14.3.3. When toxicity grading scales are",
          "bbox": [
            0.972,
            8.016,
            7.0925,
            8.1966
          ]
        },
        {
          "block_id": "p34_line_35",
          "block_type": "paragraph",
          "text": "used (e.g., WHO, NCI), changes graded as severe should be discussed regardless of",
          "bbox": [
            0.9725,
            8.1977,
            7.1042,
            8.3883
          ]
        },
        {
          "block_id": "p34_line_36",
          "block_type": "paragraph",
          "text": "seriousness. An analysis of the clinically significant changes, together with a",
          "bbox": [
            0.9734,
            8.3869,
            7.0889,
            8.5695
          ]
        },
        {
          "block_id": "p34_line_37",
          "block_type": "paragraph",
          "text": "recapitulation of discontinuations due to laboratory measurements, should be",
          "bbox": [
            0.9671,
            8.5689,
            7.0925,
            8.7518
          ]
        },
        {
          "block_id": "p34_line_38",
          "block_type": "paragraph",
          "text": "provided for each parameter. The significance of the changes and likely relation to",
          "bbox": [
            0.9672,
            8.7501,
            7.0877,
            8.9358
          ]
        },
        {
          "block_id": "p34_line_39",
          "block_type": "paragraph",
          "text": "the treatment should be assessed, e.g., by analysis of such features as relationship to",
          "bbox": [
            0.9697,
            8.9359,
            7.0894,
            9.1191
          ]
        },
        {
          "block_id": "p34_line_40",
          "block_type": "paragraph",
          "text": "dose, relationship to drug concentration, disappearance on continued therapy, positive",
          "bbox": [
            0.9739,
            9.1219,
            7.0902,
            9.3004
          ]
        },
        {
          "block_id": "p34_line_41",
          "block_type": "paragraph",
          "text": "dechallenge, positive rechallenge, and the nature of concomitant therapy.",
          "bbox": [
            0.9752,
            9.3013,
            6.1618,
            9.4858
          ]
        },
        {
          "block_id": "p34_line_42",
          "block_type": "paragraph",
          "text": "26",
          "bbox": [
            3.9388,
            10.9459,
            4.1228,
            11.0835
          ]
        }
      ]
    },
    {
      "page_number": 35,
      "width": 8.2639,
      "height": 11.6944,
      "unit": "inch",
      "blocks": [
        {
          "block_id": "p35_line_0",
          "block_type": "paragraph",
          "text": "Structure and Content of Clinical Study Reports",
          "bbox": [
            4.1851,
            0.7138,
            7.2878,
            0.8866
          ]
        },
        {
          "block_id": "p35_line_1",
          "block_type": "paragraph",
          "text": "12.5 VITAL SIGNS, PHYSICAL FINDINGS AND OTHER OBSERVATIONS",
          "bbox": [
            1.1786,
            1.0464,
            7.0921,
            1.2236
          ]
        },
        {
          "block_id": "p35_line_2",
          "block_type": "paragraph",
          "text": "RELATED TO SAFETY",
          "bbox": [
            1.6693,
            1.2344,
            3.4946,
            1.4007
          ]
        },
        {
          "block_id": "p35_line_3",
          "block_type": "paragraph",
          "text": "Vital signs, other physical findings, and other observations related to safety should be",
          "bbox": [
            1.1656,
            1.4547,
            7.288,
            1.6418
          ]
        },
        {
          "block_id": "p35_line_4",
          "block_type": "paragraph",
          "text": "analysed and presented in a way similar to laboratory variables. If there is evidence",
          "bbox": [
            1.1683,
            1.6392,
            7.2909,
            1.8271
          ]
        },
        {
          "block_id": "p35_line_5",
          "block_type": "paragraph",
          "text": "of a drug effect, any dose-response or drug concentration-response relationship or",
          "bbox": [
            1.1697,
            1.8273,
            7.2881,
            2.0101
          ]
        },
        {
          "block_id": "p35_line_6",
          "block_type": "paragraph",
          "text": "relationship to patient variables (e.g., disease, demographics, concomitant therapy)",
          "bbox": [
            1.1642,
            2.0095,
            7.2833,
            2.1932
          ]
        },
        {
          "block_id": "p35_line_7",
          "block_type": "paragraph",
          "text": "should be identified and the clinical relevance of the observation described.",
          "bbox": [
            1.1692,
            2.1877,
            7.2778,
            2.3691
          ]
        },
        {
          "block_id": "p35_line_8",
          "block_type": "paragraph",
          "text": "Particular attention should be given to changes not evaluated as efficacy variables",
          "bbox": [
            1.1662,
            2.3712,
            7.2901,
            2.5588
          ]
        },
        {
          "block_id": "p35_line_9",
          "block_type": "paragraph",
          "text": "and to those considered to be adverse events.",
          "bbox": [
            1.1675,
            2.5622,
            4.3533,
            2.7377
          ]
        },
        {
          "block_id": "p35_line_10",
          "block_type": "paragraph",
          "text": "12.6 SAFETY CONCLUSIONS",
          "bbox": [
            1.1759,
            2.9419,
            3.6417,
            3.1211
          ]
        },
        {
          "block_id": "p35_line_11",
          "block_type": "paragraph",
          "text": "The overall safety evaluation of the test drug(s)/investigational product(s) should be",
          "bbox": [
            1.1675,
            3.175,
            7.2879,
            3.3645
          ]
        },
        {
          "block_id": "p35_line_12",
          "block_type": "paragraph",
          "text": "reviewed, with particular attention to events resulting in changes of dose or need for",
          "bbox": [
            1.1646,
            3.3599,
            7.2908,
            3.546
          ]
        },
        {
          "block_id": "p35_line_13",
          "block_type": "paragraph",
          "text": "concomitant medication, serious adverse events, events resulting in withdrawal, and",
          "bbox": [
            1.1686,
            3.5395,
            7.2935,
            3.7287
          ]
        },
        {
          "block_id": "p35_line_14",
          "block_type": "paragraph",
          "text": "deaths. Any patients or patient groups at increased risk should be identified and",
          "bbox": [
            1.1732,
            3.718,
            7.293,
            3.9172
          ]
        },
        {
          "block_id": "p35_line_15",
          "block_type": "paragraph",
          "text": "particular attention paid to potentially vulnerable patients who may be present in",
          "bbox": [
            1.1645,
            3.9084,
            7.2905,
            4.0981
          ]
        },
        {
          "block_id": "p35_line_16",
          "block_type": "paragraph",
          "text": "small numbers, e.g., children, pregnant women, frail elderly, people with marked",
          "bbox": [
            1.1688,
            4.0874,
            7.2941,
            4.2826
          ]
        },
        {
          "block_id": "p35_line_17",
          "block_type": "paragraph",
          "text": "abnormalities of drug metabolism or excretion etc. The implication of the safety",
          "bbox": [
            1.1715,
            4.2712,
            7.2885,
            4.4653
          ]
        },
        {
          "block_id": "p35_line_18",
          "block_type": "paragraph",
          "text": "evaluation for the possible uses of the drug should be described.",
          "bbox": [
            1.1701,
            4.4527,
            5.684,
            4.6462
          ]
        },
        {
          "block_id": "p35_line_19",
          "block_type": "paragraph",
          "text": "13. DISCUSSION AND OVERALL CONCLUSIONS",
          "bbox": [
            1.1828,
            4.8398,
            5.3207,
            5.0265
          ]
        },
        {
          "block_id": "p35_line_20",
          "block_type": "paragraph",
          "text": "The efficacy and safety results of the study and the relationship of risks and benefit",
          "bbox": [
            1.1681,
            5.0673,
            7.2918,
            5.2637
          ]
        },
        {
          "block_id": "p35_line_21",
          "block_type": "paragraph",
          "text": "should be briefly summarised and discussed, referring to the tables, figures, and",
          "bbox": [
            1.1686,
            5.2537,
            7.296,
            5.4455
          ]
        },
        {
          "block_id": "p35_line_22",
          "block_type": "paragraph",
          "text": "sections above as needed. The presentation should not simply repeat the description",
          "bbox": [
            1.1668,
            5.4411,
            7.2914,
            5.6285
          ]
        },
        {
          "block_id": "p35_line_23",
          "block_type": "paragraph",
          "text": "of results nor introduce new results.",
          "bbox": [
            1.1702,
            5.6295,
            3.731,
            5.8054
          ]
        },
        {
          "block_id": "p35_line_24",
          "block_type": "paragraph",
          "text": "The discussion and conclusions should clearly identify any new or unexpected",
          "bbox": [
            1.1683,
            5.9272,
            7.2922,
            6.127
          ]
        },
        {
          "block_id": "p35_line_25",
          "block_type": "paragraph",
          "text": "findings, comment on their significance and discuss any potential problems such as",
          "bbox": [
            1.1662,
            6.1167,
            7.2887,
            6.3072
          ]
        },
        {
          "block_id": "p35_line_26",
          "block_type": "paragraph",
          "text": "inconsistencies between related measures. The clinical relevance and importance of",
          "bbox": [
            1.1641,
            6.2961,
            7.2996,
            6.4868
          ]
        },
        {
          "block_id": "p35_line_27",
          "block_type": "paragraph",
          "text": "the results should also be discussed in the light of other existing data. Any specific",
          "bbox": [
            1.1671,
            6.4789,
            7.2919,
            6.6722
          ]
        },
        {
          "block_id": "p35_line_28",
          "block_type": "paragraph",
          "text": "benefits or special precautions required for individual subjects or at-risk groups and",
          "bbox": [
            1.1651,
            6.6646,
            7.2921,
            6.8549
          ]
        },
        {
          "block_id": "p35_line_29",
          "block_type": "paragraph",
          "text": "any implications for the conduct of future studies should be identified. Alternatively,",
          "bbox": [
            1.1698,
            6.8482,
            7.2771,
            7.0373
          ]
        },
        {
          "block_id": "p35_line_30",
          "block_type": "paragraph",
          "text": "such discussions may be reserved for summaries of safety and efficacy referring to the",
          "bbox": [
            1.1682,
            7.0315,
            7.2908,
            7.2203
          ]
        },
        {
          "block_id": "p35_line_31",
          "block_type": "paragraph",
          "text": "entire dossier (integrated summaries).",
          "bbox": [
            1.1706,
            7.2174,
            3.8864,
            7.3998
          ]
        },
        {
          "block_id": "p35_line_32",
          "block_type": "paragraph",
          "text": "14. TABLES, FIGURES AND GRAPHS REFERRED TO BUT NOT",
          "bbox": [
            1.1755,
            7.5965,
            6.4837,
            7.7859
          ]
        },
        {
          "block_id": "p35_line_33",
          "block_type": "paragraph",
          "text": "INCLUDED IN THE TEXT",
          "bbox": [
            1.6634,
            7.7869,
            3.7352,
            7.9598
          ]
        },
        {
          "block_id": "p35_line_34",
          "block_type": "paragraph",
          "text": "Figures should be used to visually summarise the important results, or to clarify",
          "bbox": [
            1.166,
            8.0096,
            7.2846,
            8.2002
          ]
        },
        {
          "block_id": "p35_line_35",
          "block_type": "paragraph",
          "text": "results that are not easily understood from tables.",
          "bbox": [
            1.1626,
            8.2055,
            4.7163,
            8.3845
          ]
        },
        {
          "block_id": "p35_line_36",
          "block_type": "paragraph",
          "text": "Important demographic, efficacy and safety data should be presented in summary",
          "bbox": [
            1.1611,
            8.5087,
            7.286,
            8.6991
          ]
        },
        {
          "block_id": "p35_line_37",
          "block_type": "paragraph",
          "text": "figures or tables in the text of the report. However, if these become obtrusive because",
          "bbox": [
            1.1622,
            8.6954,
            7.2888,
            8.8748
          ]
        },
        {
          "block_id": "p35_line_38",
          "block_type": "paragraph",
          "text": "of size or number they should be presented here, cross-referenced to the text, along",
          "bbox": [
            1.1678,
            8.8751,
            7.2905,
            9.062
          ]
        },
        {
          "block_id": "p35_line_39",
          "block_type": "paragraph",
          "text": "with supportive, or additional, figures, tables or listings.",
          "bbox": [
            1.1676,
            9.0621,
            5.1612,
            9.2448
          ]
        },
        {
          "block_id": "p35_line_40",
          "block_type": "paragraph",
          "text": "The following information may be presented in this section of the core clinical study",
          "bbox": [
            1.1662,
            9.3614,
            7.2852,
            9.5539
          ]
        },
        {
          "block_id": "p35_line_41",
          "block_type": "paragraph",
          "text": "report:",
          "bbox": [
            1.1622,
            9.5775,
            1.6604,
            9.7292
          ]
        },
        {
          "block_id": "p35_line_42",
          "block_type": "paragraph",
          "text": "14.1 DEMOGRAPHIC DATA",
          "bbox": [
            1.1767,
            9.9405,
            3.52,
            10.1111
          ]
        },
        {
          "block_id": "p35_line_43",
          "block_type": "paragraph",
          "text": "Summary figures and tables",
          "bbox": [
            1.1686,
            10.1694,
            3.1866,
            10.3448
          ]
        },
        {
          "block_id": "p35_line_44",
          "block_type": "paragraph",
          "text": "27",
          "bbox": [
            4.1361,
            10.9416,
            4.3163,
            11.0846
          ]
        }
      ]
    },
    {
      "page_number": 36,
      "width": 8.2639,
      "height": 11.6944,
      "unit": "inch",
      "blocks": [
        {
          "block_id": "p36_line_0",
          "block_type": "paragraph",
          "text": "Structure and Content of Clinical Study Reports",
          "bbox": [
            0.9744,
            0.7138,
            4.0769,
            0.8846
          ]
        },
        {
          "block_id": "p36_line_1",
          "block_type": "paragraph",
          "text": "14.2 EFFICACY DATA",
          "bbox": [
            0.9802,
            1.0543,
            2.8678,
            1.2186
          ]
        },
        {
          "block_id": "p36_line_2",
          "block_type": "paragraph",
          "text": "Summary figures and tables",
          "bbox": [
            0.9716,
            1.2786,
            2.9904,
            1.4545
          ]
        },
        {
          "block_id": "p36_line_3",
          "block_type": "paragraph",
          "text": "14.3 SAFETY DATA",
          "bbox": [
            0.978,
            1.6689,
            2.6664,
            1.8365
          ]
        },
        {
          "block_id": "p36_line_4",
          "block_type": "paragraph",
          "text": "Summary figures and tables",
          "bbox": [
            0.9705,
            1.8934,
            2.9922,
            2.0753
          ]
        },
        {
          "block_id": "p36_line_5",
          "block_type": "paragraph",
          "text": "14.3.1 Displays of Adverse Events",
          "bbox": [
            0.9795,
            2.2784,
            3.4186,
            2.4611
          ]
        },
        {
          "block_id": "p36_line_6",
          "block_type": "paragraph",
          "text": "14.3.2 Listings of Deaths, Other Serious and Significant Adverse Events",
          "bbox": [
            0.9778,
            2.5885,
            6.1185,
            2.7694
          ]
        },
        {
          "block_id": "p36_line_7",
          "block_type": "paragraph",
          "text": "14.3.3 Narratives of Deaths, Other Serious and Certain Other Significant Adverse",
          "bbox": [
            0.9808,
            2.8914,
            6.8176,
            3.08
          ]
        },
        {
          "block_id": "p36_line_8",
          "block_type": "paragraph",
          "text": "Events",
          "bbox": [
            1.4735,
            3.086,
            1.9817,
            3.2447
          ]
        },
        {
          "block_id": "p36_line_9",
          "block_type": "paragraph",
          "text": "14.3.4 Abnormal Laboratory Value Listing (Each Patient)",
          "bbox": [
            0.9803,
            3.385,
            5.0796,
            3.5745
          ]
        },
        {
          "block_id": "p36_line_10",
          "block_type": "paragraph",
          "text": "15. REFERENCE LIST",
          "bbox": [
            0.9896,
            3.7029,
            2.9874,
            3.8706
          ]
        },
        {
          "block_id": "p36_line_11",
          "block_type": "paragraph",
          "text": "A list of articles from the literature pertinent to the evaluation of the study should be",
          "bbox": [
            0.9726,
            3.923,
            7.0901,
            4.1074
          ]
        },
        {
          "block_id": "p36_line_12",
          "block_type": "paragraph",
          "text": "provided. Copies of important publications should be attached in an appendix",
          "bbox": [
            0.9658,
            4.1113,
            7.096,
            4.2966
          ]
        },
        {
          "block_id": "p36_line_13",
          "block_type": "paragraph",
          "text": "(16.1.11 and 16.1.12). References should be given in accordance with the",
          "bbox": [
            0.9789,
            4.2859,
            7.0911,
            4.4748
          ]
        },
        {
          "block_id": "p36_line_14",
          "block_type": "paragraph",
          "text": "internationally accepted standards of the 1979 Vancouver Declaration on \"Uniform",
          "bbox": [
            0.9663,
            4.4711,
            7.0881,
            4.6554
          ]
        },
        {
          "block_id": "p36_line_15",
          "block_type": "paragraph",
          "text": "Requirements for Manuscripts Submitted to Biomedical Journals\" or the system used",
          "bbox": [
            0.9668,
            4.6543,
            7.0916,
            4.8403
          ]
        },
        {
          "block_id": "p36_line_16",
          "block_type": "paragraph",
          "text": "in \"Chemical Abstracts\".",
          "bbox": [
            0.964,
            4.8438,
            2.7061,
            5.0136
          ]
        },
        {
          "block_id": "p36_line_17",
          "block_type": "paragraph",
          "text": "16.",
          "bbox": [
            0.9816,
            5.2493,
            1.2008,
            5.3938
          ]
        },
        {
          "block_id": "p36_line_18",
          "block_type": "paragraph",
          "text": "APPENDICES",
          "bbox": [
            1.4637,
            5.2311,
            2.6039,
            5.4006
          ]
        },
        {
          "block_id": "p36_line_19",
          "block_type": "paragraph",
          "text": "This section should be prefaced by a full list of all appendices available for the study",
          "bbox": [
            0.9703,
            5.4526,
            7.0924,
            5.6417
          ]
        },
        {
          "block_id": "p36_line_20",
          "block_type": "paragraph",
          "text": "report. Where permitted by the regulatory authority, some of the following",
          "bbox": [
            0.9706,
            5.6468,
            7.0972,
            5.8307
          ]
        },
        {
          "block_id": "p36_line_21",
          "block_type": "paragraph",
          "text": "appendices need not be submitted with the report but need to be provided only on",
          "bbox": [
            0.9738,
            5.8288,
            7.091,
            6.015
          ]
        },
        {
          "block_id": "p36_line_22",
          "block_type": "paragraph",
          "text": "request.",
          "bbox": [
            0.9673,
            6.0357,
            1.5548,
            6.1919
          ]
        },
        {
          "block_id": "p36_line_23",
          "block_type": "paragraph",
          "text": "The applicant should therefore clearly indicate those appendices that are submitted",
          "bbox": [
            0.9711,
            6.3129,
            7.0949,
            6.5034
          ]
        },
        {
          "block_id": "p36_line_24",
          "block_type": "paragraph",
          "text": "with the report.",
          "bbox": [
            0.9688,
            6.5099,
            2.0932,
            6.6803
          ]
        },
        {
          "block_id": "p36_line_25",
          "block_type": "paragraph",
          "text": "N.B. In order to have appendices available on request, they should be finalised by the",
          "bbox": [
            0.9686,
            6.8038,
            7.0909,
            6.995
          ]
        },
        {
          "block_id": "p36_line_26",
          "block_type": "paragraph",
          "text": "time of filing of the submission.",
          "bbox": [
            0.9706,
            6.995,
            3.2052,
            7.172
          ]
        },
        {
          "block_id": "p36_line_27",
          "block_type": "paragraph",
          "text": "16.1 STUDY INFORMATION",
          "bbox": [
            0.98,
            7.3801,
            3.3588,
            7.5569
          ]
        },
        {
          "block_id": "p36_line_28",
          "block_type": "paragraph",
          "text": "16.1.1 Protocol and protocol amendments",
          "bbox": [
            0.9826,
            7.6973,
            3.9306,
            7.873
          ]
        },
        {
          "block_id": "p36_line_29",
          "block_type": "paragraph",
          "text": "16.1.2 Sample case report form (unique pages only)",
          "bbox": [
            0.9812,
            8.0008,
            4.6228,
            8.1907
          ]
        },
        {
          "block_id": "p36_line_30",
          "block_type": "paragraph",
          "text": "16.1.3 List of IECs or IRBs (plus the name of the committee Chair if required by the",
          "bbox": [
            0.9828,
            8.3075,
            6.9476,
            8.4941
          ]
        },
        {
          "block_id": "p36_line_31",
          "block_type": "paragraph",
          "text": "regulatory authority) - Representative written information for patient and",
          "bbox": [
            1.4647,
            8.4946,
            6.732,
            8.6795
          ]
        },
        {
          "block_id": "p36_line_32",
          "block_type": "paragraph",
          "text": "sample consent forms",
          "bbox": [
            1.4672,
            8.6852,
            3.018,
            8.8557
          ]
        },
        {
          "block_id": "p36_line_33",
          "block_type": "paragraph",
          "text": "16.1.4 List and description of investigators and other important participants in the",
          "bbox": [
            0.982,
            8.9845,
            6.8698,
            9.1683
          ]
        },
        {
          "block_id": "p36_line_34",
          "block_type": "paragraph",
          "text": "study, including brief (1 page) CVs or equivalent summaries of training and",
          "bbox": [
            1.4709,
            9.1705,
            6.8417,
            9.3533
          ]
        },
        {
          "block_id": "p36_line_35",
          "block_type": "paragraph",
          "text": "experience relevant to the performance of the clinical study",
          "bbox": [
            1.4702,
            9.3536,
            5.6811,
            9.5342
          ]
        },
        {
          "block_id": "p36_line_36",
          "block_type": "paragraph",
          "text": "16.1.5 Signatures of principal or coordinating investigator(s) or sponsor's responsible",
          "bbox": [
            0.9839,
            9.6602,
            6.9985,
            9.8422
          ]
        },
        {
          "block_id": "p36_line_37",
          "block_type": "paragraph",
          "text": "medical officer, depending on the regulatory authority's requirement",
          "bbox": [
            1.4674,
            9.8461,
            6.3333,
            10.0243
          ]
        },
        {
          "block_id": "p36_line_38",
          "block_type": "paragraph",
          "text": "16.1.6 Listing of patients receiving test drug(s)/investigational product(s) from",
          "bbox": [
            0.9834,
            10.1527,
            6.5452,
            10.3297
          ]
        },
        {
          "block_id": "p36_line_39",
          "block_type": "paragraph",
          "text": "specific batches, where more than one batch was used",
          "bbox": [
            1.4693,
            10.3354,
            5.2943,
            10.5153
          ]
        },
        {
          "block_id": "p36_line_40",
          "block_type": "paragraph",
          "text": "28",
          "bbox": [
            3.9394,
            10.9473,
            4.1216,
            11.0833
          ]
        }
      ]
    },
    {
      "page_number": 37,
      "width": 8.2639,
      "height": 11.6944,
      "unit": "inch",
      "blocks": [
        {
          "block_id": "p37_line_0",
          "block_type": "paragraph",
          "text": "Structure and Content of Clinical Study Reports",
          "bbox": [
            4.1846,
            0.7138,
            7.2873,
            0.8871
          ]
        },
        {
          "block_id": "p37_line_1",
          "block_type": "paragraph",
          "text": "16.1.7 Randomisation scheme and codes (patient identification and treatment",
          "bbox": [
            1.1801,
            1.0515,
            6.7007,
            1.2256
          ]
        },
        {
          "block_id": "p37_line_2",
          "block_type": "paragraph",
          "text": "assigned)",
          "bbox": [
            1.6689,
            1.2449,
            2.3415,
            1.4144
          ]
        },
        {
          "block_id": "p37_line_3",
          "block_type": "paragraph",
          "text": "16.1.8 Audit certificates (if available) (see Annex IVa and IVb of the guideline)",
          "bbox": [
            1.1795,
            1.5417,
            6.7379,
            1.7273
          ]
        },
        {
          "block_id": "p37_line_4",
          "block_type": "paragraph",
          "text": "16.1.9 Documentation of statistical methods",
          "bbox": [
            1.1787,
            1.8576,
            4.3274,
            2.0264
          ]
        },
        {
          "block_id": "p37_line_5",
          "block_type": "paragraph",
          "text": "16.1.10 Documentation of inter-laboratory standardisation methods and quality",
          "bbox": [
            1.1788,
            2.1584,
            6.8136,
            2.3489
          ]
        },
        {
          "block_id": "p37_line_6",
          "block_type": "paragraph",
          "text": "assurance procedures if used",
          "bbox": [
            1.6687,
            2.3528,
            3.7254,
            2.5279
          ]
        },
        {
          "block_id": "p37_line_7",
          "block_type": "paragraph",
          "text": "16.1.11 Publications based on the study",
          "bbox": [
            1.178,
            2.6517,
            3.9826,
            2.8339
          ]
        },
        {
          "block_id": "p37_line_8",
          "block_type": "paragraph",
          "text": "16.1.12 Important publications referenced in the report",
          "bbox": [
            1.1788,
            2.9612,
            5.0864,
            3.1457
          ]
        },
        {
          "block_id": "p37_line_9",
          "block_type": "paragraph",
          "text": "16.2. PATIENT DATA LISTINGS",
          "bbox": [
            1.1781,
            3.2629,
            3.8115,
            3.442
          ]
        },
        {
          "block_id": "p37_line_10",
          "block_type": "paragraph",
          "text": "16.2.1 Discontinued patients",
          "bbox": [
            1.1781,
            3.5803,
            3.2397,
            3.7573
          ]
        },
        {
          "block_id": "p37_line_11",
          "block_type": "paragraph",
          "text": "16.2.2 Protocol deviations",
          "bbox": [
            1.1773,
            3.8857,
            3.0264,
            4.0585
          ]
        },
        {
          "block_id": "p37_line_12",
          "block_type": "paragraph",
          "text": "16.2.3 Patients excluded from the efficacy analysis",
          "bbox": [
            1.1785,
            4.1913,
            4.7818,
            4.3845
          ]
        },
        {
          "block_id": "p37_line_13",
          "block_type": "paragraph",
          "text": "16.2.4 Demographic data",
          "bbox": [
            1.1765,
            4.5053,
            2.9805,
            4.6837
          ]
        },
        {
          "block_id": "p37_line_14",
          "block_type": "paragraph",
          "text": "16.2.5 Compliance and/or drug concentration data (if available)",
          "bbox": [
            1.1774,
            4.8072,
            5.6679,
            4.9977
          ]
        },
        {
          "block_id": "p37_line_15",
          "block_type": "paragraph",
          "text": "16.2.6 Individual efficacy response data",
          "bbox": [
            1.1787,
            5.1171,
            4.0131,
            5.3026
          ]
        },
        {
          "block_id": "p37_line_16",
          "block_type": "paragraph",
          "text": "16.2.7 Adverse event listings (each patient)",
          "bbox": [
            1.179,
            5.4253,
            4.259,
            5.6155
          ]
        },
        {
          "block_id": "p37_line_17",
          "block_type": "paragraph",
          "text": "16.2.8. Listing of individual laboratory measurements by patient, when required by",
          "bbox": [
            1.1777,
            5.7331,
            7.0631,
            5.9284
          ]
        },
        {
          "block_id": "p37_line_18",
          "block_type": "paragraph",
          "text": "regulatory authorities",
          "bbox": [
            1.6617,
            5.9278,
            3.2471,
            6.1027
          ]
        },
        {
          "block_id": "p37_line_19",
          "block_type": "paragraph",
          "text": "16.3 CASE REPORT FORMS",
          "bbox": [
            1.1751,
            6.2227,
            3.5527,
            6.3952
          ]
        },
        {
          "block_id": "p37_line_20",
          "block_type": "paragraph",
          "text": "16.3.1 CRFs for deaths, other serious adverse events and withdrawals for AE",
          "bbox": [
            1.1788,
            6.5313,
            6.6573,
            6.7169
          ]
        },
        {
          "block_id": "p37_line_21",
          "block_type": "paragraph",
          "text": "16.3.2 Other CRFs submitted",
          "bbox": [
            1.1756,
            6.8423,
            3.296,
            7.0157
          ]
        },
        {
          "block_id": "p37_line_22",
          "block_type": "paragraph",
          "text": "16.4. INDIVIDUAL PATIENT DATA LISTINGS (US ARCHIVAL LISTINGS)",
          "bbox": [
            1.1754,
            7.1404,
            7.0936,
            7.3313
          ]
        },
        {
          "block_id": "p37_line_23",
          "block_type": "paragraph",
          "text": "29",
          "bbox": [
            4.1387,
            10.948,
            4.3144,
            11.0827
          ]
        }
      ]
    },
    {
      "page_number": 38,
      "width": 8.2639,
      "height": 11.6944,
      "unit": "inch",
      "blocks": [
        {
          "block_id": "p38_line_0",
          "block_type": "paragraph",
          "text": "Structure and Content of Clinical Study Reports",
          "bbox": [
            0.9772,
            0.7195,
            4.0767,
            0.8846
          ]
        },
        {
          "block_id": "p38_line_1",
          "block_type": "paragraph",
          "text": "SYNOPSIS",
          "bbox": [
            0.9753,
            1.0564,
            1.8389,
            1.2181
          ]
        },
        {
          "block_id": "p38_line_2",
          "block_type": "paragraph",
          "text": "ANNEX I",
          "bbox": [
            6.3601,
            1.0628,
            7.0958,
            1.2122
          ]
        },
        {
          "block_id": "p38_line_3",
          "block_type": "paragraph",
          "text": "Name of Sponsor/Company:",
          "bbox": [
            1.0537,
            1.4294,
            2.6704,
            1.5903
          ]
        },
        {
          "block_id": "p38_line_4",
          "block_type": "paragraph",
          "text": "Individual Study Table",
          "bbox": [
            3.1374,
            1.4298,
            4.4998,
            1.5772
          ]
        },
        {
          "block_id": "p38_line_5",
          "block_type": "paragraph",
          "text": "Referring to Part",
          "bbox": [
            3.1401,
            1.5817,
            4.1524,
            1.7242
          ]
        },
        {
          "block_id": "p38_line_6",
          "block_type": "paragraph",
          "text": "of the Dossier",
          "bbox": [
            3.1416,
            1.735,
            3.9553,
            1.8671
          ]
        },
        {
          "block_id": "p38_line_7",
          "block_type": "paragraph",
          "text": "Volume:",
          "bbox": [
            3.1391,
            2.0442,
            3.6377,
            2.1813
          ]
        },
        {
          "block_id": "p38_line_8",
          "block_type": "paragraph",
          "text": "Page:",
          "bbox": [
            3.1414,
            2.5524,
            3.4787,
            2.6935
          ]
        },
        {
          "block_id": "p38_line_9",
          "block_type": "paragraph",
          "text": "(For National Authority",
          "bbox": [
            5.2415,
            1.4333,
            6.6249,
            1.5811
          ]
        },
        {
          "block_id": "p38_line_10",
          "block_type": "paragraph",
          "text": "Use only)",
          "bbox": [
            5.2392,
            1.5788,
            5.7826,
            1.7302
          ]
        },
        {
          "block_id": "p38_line_11",
          "block_type": "paragraph",
          "text": "Name of Finished Product:",
          "bbox": [
            1.0548,
            1.9325,
            2.6189,
            2.0806
          ]
        },
        {
          "block_id": "p38_line_12",
          "block_type": "paragraph",
          "text": "Name of Active Ingredient:",
          "bbox": [
            1.0546,
            2.4355,
            2.6346,
            2.5887
          ]
        },
        {
          "block_id": "p38_line_13",
          "block_type": "paragraph",
          "text": "Title of Study:",
          "bbox": [
            1.0577,
            2.9603,
            1.8925,
            3.1105
          ]
        },
        {
          "block_id": "p38_line_14",
          "block_type": "paragraph",
          "text": "Investigators:",
          "bbox": [
            1.0521,
            3.469,
            1.865,
            3.6167
          ]
        },
        {
          "block_id": "p38_line_15",
          "block_type": "paragraph",
          "text": "Study centre(s):",
          "bbox": [
            1.056,
            3.9691,
            1.9799,
            4.1213
          ]
        },
        {
          "block_id": "p38_line_16",
          "block_type": "paragraph",
          "text": "Publication (reference):",
          "bbox": [
            1.0509,
            4.468,
            2.4155,
            4.622
          ]
        },
        {
          "block_id": "p38_line_17",
          "block_type": "paragraph",
          "text": "Studied period (years):",
          "bbox": [
            1.0547,
            5.1261,
            2.3805,
            5.2819
          ]
        },
        {
          "block_id": "p38_line_18",
          "block_type": "paragraph",
          "text": "(date of first enrolment)",
          "bbox": [
            1.1809,
            5.2762,
            2.5615,
            5.4258
          ]
        },
        {
          "block_id": "p38_line_19",
          "block_type": "paragraph",
          "text": "(date of last completed)",
          "bbox": [
            1.1789,
            5.4247,
            2.524,
            5.5806
          ]
        },
        {
          "block_id": "p38_line_20",
          "block_type": "paragraph",
          "text": "Phase of development:",
          "bbox": [
            3.1383,
            5.1277,
            4.4533,
            5.2796
          ]
        },
        {
          "block_id": "p38_line_21",
          "block_type": "paragraph",
          "text": "Objectives:",
          "bbox": [
            1.0611,
            5.93,
            1.7014,
            6.0756
          ]
        },
        {
          "block_id": "p38_line_22",
          "block_type": "paragraph",
          "text": "Methodology:",
          "bbox": [
            1.0514,
            6.4277,
            1.843,
            6.5831
          ]
        },
        {
          "block_id": "p38_line_23",
          "block_type": "paragraph",
          "text": "Number of patients (planned and analysed):",
          "bbox": [
            1.0519,
            6.927,
            3.6147,
            7.0872
          ]
        },
        {
          "block_id": "p38_line_24",
          "block_type": "paragraph",
          "text": "Diagnosis and main criteria for inclusion:",
          "bbox": [
            1.0525,
            7.4395,
            3.4672,
            7.5907
          ]
        },
        {
          "block_id": "p38_line_25",
          "block_type": "paragraph",
          "text": "Test product, dose and mode of administration, batch number:",
          "bbox": [
            1.0571,
            7.9411,
            4.6672,
            8.097
          ]
        },
        {
          "block_id": "p38_line_26",
          "block_type": "paragraph",
          "text": "Duration of treatment:",
          "bbox": [
            1.0515,
            8.5943,
            2.387,
            8.7366
          ]
        },
        {
          "block_id": "p38_line_27",
          "block_type": "paragraph",
          "text": "Reference therapy, dose and mode of administration, batch number:",
          "bbox": [
            1.0514,
            9.2487,
            4.9963,
            9.4008
          ]
        },
        {
          "block_id": "p38_line_28",
          "block_type": "paragraph",
          "text": "30",
          "bbox": [
            3.9446,
            10.946,
            4.1177,
            11.0881
          ]
        },
        {
          "block_id": "table_6",
          "block_type": "table",
          "page_number": 38,
          "bbox": [
            0.9644,
            1.2867,
            7.2606,
            9.871
          ],
          "headers": [],
          "rows": [
            [
              "Name of Sponsor/Company:",
              "Individual Study Table Referring to Part of the Dossier Volume: Page:",
              "(For National Authority Use only)"
            ],
            [
              "Name of Finished Product:",
              "",
              ""
            ],
            [
              "Name of Active Ingredient:",
              "",
              ""
            ],
            [
              "Title of Study:",
              "",
              ""
            ],
            [
              "Investigators:",
              "",
              ""
            ],
            [
              "Study centre(s):",
              "",
              ""
            ],
            [
              "Publication (reference):",
              "",
              ""
            ],
            [
              "Studied period (years): (date of first enrolment) (date of last completed)",
              "Phase of development:",
              ""
            ],
            [
              "Objectives:",
              "",
              ""
            ],
            [
              "Methodology:",
              "",
              ""
            ],
            [
              "Number of patients (planned and analysed):",
              "",
              ""
            ],
            [
              "Diagnosis and main criteria for inclusion:",
              "",
              ""
            ],
            [
              "Test product, dose and mode of administration, batch number:",
              "",
              ""
            ],
            [
              "Duration of treatment:",
              "",
              ""
            ],
            [
              "Reference therapy, dose and mode of administration, batch number:",
              "",
              ""
            ]
          ]
        }
      ]
    },
    {
      "page_number": 39,
      "width": 8.2639,
      "height": 11.6944,
      "unit": "inch",
      "blocks": [
        {
          "block_id": "p39_line_0",
          "block_type": "paragraph",
          "text": "Structure and Content of Clinical Study Reports",
          "bbox": [
            4.1867,
            0.7195,
            7.2868,
            0.8852
          ]
        },
        {
          "block_id": "p39_line_1",
          "block_type": "paragraph",
          "text": "ANNEX 1 cont.",
          "bbox": [
            6.0637,
            1.0648,
            7.1777,
            1.2163
          ]
        },
        {
          "block_id": "p39_line_2",
          "block_type": "paragraph",
          "text": "Name of Sponsor/Company:",
          "bbox": [
            1.2455,
            1.4301,
            2.8681,
            1.589
          ]
        },
        {
          "block_id": "p39_line_3",
          "block_type": "paragraph",
          "text": "Individual Study Table",
          "bbox": [
            3.3338,
            1.4309,
            4.6962,
            1.5767
          ]
        },
        {
          "block_id": "p39_line_4",
          "block_type": "paragraph",
          "text": "Referring to Part",
          "bbox": [
            3.3392,
            1.5825,
            4.3485,
            1.7233
          ]
        },
        {
          "block_id": "p39_line_5",
          "block_type": "paragraph",
          "text": "of the Dossier",
          "bbox": [
            3.3394,
            1.7356,
            4.1528,
            1.8672
          ]
        },
        {
          "block_id": "p39_line_6",
          "block_type": "paragraph",
          "text": "(For National Authority",
          "bbox": [
            5.4333,
            1.4275,
            6.8207,
            1.5817
          ]
        },
        {
          "block_id": "p39_line_7",
          "block_type": "paragraph",
          "text": "Use Only)",
          "bbox": [
            5.4349,
            1.5774,
            6.0153,
            1.7317
          ]
        },
        {
          "block_id": "p39_line_8",
          "block_type": "paragraph",
          "text": "Name of Finished Product:",
          "bbox": [
            1.2464,
            2.0813,
            2.8174,
            2.2258
          ]
        },
        {
          "block_id": "p39_line_9",
          "block_type": "paragraph",
          "text": "Volume:",
          "bbox": [
            3.3406,
            2.1943,
            3.831,
            2.3294
          ]
        },
        {
          "block_id": "p39_line_10",
          "block_type": "paragraph",
          "text": "Name of Active Ingredient:",
          "bbox": [
            1.247,
            2.5857,
            2.8325,
            2.7352
          ]
        },
        {
          "block_id": "p39_line_11",
          "block_type": "paragraph",
          "text": "Page:",
          "bbox": [
            3.3375,
            2.5546,
            3.6722,
            2.6945
          ]
        },
        {
          "block_id": "p39_line_12",
          "block_type": "paragraph",
          "text": "Criteria for evaluation:",
          "bbox": [
            1.2574,
            3.0892,
            2.6026,
            3.2311
          ]
        },
        {
          "block_id": "p39_line_13",
          "block_type": "paragraph",
          "text": "Efficacy:",
          "bbox": [
            1.252,
            3.2417,
            1.8341,
            3.3825
          ]
        },
        {
          "block_id": "p39_line_14",
          "block_type": "paragraph",
          "text": "Safety:",
          "bbox": [
            1.2488,
            3.6915,
            1.7136,
            3.8372
          ]
        },
        {
          "block_id": "p39_line_15",
          "block_type": "paragraph",
          "text": "Statistical methods:",
          "bbox": [
            1.2538,
            4.3402,
            2.4188,
            4.4787
          ]
        },
        {
          "block_id": "p39_line_16",
          "block_type": "paragraph",
          "text": "SUMMARY - CONCLUSIONS",
          "bbox": [
            1.2519,
            5.14,
            3.0373,
            5.2818
          ]
        },
        {
          "block_id": "p39_line_17",
          "block_type": "paragraph",
          "text": "EFFICACY RESULTS:",
          "bbox": [
            1.2508,
            5.4777,
            2.6955,
            5.6187
          ]
        },
        {
          "block_id": "p39_line_18",
          "block_type": "paragraph",
          "text": "SAFETY RESULTS:",
          "bbox": [
            1.2496,
            6.6784,
            2.5296,
            6.8194
          ]
        },
        {
          "block_id": "p39_line_19",
          "block_type": "paragraph",
          "text": "CONCLUSION:",
          "bbox": [
            1.2605,
            7.8763,
            2.2463,
            8.016
          ]
        },
        {
          "block_id": "p39_line_20",
          "block_type": "paragraph",
          "text": "Date of the report:",
          "bbox": [
            1.2463,
            9.3846,
            2.334,
            9.526
          ]
        },
        {
          "block_id": "p39_line_21",
          "block_type": "paragraph",
          "text": "31",
          "bbox": [
            4.1406,
            10.9492,
            4.3093,
            11.0831
          ]
        },
        {
          "block_id": "table_7",
          "block_type": "table",
          "page_number": 39,
          "bbox": [
            1.1593,
            1.292,
            7.4604,
            9.7272
          ],
          "headers": [
            "",
            "Laboratory Tests",
            "",
            "",
            "",
            "",
            "",
            "",
            "",
            ""
          ],
          "rows": [
            [
              "Name of Sponsor/Company:",
              "Individual Study Table Referring to Part of the Dossier",
              "(For National Authority Use Only)"
            ],
            [
              "Name of Finished Product:",
              "Volume:",
              ""
            ],
            [
              "Name of Active Ingredient:",
              "Page:",
              ""
            ],
            [
              "Criteria for evaluation: Efficacy: Safety:",
              "",
              ""
            ],
            [
              "Statistical methods:",
              "",
              ""
            ],
            [
              "SUMMARY - CONCLUSIONS EFFICACY RESULTS:",
              "",
              ""
            ],
            [
              "SAFETY RESULTS: CONCLUSION: Date of the report:",
              "",
              ""
            ]
          ]
        }
      ]
    },
    {
      "page_number": 40,
      "width": 8.2639,
      "height": 11.6944,
      "unit": "inch",
      "blocks": [
        {
          "block_id": "p40_line_0",
          "block_type": "paragraph",
          "text": "Structure and Content of Clinical Study Reports",
          "bbox": [
            0.9743,
            0.7138,
            4.08,
            0.8866
          ]
        },
        {
          "block_id": "p40_line_1",
          "block_type": "paragraph",
          "text": "ANNEX II",
          "bbox": [
            6.2859,
            1.0543,
            7.0998,
            1.2059
          ]
        },
        {
          "block_id": "p40_line_2",
          "block_type": "paragraph",
          "text": "PRINCIPAL OR COORDINATING",
          "bbox": [
            2.6559,
            1.5931,
            5.5703,
            1.7744
          ]
        },
        {
          "block_id": "p40_line_3",
          "block_type": "paragraph",
          "text": "INVESTIGATOR(S) SIGNATURE(S)",
          "bbox": [
            2.5702,
            1.833,
            5.6483,
            2.0258
          ]
        },
        {
          "block_id": "p40_line_4",
          "block_type": "paragraph",
          "text": "OR SPONSOR'S RESPONSIBLE MEDICAL OFFICER",
          "bbox": [
            2.2908,
            2.0943,
            5.9322,
            2.2579
          ]
        },
        {
          "block_id": "p40_line_5",
          "block_type": "paragraph",
          "text": "STUDY TITLE:",
          "bbox": [
            1.4472,
            3.4838,
            2.6753,
            3.6641
          ]
        },
        {
          "block_id": "p40_line_6",
          "block_type": "paragraph",
          "text": "STUDY AUTHOR(S):",
          "bbox": [
            1.4467,
            4.4254,
            3.1204,
            4.6223
          ]
        },
        {
          "block_id": "p40_line_7",
          "block_type": "paragraph",
          "text": "I have read this report and confirm that to the best of my knowledge it accurately",
          "bbox": [
            1.0598,
            4.7455,
            7.1745,
            4.9371
          ]
        },
        {
          "block_id": "p40_line_8",
          "block_type": "paragraph",
          "text": "describes the conduct and results of the study",
          "bbox": [
            1.0572,
            4.9298,
            4.2305,
            5.1174
          ]
        },
        {
          "block_id": "p40_line_9",
          "block_type": "paragraph",
          "text": "INVESTIGATOR:",
          "bbox": [
            1.0512,
            5.5456,
            2.336,
            5.7152
          ]
        },
        {
          "block_id": "p40_line_10",
          "block_type": "paragraph",
          "text": "SIGNATURE(S)",
          "bbox": [
            4.218,
            5.5446,
            5.3868,
            5.7229
          ]
        },
        {
          "block_id": "p40_line_11",
          "block_type": "paragraph",
          "text": "OR SPONSOR'S RESPONSIBLE",
          "bbox": [
            1.0577,
            5.7276,
            3.4167,
            5.8978
          ]
        },
        {
          "block_id": "p40_line_12",
          "block_type": "paragraph",
          "text": "MEDICAL OFFICER",
          "bbox": [
            1.0478,
            5.913,
            2.5862,
            6.0786
          ]
        },
        {
          "block_id": "p40_line_13",
          "block_type": "paragraph",
          "text": "AFFILIATION:",
          "bbox": [
            1.0534,
            6.5311,
            2.1712,
            6.693
          ]
        },
        {
          "block_id": "p40_line_14",
          "block_type": "paragraph",
          "text": "DATE:",
          "bbox": [
            1.0485,
            8.0736,
            1.5512,
            8.2328
          ]
        },
        {
          "block_id": "p40_line_15",
          "block_type": "paragraph",
          "text": "32",
          "bbox": [
            3.9437,
            10.9439,
            4.122,
            11.0877
          ]
        }
      ]
    },
    {
      "page_number": 41,
      "width": 8.2639,
      "height": 11.6944,
      "unit": "inch",
      "blocks": [
        {
          "block_id": "p41_line_0",
          "block_type": "paragraph",
          "text": "Structure and Content of Clinical Study Reports",
          "bbox": [
            4.1861,
            0.7195,
            7.2889,
            0.8867
          ]
        },
        {
          "block_id": "p41_line_1",
          "block_type": "paragraph",
          "text": "ANNEX III a",
          "bbox": [
            6.2702,
            1.0581,
            7.2848,
            1.2087
          ]
        },
        {
          "block_id": "p41_line_2",
          "block_type": "paragraph",
          "text": "STUDY DESIGN AND SCHEDULE OF ASSESSMENTS",
          "bbox": [
            2.3295,
            1.7639,
            6.1293,
            1.9404
          ]
        },
        {
          "block_id": "p41_line_3",
          "block_type": "paragraph",
          "text": "TREATMENT PERIOD",
          "bbox": [
            1.1495,
            2.3069,
            2.8434,
            2.4691
          ]
        },
        {
          "block_id": "p41_line_4",
          "block_type": "paragraph",
          "text": "A",
          "bbox": [
            3.1133,
            2.3222,
            3.2369,
            2.4609
          ]
        },
        {
          "block_id": "p41_line_5",
          "block_type": "paragraph",
          "text": "B",
          "bbox": [
            4.2465,
            2.3156,
            4.3645,
            2.4577
          ]
        },
        {
          "block_id": "p41_line_6",
          "block_type": "paragraph",
          "text": "C",
          "bbox": [
            6.4234,
            2.3114,
            6.538,
            2.4621
          ]
        },
        {
          "block_id": "p41_line_7",
          "block_type": "paragraph",
          "text": "B1",
          "bbox": [
            3.9892,
            2.8678,
            4.1906,
            3.0158
          ]
        },
        {
          "block_id": "p41_line_8",
          "block_type": "paragraph",
          "text": "B2",
          "bbox": [
            4.5962,
            2.8672,
            4.7987,
            3.0148
          ]
        },
        {
          "block_id": "p41_line_9",
          "block_type": "paragraph",
          "text": "C1",
          "bbox": [
            6.1262,
            2.8665,
            6.3134,
            3.0162
          ]
        },
        {
          "block_id": "p41_line_10",
          "block_type": "paragraph",
          "text": "C2",
          "bbox": [
            6.7018,
            2.8666,
            6.8988,
            3.0159
          ]
        },
        {
          "block_id": "p41_line_11",
          "block_type": "paragraph",
          "text": "Test Drug/",
          "bbox": [
            3.9864,
            3.2753,
            4.7638,
            3.4417
          ]
        },
        {
          "block_id": "p41_line_12",
          "block_type": "paragraph",
          "text": "Investigational",
          "bbox": [
            3.9903,
            3.423,
            5.0738,
            3.5722
          ]
        },
        {
          "block_id": "p41_line_13",
          "block_type": "paragraph",
          "text": "Product A",
          "bbox": [
            3.9909,
            3.5545,
            4.7128,
            3.7059
          ]
        },
        {
          "block_id": "p41_line_14",
          "block_type": "paragraph",
          "text": "Test Drug/",
          "bbox": [
            6.114,
            3.2753,
            6.8891,
            3.4375
          ]
        },
        {
          "block_id": "p41_line_15",
          "block_type": "paragraph",
          "text": "Investigational",
          "bbox": [
            6.1145,
            3.4215,
            7.2006,
            3.5712
          ]
        },
        {
          "block_id": "p41_line_16",
          "block_type": "paragraph",
          "text": "Product A",
          "bbox": [
            6.1169,
            3.5532,
            6.8366,
            3.7059
          ]
        },
        {
          "block_id": "p41_line_17",
          "block_type": "paragraph",
          "text": "Run-in",
          "bbox": [
            3.1091,
            3.9233,
            3.6215,
            4.0796
          ]
        },
        {
          "block_id": "p41_line_18",
          "block_type": "paragraph",
          "text": "5 mg 10 mg",
          "bbox": [
            3.9885,
            3.7877,
            5.0743,
            3.9509
          ]
        },
        {
          "block_id": "p41_line_19",
          "block_type": "paragraph",
          "text": "5 mg",
          "bbox": [
            6.1189,
            3.7898,
            6.5046,
            3.9457
          ]
        },
        {
          "block_id": "p41_line_20",
          "block_type": "paragraph",
          "text": "10 mg",
          "bbox": [
            6.6968,
            3.7912,
            7.1637,
            3.9457
          ]
        },
        {
          "block_id": "p41_line_21",
          "block_type": "paragraph",
          "text": "Test Drug/",
          "bbox": [
            3.9859,
            4.1148,
            4.7646,
            4.2787
          ]
        },
        {
          "block_id": "p41_line_22",
          "block_type": "paragraph",
          "text": "Investigational",
          "bbox": [
            3.986,
            4.259,
            5.074,
            4.4128
          ]
        },
        {
          "block_id": "p41_line_23",
          "block_type": "paragraph",
          "text": "Test Drug/",
          "bbox": [
            6.1165,
            4.1167,
            6.8878,
            4.2769
          ]
        },
        {
          "block_id": "p41_line_24",
          "block_type": "paragraph",
          "text": "Investigational",
          "bbox": [
            6.1152,
            4.26,
            7.2022,
            4.4128
          ]
        },
        {
          "block_id": "p41_line_25",
          "block_type": "paragraph",
          "text": "Product B",
          "bbox": [
            6.1133,
            4.3942,
            6.8337,
            4.5453
          ]
        },
        {
          "block_id": "p41_line_26",
          "block_type": "paragraph",
          "text": "Product B",
          "bbox": [
            3.9876,
            4.3921,
            4.7079,
            4.5453
          ]
        },
        {
          "block_id": "p41_line_27",
          "block_type": "paragraph",
          "text": "5 mg 10 mg",
          "bbox": [
            3.9864,
            4.624,
            5.0768,
            4.7908
          ]
        },
        {
          "block_id": "p41_line_28",
          "block_type": "paragraph",
          "text": "5 mg",
          "bbox": [
            6.1165,
            4.629,
            6.5049,
            4.7903
          ]
        },
        {
          "block_id": "p41_line_29",
          "block_type": "paragraph",
          "text": "10 mg",
          "bbox": [
            6.6972,
            4.6299,
            7.1644,
            4.7875
          ]
        },
        {
          "block_id": "p41_line_30",
          "block_type": "paragraph",
          "text": "Weeks",
          "bbox": [
            1.1447,
            5.3869,
            1.6728,
            5.5481
          ]
        },
        {
          "block_id": "p41_line_31",
          "block_type": "paragraph",
          "text": "-2 (-3)",
          "bbox": [
            3.1721,
            5.3876,
            3.5828,
            5.5591
          ]
        },
        {
          "block_id": "p41_line_32",
          "block_type": "paragraph",
          "text": "0",
          "bbox": [
            4.2398,
            5.3976,
            4.3265,
            5.5388
          ]
        },
        {
          "block_id": "p41_line_33",
          "block_type": "paragraph",
          "text": "3",
          "bbox": [
            4.9479,
            5.3982,
            5.0403,
            5.5346
          ]
        },
        {
          "block_id": "p41_line_34",
          "block_type": "paragraph",
          "text": "6",
          "bbox": [
            5.663,
            5.4019,
            5.7497,
            5.534
          ]
        },
        {
          "block_id": "p41_line_35",
          "block_type": "paragraph",
          "text": "9",
          "bbox": [
            6.3698,
            5.3973,
            6.4578,
            5.5338
          ]
        },
        {
          "block_id": "p41_line_36",
          "block_type": "paragraph",
          "text": "12",
          "bbox": [
            7.0875,
            5.3971,
            7.2545,
            5.5376
          ]
        },
        {
          "block_id": "p41_line_37",
          "block_type": "paragraph",
          "text": "Visit",
          "bbox": [
            1.1536,
            5.7006,
            1.5116,
            5.8536
          ]
        },
        {
          "block_id": "p41_line_38",
          "block_type": "paragraph",
          "text": "1",
          "bbox": [
            3.1727,
            5.7089,
            3.2492,
            5.8415
          ]
        },
        {
          "block_id": "p41_line_39",
          "block_type": "paragraph",
          "text": "2",
          "bbox": [
            4.2382,
            5.7081,
            4.329,
            5.8426
          ]
        },
        {
          "block_id": "p41_line_40",
          "block_type": "paragraph",
          "text": "3",
          "bbox": [
            4.9486,
            5.7081,
            5.0406,
            5.8434
          ]
        },
        {
          "block_id": "p41_line_41",
          "block_type": "paragraph",
          "text": "4",
          "bbox": [
            5.6642,
            5.7136,
            5.752,
            5.8417
          ]
        },
        {
          "block_id": "p41_line_42",
          "block_type": "paragraph",
          "text": "5",
          "bbox": [
            6.3677,
            5.709,
            6.4581,
            5.8432
          ]
        },
        {
          "block_id": "p41_line_43",
          "block_type": "paragraph",
          "text": "6",
          "bbox": [
            7.0821,
            5.7072,
            7.1691,
            5.8434
          ]
        },
        {
          "block_id": "p41_line_44",
          "block_type": "paragraph",
          "text": "Exercise test 24 h",
          "bbox": [
            1.1573,
            6.0561,
            2.426,
            6.2168
          ]
        },
        {
          "block_id": "p41_line_45",
          "block_type": "paragraph",
          "text": "x1",
          "bbox": [
            3.6037,
            6.0684,
            3.7636,
            6.2068
          ]
        },
        {
          "block_id": "p41_line_46",
          "block_type": "paragraph",
          "text": "x2",
          "bbox": [
            4.2262,
            6.0549,
            4.3918,
            6.2127
          ]
        },
        {
          "block_id": "p41_line_47",
          "block_type": "paragraph",
          "text": "x",
          "bbox": [
            4.9602,
            6.1185,
            5.0363,
            6.1884
          ]
        },
        {
          "block_id": "p41_line_48",
          "block_type": "paragraph",
          "text": "x",
          "bbox": [
            5.6702,
            6.1185,
            5.7463,
            6.1884
          ]
        },
        {
          "block_id": "p41_line_49",
          "block_type": "paragraph",
          "text": "x",
          "bbox": [
            6.3793,
            6.1186,
            6.4554,
            6.1884
          ]
        },
        {
          "block_id": "p41_line_50",
          "block_type": "paragraph",
          "text": "x",
          "bbox": [
            7.0893,
            6.1186,
            7.1654,
            6.1884
          ]
        },
        {
          "block_id": "p41_line_51",
          "block_type": "paragraph",
          "text": "Medical history",
          "bbox": [
            1.1482,
            6.3648,
            2.268,
            6.5404
          ]
        },
        {
          "block_id": "p41_line_52",
          "block_type": "paragraph",
          "text": "x",
          "bbox": [
            3.176,
            6.4269,
            3.2521,
            6.4967
          ]
        },
        {
          "block_id": "p41_line_53",
          "block_type": "paragraph",
          "text": "Physical examination",
          "bbox": [
            1.1518,
            6.6725,
            2.6943,
            6.8465
          ]
        },
        {
          "block_id": "p41_line_54",
          "block_type": "paragraph",
          "text": "x",
          "bbox": [
            3.176,
            6.7352,
            3.2521,
            6.805
          ]
        },
        {
          "block_id": "p41_line_55",
          "block_type": "paragraph",
          "text": "x",
          "bbox": [
            7.0893,
            6.7353,
            7.1654,
            6.8051
          ]
        },
        {
          "block_id": "p41_line_56",
          "block_type": "paragraph",
          "text": "ECG",
          "bbox": [
            1.1578,
            6.9794,
            1.5099,
            7.1369
          ]
        },
        {
          "block_id": "p41_line_57",
          "block_type": "paragraph",
          "text": "x",
          "bbox": [
            3.176,
            7.0435,
            3.2521,
            7.1134
          ]
        },
        {
          "block_id": "p41_line_58",
          "block_type": "paragraph",
          "text": "x",
          "bbox": [
            7.0893,
            7.0436,
            7.1654,
            7.1135
          ]
        },
        {
          "block_id": "p41_line_59",
          "block_type": "paragraph",
          "text": "Lab. invest.",
          "bbox": [
            1.1509,
            7.2932,
            1.9918,
            7.4476
          ]
        },
        {
          "block_id": "p41_line_60",
          "block_type": "paragraph",
          "text": "x",
          "bbox": [
            3.176,
            7.3519,
            3.2521,
            7.4217
          ]
        },
        {
          "block_id": "p41_line_61",
          "block_type": "paragraph",
          "text": "x",
          "bbox": [
            7.0893,
            7.352,
            7.1654,
            7.4218
          ]
        },
        {
          "block_id": "p41_line_62",
          "block_type": "paragraph",
          "text": "Adverse events",
          "bbox": [
            1.1549,
            7.6029,
            2.2425,
            7.7572
          ]
        },
        {
          "block_id": "p41_line_63",
          "block_type": "paragraph",
          "text": "x",
          "bbox": [
            4.2502,
            7.6602,
            4.3263,
            7.73
          ]
        },
        {
          "block_id": "p41_line_64",
          "block_type": "paragraph",
          "text": "x",
          "bbox": [
            4.9602,
            7.6602,
            5.0363,
            7.7301
          ]
        },
        {
          "block_id": "p41_line_65",
          "block_type": "paragraph",
          "text": "x",
          "bbox": [
            5.6702,
            7.6602,
            5.7463,
            7.7301
          ]
        },
        {
          "block_id": "p41_line_66",
          "block_type": "paragraph",
          "text": "x",
          "bbox": [
            6.3793,
            7.6603,
            6.4554,
            7.7301
          ]
        },
        {
          "block_id": "p41_line_67",
          "block_type": "paragraph",
          "text": "x",
          "bbox": [
            7.0893,
            7.6603,
            7.1654,
            7.7301
          ]
        },
        {
          "block_id": "p41_line_68",
          "block_type": "paragraph",
          "text": "1 = 14-20 days after visit 1",
          "bbox": [
            1.1767,
            8.2166,
            3.0588,
            8.382
          ]
        },
        {
          "block_id": "p41_line_69",
          "block_type": "paragraph",
          "text": "2 = 1-7 days after the first exercise test",
          "bbox": [
            1.1666,
            8.5235,
            3.9482,
            8.6916
          ]
        },
        {
          "block_id": "p41_line_70",
          "block_type": "paragraph",
          "text": "33",
          "bbox": [
            4.1421,
            10.9472,
            4.3176,
            11.0843
          ]
        },
        {
          "block_id": "table_8",
          "block_type": "table",
          "page_number": 41,
          "bbox": [
            1.094,
            4.4604,
            7.3431,
            7.7986
          ],
          "headers": [
            "",
            "",
            "Product\n5 mg",
            "B\n10 mg",
            "",
            "5 mg",
            "10 mg"
          ],
          "rows": [
            [
              "Weeks",
              "-2 (-3)",
              "0",
              "3",
              "6",
              "9",
              "12"
            ],
            [
              "Visit",
              "1",
              "2",
              "3",
              "4",
              "5",
              "6"
            ],
            [
              "Exercise test 24 h",
              "x1 :selected:\n:unselected:",
              "x2 :selected:",
              "x :selected:",
              "x :selected:",
              "x :selected:",
              "x :selected:"
            ],
            [
              "Medical history",
              ":selected: x",
              "",
              "",
              "",
              "",
              ""
            ],
            [
              "Physical examination",
              "x :selected:",
              "",
              "",
              "",
              "",
              ":selected: x"
            ],
            [
              "ECG",
              "x :selected:",
              "",
              "",
              "",
              "",
              ":selected: x"
            ],
            [
              "Lab. invest.",
              "x :selected:",
              "",
              "",
              "",
              "",
              ":selected: x"
            ],
            [
              "Adverse events",
              "",
              ":selected: x",
              ":selected: x",
              ":selected: x",
              ":selected: x",
              ":selected: x"
            ]
          ]
        }
      ]
    },
    {
      "page_number": 42,
      "width": 8.2639,
      "height": 11.6944,
      "unit": "inch",
      "blocks": [
        {
          "block_id": "p42_line_0",
          "block_type": "paragraph",
          "text": "Structure and Content of Clinical Study Reports",
          "bbox": [
            0.9724,
            0.7138,
            4.0795,
            0.8868
          ]
        },
        {
          "block_id": "p42_line_1",
          "block_type": "paragraph",
          "text": "ANNEX III b",
          "bbox": [
            6.0814,
            1.05,
            7.0865,
            1.209
          ]
        },
        {
          "block_id": "p42_line_2",
          "block_type": "paragraph",
          "text": "STUDY DESIGN AND SCHEDULE OF ASSESSMENTS",
          "bbox": [
            2.1283,
            1.5718,
            5.9311,
            1.751
          ]
        },
        {
          "block_id": "p42_line_3",
          "block_type": "paragraph",
          "text": "Double-blind",
          "bbox": [
            5.0785,
            2.1331,
            5.764,
            2.2603
          ]
        },
        {
          "block_id": "p42_line_4",
          "block_type": "paragraph",
          "text": "placebo",
          "bbox": [
            5.0777,
            2.3534,
            5.4823,
            2.4758
          ]
        },
        {
          "block_id": "p42_line_5",
          "block_type": "paragraph",
          "text": "Single-blind",
          "bbox": [
            3.605,
            2.5086,
            4.2468,
            2.6451
          ]
        },
        {
          "block_id": "p42_line_6",
          "block_type": "paragraph",
          "text": "Screening",
          "bbox": [
            2.6216,
            2.7409,
            3.1519,
            2.8768
          ]
        },
        {
          "block_id": "p42_line_7",
          "block_type": "paragraph",
          "text": "Placebo run-in",
          "bbox": [
            3.6044,
            2.7403,
            4.3704,
            2.8687
          ]
        },
        {
          "block_id": "p42_line_8",
          "block_type": "paragraph",
          "text": "Dose 1",
          "bbox": [
            5.0813,
            2.7447,
            5.4363,
            2.8647
          ]
        },
        {
          "block_id": "p42_line_9",
          "block_type": "paragraph",
          "text": "1",
          "bbox": [
            2.6309,
            2.9599,
            2.6916,
            3.0586
          ]
        },
        {
          "block_id": "p42_line_10",
          "block_type": "paragraph",
          "text": "2",
          "bbox": [
            3.1139,
            2.9572,
            3.1878,
            3.0588
          ]
        },
        {
          "block_id": "p42_line_11",
          "block_type": "paragraph",
          "text": "3",
          "bbox": [
            3.6094,
            2.9589,
            3.6798,
            3.0624
          ]
        },
        {
          "block_id": "p42_line_12",
          "block_type": "paragraph",
          "text": "4",
          "bbox": [
            4.1051,
            2.9645,
            4.1759,
            3.06
          ]
        },
        {
          "block_id": "p42_line_13",
          "block_type": "paragraph",
          "text": "R",
          "bbox": [
            4.4674,
            2.9524,
            4.5601,
            3.064
          ]
        },
        {
          "block_id": "p42_line_14",
          "block_type": "paragraph",
          "text": "11",
          "bbox": [
            7.3919,
            2.9567,
            7.5069,
            3.0622
          ]
        },
        {
          "block_id": "p42_line_15",
          "block_type": "paragraph",
          "text": "Visit",
          "bbox": [
            1.5608,
            3.1067,
            1.8868,
            3.2539
          ]
        },
        {
          "block_id": "p42_line_16",
          "block_type": "paragraph",
          "text": "(7d)",
          "bbox": [
            2.7566,
            3.294,
            2.956,
            3.4225
          ]
        },
        {
          "block_id": "p42_line_17",
          "block_type": "paragraph",
          "text": "(7d)",
          "bbox": [
            3.2479,
            3.2933,
            3.4485,
            3.4229
          ]
        },
        {
          "block_id": "p42_line_18",
          "block_type": "paragraph",
          "text": "(7d)",
          "bbox": [
            3.7392,
            3.294,
            3.9426,
            3.4234
          ]
        },
        {
          "block_id": "p42_line_19",
          "block_type": "paragraph",
          "text": "(7d)",
          "bbox": [
            4.2324,
            3.2948,
            4.4341,
            3.4216
          ]
        },
        {
          "block_id": "p42_line_20",
          "block_type": "paragraph",
          "text": "Dose 2",
          "bbox": [
            5.0783,
            3.3375,
            5.442,
            3.4565
          ]
        },
        {
          "block_id": "p42_line_21",
          "block_type": "paragraph",
          "text": "10",
          "bbox": [
            6.6609,
            3.3832,
            6.7876,
            3.4922
          ]
        },
        {
          "block_id": "p42_line_22",
          "block_type": "paragraph",
          "text": "14d",
          "bbox": [
            7.0599,
            3.2966,
            7.2529,
            3.4065
          ]
        },
        {
          "block_id": "p42_line_23",
          "block_type": "paragraph",
          "text": "Dose 3",
          "bbox": [
            5.0802,
            3.7374,
            5.4427,
            3.857
          ]
        },
        {
          "block_id": "p42_line_24",
          "block_type": "paragraph",
          "text": "(7d)",
          "bbox": [
            4.7275,
            4.0863,
            4.9273,
            4.2177
          ]
        },
        {
          "block_id": "p42_line_25",
          "block_type": "paragraph",
          "text": "(7d)",
          "bbox": [
            5.2194,
            4.0866,
            5.4198,
            4.2161
          ]
        },
        {
          "block_id": "p42_line_26",
          "block_type": "paragraph",
          "text": "(7d)",
          "bbox": [
            5.7111,
            4.0869,
            5.9117,
            4.216
          ]
        },
        {
          "block_id": "p42_line_27",
          "block_type": "paragraph",
          "text": "(7d)",
          "bbox": [
            6.2029,
            4.0881,
            6.4013,
            4.2163
          ]
        },
        {
          "block_id": "p42_line_28",
          "block_type": "paragraph",
          "text": "5",
          "bbox": [
            4.5988,
            4.3839,
            4.6625,
            4.4975
          ]
        },
        {
          "block_id": "p42_line_29",
          "block_type": "paragraph",
          "text": "6",
          "bbox": [
            5.0888,
            4.3891,
            5.1562,
            4.4991
          ]
        },
        {
          "block_id": "p42_line_30",
          "block_type": "paragraph",
          "text": "7",
          "bbox": [
            5.5841,
            4.3837,
            5.647,
            4.4965
          ]
        },
        {
          "block_id": "p42_line_31",
          "block_type": "paragraph",
          "text": "8",
          "bbox": [
            6.0735,
            4.3872,
            6.1437,
            4.4988
          ]
        },
        {
          "block_id": "p42_line_32",
          "block_type": "paragraph",
          "text": "9",
          "bbox": [
            6.4119,
            4.389,
            6.4803,
            4.4978
          ]
        },
        {
          "block_id": "p42_line_33",
          "block_type": "paragraph",
          "text": "Assessment",
          "bbox": [
            0.8477,
            5.4642,
            1.5218,
            5.5947
          ]
        },
        {
          "block_id": "p42_line_34",
          "block_type": "paragraph",
          "text": "Screening",
          "bbox": [
            2.2326,
            5.4512,
            2.818,
            5.6049
          ]
        },
        {
          "block_id": "p42_line_35",
          "block_type": "paragraph",
          "text": "Run-in",
          "bbox": [
            3.0176,
            5.4532,
            3.4353,
            5.5918
          ]
        },
        {
          "block_id": "p42_line_36",
          "block_type": "paragraph",
          "text": "Baseline",
          "bbox": [
            3.7881,
            5.4533,
            4.2899,
            5.5932
          ]
        },
        {
          "block_id": "p42_line_37",
          "block_type": "paragraph",
          "text": "Treatment",
          "bbox": [
            4.8135,
            5.4546,
            5.4263,
            5.5943
          ]
        },
        {
          "block_id": "p42_line_38",
          "block_type": "paragraph",
          "text": "Follow-up",
          "bbox": [
            6.3583,
            5.453,
            6.9503,
            5.6059
          ]
        },
        {
          "block_id": "p42_line_39",
          "block_type": "paragraph",
          "text": "Study Week",
          "bbox": [
            0.8501,
            5.7234,
            1.5648,
            5.8749
          ]
        },
        {
          "block_id": "p42_line_40",
          "block_type": "paragraph",
          "text": "-2",
          "bbox": [
            2.5019,
            5.7388,
            2.6246,
            5.868
          ]
        },
        {
          "block_id": "p42_line_41",
          "block_type": "paragraph",
          "text": "-1",
          "bbox": [
            3.1898,
            5.7434,
            3.3043,
            5.8683
          ]
        },
        {
          "block_id": "p42_line_42",
          "block_type": "paragraph",
          "text": "0",
          "bbox": [
            3.755,
            5.7395,
            3.8381,
            5.868
          ]
        },
        {
          "block_id": "p42_line_43",
          "block_type": "paragraph",
          "text": "1",
          "bbox": [
            4.2706,
            5.7433,
            4.342,
            5.8669
          ]
        },
        {
          "block_id": "p42_line_44",
          "block_type": "paragraph",
          "text": "2",
          "bbox": [
            4.7784,
            5.7383,
            4.8623,
            5.8656
          ]
        },
        {
          "block_id": "p42_line_45",
          "block_type": "paragraph",
          "text": "3",
          "bbox": [
            5.2906,
            5.7398,
            5.3745,
            5.8655
          ]
        },
        {
          "block_id": "p42_line_46",
          "block_type": "paragraph",
          "text": "4",
          "bbox": [
            5.8071,
            5.7458,
            5.8877,
            5.8666
          ]
        },
        {
          "block_id": "p42_line_47",
          "block_type": "paragraph",
          "text": "5",
          "bbox": [
            6.3139,
            5.7381,
            6.397,
            5.8668
          ]
        },
        {
          "block_id": "p42_line_48",
          "block_type": "paragraph",
          "text": "6",
          "bbox": [
            6.8275,
            5.7414,
            6.9083,
            5.8684
          ]
        },
        {
          "block_id": "p42_line_49",
          "block_type": "paragraph",
          "text": "8",
          "bbox": [
            7.3379,
            5.7389,
            7.4211,
            5.8696
          ]
        },
        {
          "block_id": "p42_line_50",
          "block_type": "paragraph",
          "text": "Informed consent",
          "bbox": [
            0.8431,
            6.0351,
            1.8784,
            6.1776
          ]
        },
        {
          "block_id": "p42_line_51",
          "block_type": "paragraph",
          "text": "x",
          "bbox": [
            2.5257,
            6.1021,
            2.5951,
            6.1658
          ]
        },
        {
          "block_id": "p42_line_52",
          "block_type": "paragraph",
          "text": "History",
          "bbox": [
            0.8479,
            6.3738,
            1.3014,
            6.521
          ]
        },
        {
          "block_id": "p42_line_53",
          "block_type": "paragraph",
          "text": "x",
          "bbox": [
            2.5257,
            6.4354,
            2.5951,
            6.4992
          ]
        },
        {
          "block_id": "p42_line_54",
          "block_type": "paragraph",
          "text": "Physical exam.",
          "bbox": [
            0.8465,
            6.704,
            1.7266,
            6.852
          ]
        },
        {
          "block_id": "p42_line_55",
          "block_type": "paragraph",
          "text": "x",
          "bbox": [
            2.5257,
            6.7688,
            2.5951,
            6.8325
          ]
        },
        {
          "block_id": "p42_line_56",
          "block_type": "paragraph",
          "text": "x",
          "bbox": [
            7.3492,
            6.7688,
            7.4187,
            6.8325
          ]
        },
        {
          "block_id": "p42_line_57",
          "block_type": "paragraph",
          "text": "Effectiveness:",
          "bbox": [
            0.8478,
            7.036,
            1.7634,
            7.1747
          ]
        },
        {
          "block_id": "p42_line_58",
          "block_type": "paragraph",
          "text": "Primary variable",
          "bbox": [
            0.846,
            7.3739,
            1.8556,
            7.5185
          ]
        },
        {
          "block_id": "p42_line_59",
          "block_type": "paragraph",
          "text": "x",
          "bbox": [
            2.5257,
            7.4354,
            2.5951,
            7.4992
          ]
        },
        {
          "block_id": "p42_line_60",
          "block_type": "paragraph",
          "text": "x",
          "bbox": [
            3.2149,
            7.4354,
            3.2843,
            7.4992
          ]
        },
        {
          "block_id": "p42_line_61",
          "block_type": "paragraph",
          "text": "x",
          "bbox": [
            3.7665,
            7.4354,
            3.836,
            7.4992
          ]
        },
        {
          "block_id": "p42_line_62",
          "block_type": "paragraph",
          "text": "x",
          "bbox": [
            4.2782,
            7.4354,
            4.3477,
            7.4992
          ]
        },
        {
          "block_id": "p42_line_63",
          "block_type": "paragraph",
          "text": "x",
          "bbox": [
            4.7899,
            7.4354,
            4.8593,
            7.4992
          ]
        },
        {
          "block_id": "p42_line_64",
          "block_type": "paragraph",
          "text": "x",
          "bbox": [
            5.3016,
            7.4354,
            5.371,
            7.4992
          ]
        },
        {
          "block_id": "p42_line_65",
          "block_type": "paragraph",
          "text": "x",
          "bbox": [
            5.8141,
            7.4354,
            5.8835,
            7.4992
          ]
        },
        {
          "block_id": "p42_line_66",
          "block_type": "paragraph",
          "text": "x",
          "bbox": [
            6.3257,
            7.4354,
            6.3952,
            7.4992
          ]
        },
        {
          "block_id": "p42_line_67",
          "block_type": "paragraph",
          "text": "x",
          "bbox": [
            6.8374,
            7.4354,
            6.9069,
            7.4992
          ]
        },
        {
          "block_id": "p42_line_68",
          "block_type": "paragraph",
          "text": "x",
          "bbox": [
            7.3491,
            7.4354,
            7.4185,
            7.4992
          ]
        },
        {
          "block_id": "p42_line_69",
          "block_type": "paragraph",
          "text": "Secondary variable",
          "bbox": [
            0.8497,
            7.7031,
            1.9757,
            7.8515
          ]
        },
        {
          "block_id": "p42_line_70",
          "block_type": "paragraph",
          "text": "x",
          "bbox": [
            2.5257,
            7.7688,
            2.5951,
            7.8325
          ]
        },
        {
          "block_id": "p42_line_71",
          "block_type": "paragraph",
          "text": "x",
          "bbox": [
            3.2149,
            7.7688,
            3.2843,
            7.8325
          ]
        },
        {
          "block_id": "p42_line_72",
          "block_type": "paragraph",
          "text": "x",
          "bbox": [
            3.7665,
            7.7688,
            3.836,
            7.8325
          ]
        },
        {
          "block_id": "p42_line_73",
          "block_type": "paragraph",
          "text": "x",
          "bbox": [
            4.2782,
            7.7688,
            4.3477,
            7.8325
          ]
        },
        {
          "block_id": "p42_line_74",
          "block_type": "paragraph",
          "text": "x",
          "bbox": [
            5.3016,
            7.7688,
            5.371,
            7.8325
          ]
        },
        {
          "block_id": "p42_line_75",
          "block_type": "paragraph",
          "text": "x",
          "bbox": [
            6.8375,
            7.7688,
            6.9069,
            7.8325
          ]
        },
        {
          "block_id": "p42_line_76",
          "block_type": "paragraph",
          "text": "x",
          "bbox": [
            7.3491,
            7.7688,
            7.4186,
            7.8325
          ]
        },
        {
          "block_id": "p42_line_77",
          "block_type": "paragraph",
          "text": "Safety:",
          "bbox": [
            0.8479,
            8.0403,
            1.3099,
            8.186
          ]
        },
        {
          "block_id": "p42_line_78",
          "block_type": "paragraph",
          "text": "Adverse events",
          "bbox": [
            0.8485,
            8.3776,
            1.7417,
            8.5082
          ]
        },
        {
          "block_id": "p42_line_79",
          "block_type": "paragraph",
          "text": "x",
          "bbox": [
            2.5257,
            8.4354,
            2.5951,
            8.4992
          ]
        },
        {
          "block_id": "p42_line_80",
          "block_type": "paragraph",
          "text": "x",
          "bbox": [
            3.2149,
            8.4354,
            3.2843,
            8.4992
          ]
        },
        {
          "block_id": "p42_line_81",
          "block_type": "paragraph",
          "text": "x",
          "bbox": [
            3.7665,
            8.4354,
            3.836,
            8.4992
          ]
        },
        {
          "block_id": "p42_line_82",
          "block_type": "paragraph",
          "text": "x",
          "bbox": [
            4.2782,
            8.4354,
            4.3477,
            8.4992
          ]
        },
        {
          "block_id": "p42_line_83",
          "block_type": "paragraph",
          "text": "x",
          "bbox": [
            4.7899,
            8.4354,
            4.8593,
            8.4992
          ]
        },
        {
          "block_id": "p42_line_84",
          "block_type": "paragraph",
          "text": "x",
          "bbox": [
            5.3016,
            8.4354,
            5.371,
            8.4992
          ]
        },
        {
          "block_id": "p42_line_85",
          "block_type": "paragraph",
          "text": "x",
          "bbox": [
            5.8141,
            8.4354,
            5.8835,
            8.4992
          ]
        },
        {
          "block_id": "p42_line_86",
          "block_type": "paragraph",
          "text": "x",
          "bbox": [
            6.3257,
            8.4354,
            6.3952,
            8.4992
          ]
        },
        {
          "block_id": "p42_line_87",
          "block_type": "paragraph",
          "text": "x",
          "bbox": [
            6.8374,
            8.4354,
            6.9069,
            8.4992
          ]
        },
        {
          "block_id": "p42_line_88",
          "block_type": "paragraph",
          "text": "x",
          "bbox": [
            7.3491,
            8.4354,
            7.4185,
            8.4992
          ]
        },
        {
          "block_id": "p42_line_89",
          "block_type": "paragraph",
          "text": "Lab. tests",
          "bbox": [
            0.8448,
            8.7051,
            1.4326,
            8.8377
          ]
        },
        {
          "block_id": "p42_line_90",
          "block_type": "paragraph",
          "text": "x",
          "bbox": [
            2.5257,
            8.7688,
            2.5951,
            8.8325
          ]
        },
        {
          "block_id": "p42_line_91",
          "block_type": "paragraph",
          "text": "x",
          "bbox": [
            3.2149,
            8.7688,
            3.2843,
            8.8325
          ]
        },
        {
          "block_id": "p42_line_92",
          "block_type": "paragraph",
          "text": "x",
          "bbox": [
            3.7665,
            8.7688,
            3.836,
            8.8325
          ]
        },
        {
          "block_id": "p42_line_93",
          "block_type": "paragraph",
          "text": "x",
          "bbox": [
            5.3016,
            8.7688,
            5.371,
            8.8325
          ]
        },
        {
          "block_id": "p42_line_94",
          "block_type": "paragraph",
          "text": "x",
          "bbox": [
            6.3258,
            8.7688,
            6.3952,
            8.8325
          ]
        },
        {
          "block_id": "p42_line_95",
          "block_type": "paragraph",
          "text": "x",
          "bbox": [
            6.8375,
            8.7688,
            6.9069,
            8.8325
          ]
        },
        {
          "block_id": "p42_line_96",
          "block_type": "paragraph",
          "text": "Body weight",
          "bbox": [
            0.8484,
            9.0413,
            1.587,
            9.1877
          ]
        },
        {
          "block_id": "p42_line_97",
          "block_type": "paragraph",
          "text": "x",
          "bbox": [
            2.5257,
            9.1021,
            2.5951,
            9.1658
          ]
        },
        {
          "block_id": "p42_line_98",
          "block_type": "paragraph",
          "text": "x",
          "bbox": [
            3.7666,
            9.1021,
            3.836,
            9.1658
          ]
        },
        {
          "block_id": "p42_line_99",
          "block_type": "paragraph",
          "text": "x",
          "bbox": [
            6.8375,
            9.1021,
            6.907,
            9.1658
          ]
        },
        {
          "block_id": "p42_line_100",
          "block_type": "paragraph",
          "text": "x",
          "bbox": [
            7.3492,
            9.1021,
            7.4187,
            9.1658
          ]
        },
        {
          "block_id": "p42_line_101",
          "block_type": "paragraph",
          "text": "34",
          "bbox": [
            3.9434,
            10.9467,
            4.1225,
            11.0885
          ]
        },
        {
          "block_id": "table_9",
          "block_type": "table",
          "page_number": 42,
          "bbox": [
            0.7643,
            5.3756,
            7.6499,
            9.3138
          ],
          "headers": [
            "",
            "",
            "Product\n5 mg",
            "B\n10 mg",
            "",
            "5 mg",
            "10 mg"
          ],
          "rows": [
            [
              "Assessment",
              "Screening",
              "Run-in",
              "Baseline",
              "",
              "Treatment",
              "",
              "",
              "Follow-up",
              "",
              ""
            ],
            [
              "Study Week",
              "-2",
              "-1",
              "0",
              "1",
              "2",
              "3",
              "4",
              "5",
              "6",
              "8"
            ],
            [
              "Informed consent",
              ":selected: x",
              "",
              "",
              "",
              "",
              "",
              "",
              "",
              "",
              ""
            ],
            [
              "History",
              ":selected: x",
              "",
              "",
              "",
              "",
              "",
              "",
              "",
              "",
              ""
            ],
            [
              "Physical exam.",
              ":selected: x",
              "",
              "",
              "",
              "",
              "",
              "",
              "",
              "",
              ":selected: x"
            ],
            [
              "Effectiveness:",
              "",
              "",
              "",
              "",
              "",
              "",
              "",
              "",
              "",
              ""
            ],
            [
              "Primary variable",
              ":selected: x",
              ":selected: x",
              ":selected: x",
              ":selected: x",
              ":selected: x",
              ":selected: x",
              ":selected: x",
              ":selected: x",
              ":selected: x",
              ":selected: x"
            ],
            [
              "Secondary variable",
              ":selected: x",
              ":selected: x",
              ":selected: x",
              ":selected: x",
              ":unselected:",
              ":selected: x",
              "",
              "",
              ":selected: x",
              ":selected: x"
            ],
            [
              "Safety:",
              "",
              "",
              "",
              "",
              "",
              "",
              "",
              "",
              "",
              ""
            ],
            [
              "Adverse events",
              ":selected: x",
              ":selected: x",
              ":selected: x",
              ":selected: x",
              ":selected: x",
              ":selected: x",
              ":selected: x",
              ":selected: x",
              ":selected: x",
              ":selected: x"
            ],
            [
              "Lab. tests",
              ":selected: x",
              ":selected: x",
              ":selected: x",
              ":unselected:",
              "",
              ":selected: x",
              "",
              ":selected: x",
              ":selected: x",
              ""
            ],
            [
              "Body weight",
              ":selected: x",
              ":unselected:",
              ":selected: x",
              ":unselected:",
              "",
              "",
              "",
              "",
              ":selected: x",
              ":selected: x"
            ]
          ]
        }
      ]
    },
    {
      "page_number": 43,
      "width": 11.6944,
      "height": 8.2639,
      "unit": "inch",
      "blocks": [
        {
          "block_id": "p43_line_0",
          "block_type": "paragraph",
          "text": "Structure and Content of Clinical Study Reports",
          "bbox": [
            7.6102,
            0.7196,
            10.7203,
            0.8815
          ]
        },
        {
          "block_id": "p43_line_1",
          "block_type": "paragraph",
          "text": "ANNEX IV a",
          "bbox": [
            9.7168,
            1.2879,
            10.7202,
            1.4331
          ]
        },
        {
          "block_id": "p43_line_2",
          "block_type": "paragraph",
          "text": "DISPOSITION OF PATIENTS",
          "bbox": [
            4.7947,
            1.5107,
            6.8903,
            1.6719
          ]
        },
        {
          "block_id": "p43_line_3",
          "block_type": "paragraph",
          "text": "N=1,724",
          "bbox": [
            5.5195,
            1.7995,
            6.1389,
            1.9542
          ]
        },
        {
          "block_id": "p43_line_4",
          "block_type": "paragraph",
          "text": "PATIENTS RECEIVING",
          "bbox": [
            4.9318,
            1.9764,
            6.721,
            2.1312
          ]
        },
        {
          "block_id": "p43_line_5",
          "block_type": "paragraph",
          "text": "DOUBLE-BLIND MEDICATION",
          "bbox": [
            4.6382,
            2.1575,
            7.0157,
            2.317
          ]
        },
        {
          "block_id": "p43_line_6",
          "block_type": "paragraph",
          "text": "N = 340",
          "bbox": [
            1.4005,
            2.9764,
            1.982,
            3.1228
          ]
        },
        {
          "block_id": "p43_line_7",
          "block_type": "paragraph",
          "text": "REGIMEN A",
          "bbox": [
            1.2153,
            3.1583,
            2.1725,
            3.3059
          ]
        },
        {
          "block_id": "p43_line_8",
          "block_type": "paragraph",
          "text": "N =",
          "bbox": [
            3.622,
            2.9767,
            3.9026,
            3.1181
          ]
        },
        {
          "block_id": "p43_line_9",
          "block_type": "paragraph",
          "text": "REGIMEN B",
          "bbox": [
            3.2818,
            3.1564,
            4.2397,
            3.3067
          ]
        },
        {
          "block_id": "p43_line_10",
          "block_type": "paragraph",
          "text": "N =",
          "bbox": [
            5.6873,
            2.9773,
            5.9708,
            3.1171
          ]
        },
        {
          "block_id": "p43_line_11",
          "block_type": "paragraph",
          "text": "REGIMEN C",
          "bbox": [
            5.3462,
            3.1549,
            6.3048,
            3.3099
          ]
        },
        {
          "block_id": "p43_line_12",
          "block_type": "paragraph",
          "text": "N =",
          "bbox": [
            7.7554,
            2.9776,
            8.0401,
            3.115
          ]
        },
        {
          "block_id": "p43_line_13",
          "block_type": "paragraph",
          "text": "REGIMEN D",
          "bbox": [
            7.4118,
            3.1561,
            8.3704,
            3.3065
          ]
        },
        {
          "block_id": "p43_line_14",
          "block_type": "paragraph",
          "text": "N =",
          "bbox": [
            9.8258,
            2.9788,
            10.1027,
            3.115
          ]
        },
        {
          "block_id": "p43_line_15",
          "block_type": "paragraph",
          "text": "REGIMEN E",
          "bbox": [
            9.483,
            3.1575,
            10.4418,
            3.3067
          ]
        },
        {
          "block_id": "p43_line_16",
          "block_type": "paragraph",
          "text": "N=281",
          "bbox": [
            1.0968,
            4.0924,
            1.5489,
            4.2103
          ]
        },
        {
          "block_id": "p43_line_17",
          "block_type": "paragraph",
          "text": "COMPLETED",
          "bbox": [
            0.9931,
            4.2555,
            1.6522,
            4.3591
          ]
        },
        {
          "block_id": "p43_line_18",
          "block_type": "paragraph",
          "text": "STUDY",
          "bbox": [
            1.1393,
            4.4059,
            1.5099,
            4.5068
          ]
        },
        {
          "block_id": "p43_line_19",
          "block_type": "paragraph",
          "text": "N=59",
          "bbox": [
            2.0163,
            4.0905,
            2.4037,
            4.2096
          ]
        },
        {
          "block_id": "p43_line_20",
          "block_type": "paragraph",
          "text": "WITHDRAWN",
          "bbox": [
            1.8726,
            4.2542,
            2.5488,
            4.3614
          ]
        },
        {
          "block_id": "p43_line_21",
          "block_type": "paragraph",
          "text": "N =",
          "bbox": [
            3.275,
            4.0953,
            3.5071,
            4.2027
          ]
        },
        {
          "block_id": "p43_line_22",
          "block_type": "paragraph",
          "text": "COMPLETED",
          "bbox": [
            3.0645,
            4.2541,
            3.7228,
            4.36
          ]
        },
        {
          "block_id": "p43_line_23",
          "block_type": "paragraph",
          "text": "STUDY",
          "bbox": [
            3.2075,
            4.4062,
            3.577,
            4.5072
          ]
        },
        {
          "block_id": "p43_line_24",
          "block_type": "paragraph",
          "text": "N=",
          "bbox": [
            4.1677,
            4.0939,
            4.3912,
            4.2024
          ]
        },
        {
          "block_id": "p43_line_25",
          "block_type": "paragraph",
          "text": "WITHDRAWN",
          "bbox": [
            3.9391,
            4.254,
            4.6171,
            4.3628
          ]
        },
        {
          "block_id": "p43_line_26",
          "block_type": "paragraph",
          "text": "N=",
          "bbox": [
            5.3478,
            4.0933,
            5.5718,
            4.2023
          ]
        },
        {
          "block_id": "p43_line_27",
          "block_type": "paragraph",
          "text": "COMPLETED",
          "bbox": [
            5.1306,
            4.2547,
            5.7896,
            4.3603
          ]
        },
        {
          "block_id": "p43_line_28",
          "block_type": "paragraph",
          "text": "STUDY",
          "bbox": [
            5.2748,
            4.4039,
            5.6461,
            4.5069
          ]
        },
        {
          "block_id": "p43_line_29",
          "block_type": "paragraph",
          "text": "N=",
          "bbox": [
            6.2377,
            4.0946,
            6.4566,
            4.2011
          ]
        },
        {
          "block_id": "p43_line_30",
          "block_type": "paragraph",
          "text": "WITHDRAWN",
          "bbox": [
            6.008,
            4.254,
            6.6841,
            4.363
          ]
        },
        {
          "block_id": "p43_line_31",
          "block_type": "paragraph",
          "text": "N=",
          "bbox": [
            7.4174,
            4.0959,
            7.6384,
            4.2012
          ]
        },
        {
          "block_id": "p43_line_32",
          "block_type": "paragraph",
          "text": "COMPLETED",
          "bbox": [
            7.1986,
            4.2551,
            7.8585,
            4.3608
          ]
        },
        {
          "block_id": "p43_line_33",
          "block_type": "paragraph",
          "text": "STUDY",
          "bbox": [
            7.3415,
            4.4051,
            7.7089,
            4.5073
          ]
        },
        {
          "block_id": "p43_line_34",
          "block_type": "paragraph",
          "text": "N=",
          "bbox": [
            8.3007,
            4.0951,
            8.5251,
            4.2027
          ]
        },
        {
          "block_id": "p43_line_35",
          "block_type": "paragraph",
          "text": "WITHDRAWN",
          "bbox": [
            8.0767,
            4.2553,
            8.7534,
            4.3615
          ]
        },
        {
          "block_id": "p43_line_36",
          "block_type": "paragraph",
          "text": "N=",
          "bbox": [
            9.4823,
            4.0957,
            9.7062,
            4.2012
          ]
        },
        {
          "block_id": "p43_line_37",
          "block_type": "paragraph",
          "text": "COMPLETED",
          "bbox": [
            9.2655,
            4.2551,
            9.9229,
            4.3596
          ]
        },
        {
          "block_id": "p43_line_38",
          "block_type": "paragraph",
          "text": "STUDY",
          "bbox": [
            9.4079,
            4.4055,
            9.7775,
            4.5073
          ]
        },
        {
          "block_id": "p43_line_39",
          "block_type": "paragraph",
          "text": "N=",
          "bbox": [
            10.3738,
            4.0927,
            10.5914,
            4.2008
          ]
        },
        {
          "block_id": "p43_line_40",
          "block_type": "paragraph",
          "text": "WITHDRAWN",
          "bbox": [
            10.1441,
            4.255,
            10.8184,
            4.3605
          ]
        },
        {
          "block_id": "p43_line_41",
          "block_type": "paragraph",
          "text": "ADVERSE EVENT (20)",
          "bbox": [
            0.9723,
            4.9222,
            2.1024,
            5.0441
          ]
        },
        {
          "block_id": "p43_line_42",
          "block_type": "paragraph",
          "text": "UNSAT. RESPONSE",
          "bbox": [
            0.9748,
            5.0745,
            1.9635,
            5.1851
          ]
        },
        {
          "block_id": "p43_line_43",
          "block_type": "paragraph",
          "text": "EFFICACY (1)",
          "bbox": [
            0.973,
            5.2168,
            1.6859,
            5.3412
          ]
        },
        {
          "block_id": "p43_line_44",
          "block_type": "paragraph",
          "text": "FAILURE TO RETURN (6)",
          "bbox": [
            0.9716,
            5.3716,
            2.2523,
            5.4925
          ]
        },
        {
          "block_id": "p43_line_45",
          "block_type": "paragraph",
          "text": "OTHER MED. EVENT (5)",
          "bbox": [
            0.9718,
            5.5207,
            2.2043,
            5.641
          ]
        },
        {
          "block_id": "p43_line_46",
          "block_type": "paragraph",
          "text": "OTHER NONMED. EVENT (5)",
          "bbox": [
            0.9727,
            5.6703,
            2.2945,
            5.791
          ]
        },
        {
          "block_id": "p43_line_47",
          "block_type": "paragraph",
          "text": "PROTOCOL VIOLATION (10)",
          "bbox": [
            0.9712,
            5.8171,
            2.4057,
            5.9416
          ]
        },
        {
          "block_id": "p43_line_48",
          "block_type": "paragraph",
          "text": "PATIENT REQUEST (12)",
          "bbox": [
            0.9677,
            5.972,
            2.2027,
            6.0919
          ]
        },
        {
          "block_id": "p43_line_49",
          "block_type": "paragraph",
          "text": "ADVERSE EVENT (19)",
          "bbox": [
            3.0381,
            4.9213,
            4.1712,
            5.0429
          ]
        },
        {
          "block_id": "p43_line_50",
          "block_type": "paragraph",
          "text": "UNSAT. RESPONSE",
          "bbox": [
            3.0423,
            5.075,
            4.0319,
            5.1855
          ]
        },
        {
          "block_id": "p43_line_51",
          "block_type": "paragraph",
          "text": "EFFICACY (2)",
          "bbox": [
            3.042,
            5.2173,
            3.7497,
            5.3395
          ]
        },
        {
          "block_id": "p43_line_52",
          "block_type": "paragraph",
          "text": "FAILURE TO RETURN (8)",
          "bbox": [
            3.0398,
            5.3715,
            4.3212,
            5.4935
          ]
        },
        {
          "block_id": "p43_line_53",
          "block_type": "paragraph",
          "text": "OTHER MED. EVENT (8)",
          "bbox": [
            3.0402,
            5.5205,
            4.2733,
            5.6416
          ]
        },
        {
          "block_id": "p43_line_54",
          "block_type": "paragraph",
          "text": "OTHER NONMED. EVENT (4)",
          "bbox": [
            3.0387,
            5.6696,
            4.3628,
            5.7896
          ]
        },
        {
          "block_id": "p43_line_55",
          "block_type": "paragraph",
          "text": "PROTOCOL VIOLATION (10)",
          "bbox": [
            3.0381,
            5.8156,
            4.4733,
            5.9408
          ]
        },
        {
          "block_id": "p43_line_56",
          "block_type": "paragraph",
          "text": "PATIENT REQUEST (10)",
          "bbox": [
            3.0376,
            5.9709,
            4.2744,
            6.0909
          ]
        },
        {
          "block_id": "p43_line_57",
          "block_type": "paragraph",
          "text": "ADVERSE EVENT (26)",
          "bbox": [
            5.1055,
            4.9206,
            6.2377,
            5.0429
          ]
        },
        {
          "block_id": "p43_line_58",
          "block_type": "paragraph",
          "text": "UNSAT. RESPONSE",
          "bbox": [
            5.1061,
            5.0734,
            6.1006,
            5.1852
          ]
        },
        {
          "block_id": "p43_line_59",
          "block_type": "paragraph",
          "text": "EFFICACY (1)",
          "bbox": [
            5.1074,
            5.2165,
            5.8167,
            5.3426
          ]
        },
        {
          "block_id": "p43_line_60",
          "block_type": "paragraph",
          "text": "FAILURE TO RETURN (7)",
          "bbox": [
            5.1072,
            5.372,
            6.3903,
            5.4923
          ]
        },
        {
          "block_id": "p43_line_61",
          "block_type": "paragraph",
          "text": "OTHER MED. EVENT (4)",
          "bbox": [
            5.1071,
            5.5209,
            6.3467,
            5.6401
          ]
        },
        {
          "block_id": "p43_line_62",
          "block_type": "paragraph",
          "text": "OTHER NONMED. EVENT (6)",
          "bbox": [
            5.1071,
            5.671,
            6.4313,
            5.7882
          ]
        },
        {
          "block_id": "p43_line_63",
          "block_type": "paragraph",
          "text": "PROTOCOL VIOLATION (3)",
          "bbox": [
            5.1056,
            5.8181,
            6.4694,
            5.939
          ]
        },
        {
          "block_id": "p43_line_64",
          "block_type": "paragraph",
          "text": "PATIENT REQUEST (25)",
          "bbox": [
            5.1036,
            5.9709,
            6.3422,
            6.0904
          ]
        },
        {
          "block_id": "p43_line_65",
          "block_type": "paragraph",
          "text": "ADVERSE EVENT (24)",
          "bbox": [
            7.1739,
            4.9212,
            8.3071,
            5.0441
          ]
        },
        {
          "block_id": "p43_line_66",
          "block_type": "paragraph",
          "text": "UNSAT. RESPONSE",
          "bbox": [
            7.1773,
            5.0731,
            8.1677,
            5.1856
          ]
        },
        {
          "block_id": "p43_line_67",
          "block_type": "paragraph",
          "text": "EFFICACY (1)",
          "bbox": [
            7.1762,
            5.2176,
            7.8889,
            5.34
          ]
        },
        {
          "block_id": "p43_line_68",
          "block_type": "paragraph",
          "text": "FAILURE TO RETURN (6)",
          "bbox": [
            7.1754,
            5.3717,
            8.4552,
            5.4925
          ]
        },
        {
          "block_id": "p43_line_69",
          "block_type": "paragraph",
          "text": "OTHER MED. EVENT (8)",
          "bbox": [
            7.1762,
            5.5211,
            8.4095,
            5.6399
          ]
        },
        {
          "block_id": "p43_line_70",
          "block_type": "paragraph",
          "text": "OTHER NONMED. EVENT (7)",
          "bbox": [
            7.1761,
            5.6691,
            8.4992,
            5.7909
          ]
        },
        {
          "block_id": "p43_line_71",
          "block_type": "paragraph",
          "text": "PROTOCOL VIOLATION (6)",
          "bbox": [
            7.1732,
            5.8178,
            8.5368,
            5.9386
          ]
        },
        {
          "block_id": "p43_line_72",
          "block_type": "paragraph",
          "text": "PATIENT REQUEST (27)",
          "bbox": [
            7.1711,
            5.9719,
            8.4103,
            6.0916
          ]
        },
        {
          "block_id": "p43_line_73",
          "block_type": "paragraph",
          "text": "ADVERSE EVENT (42)",
          "bbox": [
            9.2405,
            4.9214,
            10.3694,
            5.0418
          ]
        },
        {
          "block_id": "p43_line_74",
          "block_type": "paragraph",
          "text": "UNSAT. RESPONSE",
          "bbox": [
            9.243,
            5.0741,
            10.2325,
            5.1841
          ]
        },
        {
          "block_id": "p43_line_75",
          "block_type": "paragraph",
          "text": "EFFICACY (0)",
          "bbox": [
            9.2411,
            5.219,
            9.9519,
            5.3385
          ]
        },
        {
          "block_id": "p43_line_76",
          "block_type": "paragraph",
          "text": "FAILURE TO RETURN (6)",
          "bbox": [
            9.2398,
            5.3691,
            10.5224,
            5.494
          ]
        },
        {
          "block_id": "p43_line_77",
          "block_type": "paragraph",
          "text": "OTHER MED. EVENT (14)",
          "bbox": [
            9.2401,
            5.5202,
            10.5455,
            5.6421
          ]
        },
        {
          "block_id": "p43_line_78",
          "block_type": "paragraph",
          "text": "OTHER NONMED. EVENT (1)",
          "bbox": [
            9.2407,
            5.6677,
            10.5614,
            5.7917
          ]
        },
        {
          "block_id": "p43_line_79",
          "block_type": "paragraph",
          "text": "PROTOCOL VIOLATION (14)",
          "bbox": [
            9.2384,
            5.8156,
            10.6766,
            5.9395
          ]
        },
        {
          "block_id": "p43_line_80",
          "block_type": "paragraph",
          "text": "PATIENT REQUEST (15)",
          "bbox": [
            9.2351,
            5.9705,
            10.4736,
            6.092
          ]
        },
        {
          "block_id": "p43_line_81",
          "block_type": "paragraph",
          "text": "N=1,361",
          "bbox": [
            5.5319,
            6.4276,
            6.1431,
            6.5813
          ]
        },
        {
          "block_id": "p43_line_82",
          "block_type": "paragraph",
          "text": "PATIENTS COMPLETING STUDY",
          "bbox": [
            4.5618,
            6.6035,
            7.1244,
            6.7562
          ]
        },
        {
          "block_id": "p43_line_83",
          "block_type": "paragraph",
          "text": "35",
          "bbox": [
            5.7554,
            7.5177,
            5.9354,
            7.6511
          ]
        }
      ]
    },
    {
      "page_number": 44,
      "width": 8.2639,
      "height": 11.6944,
      "unit": "inch",
      "blocks": [
        {
          "block_id": "p44_line_0",
          "block_type": "paragraph",
          "text": "Structure and Content of Clinical Study Reports",
          "bbox": [
            0.9738,
            0.7195,
            4.0773,
            0.885
          ]
        },
        {
          "block_id": "p44_line_1",
          "block_type": "paragraph",
          "text": "DISPOSITION OF PATIENTS",
          "bbox": [
            1.4671,
            1.1453,
            3.5577,
            1.3116
          ]
        },
        {
          "block_id": "p44_line_2",
          "block_type": "paragraph",
          "text": "ANNEX IV b",
          "bbox": [
            6.2073,
            1.1511,
            7.1881,
            1.3019
          ]
        },
        {
          "block_id": "p44_line_3",
          "block_type": "paragraph",
          "text": "N=2670",
          "bbox": [
            3.7689,
            1.7007,
            4.386,
            1.8514
          ]
        },
        {
          "block_id": "p44_line_4",
          "block_type": "paragraph",
          "text": "PATIENTS SCREENED",
          "bbox": [
            3.3115,
            1.9415,
            4.8442,
            2.0865
          ]
        },
        {
          "block_id": "p44_line_5",
          "block_type": "paragraph",
          "text": "N=1732",
          "bbox": [
            3.7897,
            2.6138,
            4.4067,
            2.7661
          ]
        },
        {
          "block_id": "p44_line_6",
          "block_type": "paragraph",
          "text": "PATIENTS RANDOMISED",
          "bbox": [
            3.2339,
            2.8558,
            4.9646,
            3.0005
          ]
        },
        {
          "block_id": "p44_line_7",
          "block_type": "paragraph",
          "text": "N=938",
          "bbox": [
            5.689,
            2.5948,
            6.1772,
            2.7433
          ]
        },
        {
          "block_id": "p44_line_8",
          "block_type": "paragraph",
          "text": "Screening Failures",
          "bbox": [
            5.6859,
            2.7764,
            7.2096,
            2.9496
          ]
        },
        {
          "block_id": "p44_line_9",
          "block_type": "paragraph",
          "text": "Reasons:",
          "bbox": [
            5.6837,
            2.967,
            6.3294,
            3.1235
          ]
        },
        {
          "block_id": "p44_line_10",
          "block_type": "paragraph",
          "text": "(300)",
          "bbox": [
            6.5814,
            3.1901,
            6.9395,
            3.3505
          ]
        },
        {
          "block_id": "p44_line_11",
          "block_type": "paragraph",
          "text": "(271)",
          "bbox": [
            6.5857,
            3.4112,
            6.9406,
            3.571
          ]
        },
        {
          "block_id": "p44_line_12",
          "block_type": "paragraph",
          "text": "N=8",
          "bbox": [
            1.0891,
            3.9205,
            1.4528,
            4.0707
          ]
        },
        {
          "block_id": "p44_line_13",
          "block_type": "paragraph",
          "text": "DID NOT RECEIVE",
          "bbox": [
            1.0869,
            4.2227,
            2.2962,
            4.36
          ]
        },
        {
          "block_id": "p44_line_14",
          "block_type": "paragraph",
          "text": "ANY MEDICATION",
          "bbox": [
            1.0903,
            4.4121,
            2.2917,
            4.5485
          ]
        },
        {
          "block_id": "p44_line_15",
          "block_type": "paragraph",
          "text": "N=1724",
          "bbox": [
            3.1651,
            4.5092,
            3.7844,
            4.6609
          ]
        },
        {
          "block_id": "p44_line_16",
          "block_type": "paragraph",
          "text": "PATIENTS RECEIVING",
          "bbox": [
            3.1664,
            4.7053,
            4.6334,
            4.8471
          ]
        },
        {
          "block_id": "p44_line_17",
          "block_type": "paragraph",
          "text": "DOUBLE-BLIND",
          "bbox": [
            3.166,
            4.8963,
            4.2153,
            5.0346
          ]
        },
        {
          "block_id": "p44_line_18",
          "block_type": "paragraph",
          "text": "MEDICATION",
          "bbox": [
            3.162,
            5.0795,
            4.0572,
            5.2163
          ]
        },
        {
          "block_id": "p44_line_19",
          "block_type": "paragraph",
          "text": "Reasons:",
          "bbox": [
            1.0852,
            4.6863,
            1.7262,
            4.8365
          ]
        },
        {
          "block_id": "p44_line_20",
          "block_type": "paragraph",
          "text": "(2)",
          "bbox": [
            1.8324,
            4.9744,
            2.0127,
            5.1327
          ]
        },
        {
          "block_id": "p44_line_21",
          "block_type": "paragraph",
          "text": "(4)",
          "bbox": [
            1.83,
            5.2592,
            2.016,
            5.4158
          ]
        },
        {
          "block_id": "p44_line_22",
          "block_type": "paragraph",
          "text": "(2)",
          "bbox": [
            1.8307,
            5.5396,
            2.0132,
            5.7018
          ]
        },
        {
          "block_id": "p44_line_23",
          "block_type": "paragraph",
          "text": "N=",
          "bbox": [
            1.4718,
            6.8277,
            1.6856,
            6.9499
          ]
        },
        {
          "block_id": "p44_line_24",
          "block_type": "paragraph",
          "text": "REGIMEN A",
          "bbox": [
            1.4697,
            7.0065,
            2.253,
            7.1411
          ]
        },
        {
          "block_id": "p44_line_25",
          "block_type": "paragraph",
          "text": "N=",
          "bbox": [
            3.6301,
            6.8275,
            3.8429,
            6.949
          ]
        },
        {
          "block_id": "p44_line_26",
          "block_type": "paragraph",
          "text": "REGIMEN B",
          "bbox": [
            3.6286,
            7.0061,
            4.414,
            7.1399
          ]
        },
        {
          "block_id": "p44_line_27",
          "block_type": "paragraph",
          "text": "N=",
          "bbox": [
            5.8152,
            6.8271,
            6.0246,
            6.9492
          ]
        },
        {
          "block_id": "p44_line_28",
          "block_type": "paragraph",
          "text": "REGIMEN C",
          "bbox": [
            5.8094,
            7.0033,
            6.5943,
            7.1426
          ]
        },
        {
          "block_id": "p44_line_29",
          "block_type": "paragraph",
          "text": "N=",
          "bbox": [
            0.8776,
            7.9214,
            1.1083,
            8.0628
          ]
        },
        {
          "block_id": "p44_line_30",
          "block_type": "paragraph",
          "text": "N=",
          "bbox": [
            1.9576,
            7.9243,
            2.192,
            8.0604
          ]
        },
        {
          "block_id": "p44_line_31",
          "block_type": "paragraph",
          "text": "Completed",
          "bbox": [
            0.8781,
            8.1457,
            1.6509,
            8.3129
          ]
        },
        {
          "block_id": "p44_line_32",
          "block_type": "paragraph",
          "text": "Withdrawn",
          "bbox": [
            1.9598,
            8.1501,
            2.7756,
            8.3048
          ]
        },
        {
          "block_id": "p44_line_33",
          "block_type": "paragraph",
          "text": "ADVERSE EVENT (20)",
          "bbox": [
            0.8752,
            8.7194,
            2.3037,
            8.8764
          ]
        },
        {
          "block_id": "p44_line_34",
          "block_type": "paragraph",
          "text": "UNSAT. RESPONSE (32)",
          "bbox": [
            0.8762,
            8.9066,
            2.4265,
            9.0668
          ]
        },
        {
          "block_id": "p44_line_35",
          "block_type": "paragraph",
          "text": "etc. ......",
          "bbox": [
            0.8738,
            9.1095,
            1.4345,
            9.2446
          ]
        },
        {
          "block_id": "p44_line_36",
          "block_type": "paragraph",
          "text": "etc. ......",
          "bbox": [
            0.8738,
            9.2905,
            1.4382,
            9.4275
          ]
        },
        {
          "block_id": "p44_line_37",
          "block_type": "paragraph",
          "text": "36",
          "bbox": [
            3.9437,
            10.9456,
            4.1217,
            11.0848
          ]
        }
      ]
    },
    {
      "page_number": 45,
      "width": 8.2639,
      "height": 11.6944,
      "unit": "inch",
      "blocks": [
        {
          "block_id": "p45_line_0",
          "block_type": "paragraph",
          "text": "Structure and Content of Clinical Study Reports",
          "bbox": [
            4.1879,
            0.7195,
            7.2902,
            0.8854
          ]
        },
        {
          "block_id": "p45_line_1",
          "block_type": "paragraph",
          "text": "ANNEX V",
          "bbox": [
            6.5125,
            1.0561,
            7.3025,
            1.2048
          ]
        },
        {
          "block_id": "p45_line_2",
          "block_type": "paragraph",
          "text": "STUDY #",
          "bbox": [
            3.8387,
            1.5895,
            4.6189,
            1.7587
          ]
        },
        {
          "block_id": "p45_line_3",
          "block_type": "paragraph",
          "text": "(Data Set Identification)",
          "bbox": [
            3.2606,
            1.8273,
            5.1966,
            2.0023
          ]
        },
        {
          "block_id": "p45_line_4",
          "block_type": "paragraph",
          "text": "LISTING OF PATIENTS WHO DISCONTINUED THERAPY",
          "bbox": [
            1.8482,
            2.4552,
            6.6071,
            2.6538
          ]
        },
        {
          "block_id": "p45_line_5",
          "block_type": "paragraph",
          "text": "Centre:",
          "bbox": [
            1.1838,
            3.0378,
            1.6875,
            3.1863
          ]
        },
        {
          "block_id": "p45_line_6",
          "block_type": "paragraph",
          "text": "Treatment",
          "bbox": [
            1.0462,
            3.5077,
            1.7528,
            3.653
          ]
        },
        {
          "block_id": "p45_line_7",
          "block_type": "paragraph",
          "text": "Patient #",
          "bbox": [
            2.2296,
            3.5069,
            2.8436,
            3.6513
          ]
        },
        {
          "block_id": "p45_line_8",
          "block_type": "paragraph",
          "text": "Sex",
          "bbox": [
            3.0097,
            3.5128,
            3.2588,
            3.6545
          ]
        },
        {
          "block_id": "p45_line_9",
          "block_type": "paragraph",
          "text": "Age",
          "bbox": [
            3.473,
            3.5161,
            3.7371,
            3.6587
          ]
        },
        {
          "block_id": "p45_line_10",
          "block_type": "paragraph",
          "text": "Last",
          "bbox": [
            3.9366,
            3.3422,
            4.2433,
            3.479
          ]
        },
        {
          "block_id": "p45_line_11",
          "block_type": "paragraph",
          "text": "Visit",
          "bbox": [
            3.9333,
            3.5083,
            4.2625,
            3.6498
          ]
        },
        {
          "block_id": "p45_line_12",
          "block_type": "paragraph",
          "text": "Duration",
          "bbox": [
            4.516,
            3.5062,
            5.1258,
            3.6565
          ]
        },
        {
          "block_id": "p45_line_13",
          "block_type": "paragraph",
          "text": "Dose",
          "bbox": [
            5.3137,
            3.5095,
            5.6501,
            3.6536
          ]
        },
        {
          "block_id": "p45_line_14",
          "block_type": "paragraph",
          "text": "Concomitant_",
          "bbox": [
            5.9095,
            3.3423,
            6.7775,
            3.4916
          ]
        },
        {
          "block_id": "p45_line_15",
          "block_type": "paragraph",
          "text": "Medication",
          "bbox": [
            5.8956,
            3.5064,
            6.6394,
            3.6559
          ]
        },
        {
          "block_id": "p45_line_16",
          "block_type": "paragraph",
          "text": "Reason for_",
          "bbox": [
            6.9448,
            3.3427,
            7.6786,
            3.491
          ]
        },
        {
          "block_id": "p45_line_17",
          "block_type": "paragraph",
          "text": "Discontin.",
          "bbox": [
            6.9494,
            3.5077,
            7.6179,
            3.6525
          ]
        },
        {
          "block_id": "p45_line_18",
          "block_type": "paragraph",
          "text": "Test Drug/",
          "bbox": [
            1.0482,
            3.837,
            1.7442,
            3.9879
          ]
        },
        {
          "block_id": "p45_line_19",
          "block_type": "paragraph",
          "text": "investigational",
          "bbox": [
            1.0452,
            4.0093,
            2.027,
            4.1565
          ]
        },
        {
          "block_id": "p45_line_20",
          "block_type": "paragraph",
          "text": "product",
          "bbox": [
            1.0425,
            4.1856,
            1.5591,
            4.3293
          ]
        },
        {
          "block_id": "p45_line_21",
          "block_type": "paragraph",
          "text": "Adverse",
          "bbox": [
            6.9541,
            3.8423,
            7.4868,
            3.9776
          ]
        },
        {
          "block_id": "p45_line_22",
          "block_type": "paragraph",
          "text": "reaction*",
          "bbox": [
            6.9464,
            4.0111,
            7.5557,
            4.1455
          ]
        },
        {
          "block_id": "p45_line_23",
          "block_type": "paragraph",
          "text": "",
          "bbox": [
            6.9697,
            4.5633,
            7.0194,
            4.614
          ]
        },
        {
          "block_id": "p45_line_24",
          "block_type": "paragraph",
          "text": "",
          "bbox": [
            6.9697,
            4.8167,
            7.0194,
            4.8673
          ]
        },
        {
          "block_id": "p45_line_25",
          "block_type": "paragraph",
          "text": "",
          "bbox": [
            6.9697,
            5.07,
            7.0194,
            5.1207
          ]
        },
        {
          "block_id": "p45_line_26",
          "block_type": "paragraph",
          "text": "Therapy",
          "bbox": [
            6.9481,
            5.2655,
            7.5088,
            5.4241
          ]
        },
        {
          "block_id": "p45_line_27",
          "block_type": "paragraph",
          "text": "failure",
          "bbox": [
            6.9458,
            5.4304,
            7.3955,
            5.5716
          ]
        },
        {
          "block_id": "p45_line_28",
          "block_type": "paragraph",
          "text": "Treatment",
          "bbox": [
            1.0465,
            6.0595,
            1.7536,
            6.2053
          ]
        },
        {
          "block_id": "p45_line_29",
          "block_type": "paragraph",
          "text": "Patient #",
          "bbox": [
            2.2318,
            6.0584,
            2.8423,
            6.203
          ]
        },
        {
          "block_id": "p45_line_30",
          "block_type": "paragraph",
          "text": "Sex",
          "bbox": [
            3.0097,
            6.0638,
            3.2587,
            6.2058
          ]
        },
        {
          "block_id": "p45_line_31",
          "block_type": "paragraph",
          "text": "Age",
          "bbox": [
            3.4736,
            6.0696,
            3.7376,
            6.2132
          ]
        },
        {
          "block_id": "p45_line_32",
          "block_type": "paragraph",
          "text": "Last",
          "bbox": [
            3.9371,
            5.8941,
            4.2447,
            6.0312
          ]
        },
        {
          "block_id": "p45_line_33",
          "block_type": "paragraph",
          "text": "Visit",
          "bbox": [
            3.9349,
            6.0608,
            4.2638,
            6.2013
          ]
        },
        {
          "block_id": "p45_line_34",
          "block_type": "paragraph",
          "text": "Duration",
          "bbox": [
            4.5174,
            6.0585,
            5.1248,
            6.207
          ]
        },
        {
          "block_id": "p45_line_35",
          "block_type": "paragraph",
          "text": "Dose",
          "bbox": [
            5.3139,
            6.0611,
            5.6514,
            6.2068
          ]
        },
        {
          "block_id": "p45_line_36",
          "block_type": "paragraph",
          "text": "Concomitant_",
          "bbox": [
            5.9094,
            5.8946,
            6.7703,
            6.0441
          ]
        },
        {
          "block_id": "p45_line_37",
          "block_type": "paragraph",
          "text": "Medication",
          "bbox": [
            5.8964,
            6.0579,
            6.639,
            6.208
          ]
        },
        {
          "block_id": "p45_line_38",
          "block_type": "paragraph",
          "text": "Reason for_",
          "bbox": [
            6.9453,
            5.8937,
            7.6793,
            6.044
          ]
        },
        {
          "block_id": "p45_line_39",
          "block_type": "paragraph",
          "text": "Discontin.",
          "bbox": [
            6.9486,
            6.0589,
            7.6191,
            6.2057
          ]
        },
        {
          "block_id": "p45_line_40",
          "block_type": "paragraph",
          "text": "Active Control/",
          "bbox": [
            1.0496,
            6.3885,
            2.0308,
            6.5352
          ]
        },
        {
          "block_id": "p45_line_41",
          "block_type": "paragraph",
          "text": "Comparator",
          "bbox": [
            1.0565,
            6.5624,
            1.8392,
            6.7134
          ]
        },
        {
          "block_id": "p45_line_42",
          "block_type": "paragraph",
          "text": "Treatment",
          "bbox": [
            1.046,
            7.8922,
            1.7536,
            8.036
          ]
        },
        {
          "block_id": "p45_line_43",
          "block_type": "paragraph",
          "text": "Patient #",
          "bbox": [
            2.2308,
            7.8919,
            2.8419,
            8.0368
          ]
        },
        {
          "block_id": "p45_line_44",
          "block_type": "paragraph",
          "text": "Sex",
          "bbox": [
            3.0109,
            7.8984,
            3.2578,
            8.0388
          ]
        },
        {
          "block_id": "p45_line_45",
          "block_type": "paragraph",
          "text": "Age",
          "bbox": [
            3.4752,
            7.9009,
            3.735,
            8.0439
          ]
        },
        {
          "block_id": "p45_line_46",
          "block_type": "paragraph",
          "text": "Last",
          "bbox": [
            3.9379,
            7.7279,
            4.2433,
            7.8641
          ]
        },
        {
          "block_id": "p45_line_47",
          "block_type": "paragraph",
          "text": "Visit",
          "bbox": [
            3.9349,
            7.8934,
            4.263,
            8.0342
          ]
        },
        {
          "block_id": "p45_line_48",
          "block_type": "paragraph",
          "text": "Duration",
          "bbox": [
            4.5174,
            7.8926,
            5.1251,
            8.0399
          ]
        },
        {
          "block_id": "p45_line_49",
          "block_type": "paragraph",
          "text": "Dose",
          "bbox": [
            5.317,
            7.8952,
            5.65,
            8.0384
          ]
        },
        {
          "block_id": "p45_line_50",
          "block_type": "paragraph",
          "text": "Concomitant_",
          "bbox": [
            5.911,
            7.7279,
            6.7777,
            7.8767
          ]
        },
        {
          "block_id": "p45_line_51",
          "block_type": "paragraph",
          "text": "Medication",
          "bbox": [
            5.8965,
            7.8904,
            6.6394,
            8.0413
          ]
        },
        {
          "block_id": "p45_line_52",
          "block_type": "paragraph",
          "text": "Reason for_",
          "bbox": [
            6.9453,
            7.7274,
            7.6787,
            7.8757
          ]
        },
        {
          "block_id": "p45_line_53",
          "block_type": "paragraph",
          "text": "Discontin.",
          "bbox": [
            6.9481,
            7.8923,
            7.6187,
            8.0371
          ]
        },
        {
          "block_id": "p45_line_54",
          "block_type": "paragraph",
          "text": "Placebo",
          "bbox": [
            1.0474,
            8.2217,
            1.5568,
            8.3658
          ]
        },
        {
          "block_id": "p45_line_55",
          "block_type": "paragraph",
          "text": "*The specific reaction leading to discontinuation",
          "bbox": [
            0.9789,
            8.8004,
            4.0979,
            8.964
          ]
        },
        {
          "block_id": "p45_line_56",
          "block_type": "paragraph",
          "text": "(Repeat for other centres)",
          "bbox": [
            1.0771,
            9.3932,
            2.834,
            9.5693
          ]
        },
        {
          "block_id": "p45_line_57",
          "block_type": "paragraph",
          "text": "37",
          "bbox": [
            4.1416,
            10.946,
            4.3161,
            11.0862
          ]
        },
        {
          "block_id": "table_10",
          "block_type": "table",
          "page_number": 45,
          "bbox": [
            1.0059,
            3.3096,
            7.6963,
            4.3497
          ],
          "headers": [
            "Treatment",
            "Patient #",
            "Sex",
            "Age",
            "Last Visit",
            "Duration",
            "Dose",
            "Concomitant_ Medication",
            "Reason for_ Discontin."
          ],
          "rows": [
            [
              "Test Drug/ investigational product",
              "",
              "",
              "",
              "",
              "",
              "",
              "",
              "Adverse reaction*"
            ]
          ]
        },
        {
          "block_id": "table_11",
          "block_type": "table",
          "page_number": 45,
          "bbox": [
            1.0064,
            5.8804,
            7.7075,
            6.7396
          ],
          "headers": [
            "Treatment",
            "Patient #",
            "Sex",
            "Age",
            "Last Visit",
            "Duration",
            "Dose",
            "Concomitant_ Medication",
            "Reason for_ Discontin."
          ],
          "rows": [
            [
              "Active Control/ Comparator",
              "",
              "",
              "",
              "",
              "",
              "",
              "",
              ""
            ]
          ]
        },
        {
          "block_id": "table_12",
          "block_type": "table",
          "page_number": 45,
          "bbox": [
            1.0074,
            7.7784,
            7.716,
            8.3773
          ],
          "headers": [
            "Treatment",
            "Patient #",
            "Sex",
            "Age",
            "Last Visit",
            "Duration",
            "Dose",
            "Concomitant_ Medication",
            "Reason for_ Discontin."
          ],
          "rows": [
            [
              "Placebo",
              "",
              "",
              "",
              "",
              "",
              "",
              "",
              ""
            ]
          ]
        }
      ]
    },
    {
      "page_number": 46,
      "width": 8.2639,
      "height": 11.6944,
      "unit": "inch",
      "blocks": [
        {
          "block_id": "p46_line_0",
          "block_type": "paragraph",
          "text": "Structure and Content of Clinical Study Reports",
          "bbox": [
            0.9796,
            0.7195,
            4.0774,
            0.8833
          ]
        },
        {
          "block_id": "p46_line_1",
          "block_type": "paragraph",
          "text": "ANNEX VI",
          "bbox": [
            6.252,
            1.0592,
            7.1002,
            1.2027
          ]
        },
        {
          "block_id": "p46_line_2",
          "block_type": "paragraph",
          "text": "STUDY #",
          "bbox": [
            3.6458,
            1.5942,
            4.4208,
            1.7549
          ]
        },
        {
          "block_id": "p46_line_3",
          "block_type": "paragraph",
          "text": "(Data Set Identification)",
          "bbox": [
            3.0675,
            1.8305,
            4.9958,
            2.002
          ]
        },
        {
          "block_id": "p46_line_4",
          "block_type": "paragraph",
          "text": "LISTING OF PATIENTS AND OBSERVATIONS EXCLUDED",
          "bbox": [
            1.6112,
            2.4611,
            6.4461,
            2.6516
          ]
        },
        {
          "block_id": "p46_line_5",
          "block_type": "paragraph",
          "text": "FROM EFFICACY ANALYSIS",
          "bbox": [
            2.8368,
            2.704,
            5.2296,
            2.8812
          ]
        },
        {
          "block_id": "p46_line_6",
          "block_type": "paragraph",
          "text": "Centre:",
          "bbox": [
            0.9887,
            3.2712,
            1.4906,
            3.4227
          ]
        },
        {
          "block_id": "p46_line_7",
          "block_type": "paragraph",
          "text": "Treatment",
          "bbox": [
            0.9748,
            3.5779,
            1.7452,
            3.7328
          ]
        },
        {
          "block_id": "p46_line_8",
          "block_type": "paragraph",
          "text": "Patient #",
          "bbox": [
            2.059,
            3.5775,
            2.724,
            3.7302
          ]
        },
        {
          "block_id": "p46_line_9",
          "block_type": "paragraph",
          "text": "Sex",
          "bbox": [
            3.0448,
            3.58,
            3.314,
            3.7344
          ]
        },
        {
          "block_id": "p46_line_10",
          "block_type": "paragraph",
          "text": "Age",
          "bbox": [
            3.6364,
            3.5868,
            3.9169,
            3.7383
          ]
        },
        {
          "block_id": "p46_line_11",
          "block_type": "paragraph",
          "text": "Observation Excluded",
          "bbox": [
            4.2249,
            3.5696,
            5.798,
            3.7345
          ]
        },
        {
          "block_id": "p46_line_12",
          "block_type": "paragraph",
          "text": "Reason(s)",
          "bbox": [
            6.1931,
            3.5811,
            6.8866,
            3.7326
          ]
        },
        {
          "block_id": "p46_line_13",
          "block_type": "paragraph",
          "text": "Test Drug/Investigational Product",
          "bbox": [
            0.9789,
            4.0646,
            3.4107,
            4.235
          ]
        },
        {
          "block_id": "p46_line_14",
          "block_type": "paragraph",
          "text": "Treatment",
          "bbox": [
            0.9753,
            4.992,
            1.7451,
            5.1499
          ]
        },
        {
          "block_id": "p46_line_15",
          "block_type": "paragraph",
          "text": "Patient #",
          "bbox": [
            2.0617,
            4.9944,
            2.7242,
            5.1471
          ]
        },
        {
          "block_id": "p46_line_16",
          "block_type": "paragraph",
          "text": "Sex",
          "bbox": [
            3.0466,
            4.9952,
            3.3148,
            5.1524
          ]
        },
        {
          "block_id": "p46_line_17",
          "block_type": "paragraph",
          "text": "Age",
          "bbox": [
            3.6379,
            5.0029,
            3.9178,
            5.158
          ]
        },
        {
          "block_id": "p46_line_18",
          "block_type": "paragraph",
          "text": "Observation Excluded",
          "bbox": [
            4.2251,
            4.9863,
            5.7979,
            5.1506
          ]
        },
        {
          "block_id": "p46_line_19",
          "block_type": "paragraph",
          "text": "Reason(s)",
          "bbox": [
            6.1942,
            4.9979,
            6.8862,
            5.1494
          ]
        },
        {
          "block_id": "p46_line_20",
          "block_type": "paragraph",
          "text": "Active Drug/Comparator",
          "bbox": [
            0.9802,
            5.4818,
            2.7279,
            5.6531
          ]
        },
        {
          "block_id": "p46_line_21",
          "block_type": "paragraph",
          "text": "Treatment",
          "bbox": [
            0.9748,
            6.4095,
            1.7455,
            6.5656
          ]
        },
        {
          "block_id": "p46_line_22",
          "block_type": "paragraph",
          "text": "Patient #",
          "bbox": [
            2.0592,
            6.4108,
            2.7242,
            6.5623
          ]
        },
        {
          "block_id": "p46_line_23",
          "block_type": "paragraph",
          "text": "Sex",
          "bbox": [
            3.0463,
            6.4141,
            3.3147,
            6.5662
          ]
        },
        {
          "block_id": "p46_line_24",
          "block_type": "paragraph",
          "text": "Age",
          "bbox": [
            3.6379,
            6.4196,
            3.9178,
            6.5724
          ]
        },
        {
          "block_id": "p46_line_25",
          "block_type": "paragraph",
          "text": "Observation Excluded",
          "bbox": [
            4.2263,
            6.4036,
            5.7979,
            6.5667
          ]
        },
        {
          "block_id": "p46_line_26",
          "block_type": "paragraph",
          "text": "Reason(s)",
          "bbox": [
            6.1943,
            6.4131,
            6.8859,
            6.566
          ]
        },
        {
          "block_id": "p46_line_27",
          "block_type": "paragraph",
          "text": "Placebo",
          "bbox": [
            0.9766,
            6.898,
            1.5275,
            7.0539
          ]
        },
        {
          "block_id": "p46_line_28",
          "block_type": "paragraph",
          "text": "(Repeat for other centres)",
          "bbox": [
            0.9814,
            7.9478,
            2.7323,
            8.1251
          ]
        },
        {
          "block_id": "p46_line_29",
          "block_type": "paragraph",
          "text": "Reference Tables",
          "bbox": [
            0.9744,
            8.5656,
            2.1975,
            8.7226
          ]
        },
        {
          "block_id": "p46_line_30",
          "block_type": "paragraph",
          "text": "Summary :_",
          "bbox": [
            0.9777,
            8.8798,
            1.775,
            9.0477
          ]
        },
        {
          "block_id": "p46_line_31",
          "block_type": "paragraph",
          "text": "38",
          "bbox": [
            3.9473,
            10.9472,
            4.1234,
            11.0852
          ]
        },
        {
          "block_id": "table_13",
          "block_type": "table",
          "page_number": 46,
          "bbox": [
            0.9398,
            3.4937,
            6.946,
            7.0476
          ],
          "headers": [
            "Treatment",
            "Patient #",
            "Sex",
            "Age",
            "Last Visit",
            "Duration",
            "Dose",
            "Concomitant_ Medication",
            "Reason for_ Discontin."
          ],
          "rows": [
            [
              "Treatment",
              "Patient #",
              "Sex",
              "Age",
              "Observation Excluded",
              "Reason(s)"
            ],
            [
              "Test Drug/Investigational Product",
              "",
              "",
              "",
              "",
              ""
            ],
            [
              "Treatment",
              "Patient #",
              "Sex",
              "Age",
              "Observation Excluded",
              "Reason(s)"
            ],
            [
              "Active Drug/Comparator",
              "",
              "",
              "",
              "",
              ""
            ],
            [
              "Treatment",
              "Patient #",
              "Sex",
              "Age",
              "Observation Excluded",
              "Reason(s)"
            ],
            [
              "Placebo",
              "",
              "",
              "",
              "",
              ""
            ]
          ]
        }
      ]
    },
    {
      "page_number": 47,
      "width": 8.2639,
      "height": 11.6944,
      "unit": "inch",
      "blocks": [
        {
          "block_id": "p47_line_0",
          "block_type": "paragraph",
          "text": "Structure and Content of Clinical Study Reports",
          "bbox": [
            4.1875,
            0.7195,
            7.2871,
            0.886
          ]
        },
        {
          "block_id": "p47_line_1",
          "block_type": "paragraph",
          "text": "ANNEX VII",
          "bbox": [
            6.3701,
            1.0555,
            7.2975,
            1.2048
          ]
        },
        {
          "block_id": "p47_line_2",
          "block_type": "paragraph",
          "text": "STUDY #",
          "bbox": [
            3.8378,
            1.5887,
            4.6172,
            1.7587
          ]
        },
        {
          "block_id": "p47_line_3",
          "block_type": "paragraph",
          "text": "(Data Set Identification)",
          "bbox": [
            3.2591,
            1.8273,
            5.1959,
            2.003
          ]
        },
        {
          "block_id": "p47_line_4",
          "block_type": "paragraph",
          "text": "NUMBER OF PATIENTS EXCLUDED FROM EFFICACY ANALYSIS",
          "bbox": [
            1.4839,
            2.456,
            6.9656,
            2.6534
          ]
        },
        {
          "block_id": "p47_line_5",
          "block_type": "paragraph",
          "text": "Test Drug/Investigational Product",
          "bbox": [
            1.1686,
            3.2924,
            3.911,
            3.4762
          ]
        },
        {
          "block_id": "p47_line_6",
          "block_type": "paragraph",
          "text": "N =",
          "bbox": [
            4.3849,
            3.2951,
            4.672,
            3.4527
          ]
        },
        {
          "block_id": "p47_line_7",
          "block_type": "paragraph",
          "text": "Reason",
          "bbox": [
            1.3956,
            3.9197,
            1.9918,
            4.0762
          ]
        },
        {
          "block_id": "p47_line_8",
          "block_type": "paragraph",
          "text": "1",
          "bbox": [
            3.1777,
            3.929,
            3.2595,
            4.061
          ]
        },
        {
          "block_id": "p47_line_9",
          "block_type": "paragraph",
          "text": "Week",
          "bbox": [
            4.9121,
            3.6047,
            5.3587,
            3.7628
          ]
        },
        {
          "block_id": "p47_line_10",
          "block_type": "paragraph",
          "text": "2",
          "bbox": [
            4.4531,
            3.9234,
            4.5441,
            4.062
          ]
        },
        {
          "block_id": "p47_line_11",
          "block_type": "paragraph",
          "text": "4",
          "bbox": [
            5.7323,
            3.9303,
            5.824,
            4.0638
          ]
        },
        {
          "block_id": "p47_line_12",
          "block_type": "paragraph",
          "text": "8",
          "bbox": [
            7.0121,
            3.9243,
            7.105,
            4.0635
          ]
        },
        {
          "block_id": "p47_line_13",
          "block_type": "paragraph",
          "text": "Total",
          "bbox": [
            1.1721,
            6.778,
            1.6041,
            6.9318
          ]
        },
        {
          "block_id": "p47_line_14",
          "block_type": "paragraph",
          "text": "Similar tables should be prepared for the other treatment groups.",
          "bbox": [
            1.1704,
            7.5789,
            5.6528,
            7.7714
          ]
        },
        {
          "block_id": "p47_line_15",
          "block_type": "paragraph",
          "text": "39",
          "bbox": [
            4.1427,
            10.948,
            4.3139,
            11.0864
          ]
        },
        {
          "block_id": "table_14",
          "block_type": "table",
          "page_number": 47,
          "bbox": [
            1.0677,
            3.5371,
            7.6431,
            7.0481
          ],
          "headers": [
            "Treatment",
            "Patient #",
            "Sex",
            "Age",
            "Last Visit",
            "Duration",
            "Dose",
            "Concomitant_ Medication",
            "Reason for_ Discontin."
          ],
          "rows": [
            [
              "Reason",
              "1",
              "Week",
              ""
            ],
            [
              "",
              "",
              "2 4",
              "8"
            ],
            [
              "",
              "",
              "",
              ""
            ],
            [
              "",
              "",
              "",
              ""
            ],
            [
              "",
              "",
              "",
              ""
            ],
            [
              "",
              "",
              "",
              ""
            ],
            [
              "",
              "",
              "",
              ""
            ],
            [
              "",
              "",
              "",
              ""
            ],
            [
              "",
              "",
              "",
              ""
            ],
            [
              "Total",
              "",
              "",
              ""
            ]
          ]
        }
      ]
    },
    {
      "page_number": 48,
      "width": 8.2639,
      "height": 11.6944,
      "unit": "inch",
      "blocks": [
        {
          "block_id": "p48_line_0",
          "block_type": "paragraph",
          "text": "Structure and Content of Clinical Study Reports",
          "bbox": [
            0.9738,
            0.7138,
            4.0776,
            0.8861
          ]
        },
        {
          "block_id": "p48_line_1",
          "block_type": "paragraph",
          "text": "ANNEX VIII",
          "bbox": [
            6.0999,
            1.0522,
            7.0988,
            1.2056
          ]
        },
        {
          "block_id": "p48_line_2",
          "block_type": "paragraph",
          "text": "GUIDANCE FOR SECTION 11.4.2 - STATISTICAL/ANALYTICAL ISSUES AND",
          "bbox": [
            0.977,
            1.5431,
            6.498,
            1.7282
          ]
        },
        {
          "block_id": "p48_line_3",
          "block_type": "paragraph",
          "text": "APPENDIX 16.1.9",
          "bbox": [
            0.9707,
            1.7506,
            2.3006,
            1.9212
          ]
        },
        {
          "block_id": "p48_line_4",
          "block_type": "paragraph",
          "text": "A. Statistical Considerations",
          "bbox": [
            0.9851,
            2.0648,
            3.4459,
            2.2413
          ]
        },
        {
          "block_id": "p48_line_5",
          "block_type": "paragraph",
          "text": "Details of the statistical analysis performed on each primary efficacy variable",
          "bbox": [
            1.3601,
            2.2865,
            7.0908,
            2.4718
          ]
        },
        {
          "block_id": "p48_line_6",
          "block_type": "paragraph",
          "text": "should be presented in an appendix. Details reported should include at least the",
          "bbox": [
            1.365,
            2.475,
            7.0956,
            2.6609
          ]
        },
        {
          "block_id": "p48_line_7",
          "block_type": "paragraph",
          "text": "following information:",
          "bbox": [
            1.3615,
            2.6593,
            2.9438,
            2.838
          ]
        },
        {
          "block_id": "p48_line_8",
          "block_type": "paragraph",
          "text": "a) The statistical model underlying the analysis. This should be presented",
          "bbox": [
            1.3694,
            2.9638,
            7.0929,
            3.152
          ]
        },
        {
          "block_id": "p48_line_9",
          "block_type": "paragraph",
          "text": "precisely and completely, using references if necessary.",
          "bbox": [
            1.6086,
            3.152,
            5.5142,
            3.341
          ]
        },
        {
          "block_id": "p48_line_10",
          "block_type": "paragraph",
          "text": "b) A statement of the clinical claim tested in precise statistical terms, e.g., in",
          "bbox": [
            1.3636,
            3.4547,
            7.0949,
            3.6452
          ]
        },
        {
          "block_id": "p48_line_11",
          "block_type": "paragraph",
          "text": "terms of null and alternative hypotheses.",
          "bbox": [
            1.6105,
            3.6401,
            4.5368,
            3.8232
          ]
        },
        {
          "block_id": "p48_line_12",
          "block_type": "paragraph",
          "text": "c) The statistical methods applied to estimate effects, construct confidence",
          "bbox": [
            1.3728,
            3.95,
            7.0896,
            4.1309
          ]
        },
        {
          "block_id": "p48_line_13",
          "block_type": "paragraph",
          "text": "intervals etc. Literature references should be included where appropriate.",
          "bbox": [
            1.6105,
            4.1285,
            6.9693,
            4.3183
          ]
        },
        {
          "block_id": "p48_line_14",
          "block_type": "paragraph",
          "text": "d) The assumptions underlying the statistical methods. It should be shown,",
          "bbox": [
            1.3746,
            4.4348,
            7.0815,
            4.6281
          ]
        },
        {
          "block_id": "p48_line_15",
          "block_type": "paragraph",
          "text": "insofar as statistically reasonable, that the data satisfy crucial assumptions,",
          "bbox": [
            1.6088,
            4.6196,
            7.0839,
            4.8123
          ]
        },
        {
          "block_id": "p48_line_16",
          "block_type": "paragraph",
          "text": "especially when necessary to confirm the validity of an inference. When",
          "bbox": [
            1.6176,
            4.8023,
            7.093,
            4.9964
          ]
        },
        {
          "block_id": "p48_line_17",
          "block_type": "paragraph",
          "text": "extensive statistical analyses have been performed by the applicant, it is",
          "bbox": [
            1.618,
            4.987,
            7.0917,
            5.1747
          ]
        },
        {
          "block_id": "p48_line_18",
          "block_type": "paragraph",
          "text": "essential to consider the extent to which the analyses were planned prior to",
          "bbox": [
            1.6181,
            5.1714,
            7.0907,
            5.3563
          ]
        },
        {
          "block_id": "p48_line_19",
          "block_type": "paragraph",
          "text": "the availability of data and, if they were not, how bias was avoided in",
          "bbox": [
            1.6149,
            5.3527,
            7.091,
            5.5389
          ]
        },
        {
          "block_id": "p48_line_20",
          "block_type": "paragraph",
          "text": "choosing the particular analysis used as a basis for conclusions. This is",
          "bbox": [
            1.6162,
            5.5354,
            7.0919,
            5.7296
          ]
        },
        {
          "block_id": "p48_line_21",
          "block_type": "paragraph",
          "text": "particularly important in the case of any subgroup analyses, because if such",
          "bbox": [
            1.6133,
            5.7222,
            7.089,
            5.9172
          ]
        },
        {
          "block_id": "p48_line_22",
          "block_type": "paragraph",
          "text": "analyses are not preplanned they will ordinarily not provide an adequate",
          "bbox": [
            1.6165,
            5.9081,
            7.0924,
            6.0985
          ]
        },
        {
          "block_id": "p48_line_23",
          "block_type": "paragraph",
          "text": "basis for definitive conclusions.",
          "bbox": [
            1.6072,
            6.09,
            3.829,
            6.2687
          ]
        },
        {
          "block_id": "p48_line_24",
          "block_type": "paragraph",
          "text": "(i) In the event data transformation was performed, a rationale for the choice",
          "bbox": [
            1.5766,
            6.3969,
            7.0914,
            6.5836
          ]
        },
        {
          "block_id": "p48_line_25",
          "block_type": "paragraph",
          "text": "of data transformation along with interpretation of the estimates of",
          "bbox": [
            1.8089,
            6.581,
            7.1055,
            6.7666
          ]
        },
        {
          "block_id": "p48_line_26",
          "block_type": "paragraph",
          "text": "treatment effects based on transformed data should be provided.",
          "bbox": [
            1.8076,
            6.7636,
            6.3744,
            6.9468
          ]
        },
        {
          "block_id": "p48_line_27",
          "block_type": "paragraph",
          "text": "(ii) A discussion of the appropriateness of the choice of statistical procedure",
          "bbox": [
            1.5754,
            7.0274,
            7.0913,
            7.2177
          ]
        },
        {
          "block_id": "p48_line_28",
          "block_type": "paragraph",
          "text": "and the validity of statistical conclusions will guide the regulatory",
          "bbox": [
            1.8104,
            7.2122,
            7.0914,
            7.4034
          ]
        },
        {
          "block_id": "p48_line_29",
          "block_type": "paragraph",
          "text": "authority's statistical reviewer in determining whether reanalysis of data",
          "bbox": [
            1.8101,
            7.397,
            7.0878,
            7.5858
          ]
        },
        {
          "block_id": "p48_line_30",
          "block_type": "paragraph",
          "text": "is needed.",
          "bbox": [
            1.8036,
            7.5857,
            2.5221,
            7.7497
          ]
        },
        {
          "block_id": "p48_line_31",
          "block_type": "paragraph",
          "text": "e) The test statistic, the sampling distribution of the test statistic under the",
          "bbox": [
            1.3722,
            7.8481,
            7.0916,
            8.0316
          ]
        },
        {
          "block_id": "p48_line_32",
          "block_type": "paragraph",
          "text": "null hypothesis, the value of the test statistic, significance level (i.e., p-",
          "bbox": [
            1.6089,
            8.0295,
            7.0846,
            8.216
          ]
        },
        {
          "block_id": "p48_line_33",
          "block_type": "paragraph",
          "text": "value), and intermediate summary data, in a format that enables the",
          "bbox": [
            1.613,
            8.2123,
            7.0896,
            8.3996
          ]
        },
        {
          "block_id": "p48_line_34",
          "block_type": "paragraph",
          "text": "regulatory authority's statistical reviewer to verify the results of the analysis",
          "bbox": [
            1.6091,
            8.3962,
            7.0903,
            8.5824
          ]
        },
        {
          "block_id": "p48_line_35",
          "block_type": "paragraph",
          "text": "quickly and easily. The p-values should be designated as one- or two-tailed.",
          "bbox": [
            1.6171,
            8.5782,
            7.0839,
            8.7644
          ]
        },
        {
          "block_id": "p48_line_36",
          "block_type": "paragraph",
          "text": "The rationale for using a one-tailed test should be provided.",
          "bbox": [
            1.6156,
            8.7632,
            5.8404,
            8.9449
          ]
        },
        {
          "block_id": "p48_line_37",
          "block_type": "paragraph",
          "text": "For example, the documentation of a two-sample t-test should consist of the",
          "bbox": [
            1.6115,
            9.0667,
            7.0905,
            9.2505
          ]
        },
        {
          "block_id": "p48_line_38",
          "block_type": "paragraph",
          "text": "value of the t-statistic, the associated degrees of freedom, the p-value, the",
          "bbox": [
            1.6125,
            9.2529,
            7.093,
            9.4332
          ]
        },
        {
          "block_id": "p48_line_39",
          "block_type": "paragraph",
          "text": "two sample sizes, mean and variance for each of the samples, and the pooled",
          "bbox": [
            1.6108,
            9.44,
            7.0935,
            9.6261
          ]
        },
        {
          "block_id": "p48_line_40",
          "block_type": "paragraph",
          "text": "estimate of variance. The documentation of multi-centre studies analysed by",
          "bbox": [
            1.6155,
            9.6216,
            7.0969,
            9.8061
          ]
        },
        {
          "block_id": "p48_line_41",
          "block_type": "paragraph",
          "text": "analysis of variance techniques should include, at a minimum, an analysis of",
          "bbox": [
            1.6147,
            9.8088,
            7.1032,
            9.9901
          ]
        },
        {
          "block_id": "p48_line_42",
          "block_type": "paragraph",
          "text": "variance table with terms for centres, treatments, their interaction, error,",
          "bbox": [
            1.611,
            9.9928,
            7.0839,
            10.1733
          ]
        },
        {
          "block_id": "p48_line_43",
          "block_type": "paragraph",
          "text": "and total. For crossover designs, the documentation should include",
          "bbox": [
            1.616,
            10.1744,
            7.0899,
            10.3495
          ]
        },
        {
          "block_id": "p48_line_44",
          "block_type": "paragraph",
          "text": "information regarding sequences, patients within sequences, baselines at the",
          "bbox": [
            1.6081,
            10.3602,
            7.0892,
            10.5374
          ]
        },
        {
          "block_id": "p48_line_45",
          "block_type": "paragraph",
          "text": "40",
          "bbox": [
            3.9436,
            10.9486,
            4.119,
            11.0855
          ]
        }
      ]
    },
    {
      "page_number": 49,
      "width": 8.2639,
      "height": 11.6944,
      "unit": "inch",
      "blocks": [
        {
          "block_id": "p49_line_0",
          "block_type": "paragraph",
          "text": "Structure and Content of Clinical Study Reports",
          "bbox": [
            4.1827,
            0.7138,
            7.2883,
            0.8884
          ]
        },
        {
          "block_id": "p49_line_1",
          "block_type": "paragraph",
          "text": "start of each period, washouts and length of washouts, dropouts during each",
          "bbox": [
            1.8084,
            1.0507,
            7.2877,
            1.2306
          ]
        },
        {
          "block_id": "p49_line_2",
          "block_type": "paragraph",
          "text": "period, treatments, periods, treatment by period interaction, error, and total.",
          "bbox": [
            1.8053,
            1.2391,
            7.2796,
            1.4189
          ]
        },
        {
          "block_id": "p49_line_3",
          "block_type": "paragraph",
          "text": "For each source of variation, aside from the total, the table should contain",
          "bbox": [
            1.8091,
            1.4222,
            7.2894,
            1.6005
          ]
        },
        {
          "block_id": "p49_line_4",
          "block_type": "paragraph",
          "text": "the degrees of freedom, the sum of squares, the mean square, the",
          "bbox": [
            1.8094,
            1.6062,
            7.2905,
            1.7867
          ]
        },
        {
          "block_id": "p49_line_5",
          "block_type": "paragraph",
          "text": "appropriate F-test, the p-value, and the expected mean square.",
          "bbox": [
            1.8095,
            1.7891,
            6.2669,
            1.974
          ]
        },
        {
          "block_id": "p49_line_6",
          "block_type": "paragraph",
          "text": "Intermediate summary data should display the demographic data and",
          "bbox": [
            1.8065,
            2.0899,
            7.2926,
            2.2784
          ]
        },
        {
          "block_id": "p49_line_7",
          "block_type": "paragraph",
          "text": "response data, averaged or otherwise summarised, for each centre-by-",
          "bbox": [
            1.8052,
            2.2801,
            7.2832,
            2.4604
          ]
        },
        {
          "block_id": "p49_line_8",
          "block_type": "paragraph",
          "text": "treatment combination (or other design characteristic such as sequence) at",
          "bbox": [
            1.808,
            2.4611,
            7.2919,
            2.6459
          ]
        },
        {
          "block_id": "p49_line_9",
          "block_type": "paragraph",
          "text": "each observation time.",
          "bbox": [
            1.8083,
            2.6518,
            3.4111,
            2.8162
          ]
        },
        {
          "block_id": "p49_line_10",
          "block_type": "paragraph",
          "text": "B. Format and Specifications for Submission of Data Requested by",
          "bbox": [
            1.1724,
            3.0265,
            7.2822,
            3.2268
          ]
        },
        {
          "block_id": "p49_line_11",
          "block_type": "paragraph",
          "text": "Regulatory Authority's Statistical Reviewers",
          "bbox": [
            1.5624,
            3.2191,
            5.1319,
            3.4025
          ]
        },
        {
          "block_id": "p49_line_12",
          "block_type": "paragraph",
          "text": "In the report of each controlled clinical study, there should be data listings",
          "bbox": [
            1.5607,
            3.4375,
            7.2904,
            3.6273
          ]
        },
        {
          "block_id": "p49_line_13",
          "block_type": "paragraph",
          "text": "(tabulations) of patient data utilised by the sponsor for statistical analyses and",
          "bbox": [
            1.5713,
            3.6246,
            7.2927,
            3.8104
          ]
        },
        {
          "block_id": "p49_line_14",
          "block_type": "paragraph",
          "text": "tables supporting conclusions and major findings. These data listings are",
          "bbox": [
            1.5615,
            3.8087,
            7.29,
            3.9946
          ]
        },
        {
          "block_id": "p49_line_15",
          "block_type": "paragraph",
          "text": "necessary for the regulatory authority's statistical review, and the sponsor may",
          "bbox": [
            1.5599,
            3.9985,
            7.2867,
            4.1845
          ]
        },
        {
          "block_id": "p49_line_16",
          "block_type": "paragraph",
          "text": "be asked to supply these patient data listings in a computer-readable form.",
          "bbox": [
            1.5551,
            4.178,
            6.8635,
            4.3663
          ]
        },
        {
          "block_id": "p49_line_17",
          "block_type": "paragraph",
          "text": "41",
          "bbox": [
            4.1406,
            10.9485,
            4.3085,
            11.0816
          ]
        }
      ]
    }
  ]
}